1 Ribozymes An Introduction Helen A. James and Philip C. Turner 1. Introduction One of the more important new insights in the field of molecular biology in the past 15 years was the discovery that RNA molecules, once thought to be primarily passive carriers of genetic information, can carry out some functions previously ascribed to proteins. Some RNAs are capable of acting as enzymes even in the complete absence of proteins. The reactions observed include cleavmg themselves or other RNA molecules, ligation, and trans-splicing. Other new biochemical activities are being developed using in vitro selection protocols. The rapid identificatton of features that allow these catalytic RNA molecules, or ribozymes, to carry out their specific reactions has led to the realization that ribozymes can easily be manipulated to act on novel substrates. These custom-designed RNAs have great potential as therapeutic agents and are becommg a powerful tool for molecular biologrsts. This book is a fairly comprehensive collection of contributions aimed at giving practical advice to anyone wanting to design and use ribozymes. It covers the selection of target sites (Chapters 2-6), the synthesis and production of ribozymes in vitro and in viva (Chapters 7-20), reaction parameters, kinetics, product detection, and optimization (Chapters 21-36), methods for analyzing ribozyme structure (Chapters 37-41), and delivery methods and some examples of current applications (Chapters 42-49). This chapter provides a brief introduction to ribozymes, which we hope will be useful to those wishing to use the various protocols in subsequent chapters. From
Methods m Molecular Edlted by P C Turner
Biology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
2
James and Turner
1.1. RNA Cata/ysis A rtbozyme is an RNA molecule that can break and/or form covalent bonds (I). It greatly accelerates the rate of the reaction, and shows extraordinary specificity with respect to the substrates it acts on and the products it produces. RNA catalysis has been demonstrated in members of the group I and II introns, the genomes of viroids, virusoids, and satellite RNAs of a number of vu-uses, and m the prokaryotic pre-tRNA processing machinery. In several other cellular processes involving ribonucleoproteins (RNPs), it has been proposed that an RNA component may be acting as a ribozyme, e.g., rRNA in translation, U6 snRNA in the spliceosome, snoRNAs in rRNA processing, and guide RNAs in RNA editing. 1.2. Self-Cleaving RNAs One category of intramolecular RNA catalysis is that which produces 2’,3’-cyclic phosphate and 5’-OH termim on the reaction products. A number of small plant pathogenic RNAs (viroids, satellite RNAs, and virusoids), a transcript from a Neurospora mitochondrial DNA plasmid, and the animal virus hepatms delta virus (HDV) undergo a self-cleavage reaction in vitro m the absence of protein. The reactions require neutral pH and Mg2’ (2,3). In the case of the pathogenic RNAs, it is thought that the self-cleavage reaction IS an integral part of their in viva rolling circle mechanism of replicatton (4). These self-cleaving RNAs can be subdivided mto groups depending on the sequence and secondary structure formed about the cleavage site. 7.2.1, Hammerhead Ribozymes This group of RNAs share a two-dimensional structural motif known as the “hammerhead” which has been shown to be sufficient to direct site-specific cleavage (although the three-dtmenstonal structure recently elucidated 1.51suggests that the ribozyme should be renamed “wishbone”). The hammerhead structure consists of three base-paired stems (helices I, II, and III), which flank the susceptible phosphodtester bond, and two single-stranded regions, which are highly conserved m sequence (3,6). Extensive mutagenesis has revealed the important nucleotides and functional groups for efficient catalysis. The hammerhead cleavage domain has been split mto two (6) or three (7) independent RNAs, and trans-cleavage has been demonstrated in vitro. Haseloff and Gerlach (8) proposed a model (see Fig. 1) whereby the hammerhead domam 1sseparated such that the substrate RNA contains just the cleavage site, and the ribozyme contains the other conserved nucleotides of the catalytic core. Mutagenesis has revealed that the target site can be any NUH sequence where H = A, C, or U (IUB system) and N is any nucleotide (8,9). However, identifying a suitable target site 1ssubject to a number of other variables, none
3
Introduction to Ribozymes
Substrate
5’
I&.)1.7 + I, ,2 NNNNNNNNNU8-NNNNNNNNNN3’ 11111111 I I I I I I I NNNNNN,$& JjgNNNNNN 3’ 1424 csu ,,A “c, 12G A As X-G,: !’ UT Ribozyme
I
5’
g-E G-C A
G GU
Fig. 1. The hammerhead ribozyme. Shaded sequences are conserved, and the arrow indicates the bond cleaved. Numbering is that of Hertel et al. (36).
of which can be easily overcome (see Chapters 2-6). The sequence of the arms of the rtbozyme aligns the catalytic core to the target site via complementary base pairing. Analysis has also allowed determination of the mimmum core sequence required for catalytic activity. This has resulted m the “mmrzyme” of McCall et al. (ZO) described in Chapter 17. Haseloff and Gerlach’s model has allowed the design of specrtic endoribonucleases. They tested this by designing three ribozymes against the mRNA for chloramphemcol acetyl transferase (CAT), all of which cleaved in vitro. This work encouraged others to design trans-acting rrbozymes. The ability to cleave the RNA and thereby inhibit the expression of a specific gene selec-
tively has two main applications: as a tool for molecular biology (in vitro manipulation
of RNAs)
and the inactivation
of gene transcripts
in VIVO, as
antiviral agents, for example. The use of ribozymes for both applications has become possible with the development of chemical synthesis of RNA, with or without modtfied nucleosides and links (see Chapters 7 and 8) and the identification of suitable expression vectors (see Chapter 42).
1.2.2. Hairpin Ribozyme A second small catalytic domain is the “hairpin” structure (see Fig. 1 m Chapters 18 and 19), which has four helical domains and five loops (I I, 12). Two helices of the hanpin domain form between the substrate and rtbozyme, and this allows the design and specificrty of binding for trans-acting hairpin
4
James and Turner
ribozymes. The hairpin ribozyme has a more complicated substrate requirement than the hammerhead ribozyme, but despite this, any RNA of interest is expected to have numerous potential target sites. The design and uses of hairpin ribozymes are discussed further m Chapters 18, 19,23, 37, and 48. 1.2.3. Hepatitis Delta Virus HDV genomic and antigenomic RNAs contam a self-cleavage site hypothesized to function during rolling circle replication (13). Like the plant pathogens, the sites m HDV are postulated to have a related secondary structure, three models of which have been proposed: cloverleaf (13); pseudoknot (14), and axehead (15), none of which is similar to the catalytic domains previously described Like the other ribozyme motifs, the HDV ribozymes require a divalent cation (131, and cleavage results m products with 2’,3’-cychc phosphate and S-OH termim (IS). Investigations of truns-cleavage with the HDV ribozyme are not so advanced, and consequently, the use of the HDV ribozyme m trans is not covered in this book, although it has been used in czsin Chapter 38. 7.2.4. Neurospora Mitochondrial
VS RNA
The Neurosporu mitochondrial VS RNA, a single-stranded circular RNA of 88 1nt, sharessome features of the self-catalytic RNAs of HDV, group I mtrons, and some plant vu-al satellite RNAs (16). Although VS RNA can be drawn to have a secondary structure like group I mtrons, it is missmg essential basepairing regions, the cleavage site is m a different position, and the termini produced are 2’,3’-cyclic phosphate and 5’-OH. Like hammerhead ribozymes, VS RNA requires divalent cations for cleavage in vitro. The catalytic core of Neurosporu VS RNA has been shown to consist of 154 nt (17). 1.3. Self-Splicing RNAs A second group of catalytic RNAs are those that produce S-phosphate and 3’-OH termini on the reaction products. 1.3.7. Group I In trons Group I intron self-splicing (in vitro) in the absence of protein was first observed for the intervening sequence (IVS, intron) of the nuclear 26s rRNA gene in Tetrahymena thermophila (1). Splicing proceeds by two consecutive trans-esterification reactions (18). The reaction (see Fig. 2A) is initiated by a nucleophilic attack by the 3’-hydroxyl of a guanosme (or a phosphorylated derivative: GMP, GDP, or GTP) at the phosphodiester bond between the 5’-exon and the intron (5’-splice site). The new 3’-hydroxyl group of the 5’-exon then initiates a second nucleophilic attack,
5
introduction to Ribozymes
A
5’ exon
G
CUpA
PU-
3’exon
1c GOH 1
1
Intermediate -CuO
H
GpU -
__)
UGpA / U O---MA
-C
H
Ligated exons
ucgu
+ GpA- WUpA 4 HOG
-
CpA+
Intron Lariat intron
UGDA ‘1 UOH
1
circnlar intron
Fig. 2. Self-splicing of group I and group II introns. (A) Group I introns: splicing of the Tetrahymena pre-rRNA IVS and cyclization of the excised IVS. (B) Group II introns with the formation of a lariat.
this time on the phosphodiester bond between the 3’-exon and the intron (the 3’-splice site). This results in ligation of the exons and excision of the intron. Self-splicing is, by definition, an intramolecular event, and the intron is therefore not acting as a true enzyme. However, the catalytic activity found
6
James and Turner
within the conserved core can be dissociated mto dtstmct active enzyme and substrate molecules. Shortened verstons of the Tetrahymena IVS (L- 19 IVS and L-2 1 &a1 IVS) have been shown to be true enzymes m vitro, for example, as a restriction endoribonuclease (19) and as a template-dependent polymerase (20). Despite all the evidence for self-spltcing m vitro, it is clear that splicing m vivo requires protein factors. Even the Tetrahymena IVS, which at low levels of Mg2+ splices efficiently m vitro, is splicing at a rate of about 50-fold less than the level estimated for splicing in vivo (1). 1.3.2. Group II lntrons It has also been demonstrated that some members of the group II introns can self-splice m vitro. The urnmolecular reaction was shown to be Mg2+-dependent, require spermidine, have a temperature optimum of 45OC,have a requirement for ribonucleotides or monovalent cations as cofactors, and have a pH optimum of between 6.5 and 8.5 (ZZ). Group II mtrons splice by way of two successive phosphate transfer reactions (see Fig. 2B). In the first step, the 2’-OH group of an intramolecular branchpoint adenosine attacks the phosphodiester bond at the 5’-splice site (creating a 2’,5’ bond), producing the free 5’-exon and a sphcmg intermediate, the mtron-3’-exon. The second step involves cleavage at the 3’-splice site by the 3’-OH of the 5’-exon. Simultaneously, the exons are ligated and the intron lariat, with a 2’,5’-phosphodiester bond, is released. The ability of the group II introns to bmd the 5’-exon spectfically has been exploited to encourage the IVS to catalyze reactions on exogenous substrates. Investigations have now shown, as well as a reversal of splicing (22), a group II intron can ligate ssDNA to RNA, and another cleave an ssDNA substrate, 1.4. Ribonuclease P Ribonuclease P (RNase P) is the ubiquitous endoribonuclease that processesthe 5’-end of precursor tRNA molecules (23). It cleaves specific bonds to produce 5’-phosphate and 3’-OH termini, and in vitro requires adtvalent metal ton. RNase P consistsof a protein moiety and an RNA moiety. It was dtscovered that, at least m bacteria, tt is the RNA moiety that is the catalyst (24) and, as such, ts the only rtbozyme that is a true enzyme:it catalyzesan intermolecular reaction, 1sunaltered by the event, follows Michaelis-Menten kinetics, and is stable.Several studieshave now shown that RNase P can be tricked into cleaving any desired substrate (25), and Chapter 20 details the design and preparatton of RNase P ribozymes. 1.5. Ribozyme Delivery Whatever type of ribozyme is chosen, it must be introduced mto its target cell. Two general mechanismsexist for introducing catalytic RNA molecules into cells:
Introduction to Ribozymes
7
(1) exogenousdelivery of the preformed ribozyme (seeChapters44 and 46) and (2) endogenousexpressionfrom a transcriptional umt (seeChapters42-45,47, and 48). Preformed ribozymes can be delivered mto cells using hposomes (26), electroporation, or microinlection. Efforts have been made to overcome the lack of stability of introduced RNAs by using modified nucleottdes, 2’-fluoroand 2’-ammo- (271, or 2’-Gallyl- and 2’-O-methyl- (28), mixed DNA/RNA molecules (29), or by the addition of termmal sequences (such as the bacteriophage T7 transcriptional terminator) at the 3’-end of the RNA to protect against cellular nucleases (30). Endogenous expression has been achieved by inserting ribozyme sequences into the untranslated regions of genes transcribed by RNA polymerase II (pol II), which have strong promoters, such as the SV40 early promoter (32), the actin gene (32), or a retrovrral long terminal repeat (LTR) (33). Ribozymes have also been inserted into the anticodon loop of tRNA (transcribed by RNA polymerase III) and shown to be functional in Xenopus oocytes (34) or in plant cells (35). References 1. Kruger, K , Grabowskl, P. J., Zaug, A J., Sands, J , Gottschlmg, D E , and Cech, T. R. (1982) Self-splicmg RNA. autoexctsion and autocyclization of the rtbosoma1 RNA intervening sequence of Tetrahymena. Cell 31, 147-157. 2 Hutchins, C J , RathJen, P. D., Forster, A. C., and Symons, R. H. (1986) Selfcleavage of plus and minus RNA transcripts of avocado sunblotch vtroid Nuclezc Acids Res. 14,3627-3640. 3. Forster, A C and Symons, R. H. (1987) Self-cleavage of plus and minus RNAs of a virusotd and a structural model for the active sites. Cell 49,2 1 l-220. 4. Branch, A. D. and Robertson, H D. (1984) A replication cycle for vnolds and other small mfectrous RNA’s Science 223,450-455 5. Pley, H. W., Flaherty, K. M., and Mckay, D. B. (1994) Three dimensional structure of a hammerhead rtbozyme. Nature 372,68-74. 6. Uhlenbeck, 0 C. (1987) A small catalytic oligoribonucleotide. Nature 328,59&600 7 Kotzumt, M , Iwat, S , and Ohtsuka, E (1988) Cleavage of specific sites of RNA by designed ribozymes. FEBS Lett 239,285-288. 8 Haseloff, J. and Gerlach, W. L. (1988) Sample RNA enzymes with new and hrghly specific endoribonuclease activities Nature 334,585-59 1 9. Perrtman, R., Deices, A., and Gerlach, W. L. (1992) Extended target-site spectficity for a hammerhead ribozyme. Gene 113, 157-l 63. 10 McCall, M J , Hendry, P , and Jennings, P A. (1992) Minimal sequence requirements for ribozyme activtty Proc Nat1 Acad Scl USA 89, 5710-57 14 11 Hampel, A. and Tritz, R. (1989) RNA catalytic properttes of the minimum (-) sTRSV sequence. Bzochemzstvy 28,4929-4933 12 Berzal-Herranz, A., Joseph, S , Chowrira, B. M., Butcher, S. E., and Burke, J. M (1993) Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme EMBO J 12,2567-2574
8
James and Turner
13 Wu, H.-N., Lin, Y.-J., Lin, F.-P., Makino, S., Chang, M.-F., and Lai, M. M. C. (1989) Human hepatitis 6 vu-us RNA subfragments contain an autocleavage activity. Proc. Nat1 Acad Scz USA 86, 183 1-1835 14. Perrotta, A. T. and Been, M D. (1990) The self-cleavmg domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant. Nucleic Acids Res 18,6821-6827. 15. Branch, A. D. and Robertson, H. D (1991) Efficient trans cleavage and a common structural motif for the rtbozymes of the human hepatitis 6 agent. Proc Natl Acad. Sci USA 88, 10,163-10,167. 16. Saville, B. J and Collins, R. A (1990) A site-specific self-cleavage reaction performed by a novel RNA in Neurospora mltochondria. Cell 61,685-696. 17. Guo, H. C. T., Abreu, D. M. D., Tilher, E. R. M , Savllle, B J., Olive, J E., and Collms, R A. (1993) Nucleotide sequence requirements for self-cleavage of Neurospora VS RNA. J Mol Bzol 232,35 1-361. 18. Zaug, A. J , Grabowski, P. J and Cech, T R. (1983) Autocatalytic cychzation of an excised intervening sequence RNA IS a cleavage-ligation reaction. Nature 301, 578-583. 19. Zaug, A. J., Been, M. D., and Cech, T. R. (1986) The Tetrahymena ribozyme acts hke an RNA restriction endonuclease. Nature 324,429-433 20. Kay, P. S. and Inoue, T. (1987) Catalysis of splicing-related reactions between dmucleotides by a ribozyme. Nature 327,343-346 21. Peebles, C. L., Perlman, P. S., Mecklenburg, K L , Petrillo, M L , Tabor, J H , Jarrell, K A , and Cheng, H -L (1986) A self-splicing RNA excises an mtron lariat. Cell 44,2 13-223. 22. Augustin, S., Muller, M W., and Schweyen, R. J (1990) Reverse self-spllcmg of group II mtron RNAs in vztro. Nature 343,383-386. 23. Darr, S. C., Brown, J. W., and Pace, N. R (1992) The varieties of ribonuclease P. TIBS 17,178-182. 24. Guerrier-Takada, C , Gardiner, K., Marsh, T., Pace, N., and Altman, S. (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. CelZ 35,849857 25. Forster, A. C. and Altman, S. (1990) External gutde sequences for an RNA enzyme. Science 249,783-786. 26. Sulhvan, S A (1993) Liposome-mediated uptake of ribozymes. Methods A Companzon to Methods zn Enzymol 5,61-66 27 Pieken, W A., Olsen, D. B., Benseler, F., Aurup, H., and Eckstem, F. (199 1) Kinetic characterization of ribonuclease-resistant 2’-modified hammerhead ribozymes Sczence 253,3 14-3 17 28 Paolella, G., Sproat, B. S., and Lamond, A. I. (1992) Nuclease resistant ribozymes with high catalytic activity. EMBO J 11, 19 13-l 9 19. 29. Snyder, D. S., Wu, Y., Wang, J. L., Rossi, J. J., Swlderski, P , Kaplan, B. E., and Forman, S. J. (1993) Ribozyme-mediated inhibition of bcr-abl gene expression m a Philadelphia chromosome-positive cell line. Blood 82,600-605 30. Sioud, M., Natvig, J. B., and Forre, 0. (1992) Preformed ribozyme destroys tumour necrosis factor mRNA in human cells. J MoZ Bzol 223,83 l-835
Introduction to Ribozymes
9
31 Cameron, F. H. and Jennings, P. A. (1989) Specific gene suppression by engineered ribozymes in monkey cells. Proc. Natl. Acad. Sci. USA 86,9139-9143. 32. Sarver, N., Cantm, E. M , Chang, P S , Zaia, J. A , Ladne, P. A , Stephens, D. A , and Rossi, J. J. (1990) Ribozymes as potential anti-HIV-l therapeutic agents. Science 247,1222-1225.
33. Kolzumi, M., Kamlya, H., and Ohtsuka, E. (1992) Rlbozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene. Gene 117, 179-184. 34. Cotten, M. and Bimstiel, M. L. (1989) Ribozyme mediated destruction of RNA zn vzvo. EMBO J 8,3861-3866.
35. Perrlman, R., Bruenmg, G. B., Dennis, E. S., and Peacock, W. J. (1995) Efficient ribozyme delivery to plant cells. Proc Nat1 Acad. Sci USA 92, 6175-6179 36 Hertel, K. J , Pardl, A , Uhlenbeck, 0. C , Koizumi, M , Ohtsuka, E., Uesugl, S., Cedergren, R., Eckstein, F., Gerlach, W. L., Hodgson, R., and Symons, R. H. (1992) Numbering system for the hammerhead. Nuclezc Acids Res. 20,3252.
2 Computer-Aided Calculation of the Local Folding Potential of Target RNA and Its Use for Ribozyme Design Georg Sczakiel and Martin Tabler 1. Introduction Ribozymes first bmd their target via complementary sequences like a conventional antisense strand and, subsequently, catalyze the hydrolyses of the cleavable motif. In the case of hammerhead ribozymes, this is a specific base triplet. Even though it has been described that there are 12 conceivable motifs recognized by hammerhead ribozymes that are cleaved with different efficiencies (1,2), a typical long-chain target RNA provides a large number of potential cleavage sites. Given this flexibility, one important step in ribozyme design is the selection of an appropriate cleavable motif within the target For ribozyme-mediated mhibition in living cells, the contribution of antisense effects and catalytic effects to the overall extent of inhibition remains unresolved, and may well be dependent on the specific constructs and biologtcal systems. However, it is reasonable to assume that the first step, the binding of the ribozyme with its target, is crucial. Therefore, the local target sequence against which a ribozyme is directed does not only have to contain a cleavable triplet, but should also be accessible for the rtbozyme. To monitor the local accessibility of a given RNA sequence, one can perform experimental analyses, such as nuclease mapping (see Chapter 5), chemical probing, or kinetic selection for effective annealing (3) (see Chapter 30). On the other hand, theoretical analyses and the use of computer algorithms can be performed with less expense, although at reduced reliability. Different assumptions have been made, and various attempts have been reported to understand the different effectiveness of related, but not identical antisense From
Methods Edlted by
m Molecular P C Turner
Brology, Humana
Vol 74 Rfbozyme Protocols Press Inc , Totowa, NJ
12
Sczakiel and Tabler
inhibitors and to increase the probability of selecting effective local target sequences by using computer programs (4,5) (see Chapter 3). Such programs are aimed at increasing the probabihty of applying antisense and ribozyme inhibitors more successfully than on a purely statistic basis. The algorithm described m the followmg can be used to calculate the extent of local folding of a given target sequence (see Note 1). For a certain stretch of bases (window), the program calculates the most stable structure, and plots the correspondmg value for the lowest possible free energy (AG) against the target sequence position. Subsequently, the window is shifted for the step width along the target sequence,and the next AG value is calculated thereby, scanning along the sequence to be analyzed. Local maxima correspond to relatively unstable local sequence stretches and indicate potential target regions for complementary RNA. The cleavable motif for hammerhead ribozymes should be chosen such that its antisense sequencesthat form helix I or helix III (see Note 2) are directed against a target region with a low folding potential. 2. Materials
2.1. Programs The program that calculates the local folding potential for a given nucleottde sequence is termed “foldsplit.” It is based on the GCG package (6) and is available as part of the Heidelberg Unix Sequence Analysis Resources (HUSAR) (7). On request, tt can be made available for external users of HUSAR as well as for those who hold a license for GCG programs (see Note 3).
2.2. Definitions Within the Program “Foldsplit” The principle of the “foldsplit” program is schematically depicted in Fig. 1. To run the program, one first defines two variable parameters, the step width and the window size. The window defines the length of the sequence stretch for which the structure with the lowest possible free energy (AG) 1scalculated (see Note 4). Note that it is the AG value that is used and not the particular structure. The distance along which this window is shd before the next AG value is calculated is defined by the step width (see Note 5). In the case of a step width that is smaller than the window, the given sequence is scanned by overlappmg windows. The folding potential for a given sequence is represented by the plot of the AG values vs the sequence position (Fig. 2). 3. Methods
3.7. Setting up and Running “Foldsplit” To run the program “foldsplit,” one first defines the wmdow and the step width. Usually the calculation of a set of window sizesis recommend, e.g., 50, 100,200, and 300 nt (see Note 6). The step width depends on the capacity of
Local Foldmg Potential of Target RNA
13
5’
step (
Fig. 1. Definition of the step width (here 2 nt) and the wmdow size (here 10 nt) for a gtven sequence. The AG values are calculated for sequences contained within a sequence stretch that is defined by the begmnmg (usually the first position of the sequence) and the step width (location), aswell as by the window size (length) For example, the AG value AG(3) corresponds to a sequence startmg at position +3 and ending at positron + 12 (10 nt in length).
AG (kcal/mole)
A’ 1
B’
length (nt) Fig. 2. Plot of the folding potential of the genomic RNA strand of the human immunodeficiency vnus type 1 (HIV-l) at a step width of 1 nt and a window size of 250 nt. A’ and B’ indicate local maxima of the folding potential. A and B indicate two minima of the folding potential that comcide with functional RNA structures, the TAR element (A) and the RRE element (B) of HIV- 1. the computer system. In principle,
the optimal parameter is 1 nt, but even plots of the folding potential that had been calculated with a step width of 10 nt unequivocally showed the existing peaks (5).
Sczakiel and Tabler 3.2. Interpretation of the Folding Potential It is important to remember that the folding potential represents the lowest possible free energy according to a given structure prediction algorithm. Assuming that the prediction algorithm is correct, one can conclude that the true values for AG are equal to or greater than the calculated ones.This has two imphcations. A local mimmum (see A and B in Fig. 2) Indicates that the sequence starting at this position and extending with the chosen window size has the potential to form a relatively stable structure. This does not necessarily mean that the corresponding low-energy structure is indeed formed m vitro or in VIVO.However, a more complex computer study that included a similar program to that used here was able to identify the functional RRE element of HIV- 1 (7), mdicating that the potential to form stable RNA structurescan have biological relevance Note that RNA domains that contam extensive palmdromes, long inverted repeats, or other extensively folded sequenceswith biological functions can also be identified by calculating the folding potential at a certam window size. Conversely, local maxima indicate sequence stretches that cannot form stable structures (see A’ and B’ m Fig. 2). Considermg that the existmg structures can even be of higher energy, but not of lower energy, such local sequences could represent suitable targets for complementary nucletc acids, such as chemically synthesized antisense oligonucleotides, endogenously expressed antisense RNA, and ribozymes. If one makes use of “foldspllt” to select target sequences for anttsense nucleic acids and ribozymes, it is recommended to calculate the folding potential for both strands. Local maxima occurring at complementary sequence positions of both strands indicate potentially effective targets as well as the corresponding complementary sequence (see Note 7) In prmciple, one should select the window size such that it corresponds to the length of the antisense sequence that is planned to be delivered. However, one should consider that local maxima of the folding potential can be broad and indicate the accessibility over a wide sequence stretch of the target strand. Further, the location of local maxima is not dependent on the chosen window size. Thus, there is no absolute requirement to fit exactly the size of the wmdow and the size of the ribozyme or antisense construct that one plans to use m btologtcal experiments. 4. Notes 1. The calculationof the localfolding potentialseemsto beparticularlysuitablefor longchainRNA, including long-chainhammerheadnbozymesthatarealsotermed“catalytic antisenseRNA.” CatalyticantisenseRNA is describedin detailin Chapter14 2 For long-chain hammerheadnbozymes,only one antisensearm (helix III-forming) IS sufficient for function provided that at leastthe inner three basepairs can
Local Folding Potential of Target RNA
3.
4.
5
6.
7.
15
be formed in the second one (helix I) The resultmg asymmetric hammerhead ribozymes (8) are described m detail m Chapter 16 External users of HUSAR as well as those who wish to obtain accessto HUSAR and “foldspht” should contact the following E-mail address:
[email protected] and ask for the service “GENIUSnet.” Those who wish to receive “foldspht” on request, need to own a license agreement for the GCG package. In prmciple, any program that calculates secondary or even partial tertiary RNA structure can be used to define the lowest possible AG value for a sequence stretch with a given length at a given sequence position. Ideally, the step width is 1 nt, which, however, costs the maximal computing time In the case of large window sizes, e.g., >lOO nt, it 1s not necessary to perform the algorithm for every sequence position rn order to draw a sigmficant plot, since the differences m AG values of neighboring and overlappmg windows are usually not as dramatic For almost all sequences for which the folding potential has been calculated so far, the locations of local minima and maxima were not dependent on the selected window size Surprtsmgly, the folding potentials for two complementary strands often correspond to each other, i.e., local maxima and local minima occur at complementary sequence positions of both strands.
References 1. Shimayama, T., Nishrkawa, S., and Taira, K. (1995) Generality of the NUX rule* kinetic analyses of the results of systematic mutations m the trmucleottde at the cleavage site of hammerhead ribozymes. Biochemistry 34,3649-3654 2. Zoumadakis, M. and Tabler, M (1995) Comparative analysis of cleavage rates after systematic permutation of the NUX$ consensus target motif for hammerhead ribozymes. Nucleic Aczds Res 23, 1192-l 196 3 Rittner, K , Burmester, C , and Sczakiel, G. (1993) In vztro selection of fast-hybridizing and effective antisense RNAs directed against the human unmunodeficiency vuus type 1 Nuclezc Aczds Res 21, 1381-1387. 4 Rhodes A. and James W J (1990) Inhibition of human mmmnodeficiency virus replication by endogenously synthesized antisense RNA. J Gen Vzrol 71, 1965-1974. 5 Sczakrel, G., Homann, M , and Rrttner, K. (1993) Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1 An&sense Res Dev 3,45-52. 6. Devereux, J , Haeberh, P , and Smithies, 0. (1984) A comprehensive set of sequence analysis programs for the VAX. Nucleic Aczds Res 12,387-395 7 Senger, M , Glatting, K -H , Ritter, 0 , and Suhai, S. (1995) X-HUSAR, an X-based graphical interface for the analysis of genomic sequences. Comput Programs Blamed. 46, 13 1-141 8. Tabler, M., Homann, M , Tzortzakai, S , and Sczakiel, G (1994) A three-nucleotide helix Its sufficient for full acttvtty of a hammerhead rtbozyme. advantages of an asymmetric design Nuclerc Acids Res 22, 3958-3965.
3 Computational Approaches to the Identification of Ribozyme Target Sites William James and Elizabeth Cowe 1. Introduction Artificial antisense RNAs and recombinant, trans-acting ribozymes have been developed whose abihty to inhibtt gene expresston varies from negligible to profound. Although we are only beginning to understand the underlying reasons for this extreme variation, we can identify a number of variables that might well be significant in the process, and some of these can be modeled computationally. It must be emphasized, however, that only well-designed and systematic experimentation will prove whether one or the other of these variables is of key significance in living cells. In order for an endogenously expressed antisense RNA or a trans-acting ribozyme to exert its inhibitory effect, we envisage the following stages m the process and propose factors that will influence their outcome. 1.1. Encounter
That is, the probabihty that each molecule of target mRNA will encounter the potentially mhibitory RNA before it becomestranslated into protein. This will be determined by a large number of factors,of which the following arethe most obvious: 1. Global abundance of the complementary RNA relative to the target mRNA This, m turn, might be affected by a. Positron effect: The chromosomal locus from which the two genes are being expressed b. Promoter/enhancer strength. c. Relative stability of the RNAs. 2 Colocalizatron of the mteractmg RNAs To take an extreme example, rrbosomal RNAs follow very constramed paths from the site of their transcription to the site of nbosome assembly. Consequently, the volume of nucleoplasm m which they might From
Methods m Molecular Edited by P C Turner
B/ology, Vol 74 R/bo.zyme Protocols Humana Press Inc , Totowa, NJ
17
James and Cowe
18
be available for pamng with artificial complementary RNAs is very small. It is becoming tncreasnrgly clear that transcripts of all types are, to a lesser or greater extent, confined to small subregions of the nucleus, either by virtue of the locus from which they are transcribed or addressing signals within the RNA (I-3). One may therefore have very abundant complementary RNAs that never encounter their target 3. Dwell time/mtcrocolhstons: The nbozyme-mediated cleavage reaction can only occur after the nbozyme and the substrate encounter each other m solution. The portions of the two complementary RNAs that first come into contact are unlikely themselves to be complementary. However, the so-called “encounter complex” that is formed between both strands 1s believed to allow short-distance dtssociatton, reorientatton, and reassociation, processes that are sometimes summarized by the term “microcolhsion ” Consequently, the longer the life-time of the encounter complex, the greater the chance that the complementary portions of both strands may colhde and initiate the formation of the nbozyme/substrate complex It is possible that RNA-binding proteins m the cell that are normally used to facilitate snRNAhnRNA interactions during splicing may also facilitate the microcollisions that enable the complementary nucleotides to encounter each other
1.2. Nucleation
and Propagation
of the Hybrid
1. Nucleation involves the interaction between two short complementary RNA stretches that results in a low-binding-strength hybridization complex For this to occur, the two stretches of RNA must be available for mtermolecular pamng, and so must not be engaged m intramolecular pamng or mteractrons with other molecules (such as proteins), the binding strength of which is greater than that of intermolecular reaction 2. Propagation involves the extension of the mtermolecular hybnd 5’ and 3’ of its nucleation site The extent to which propagation is required for mhibition is determmed by the relative posmon of the nucleation site and the site for cleavage (m the case of nbozymes), or by the size of duplex requtred for the host cell machinery to &grade the RNA before dissociation (in the case of antisense RNA). Propagation may be slowed or even halted by regions of highly stable secondary structure.
1.3. Cleavage,
Degradation,
and Recycling
1 Cleavage, in the case of truns-acting ribozymes, happens very rapidly after the complementary regions flanking the catalytic motif hybridize to their target Thereafter, the target RNA appears to be rapidly degraded by host cell enzymes 2. Degradation, m the case of antisense RNAs, appears to be a less efficient process and depends on substantial duplexes between the target and mhtbitor 3 Recycling of trans-acting ribozyme to allow it to cleave further molecules of target RNA, occurs in cell-free systems when flanking complementary regions (helices I and III) are very short. It is far from clear that this occurs inside cells, since there is no general correlation between k,,, and potency. It is also possible that the locations of encounter, nucleation, and cleavage are successive compartments of the nucleus, and so released ribozyme may no longer be in a position to encounter further molecules of target.
/dent/f/cat/on of Ribozyme Target Sites
19
From the above discussion, it should be apparent that the identity of the potency-determining step should determine the approach one would take to enhance potency. For example, there would be little point m optimtzing m vitro determined k,,, if the rate-limiting step in the cell were nucleation, It is therefore of value to attempt to identify the factors that may influence each step in the process, and to devise experimental or computattonal methods that analyze them. There are a number of reasons for believing that the nucleation and propagation stages are of key importance, and that they may be significantly affected by the structural properties of the interactmg RNAs. For example, in many cases of prokaryotic antisense regulation, it is clear that small, complementary loops are required to form “kissing complexes” during the nucleation event. Moreover, an inverse correlation between the degree of secondary structure of the complementary RNAs and the potency of inhibition of gene expression has been noted in eukaryotic systems (4,5). For more detailed treatment of these concepts, the reader 1sreferred elsewhere (6-10). It is very nearly nnpossibleto desrgnaribozyme, or an RNA complementaryto an mRNA, that will have the desired structurewhen embeddedin a long transcript, so tt is more practtcable to attempt to identify regions of the target RNA that might have the structural properties that favor mtermolecular hybridization. A method 1spresentedbelow for the identification of such sites.As with the method of Sczakieland Tabler (see Chapter 2), it startsfrom the premise that the probabtlity of successful intermolecular hybridization is adversely affected by high levels of mtramolecular basepaning. It attemptsto simplify and enrich the interpretation of secondarystructure predictions by the use of methodsto summarizethe thermodynamic parameters. 2. Materials 1 The sequenceof the target RNA m PIR format. 2 A computer that has a FORTRAN compiler. We use a DEC VAX rumung VMS, but the RiboSite code usesstandard syntax and can be compiled with any standard compiler. 3. A copy of the MFOLD program (see Note 1) by Zuker (II), or any other secondary structure program that can produce output files (.CT and REG) m an identical format (see Note 2) MFOLD can be obtained by FTP from snark.wustl.edu/pub. It 1s possible to run MFOLD remotely by pointing an mternet browser, such as Mosaic, at: http://ibc.wustl.edu/-zuker. 4. The source code for the RiboSite program. This can be obtained by E-mail request to Ribosite@molbiol ox ac uk 5. Data presentation software, such as Sigmaplot, Excel, or CricketGraph.
3. Method 3.7. Overview The method attempts to do three things. First, since there 1sa very large number of possible alternative structures for any long RNA molecule (22), tt summa-
James and Cowe
20
/---zzr/
RlboSub
1.((: “save”
file
G&r--1
/ cc;nuatto;”
/Yiiq
N-best best 10% 1000 tracebacks 1, window size
17
piy7 \
I 4 read in CT, REG and sequence files
asslgnatlon
of nucleotides
nt parsmg weighted
u
RiboSlte 4 to hellces
i
of helix delta Gs
(5) window size (1) #of 1st base (ribosite.out) output filename
i
mean of dGs over all structures duplex potentral
sum dp over user-defined wlndow wmdow duplex potent/a/ determme stacking energy of Intermolecular hybrids of user-defined length wmdow hybrrdrzatron potent/a/ calculate
(mn hp)/(mn
dp)+ratro
potent/a/ I
I
Fig. 1.
A flow diagram of the RiboSub commandfile and the RiboSite procedures
rizes the information contained m as many of the suboptimal structures the user choosesto consider, using an averaging method that takes into account the overall AG of each alternative structure. Second, it determines the free energy required to melt a given region of the “average” RNA structure mto its unwound form, over a user-defined window of conttguous nucleottdes (duplex potential, d.p.).
ldentificabon of Ribozyme Target Sites Table 1 A Sample
21
Run of RiboSiteO
Local> RiboSite Name of sequence file m PIR format ? myseq.pir Name of MFOLD region (KEG) tile ? myseq.reg Name of MFOLD connect (CT) file ? myseq.ct Window size for averagmg (* 5 *) ? 5 Number of first base m sequence (* 1 *) ? 1 Name for output file ( * RlboSlte.Out * )? myseq.rzt aPrompts from the program are shown m courter roman and user Inputs are m courier bold
Third, It evaluates whether a perfectly matched complementary sequence on a second RNA molecule has a higher binding energy to the target RNA (hybridizatron potential, h.p.) than the energy required to melt the probable mtermolecular base pairing. Finally, It identifies all the potential hammerhead cleavage sites m the molecule and lists them with their score, as determmed above
3.2. Operation The relationships between the RiboSub command file and the RiboSlte procedures are presented as a flow diagram in Fig. 1 (opposite). The precise operations to be carried out are as follows: 1 Submit your sequence to the MFOLD program, definmg the region over which you want to Identify rlbozyme sites (see Note 3), the number of alternatlve structures you want to evaluate (default = lOOO), and the centile of near-optimal structures mto which they must fall (default = 10%). 2 Run the RlboSite program (see Table l), speclfymg the name of the sequence file (e.g , myseq.PIR) and the output files from MFOLD (e.g , myseq.CT and myseq REG) (see Note 4). 3. Type in the window size over which you wish to evaluate the data (i.e., the length of the subfragments whose interaction you want to model) The default 1s5 4. Type m the number of the first base (m case the folded sequence does not start at the beginning of the target RNA). 5. Type m a filename for the output (e.g., myseq.Rzt).
3.3. output The output (see Table 2) 1s in the form of a fixed-width table that can be incorporated into most spreadsheets, graphmg, or presentation packages (see Note 5). The output file consists of the followmg columns. 1 The nucleotlde number (hlstoncal number: user-defined) 2 The nucleotlde base code.
Table 2 Sample Output
8
File from RiboSite
0.000
n
0.000
0 000
0.000
0 000
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
G A A C A C A G A C A A G G A T G T A T G T G T
-0 13 -0.55 a.6 -0.61 -0.61 -0 63 -0 63 -0 58 Al 11 4 14 -0 13 a.08 -0.37 a.42 -0 42 -0 45 4 48 446 -0.05 -0.11 4 11 -0 89 -0.89 a.9
0 0 -2.49 -2 99 -3.07 -3.06 -2 56 -2 09 -1 59 -1 04 4 83 -1 13 -1.42 -1.73 -2 13 -2 22 -1 85 -1 54 -12 -1.61 -2.03 -2 89 -3 66 4.45
-2.3 -0.9 -2 1 -1.8 -2 1 -1.8 -1 7 -2.3 -2.1 -1.8 -0.9 -1.7 -2 9 -2.3 a.9 -1.8 -2.1 -1.1 -09 -1.8 -2.1 -1.8 -2 1 -1 8
0 0 -5.8 -5.3 -6.1 43 -66 4.3 -5.4 -5.4 -6 -6.2 -5.3 -62 -66 -4.8 -3.4 -4.3 -4.6 43 -5 3 42 -7.3 -8.1
0.000
0 000
0.000
0 000
0.000
0.000
2.3293 1 7726 1 987 2 0588 2 5781 3 0144 3 3962 5 1923 7 2289 5.4867 3.7324 3.5838 3 0986 2 1622 1 8378 2 7922 3 8333 2.6708 2 6108 2 1453 1 9945 1 8202
-
-
-
-
-
-
-
-
-
-
-
3.8333 -
-
25 26 27 28 29 30 31 32 33 34 35
G G G T T C A G C A G
a.88 XI.89 -0.89 a.89 -0 02 -0.01 -0.02 a.03 -0.02 a.02 4.88
4.45 4 45 -3.57 -2.7 -1.82 -0.96 -0.1 -0 1 -0.98 -1 85 -2.7 1
-2.9 -2 9 -2.1 -0 9 -2 3 -1 8 -1 7 -3 4 -1 8 -1 7 -3 4
-84 -7 2 -7 7 A.6 -5.4 47 -7.6 -7 46 -9 8 -9 3
1 8876 1.618 2 1569 2.4444 2 967 6.9792 76 70 8 7755 5.2973 3 4317
-
-
-
-
2.967 -
-
6.9792 -
24
James and Cowe 8 0 GUC o 0 GUA
1000 100
4
V
GUU
v
cut
i-Juuc
10 2
A
B
0
/ I’
-
-cl
-.
.
400
- emplncally determined hybndlzatlon predlcled rabo hybndlzabon
potenbal
600
Nucleotlde number
10 too rabo hybrldtzabon potenbal
tendency
1000
c’
Fig. 2. (A) A plot of hybndtzation rano potential for the rat OX40 mRNA sequence, together with the positions of hammerhead target triplets (B) A plot of hybridization ratto potential over a subregron of the rat OX40 mRNA (upper panel) and the hybndtzatton tendency of the same region empirically determmed using a solid-phase ohgonucleotide array method. (C) A frequency dtstnbution of hybndization ratto potential n-rrat OX40 mRNA 3 4 5 6. 7 8. 9 10 11. 12.
The nucleottde duplex potenttal. The window-summed duplex potential The hybrtdrzation potenttal. The window-summed hybrtdtzatton potential. The ratto of hybrrdtzatton:duplex potentrals The value of column 7 tf the sequence is GUC (null otherwrse). Ditto for GUA Ditto for GUU. Ditto for CUC Ditto for UUC
The first line consistsof pad charactersthat define the data type and sizefor each column, facilitating import into programs, such as Mtcrosoft Excel or Sigmaplot. In the sample output graph, shown rn Fig. 2, the hybrrdization.duplex ratio potential is plotted on a logarithmic scale against the sequence nucleotide number. The great majority of the sequence has a ratio hybridization potential oscillatmg between 2 and 4 (median value = 2.98), but occasional small patches
identification of Ribozyme Target Sites
25
reach 100-1000 (see Fig. 2C). When the predicted structures are inspected, these correspond to loops, stabthzed by highly conserved hehces. It should be noted that many of the loops that are predicted tn the minimal energy structure are not present m a large proportion of alternative structures, and these do not appear as peaks on the plot. The position and ratio potential of all potential hammerhead ribozyme sites are marked. The ideal ribozyme may not be one whose target is in the middle of a narrow peak, but one m which a peak corresponds to one of Its flanking arms, allowing efficient intermolecular hybridization. In Frg. 2B, a small portron of the plot from Fig. 2A is displayed above an experimentally derived estimate of the availability of the same sequence (within a full-length transcript) to hybridize to a set of solid-phase, overlapping 15mer DNA oligodeoxynucleotides (data courtesy of Ed Southern, Kalim Mir, and Aymen Al-Shamkhani, Biochemtstry Department, University of Oxford, OX1 3QU, UK). It is apparent that the large peak of predicted high hybridization potential is comcrdent with the region of strong hybridization to DNA oligos, indicating that the method successfully predicts the presence of major sites of strong hybrtdization. It should be noted, however, that the prediction does not take into account the enthalpic barriers to interstrand annealing, nor does it use the recently determined thermodynamic parameters for RNA/DNA duplex formation appropriate to the empirical method (13,14). 4. Notes 1. The MFOLD program of Zuker (Zl) can be obtained by FTP from snark.wustl.
edulpub. Zuker’s WWW site IS at http://ibc.wustl.edu/-zukerlcgi-bin/indexcgi, from which it is possibleto run MFOLD interactrvely 2. Programsbasedon the earlier FOLD program that do not give suboptimal alternative secondary structures are not suitable for this procedure 3. The “save” run of MFOLD consumes a large amount of cpu time and system resources for long molecules. On the VAX, an effective limit is 1200 nt, although on machines such as the Convex, tt has proven possible to fold molecules of more than 9000 nt. However, you should liaise closely with your systems manager before runnmg these programs for the first time, and you should expect to be told the programs will run m batch mode, perhaps overnight 4. We have produced a VMS DCL command file (RiboSub) that will automattcally run MFOLD and RrboStte, and this 1s available for interested users 5 It is helpful to import the output file into a spreadsheet program, such as Excel, or a spectahzed scientific graphics program, such as Stgmaplot
References 1 Carter, K C , Bowman, D., Carrmgton, W., Fogarty, K , McNeil, J A., Fay, F. S , and Lawrence, J B (1993) A three-dimensional view of precursor messenger RNA metabolism wtthm the mammahan nucleus. Sczence 259, 1330-1335
26
James and Cowe
2. Izaurralde, E and MattaJ, I. W (1995) RNA export Cell 81, 153-159 3. St-Johnston, D (1995) The intracellular localization of messenger RNAs. Cell 81, 161-170 4. Rhodes, A. and James, W. (1990). Inhibition of HIV rephcation m cell culture by endogenously synthesized antisense RNA. J Gen Vu-01 71, 1965-l 974 5 Sczakiel, G , Homann, M , and Rittner, K. (1993). Computer-aided search for effective antisense RNA target sequences of HIV- 1. Antrsense Res Dev 3,45-52 6 Sczakiel, G and Goody, R S. (1994) Catalytic antisense RNA. antisense prmciple or ribozyme action? Bzol Chem Hoppe-Seyler 375, 745-746. 7 Nordstrom, K and Wagner, E G. H. (1994) Kmetic aspects of control of plasmid replication by antrsense RNA. TIBS 19,294-300. 8. Wagner, E. G. H. and Simons, R W. (1994). Antisense control m bacteria, phage and plasmids. Ann Rev Mcroblol. 48,713-742 9 James, W. and Al-Shamkham, A (1995) RNA enzymes as tools for gene ablation Curr. Opinion Blotechnol
6,44-49.
10 Nellen, W. and Lichtenstem, C. P. (1993) What makes an mRNA anti-sense-itwe? TIBS l&419-423
11 Zuker, M. (1989) Computer prediction of RNA structure Methods Enzymol 180, 262-288
12. Zuker, M. (1989) On finding all suboptimal foldings of an RNA molecule
Scr-
ence 244,48-52
13. Freier, S. M , Kterzek, R., Jaeger, J. A., Sugimoto, N., Caruthers, M. H , Neilson, T , and Turner, D. H. (1986) Improved free-energy parameters for predictions of RNA duplex stability Proc Nat1 Acad Sci. USA 83,9373-9377. 14 Sugimoto, N , Nakano, S., Katoh, M , Matsumura, A., Nakamuta, H , Ohmichi, T , Yoneyama, M., and Sasaki, M (1995) Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Bzochemistry 34, 11,21 l-l 1,216
Computer Analysis of the Conservation and Uniqueness of Ribotyme-Targeted HIV Sequences Mary Beth DeYoung and Arnold Hampel 1. Introduction Ribozymes are currently being developed as therapeutic agents agamst AIDS (2,2). Successful cleavage of the mRNAs produced by HIV or the HIV genome itself could produce improvement by stgmficantly reducing the patients’ viral burden. However, choosmg the appropriate target sites in HIV RNA 1scomplicated by its high mutability It is estimated that nme sequence errors occur with each reverse transcription of the genome (3). Since ribozyme action is highly sequence-dependent, the virus may thus escaperibozyme cleavage with time. However, some mutations will inactivate critical viral functions and cannot be propagated m the host. The goal of ribozyme design is to locate and target the sequences m HIV RNA whose importance results in conservation m a majority of patients. An additional concern is that these highly conserved HIV sequences may not be virus-specific. If an important functional motif is also present rn normal human mRNA, it too might be cleaved by the HIV therapeutic ribozyme, possibly resulting in harmful side effects. For these reasons, a procedure has been developed for searching the available sequence databases to determine (1) an approximate percentage of conservation among HIV strains for a potential ribozyme target site and (2) which known human mRNAs have a similar sequence. The search process can be performed relatively easily using any computer system with accessto the Internet. The key to the sequence analysis strategy to be described is Genbank, the database provided by the National Center for Biotechnology Information (NCBI), which is part of the National Library of Medicine (NLM), under the From
Methods
In MOi8CUkU
Edited by P C Turner
Btology,
Humana
27
Vol
74
R/bo.?yme
Press Inc , Totowa,
Protocols
NJ
28
DeYoung and Hampel
auspices of the National Institutes of Health (NIH). The NIH has been orgamzmg Genbank since 1982, and it is currently a collection of over 3 18,000,OOO nucleotides from 425,000 sequences, which is updated on a daily basis. Sequences are exchanged with the library of the European Biomformatics Institute (EMBL) and the DNA Data Bank of Japan (DDBJ) to give the most up-to-date and comprehensive sequence collection possible. Furthermore, the NCBI provides software known as Basic Local Alignment Search Tool (BLAST), whtch raptdly and thoroughly compares query sequences to each sequence m the database, and collects a list of identical or highly homologous sequences as output (4). No additional software needs to be developed by the researcher for this purpose. BLAST can be accessedvia an E-mail message, through the World Wide Web or with the experimental “BLAST client,” which directly contacts the NCBI network server through the Internet. The BLAST system was originally designed, and is most frequently used, to find similarities between newly discovered protem or DNA sequences and sequences of known function. Default parameters have been established for BLAST based on an “average” query. First, it is assumed that 100 descriptions will be sufficient to summarize the similar sequences found in the database, and that no more than 50 high-scoring or highly similar sequences will be found. However, when searching for highly conserved HIV sequences, more than 100 identical sequences can eastly be retrteved, all of whtch are not reported unless the default parameters are changed. Additionally, the default statistical significance threshold for reporting matches is set at 10, assuming that 10 matches are expected to occur merely by chance. Since it is desired that the search for randomly similar sequence m normal human mRNA produce as many matches as possible, this value is increased to retrieve more dissimilar sequences.Finally, to locate extensive areas of similarity with an average gene, the BLAST sequence initially selects sequences with 12 matched residues m a row, and then extends the search on either side. For a ribozyme target that may be only 15 or 16 bases long, the requirement for 12 identical bases m a row causes many sequences with a single mismatch m the center to be missed. Thus, the number of matched residues required for a “hit,” also known as the wordlength, must be adjusted. When the changes in the program specifications have been made, a query sequence is sent, the received output is read, and the number of mismatched HIV sequences and similar, but non-HIV human sequencesare tabulated. The ease with which this procedure can be performed depends in part on the computer system and user support available to the searcher. Several alternative means for establishing the proper computer connections will be discussed. Once commumcation channels are established, the search process is rapid, reproducible, and invaluable in choosmg the least-variable, most virus-specific targets for a therapeutic ribozyme against HIV.
Ribozyme-Targeted HIV Sequences
29
2. Materials 1 A computer with access to the Internet 2. An E-mail address 3 Sufficient memory to install an Internet information browser or Navigator (approx 1 5-3.0 MB) and to receive output files from the BLAST server (about 100 kB each, although the stze 1ssearch-dependent). 4 A text-management program such as Microsoft Word. 5 A mouse. 6 A computer printer.
3. Method 1 The starting point of the procedure depends on the available computer system. An Internet Navigator, such as Netscape or Mosaic, must be installed and available. Information on Netscape can be obtained by E-mall at
[email protected] or by calling 415-528-2555 in the US. Mosaic is available through the National Center for Supercomputing Apphcattons at the University of Illinois at UrbanaChampaign 2 With access to the world-wide-web via the Navigator, up-to-date mformation on the BLAST system, Genbank, and the AIDS database can be obtained This is important, because the databases and programs are contmually being updated (see Note 1). The addresses at the time of writing are given below a. NCBI home page http://www.ncbi.nlm.nih.gov b. BLAST notebook Home Page with the BLAST theory and algorithm, bibhography, manual, program hst, database descriptions, frequently asked questtons, bug list, BLAST search form, BLAST network server information, and so forth. http://www.nlm.nih.gov/Recipon/index.html c National Online Information Services at the NLM Information for estabhshmg a connection to the AIDS data base http:Nwww.nlm.nih.gov/top~leveI.dir/nlm_online~info.html After opening a Navigator program (see Note 2), an address is typed mto a space labeled “location,” and the connection is made by the program. Once at a location, a mouse is used to “point and click” on underlined phrases that make subsequent connecttons to locations of interest automattcally 3. The first information to obtain m a search for conserved HIV sequences is a copy of the AIDS database This collection of HIV sequences from throughout the world is mcorporated into Genbank, but can also be obtained on its own. Although many researchers may be comfortable accessing it online, we prefer to have a printout that can be marked with comments Application materials can be obtained over the net at the online information service address given above or by calling the MEDLARS service desk at l-800-638-8480. Questions can be sent by E-mail to
[email protected]. The database can be viewed online, downloaded, obtained on a disk, or received as a printout The prmtout 1scurrently more than 4 in thick, printed on both sides
30
DeYoung and Hampel
4. A useful section of the AIDS database for quickly findmg regions of conserved sequence is Part I Alignments This chapter collects full-length HIV sequences and aligns them for direct comparison Partial sequences are omitted for the sake of clarity. When a given HIV sequence matches the consensus sequence for that region, a dash is used m place of a letter. When a different base 1sfound, the letter of the replacing nucleotide 1s recorded as shown below Consensus sequence Type B TGCCCGTCTGTTGTGT ----_---_------_ HIVlSG3X _-___-__-_-A- _ _ HIVlE6LTR _ _ -A---------HIVlE5LTR _-___-______HIV4BlLTR -AThus, the pages can be scanned for areas with a high proportron of dashes instead of letters The “dashed” areas can then be assessed for possible ribozyme targets. Targeting rules for the hanpm rrbozyme are given elsewhere in this volume (see Chapters 18 and 19) When a conserved candidate target is found by thus superficial process, the sequence IS further analyzed with a BLAST search to find the relative proportions of variants. 5 A BLAST search can be completed by several methods that do not all allow mampulatlon of the program parameters (see Note 3) The changes we make in the program are to the “expect” value, which sets the statrstrcal srgmticance threshold for reporting matches; “descrrptions,” which establishes how many matches are reported; and “alrgnments,” which establishes the number of high-scoring pairs reported. In an E-mail message addressed to
[email protected] the followmg format is used. PROGRAM blastn DATALIB nr EXPECT 1000 DESCRIPTIONS 500 ALIGNMENTS 500 BEGIN >S’LTR HIV sequence TGCCCGTCTGTTGTGT The program “blastn” 1s selected because rt compares two nucleic acid sequences (n), not protein sequences The data library chosen 1s“nonredundant,” which is a complete collection of the updated Genbank and EMBL data banks, with overlapping (redundant) sequences deleted. 1000 1s the highest EXPECT value allowed, which gives the lowest stringency. 500 DESCRIPTIONS and ALIGNMENTS should be sufficient for a complete output, although they may be set to higher values if the program reports that additional matches were omitted We use T in place of U in the sequences submitted, More information on the BLAST system can be obtained by sending the message “help” to the same E-marl address. A form that provides the same information to the BLAST server is available at http://www.ncbi.nlm.nih.gov/Recipon/bs-seq.html. The desired program 1s
Rhozyme- Targeted HIV Sequences
31
chosen from a list of choices by chckmg on it with a mouse. Similarly, the data library, and the number of descriptions and alignments are chosen. Only the sequence needs to be typed in. For both the E-mail and form submission, output is received by E-mail (see Note 4) 6 Although the search method above will give an approximation of the degree of conservatron for a given sequence, the hmitation with either E-mail or the BLAST form is that the wordlength searched, set at 12, cannot be modified Thus, the previous searches will report only sequences in which 12 residues in a row match the submitted sequence. To modify the wordlength, the search must be completed through the BLAST client (see Note 5) This program allows more flexrbilny in adjusting BLAST parameters, since it contacts the BLAST server directly. At the time ofwrttmg, mformation on downloadmg the BLAST client is available at the BLAST Notebook Home Page under the heading “BLAST Network Services ” This is an experimental system with Client interfaces available for UNIX platforms, Macintosh with MacTCP, DEC VMS and MS-DOS, but not MS-Windows. The program can be obtained by tile transfer protocol (FTP) from the mtemet address given in Section 3 , step 2b, by highlighting the word FTP on the page and clicking on it with the mouse However, the software will not work until the copy is registered with NCBI The registration form requires contact information for a computer system administrator at your mstitution, description of the intended use of the system, the approximate number of users, the expected average number of sequences per week, and the numerical Internet address for the computer or computer subnet accessing the system (i.e., 130 14.25) The E-mail address for questions is
[email protected]~h.gov. Once the BLAST client is Installed and opened, a short form appears onscreen The sequence is typed first m the indicated area (capital letters, standard nucleotide abbreviations), the nonredundant nucleotide database is chosen from a list of 24 possible databases, the “display alignments” option is chosen, and a “0” is typed after “limit output to,” indicating no restrictions Then “Other parameters” is followed by a space The program parameters described m the BLAST manual (available at the home page) are entered in this area. Previously, the parameters have been referred to as “expect,” “descriptions, ” “alignments,” and “wordlength.” In the BLAST program itself, “expect” is E, “descriptions” is V, “ahgnments” is B, and “wordlength” is W. Thus, a horizontal list 1s typed to change the parameters as follows: E = 1000, V = 500, B = 500, W = 4. This list of commands alters the expect, description, and alignment commands as before. It also changes the wordlength to 4, so that 4 matched nucleotrdes m a row will generate a “hit ” The “blastofp command IS then chcked on, and an output file appears m a matter of minutes, whereas E-mail and form submissions can take several hours depending on the mquny volume being handled (see Note 6). 7 The size of the output file often means that it IS easier to review the results after prmting them out. To do this, we usually open the file m Mrcrosoft Word with text formattmg. On a Macmtosh system, this is accomplished by dragging the recetved file with a mouse over the icon for Microsoft Word We then reformat
32
DeYoung and Hampel
the file to a 10 point nonproportronally spaced font, specify 1 m margins, and print it on a laser printer. 8. The prmted copy may begin with a histogram showing the number of Database Sequences that satisfy various E parameter values. This 1s followed by a list of the sequences found, beginning with the database m which they were found (gb = genbank, emb = EMBL, dbJ = the data bank of Japan), the accession number the sequence 1sfiled under (t e , M64586), and a more specific name (HIVN7201) as shown below. The high score given drmmrshes as more mismatches occur Sequences high-scoring
producing segment
emblA24330/A24330 gblM64586(HIVN7201 gblM64582
HIVA19
gblM64581
HIVA21
gblS69617
S69617
gblM64578
HIVN60
gblM64579
HIVN63
gbjL28853
HIVlB5LTR
gblT23947lT23947 gblH162221H16222 gblH03906lH03906 db] ID28215lRICC1018A gblLO5545lRATPMCA2A2
pairsSK31 probe Human immunodeficiency virus type 1 . . . Human immunodefrciency virus type 1 . . . Human xtununodeficiency virus type 1 . . gag ILTR, patient Mal, provirus) [hu.. Human immunodeficiency virus type 1 . . . Human immunodeflciency virus type 1 . . . Human immunodeficiency virus type 1 . . . seq2099 Homo sapiens cDNA clone HB3M , y128flO.sl Homo sapiens cDNA clone l... yl39e09.rl Homo sapiens cDNA clone 1. . Rice cDNA, partial sequence (C1018-l... Rat plasma membrane calcium ATPase i. .
Sum high score
Probability P(N)
11 80
0.9999 1.000000
N 1 1
80
1.000000
1
80
1.000000
1
80
1.000000
1
80
1.000000
1
75
1.000000
1
75
1.000000
66
1.000000
1
66
1.000000
1
66
1.000000
1
66
1.000000
1
66
1.000000
1
The printout continues with a detailed list of sequence alignments of whrch two are given below. No vertical bar 1sseen between the two sequences when a mrsmatch 1spresent. >gblS69617)S69617 gag {LTR, patient Mal, provirus} [human immunodeficiency virus type 1 HIV-l, South India isolate, Genomic, 156 ntl. Length = 156
Ribozyme- Targeted HIV Sequences Plus Strand HSPs: Score = 80 (22.1 bits), Expect = 40., Identities = 16/16 (lOO%), Positives (100%) , Strand = Plus ! Plus Query: 1 TGCCCGTCTGTTGTGT 16
33 P = 1.0 = 16/16
IIIIIIIIIIIIIIII 45 TGCCCGTCTGTTGTGT 60 Sbjct: >gblL28841)HIVlBlLTR Human immunodeficiency virus type 1 (clone lB-1) long terminal repeat (LTR). Length = 657 Plus Strand HSPs: Score = 71 (19.6 bits), Expect = 2.9e+02, P = 1.0 Identities = 15/16 (93%), Positives = 15/16 (93%), Strand = Plus / Plus Query: 1 TGCCCGTCTGTTGTGT 16
IIIIIII
IIIIIIII
Sbjct: 435 TGCCCGTTTGTTGTGT 450 Alignments with the negative strands of DNA may also be retrieved These will not match a messenger RNA sequence and can be disregarded 9 Our method of tabulating the HIV sequences is straightforward We count the total number of HIV sequences obtained (see Note 7) and, of those sequences, how many are identical to the query sequence. (Identrcal sequences)/(total HIV sequences) x 100 = % conservation Mismatches are also categorized as those likely to be cleaved, and those that are not. Pernnssible mutations m hairpin ribozyme substrates are described elsewhere (see Chapter 19) (.5,6) The ideal for a ribozyme target would be >90% cleavable, although this is difficult to achieve. 10. The number of similar human non-HIV sequences are also tabulated In some cases, several alternative substrates may be found. For example: POL 3493 Query sequence AGTTTGTCAATACCCCTC gblL Human retinoblastoma susceptibility gene exons l-27 AGTTTGTCAATACCC*** embJX75208)HSPKTR H Sapiens HEK2 mRNA for protein tyrosine kinase receptor AGATTGTCAATACCC*** gb(M63397lHUM3BHSD03 Human 3-beta-hydroxysteroid dehydrogenase/delta-5-4 isomerase gene, exon 3 and complete coding sequence A&TTTGTCAATACCCTT* emb)X51755(HSIGLAMB Human lamda-immunoglobulin constant region complex (germlime) *GTTTGTCQATQCCCTC
34
De Young and Hampel
Of the above group, the human retmoblastoma sequence 1s most likely to be cleaved efficiently. The observed similarities with functionally important human genes may have no consequences For example, the stmilar area may be in a nontranscrtbed regton of a gene. If it IS transcrtbed, that section of mRNA may be structurally maccessible to rtbozyme bmdmg or be covered with protein The ratto of HIV mRNA to the mRNA of the human gene may be so high that httle spurious cleavage will occur. However, this informatton 1s useful in desrgnmg control experiments exammmg the specifictty of rtbozyme cleavage m human cells Homologous sequences are more hkely to be promtscuously cleaved than random cellular mRNA controls 11 More mformatton on the human sequences reported to have sequence simtlarmes can be obtained using the accesston number associated with the sequence on the prmtout If the “Entrez” database connection (also available as a network resource through the BLAST home page) is available, simply entering the accession number will retrieve a tile with all of the sequence mformatton available, the names of the researchers who submttted It, and any associated publication reference Alternattvely, the “retneve” server can be utilized to obtain the same mformatton via E-mail The mail IS addressed to retieve@ncbi nlm.nih.gov. An example of a message is DATALIB genbank BEGIN Ml5782 More mformation on the “retrteve” system can be obtained by writing to the above address wtth the message “help ” 12. The BLAST search process is repeated with as many potenttal HIV target sequences as necessary to obtam the least-vartable, most virus-specific sequences possible for ribozyme targeting (see Note 8).
4. Notes 1. The BLAST system and databases are continually evolvmg A year ago, the AIDS database was avatlable through Los Alamos National Laboratory, and the BLAST client had not been implemented The BLAST administrators mdtcate that the present form of the BLAST client is likely to change, and current programs will be inactivated. For this reason, multiple means of making contact with the system are given m this chapter, since not all routes may be active m the future If dtfticulties are encountered with the addresses given, a Search Engine, such as “Infoseek” or “Webcrawler,” can be used through your Navigation Program Entry of the keyword BLAST, NIH, NLM, or NCBI should lead you to any new destmattons. 2. The BLAST forms and BLAST client are available from sources other than those given m the text. The most complete hsting of alternate BLAST sources is the Homology Search Home Page on DNA Information and Stock Center (DISC) Seven other search sttes are listed there at this time The location IS http:// www.dna.affrc.go.jp/htdocs/homology/homo~ogy.html.
Ribozyme-Targeted
3.
4.
5
6
7.
8.
HIV Sequences
35
The BLAST chent is also available by FTP from colsa.unh.edu The contact person given for mformatton is William A. Gilbert at the University of New Hampshire at Durham, NH. HIS E-mail address is Will.Gilbert@unh edu. If a BLAST form other than the one specified here is used, the default parameters should be checked to be sure that the number of alignments and descriptions IS either suffictent or can be adjusted as necessary. Some forms are unsuitable for the method described here. A problem with retrieving BLAST output via E-mail can be the size of the message Some mailers will not accept files of more than 1000 lines Adding the command SPLIT to the E-marl message example given before BEGIN instructs the BLAST server to split the output mto messages of 1000 lines each. If another message length is desired, the number of lmes can be put after the SPLIT command, as in “SPLIT 500” to receive 500 lines per file. If the BLAST client is discontinued or unavailable, the 12 base wordlength settmg of the E-mail and BLAST form methods can be partially compensated for. Sequences longer than the intended target size, with a mmlmum length of 24 nucleotides, should be entered Adding 12 bases to each end further increases the hkehhood of finding rmsmatches toward the center of a sequence (which are most likely to be missed because of the reqmrement for 12 bases in a row) The disadvantage of this approach is that the output needs to be heavily edited, since semiIarnies in the “filler” regions are not of Interest. FASTA is another program suitable for homology searches (7). FASTA has the advantage that it uses a wordlength or “ktup” of l-6 for a “hit ” However, available support systems for FASTA are less elaborate than for BLAST (see the DISC location m Note 2), and do not report a sufficient number of descriptions at this time The BLAST search for conserved HIV sequences described here has the weakness that only highly similar sequences are retrieved. If, for some reason, two highly disparate HIV sequence populatrons exist, only one will be detected For example, there is a unique HIV variant found m Cameroon, known as Type 0 (8) with sequences that are rarely similar enough to the query sequence to be mcluded in the BLAST output. However, these sequences are listed in the Alignment section of the AIDS data base described m Section 3., step 4 and can be added to the total number of HIV sequences. A second BLAST search on the variant sequence may be indicated A clue that the search sequence is not dominant m the population IS retrieval of a small number of sequences (<50), except when the query is part of the POL region, which IS represented by fewer sequences m the database The final caution m mterpretmg the results of this method is that the search is only as good as the database. Only a fraction of HIV viral genomes are sequenced, and sometimes only portions of the genome are known. Further, the viral genomes m the database are most likely not randomly distributed: a researcher m a given city may sequence multiple vnuses evolved from a single source. If more work has been done on a given patient population, that variant will be overrepresented m the database, skewing the sequence distribution Additionally, not all alterna-
36
LIeYoung and Hampel ttve target mRNAs will be detected, since not all human mRNAs are m the database Thus, the results obtained are not definmve, but are the best achievable at this time If a search of the present HIV database indicates that a sequence is poorly conserved, it is a poor ribozyme target However, an absence of variants does not guarantee that none exist. Further, if a normal human mRNA is shown to be nearly identical to the HIV sequence, the possibility that a rlbozyme will cleave it must be explored However, an absence of human mRNA targets does not mean that none exists
References 1 OJwang, J. O., Hampel, A , Looney, D J , Wong-Staal, F , and Rappaport J. (1992) Inhibition of human immunodeficiency vn-us 1 expression by a hanpm ribozyme Proc Nat1 Acad Sci USA 89, 10,802-10,806 2 Yu, M , Poeschla E., Yamada, O., Degrandis, P , Leavitt, M. C , Heusch, M , Yees, J. K., Wong-Staal, F., and Hampel, A. (1995) In vztro and zn vzvo charactenzanon of a second functional hairpin nbozyme against HIV- 1. VkoZogy 206,38 l-386 3 Vaishnav, Y. N and Wong-Staal, F. (1991) The biochemistry of AIDS Ann Rev Blochem 60, 577-630. 4. Altschul, S. F., Gish, W., Miller, W., Myers, E. W , and Lipman, D. J. (1990) Basic Local Alignment Search Tool. J Mol. Bzol 215,403-410. 5. Simpson, J., Berzal-Herranz, A., Chowrira, B. M., Butcher, S. E., and Burke, J. M (1993) Substrate selection rules for the hairpin ribozyme determined by zn vitro selection, mutation, and analysis of mismatched substrates. Genes Dev 7, 13&138. 6. Anderson, P , Monforte, J., Tntz, R., Nesbitt, S., Hearst, J., and Hampel, A. (1994) Mutagenesis of the hairpin ribozyme. Nucleic Acids Res 22, 1096-l 100 7. Pearson, W. R and Lipman, J R. (1988) Improved tools for biological sequence comparison Proc Nat1 Acad Scz USA 85,2444-2448. 8 Nkengasong, J. N., Janssens, W., Heyndrickx, L., Fransen, K , Ndumbe, P. M., Motte, J., Leonaers, A, Ngolle, M , Ayuk, J., Piot, P , and van der Groen, G. (1994) Genotypic subtypes of HIV-l m Cameroon AIDS 8,1405-1412.
5 Selection of Accessible Sites for Ribozymes on Large RNA Transcripts Bruce L. Frank and John Goodchild 1. Introduction Many studies of ohgonucleotide binding and catalysis involve small nucleic acid targets with secondary and tertiary structures of little complexity. However, the therapeutic target of antisense ollgonucleotldes and hammerhead ribozymes, large RNAs, are rich in structures, such as haupms and pseudoknots, which may make certain target sequences inaccessible to the ribozyme (l-3). The methods described here are used in our laboratories to probe the accesslbihty of in vitro transcribed RNAs to antisense oligonucleotldes and hammerhead nbozymes. The method involves first probing the end-labeled RNA with a degenerate oligodeoxynucleotide library. Treatment with ribonuclease H (RNase H) cleaves the RNA at sites of oligodeoxynucleotide hybridization, and these sites are identified by gel electrophoresis and autoradiography. Specific antisense ohgodeoxynucleotides, complementary to those regions Identlfied by the random library, can then be made to hammerhead ribozyme NUX consensus target sites, where N = A, C, G, or U and X = A, C, and U ($5). Cleavage with RNase H can be used to evaluate the binding of these antisense oligodeoxynucleotides and so to choose target sites for ribozymes. We have used this protocol to discover several hammerhead ribozymes with excellent activity against viral RNAs transcribed m vitro. 2. Materials 2.1. Linearization
of Plasmid DNA
1. DNA (0.5 pg/mL) that codes for the RNA of interest inserted in a plasmid carrymg a bacteriophage RNA polymerase promoter sequence (T7 RNA polymerase From
Methods m Molecular Edited by P C Turner
Bfology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
37
38
2.
3. 4. 5. 6 7 8. 9 10
Frank and Goodchild IS recommended, but T3 and SP6 work as well). Suitable plasmids contammg bacteriophage RNA polymerase promoters are commercially available (e.g , the pGEM series from Promega, Madison, WI). Appropriate restriction enzyme (l-20 U/pL; store at -20°C) to cut the plasmid downstream from the promoter, and the sequence to be analyzed For best results the restriction enzyme should produce a 5’-overhang m the cut DNA. 10X Restriction enzyme buffer (normally supplied by the manufacturer with the enzyme; store at -20°C). Dtethylpyrocarbonate (DEPC)-treated RNase-free distilled water (see Note 1) Protemase K 10 mg/mL; store at -20°C Phenol:chloroform:tsoamyl alcohol (25:24*1, v/v) saturated with 50 mA4Tris-HCl buffer, pH 7.5 (store at +4“(Z). 3 M Sodmm acetate, pH 5 2 Absolute ethanol 70% Ethanol. TE buffer 10 mMTns-HCl, pH 8 0, 1 mMEDTA.
2.2. Transcription
of Target RNA
1 Guanosme hydrate: 17 mg/mL suspension in RNase-free water. This permits endlabeling without dephosphorylation. 2. In vitro transcription kit (available from many biochemical supply compames, mcludmg Ambion (Austin, TX), Stratagene (La Jolla, CA), and Promega; store at -2OOC) or equivalent reagents, including 10X transcription buffer (0.4 M TrisHCI, pH 7.5,O 1 MMgCI,, 50 mMDTT, 0 5 mg/mL BSA), bacteriophage RNA polymerase (10-60 U/pL), and NTPs (7 5 mM each). 3. RNasin placental ribonuclease inhibitor (40 U/pL) 4 RNase-free DNase I (l-10 U/a). 5. Phenohchlorofotmtsoamyl alcohol (25:24: 1, v/v) 6 G-50 Sephadex spin columns in TE or RNase-free water (commercially available from several suppliers)
2.3. End-Labeling
of RNA
1. 10X Kmase buffer (often supplied by the manufacturer with enzyme, or 0 5 M Tris-HCI, pH 7.5,O. 1 M MgCl,, 50 mM DTT, 0 5 mg/mL BSA). 2 T4 Polynucleotide kmase (PNK) (8-10 U/pL). 3, DEPC-treated RNase-free water 4. [Y-~*P]ATP (3000-6000 Ci/mmol, 10 mCi/mL) 5. RNasm placental ribonuclease inhibitor (40 U/pL). 6 G-50 Sephadex spm column
2.4. Ribonuclease H Cleavage of RNA with Degenerate Oligodeoxynucleotides 1. Degenerate library of oltgodeoxynucleotides (see Note 2).
of umform length (12-20 bases)
39
Accessible Sites for Ribozymes 2 10X RNase H buffer. 400 mA4 Tris-HCl, pH 7.5, 40 mM M&l,, Stable for 6 mo at -20°C (see Note 3). 3. Labeled RNA aliquot from Sectton 2 3. (0 2-2 pA4). 4. Ribonuclease H 1 U/l.tL (see Note 4). 5. Formamide loading dye 95% formamide (v/v), 10 mM EDTA, cyan01 and phenol red or bromophenol blue. 6 Dry ice 7 32P-labeled DNA mol wt markers; many markers are available (from Promega, Pharmacia, Uppsala, Sweden, and so forth) that labeled as m Section 3 3 8. Whatman 3MM filter paper, 46 x 57 cm. 9. Plastic kitchen wrap. 10 Kodak X-OMAT photographic film
2.5. RNase H Cleavage
10 mM DTT
0 01% xylene
commercially can be S-end-
with Specific Oligodeoxynucleotides
1 Specific oligodeoxynucleotide (1 CUM). 2. Reagents 2-10 in Section 2.4.
2.6. RNA Cleavage 1. 2. 3 4 5. 6
with Hammerhead
Ribozymes
5’-End-labeled RNA (0 2-2 uA4). DEPC-treated water 500 mM Trts-HCl buffer, pH 7 4. 10X MgC12 soluttons l&200 mM (see Note 5). Hammerhead rtbozyme (0.2-20 pM). Reagents 5-10 in Section 2 4.
3. Methods 3.1. Linearization
of Plasmid DNA
1 Choose a unique restrictton site downstream from the sequence to be analyzed. Preferably, this should give a blunt end or 5’-overhang on cleavage (see Note 6). 2 In a clean autoclaved 0 5 or 1 5 mL mtcrofuge tube, add 10X restriction enzyme buffer (usually supplied with the restriction enzyme) (2 pL), circularized plasmid DNA (4-10 pg) dtssolved in water or TE buffer, and deionized dtsttlled water to a volume of 20 pL Add restriction endonuclease (4-40 U), and incubate 1-2 h at the recommended temperature (usually 37°C) 3 Add protemase K (14 pL, 10 mg/mL) to the reaction, and incubate at 37°C for 60 mm 4. Stop the reaction with 1 vol of phenol:chloroform:isoamyl alcohol, vortex vigorously for 10 s, and centrifuge for 1 mm to separate the phases 5. Transfer the top (aqueous) layer to a clean, autoclaved mtcrofuge tube, and repeat the extraction as m step 4. 6. To the aqueous phase containing the linearized DNA add 0 1 vol of 3 A4 sodmm acetate, pH 5.2, and vortex briefly 7 Add 2.5 vol absolute ethanol, vortex, and incubate on crushed dry me (10 mm) or m a -20°C freezer (60 mm)
40
Frank and Goodchild
8 Centrifuge at >lO,OOOg m a microfuge for 10-30 mm Remove the supematant carefnlly with a drawn-out Pasteur pipet being careful not to disturb the DNA pellet. 9 Wash the pellet with ice-cold 70% ethanol (500 pL) by gently mvertmg the tube several times 10 Centrifuge for 5 mm, remove the supematant carefully so as not to disturb the DNA pellet, and dry the pellet under vacuum. 11 Redissolve the pellet in RNase-free water or TE to a concentration of 0 5 pg/&
3.2. In Vitro Transcription
of Target Gene
1 Commercially available kits are available for the m vitro transcription of RNA. We have found that the MEGAscnpt kit from Ambion gives a very good yield of complete transcripts The manufacturer supplies the appropriate enzyme (SP6, T7, or T3 RNA polymerase), buffers, and nucleotides Along with the nucleotides supplied with the kit, add 2 pL of a suspension of guanosine hydrate ( 17 mg/mL)/ 20 uL reaction volume, and reduce the amount of GTP by 20% (6) Add linearized DNA (2 u.L, 0.5 pglpL)(see Note 6), and mix well by ptpetmg the reaction mixture up and down several times After adding the RNA polymerase, incubate at 37°C for l-3 h. If a commercial kit is not used, the transcription can be conducted as follows (cfchapter 10). In an autoclaved microfuge tube, add lmearized DNA (2 pL, 0 5 pg/pL) (see Note 6), 1OX transcription buffer (2 p.L) for the RNA polymerase (T7, T3, or SP6, often supplied with the enzyme), RNase-free water (4 4 CCL),ATP, CTP, UTP (7.5 mM, 2 pL each), and GTP (7 5 mM, 1.6 pL), guanosme hydrate (2 p.L), RNasin (1 pL), and RNA polymerase (1 pL) Mix components well, and incubate for 60 min at 37°C. 2 Add RNase-free DNase I (1 pL), and incubate for 15 mm at 37’C. 3 Extract twtce with phenol.chloroform:isoamyl alcohol (40 l.tL), saving the aqueous layer (top) containing the DNA 4. Purify RNA from nucleostdes and nucleotides on a G-50 Sephadex spin column (available commercially from several manufacturers) according to the manufacturer’s instructions. 5. Determine the concentration of the RNA by UV absorbance at 260 nm using an approximate extinction coefficient of (10,000 x n) M-‘/cm where n = number of bases. For example, a 1000 base transcript would have an approximate extmction coefficient of (10,000 x 1000 bases) 1M-‘/cm/base = 1 x 107M’lcm. 6 Ahquot the RNA (5 pL) mto autoclaved microfuge tubes, and store at -80°C until needed.
3.3. End-Labeling
of RNA with [y-3*P]A TP
1. Remove an ahquot of RNA (5 pL) from the -80°C freezer, add 10X T4 kmase buffer (2 pL, often supplied with the enzyme), [Y-~~P]ATP (5 pL), RNasin (1 @,), RNase-free water (11.5 ltL), and T4 PNK (2 5 pL), and incubate for 1 h at 37°C. 2. Purify the RNA from radioactive nucleotide on a G-50 Sephadex spm column as above. Store at -80°C until needed (see Note 7).
41
Accessible Sites for Ribozymes 3.4. Cleavage
of RNA with RNase H and a Random Oligodeoxynucleotide
Library
1 The end-labeled RNA (5 pL) was added to 10X RNase H buffer (1 pL) and RNase-free water (3 pL) to bring the volume to 9 & 2 Heat a randomized library of oligodeoxynucleotides for 1 mm at 95°C add ohgodeoxynucleotide (1 l.rL) to the RNA, and incubate for 90 mm at 37°C (see Note 8). Add RNase H (1 pL), and incubate for 10 mm at 37°C (see Notes 4 and 8) Quench the reaction with formamtde gel loading buffer (10 pL), and place on dry ice (see Note 9) Heat-denature the quenched cleavage reactions at 9S’C for 2 5 min, and quench on ice Load aliquots of quenched cleavage reactions (5 pL) and 32P-labeled DNA or RNA mol wt markers into indtvidual lanes of a 5% denaturing polyacrylamide gel prerun to 50-55°C Run the phenol red dye to the bottom (l-l .5 h) at 50-90 W (constant power). Remove the top plate and spacers, and remove the gel from the bottom plate with a piece of Whatman (Clifton, NJ) 3MM filter paper. Place this gel up onto a second piece of filter paper, cover the gel with plastic wrap, and dry on a vacuum gel dryer at 80°C for 60 mm. Expose the dried gel in the dark to Kodak (Rochester, NY) X-OMAT film for l-24 h as needed to discern cleavage products. Develop according to film supplier’s directions 10 Compare the bands resulting from RNase H cleavage with the mol-wt markers to estimate sites of RNA cleavage (see Note 10).
3.5. RNase H Cleavage of RNA with Specific Oligodeoxynucleotides 1 In a micromge tube, add end-labeled RNA prepared as above (1 pL), RNase-free water (6 uL), 10X RNase H buffer (1 l.rL), and antisense ohgodeoxynucleotide (1 pL, l-10 clM> targeted to an appropriate hammerhead ribozyme site (see Note 11) determined by the random ohgonucleotide method above. Incubate at 37’C for 15 mm 2. Add RNase H (1 pL), and incubate for 10 mm at 37°C. 3. Quench with formamide dye loading buffer (10 pL), and place the tube on dry ice. Analyze by gel electrophoresis and autoradiography as described above
3.6. Cleavage
of RNA by Hammerhead
Ribozymes
1 In a microfuge tube, add end-labeled RNA prepared as above (1 pL), Tris buffer (1 a), MgCl, (1 &), RNase-free water (6 @I,), and hammerhead ribozyme (4,5) (see Note 11) (1 pL), and incubate for l-60 min at 37°C. 2 Quench the reaction with formamide dye loading buffer (10 @), and place on dry ice 3. Analyze the products by gel electrophorests and autoradiography as described above.
42
Frank and Goodchild
4. Notes 1 When working with RNA, extreme care should be taken to avoid contammatmg reagents, glassware, or plasticware with ribonucleases Use gloves at all times, and change them regularly. It is highly recommended that all plastic tubes and tips, glass pipets, and bottles be autoclaved before use and reserved for RNA reagents. In addition, water used to prepare soluttons should be treated with DEPC (1 mL/L water) overnight at 37°C with sttrrmg to ehmmate any rtbonuclease activity. DEPC-treated water should then be autoclaved. Use gloves at all times when working with DEPC, smce it IS a suspected carcinogen. 2. Ohgodeoxynucleotides can be ordered from several commercial vendors or can be prepared by automated synthesis. Random ohgodeoxynucleottdes can be prepared using a mixture of equal amounts of deoxynucleoside phosphoramtdites and a solid support prepared from a mtxture of the four deoxynucleonde-derived controlled-pore glass supports and proceeding as mstructed by the manufacturers. 3. Addttton of NaCl to the buffer has little effect on RNase H results and is generally omitted. After about 6 mo of repeated use of the 10X RNase H buffer, the cleavage activity of ohgonucleotides decreases, probably because of oxidation of DTT. Preparation of fresh buffer is recommended every 6 mo. 4. All the commercially available RNase H preparations tested contam some nonspecific endoribonuclease activity that 1sIndependent of ohgonucleotide bindmg This activity is mostly unaffected by addmon of RNasin, but can be lessened somewhat by addition of more RNA In addition, we have found that high concentrations of phosphorothioate oligonucleotides (> 10 clM> inhibit the activtty of RNase H 5 Long RNA transcripts are susceptible to magnesium- dependent cleavage on long incubation with high concentrattons of MgCl, For incubations longer than 1 h, the concentration of magnesium chloride should not exceed 10 mM. 6. 3’-Overhanging ends have been shown to initiate transcription at the wrong end of the linearized plasmid. If the restriction endonuclease cleavage provides a 3’-overhang and there IS no altemattve site, the 3’-end can be made blunt using the 3’ + 5’ exonuclease activity of the Klenow fragment of DNA polymerase Set up the transcrtption reaction minus nucleotides and polymerase Add Klenow fragment (5 U/ug DNA), and incubate for 15 mm at 2S’C Add nucleotides and RNA polymerase, and proceed as directed. 7. Use the labeled RNA as soon as possible to mmimize damage to the transcrtpt from the radioactive decay. If it cannot be used the same day as labeling, storage overnight at -20 or -80°C is acceptable. 8. Run controls with RNase H, but no ohgonucleottde and with oltgonucleottde, but no RNase H to monitor background cleavage by contammatmg ribonucleases m the enzyme and oligonucleotide preparations. 9. For large transcripts greater than about 1500 bases, protein left m the reaction alters the migration of the bands at the top of the gel only. If this is a problem, reactions should be arrested by extraction wtth phenol chlorofotmtsoamyl alcohol (20 pL), the RNA is then precipitated with 0 1 vol of 3 M sodium acetate and
Accessible Sites for Ribozyrnes
43
3 vol of absolute ethanol. Isolate the RNA by centrifugatton, dry the pellet under vacuum, and dissolve the protein-free RNA in RNase-free water (10 pL) and formamide loading buffer (10 pL) Heat at 95°C for 3 mm and load onto the gel. 10. Graphing the migration of the bands vs the log (DNA size m bases) of the corresponding markers grves a strarght line The use of DNA standards permits RNA cleavage sites to be located to within a few bases 11. Sequences containmg the NUX motif are considered to be the most susceptible to hammerhead rtbozyme cleavage Ohgodeoxynucleotides of 12-20 bases are useful for analyzmg the accessibility of these sites.
References Tmoco, I , Jr., Davis, P. W , Hardin, C. C., Puglisi, J. D., Walker, G. T , and Wyatt, J. (1987) RNA Structure from A to Z. Cold Sprzng Harbor Symp. Quant. Bzol LII, 135-146. Wyatt, J. R , Puglisi, J D , and Tmoco, I , Jr (1989) RNA foldmg* pseudoknots, loops and bulges. BzoEssuys 11, 100-106. Zarrmkar, P P. and Williamson, J. R. (1994) Kinetic mtermediates m RNA folding. Science 265,9 18-924 Shimiyama, T , Nishikara, S , and Taira, K. (1995) Generality of the NUX rule: kinetic analysts of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes Biochemistry 34,3649-3654 Zoumadakis, M. and Tabler, M. (I 995) Comparative analysis of cleavage rates after systematic permutation of the NUX consensus target motif for hammerhead ribozymes Nucleic Acid Res 2.3, 1192-I 196 Harper, J. W and Logsdon, N. J (199 1) Refolded HIV- 1 tat protein protects both bulge and loop nucleotides m TAR RNA from ribonucleolytic cleavage Biochemwry 30,8060-8066.
Selection of Efficient Ribozyme Cleavage Sites in Target RNAs Andre Lieber, Mikkel Rohde, and Michael Strauss 1. Introduction The identification of cleavage sites for nbozymes within a particular target RNA exclusively on the basis of sequence mformatlon often leads to dlsappointing failures. Even prediction of secondary structures of the target RNA by computer modeling with a more or less exact predlctlon of smgle-stranded or loop regions does not guarantee successful cleavage of the target RNA by a synthetic or an expressed rlbozyme (I). Expensive screening tests with large numbers of individual ribozymes are the result. As an alternatlve to this tnaland-error approach, we have recently developed a novel strategy for identlfication of cleavage sites (2). The strategy 1sbased on the existence of a library of ribozyme genes cloned mto a suitable expression vector. A pool of synthetic ollgonucleotldes coding for a hammerhead rlbozyme flanked by target-binding arms of random sequences was placed in the loop portion of a unique stem-loop structure that was cloned mto a vector as part of the adenoviral vaRNA1 gene (Fig. 1). The construct allows for expression from both T7 RNA polymerase and RNA polymerase III promoters. The library consists of 5 x IO9 individual ribozyme genes. This library 1stranscribed m vitro, and the rlbozyme transcripts are incubated with total RNA from cells that contain the target transcript of interest. After cleavage in vitro, 3’-terminal fragments are purified via ohgo-dT, reverse-transcribed, and cloned. The actual cleavage sites can be identified by sequencing of the ends of fragments. Using primers specific for the flanks of the cleavage site, the respective rlbozymes can be reamphfied from the library, recloned into the expression vector, and tested for tinction in vivo The strategy is outlined in Fig. 2 and described in the following. From
Methods m Molecular Edlted by P C Turner
Bfology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
45
Lieber, Rohde, and Strauss
46 hammerhead
ribozyme
sequence
Fig. 1. Schematic map of the expression unit m the ribozyme vector pGvaL (lower part) and insert of the synthetrc rrbozyme sequences (upper part) The library constructed as described (2) has 15 and 13 random nucleotides on the 5’- and 3’-ends of the rtbozyme sequence, respectively
lribozyme
library
1. ribozyme
tn vitro
DNA 1
of Interest
cells
RNA preparation
transcrlptton
cellular
RNA
RNA
I 2.
In wtro
cleavage
l< cellular
RNA ohgo-dT reverse tailing, cloning,
3.
fragments purlflcation, transcriptton, PCR amplification, sequencing.
1 cDNA clones, sequence of cleavage primers PCR, clontng
l--L
site(s)
for cleavage
site,
1
[ selected
ribozyme
gene
(
Fig. 2. Flowchart of the methods involved in tdenttfication of cleavage sites m target RNAs and in isolatron of a parttcular ribozyme from a library of rtbozyme genes.
Selection of Ribozyme Cleavage Sites 2. Materials 2.1. Transcription
of Ribozymes
47
from a Library
1. Ribozyme library DNA (can be obtained from the authors). 2. TKB buffer: 20 mA4 Trts-HCL, pH 7.9, 10 mA4 MgCl*, 0.2 mM EDTA, 10 mM 2-mercaptoethanol, 0.1 MKCl, 20% glycerol, 0.5 mMphenylmethylsulfony1 fluoride. 3. 10 mM Drthiothrertol (DTT). 4 RNasm (Boehrmger Mannheim, Mannhelm, Germany) 5. T7-RNA polymerase (New England Biolabs, SchwalbacWTadnus, Germany). 6. NTP stock solution: 10 mM of each of ATP, GTP, CTP, UTP. 7. a[32P]-CTP (see Note 1) 8 DNase I (Boehringer Mannheim). 9. Phenol/chloroform (1.1). 10. Ethanol. Il. Agarose gel
2.2. Cleavage
of Target RNA by Ribozymes
1 500 mA4 Tns-HCl, pH 7.5 2 100mMDTT 3 100 mMMgC12. 4. RNasin
5. Stop solution: 95% formamtde, 20 mM EDTA, 0.05% bromphenol blue, 0.05% xylene cyanol. 6. 10X TBE: 108 g Tris base, 55 g boric actd, 9 3 g Na2EDTA m 1 L (pH should be 8.3, add extra solid boric acid to adjust). 7 Sequencmg gels. 6% polyacrylamide, 8 Murea, 1X TBE buffer and/or NuSieve agarose gels.
2.3. Identification of Cleavage Sites by Cloning of Cleavage Products 1. 2. 3. 4 5. 6. 7. 8. 9. 10 11. 12. 13.
Oligo-dT cellulose (PolyATract, Promega, Heidelberg, Germany). Ohgo dT primer: 0.5 mg/mL solution of oligo dT,*-is in sterile water NMWL spin filter units, 30,000 NMWL (Millipore, Eschborn, Germany) Superscript II reverse transcriptase (Life Technologies, Eggenstein, Germany). 5X Reverse transcription buffer 250 mA4 Tris-HCl, pH 8 3, 375 mM KCl, 15 mM MgC12. Gene Clean (Bio 101, LaJolla, CA). Terminal deoxynucleottdyl transferase (Life Technologies). 5X Tathng buffer: 500 mMpotassmm cacodylate, pH 7.2, 10 mMCoC12, 1 mMDTT. Cis-ohgonucleottde primer. Gene-specific PCR primer. Taq polymerase (Perkin Elmer, Langen, Germany) 10X PCR buffer: 100 nut4 Tris-HCl, pH 7 9, 500 mA4 KCl, 20% DMSO, 1% Trrton X- 100. DNA sequencing kit.
48 2.4. Isolation
Lieber, Rohde, and Strauss of Ribozyme Genes from a Library
1. Tuq polymerase (Perkin Elmer). 2 10X PCR buffer as m Section 2.3. 3 Two gene-specific primers for the sequence flankmg the cleavage site.
3. Methods 3.1. Transcription of Ribozymes from a Library For this protocol, you need plasmid DNA from a ribozyme library like the one we have generated (2). The vector pGvaL, which was especially designed for generation of this library, contains the adenoviral vaRNA gene and an additional synthetic sequence forming a stable stem-loop region with the adjacent upstream region of the vaRNA1 (see Note 2). The ribozyme sequences were cloned via their XhoI and NszI sites between the S&I and PstI sites within the loop-forming region (Fig. 1). Since the sequences of the two oltgonucleotides used for generation of the library in ref (2) contain
two errors, the correct sequences are gtven here: Oltgonucleotide S’CCGCTCGAG(N)&TGATGAGTCCGTGAGGACGAAA3’;
III*
oltgonucle-
otide IV: 5’TGCATGCAT(N)i3NoTTTCGTCCTCACGGACTCATCAG3’. The two ohgos were annealed, filled in, and cleaved with XhoI and NsiI before cloning into pGvaL. Large-scale plasmid preparations are available, generated from a total of 5 x IO9 bacterial colomes (see Note 3). 1 Mix 2 pL (2 erg) of Hind III-digested ribozyme hbrary plasmid DNA with 12 5 uL TKB, add 10 U of RNasm, 2.5 pL of 5 mMNTP stock solution, 2.5 pL 10 mM DTT, 100 U T7-RNA polymerase, and water to a total volume of 25 u.E, and incubate at 37°C for 60 mm (see Note 1). 2. Add 23 U of DNase I, and incubate for 10 min at room temperature 3 Add an equal volume of phenol/chloroform (l.l), mix, and take the aqueous phase, repeat the extraction, and add 2 5 vol of ethanol for precipitation 4 Resuspend RNA m 10 pL of water, and run an ahquot on an agarose gel to estrmate the amount of RNA About 5-10 pg RNA are normally synthestzed m a 25-pL reaction volume.
3.2. Cleavage
of Target RNA by Ribozymes
1 Mix 1 clg of purified total RNA from cells of mterest with 10 pg of library RNA from the above transcription reaction, and add 1 & of 0.5 MTris-HCl buffer, pH 7.5, and 1 pL of 100 mM DTT to give a total volume of 8 pL. 2. Carry out heat denaturation of RNA by heating to 95°C for 90 s, and quickly cool on ice 3. Add 1 u.E of 100 mM MgCl, and 1 p+Lof RNasm, and mcubate reaction for 1 h at 37°C. 4 For analyttcal purposes, run a sample on a sequencmg gel. For quality control m preparation for the method m Section 3 3 , run a sample on a NuSieve agarose gel
Selection of Ribozyme Cleavage Sites 3.3. Identification
49
of Cleavage Sites by Cloning of Cleavage Products
1. Purify RNA cleavage products by binding to oligo-dT cellulose according to the mstructtons of the supplier. 2 Anneal approx 0 2 pg of purified RNA wtth 2 5 pA4 oligo-dT primer m 10 & water for 10 min at 70°C 3 Remove unbound primer by centrtfirgation through a 30,000 NMWL filter unit 4 To 16 pL of template, add 3 pL of 10 mM dNTP stock solutton, 6 pL of 5X reverse transcription buffer, 3 & of 100 mM DTT, 1 pL of RNasm, 1 pL (200 U) of superscript II reverse transcrtptase, and water to a total volume of 30 l.tL, and incubate at 37°C for 1 h 5. Purify cDNA&NA hybrids by bmdmg to Gene Clean, and elute with 30 uL of water. 6 Boll the hybrids for 2 mm, and cool on ice. 7 Add 5 pL of dGTP (2 n&Q, 10 pL of 5X tailmg buffer, 20 U of terminal deoxynucleottdyl transferase, and water to 50 $ and incubate at 37°C for 15 mm 8. Take 2 5 pL of tatlmg reactton, and add 2 pL of dNTP (10 mA4), 1 5 mA4 MgCl,, 10 pL 1OX PCR buffer, 2.5 U of Taq polymerase, 15 @f C ,,-primer, and water to a total volume of 100 pL (see Note 4). 9 Run seven cycles of one-directtonal PCR with 30 s at 95’C, 30 s at 42°C and 90 s at 72°C 10 Add 25 pM of a gene-specific downstream primer, and carry out 40 cycles of PCR with 60 s at 94°C and 90 s at 72°C The annealing temperature depends on the primer sequence 11 Reduce the volume by drying, run reaction products on a gel, and cut out the most prominent band(s) correspondmg to the preferred cleavage products 12. Perform cloning of fragments into a suitable vector according to standard procedures, and carry out sequence analysis followmg the instructtons of the manufacturer
3.4. Isolation
of Ribozyme Genes from a Library
There are several options to continue from this stage in order to obtain a rrbozyme specific for the preferred cleavage site. We prefer the method of amplification of the rtbozyme from the library and reclonmg over clone selectron by hybridization (see Note 5). 1. Mix 50 ng ofplasmids from the nbozyme library with 20 pA4of each of the upstream and downstream primers that are specific for the sequences around the cleavage site of the sequenced fragment and add 2.5 U of Taq polymerase, 10X PCR buffer containing 1 5 mMMgC12, and water to give 100 pL total reaction volume 2. Run PCR for 40 cycles (45 s at 95°C 45 s at 52°C 45 s at 72°C) 3. Purify the reaction product by spin filtration using NMWL filter units, digest with desired restrtctton endonuclease, and perform clonmg mto a suitable expression vector, preferably pGvaL (see Note 6).
4. Notes 1. If desired, one can trace-label the transcripts using a[32P]-CTP The lowest specific activity supplied (400 Ci/mmol) is sufficient, and only 1 $ need be added to the reaction In Sectlon 3.1 , step 1 (see Chapter 10)
Lieber, Rohde, and Strauss
50
2. The vector pGvaL allows for expression from both the T7 promoter and the
3.
4.
5
6
vaRNA-associated pol III promoter. Whereas the first is preferentially used for m vitro transcription, the latter seems to be very efficient m vtvo. Alternattvely, the T7 promoter could also be used m vivo if a nuclear T7-polymerase encoding gene IS cotransfected (2) The results obtained with ribozymes directed against different target sequences (2 and our unpublished data) suggest that the size of the library could be reduced by shortening the length of the random sequences m both arms of the hammerhead to seven or eight nucleotrdes, which would still provide sufficient specificity and stability, and would even allow for more efficient cleavage owing to a higher turnover rate. The most critical step m the procedure of cleavage-sue determmation IS the amplification of specific cDNA fragments. We found tt useful to run one-directional PCR from the G-tad first m order to obtain sufficient template for genespecific amplification. The concentration of the gene-spectfic primer should be fairly high (15-25 pM), but needs to be optimrzed for any given target sequence Alternative ways to obtain spectfic ribozymes would be either selection of clones from the library by filter hybridization or generation of synthetic ribozymes based on the sequence mformatton The latter can be cloned mto a vector like pGvaL (2) Ribozymes selected by the procedure described above are highly efficient m mactivatmg the function of the target RNA, and as little as an excess of 2- to lofold over the target RNA can be sufficient to abolish the function of a particular gene completely, as demonstrated for overexpressed human growth hormone m stably transformed clones (2).
References 1 Bertrand, E L., Pictet, R., and Grange, T (1994) Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucleic Acids Res 22, 293-300 2 Lreber, A. and Strauss, M. (1995) Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. A401 Cell Biol. 15, 540-55 1
Chemical Synthesis, Analysis, and Purification of Ribozymes Ravi Vinayak 1. Introduction The chemrcal synthesis of RNA, like DNA, IS carried out in the 3’ to 5’ du-ectron to take advantage of the high chemical reactivity of the S-hydroxyl group. Solid-phase chemistry currently provides the most effective means for the scale-up of RNA synthesis. The biologtcal activity of chemrcally synthesized RNA (I--3), equivalent to that of RNA derived by transcription methods (4-6), IS contingent on efficient synthesis and purtfication protocols. Chemical synthesis also allows for site-specrfic modtfications, such as deoxynucleotrdes, phosphorothtoates and modified nucleottdes (7-11). A number of improvements have been reported recently that have stgmficantly improved the chemical synthesisand purification of RNA and rtbozymes (I 2-14). Synthesis of RNA up to 200~pm01scale has been reported, which can provide quantities sufficient for therapeutic and structural applications (14). An optimized set of protocols are presented here that assure high-quality synthetic RNA. We also provide reliable HPLC techniques for the analysis and purrficatton of these molecules. 2. Materials
2.1. Equipment 1. Automated DNA/RNA synthesizer (e g., ABI Model 392 or 394, Applied Blosystems, Foster City, CA). 2. HPLC system (e g , series 200LC pump, Perkm-Elmer, Norwalk, CT)
2.2. RNA Phosphoramidites
and Supports
1 2’-O-t-butyldnnethylsllyl-S-O-DMT-flbonucleoside phosphoramldltes (A, G, C, U) 2 Nucleoslde-functlonallzed CPG or polystyrene supports (A, G, C, U). From
Methods tn Molecular Edlted by P C Turner
Biology, Vol 74 Fhbozyme Protocols Humana Press Inc , Totowa, NJ
51
Vmayak
52
Both of these are available from a number of commercial sources (e g., Applied Blosystems, Glen Research [Sterling, VA], Perseptive Biosystems [Frammgham, MA], and so on). 2.3. Ancillary Reagents 1. Tetrazole/acetonltrrle 2 3. 4. 5
Acetic anhydride/lutidine/tetrahydrafuran 1-Methyl-lmidazole/THF. Trlchloroacetlc acuI/dichloromethane Iodme/water/pyridine/THF.
(THF)
6 HPLC-grade acetonrtrrle. 7 Anhydrous acetomtrrle (for dissolution of phosphoramldites) 8. Ethylthio-tetrazole.
All the above are available from Applied Brosystems. 2.4. Postsynthesis 1 2 3 4 5 6 7 8 9
Reagents
Tetrabutylammomum fluoride (TBAF) (Aldrich [Milwaukee, WI] P/N 21,6 14-3) Trrethylamme trrhydrofluoride (Et,N[HF],) (Aldrich P/N 34,464-8) G-25 Sephadex (Aldrich P/N 27,109-8). Dimethylformamlde (DMF). 1-Butanol (Aldrich P/N 27,067-9) 1-Propanol (Aldrich P/N 29328-8). Sodmm acetate. Lithmm perchlorate Concentrated ammomum hydroxide (30%) (Aldrich P/N 38,053-9)
2.5. HPLC Reagents 1 Reverse-phase cartridge: 220 x 4 6 mm (Aquapore RP-300, C-8; Applied Biosystems P/N 07 1 l-0059) 2 2 M Trrethyl ammonmm acetate, Applied Brosystems P/N 4006 13 3 Acetonitrtle 4. Anion-exchange cartridge: Nucleopac PA- 100 anion-exchange column (Dlonex Corporation, Sunnyvale, CA, P/N 043010) 250 x 4 mm (analytical); 250 x 9 mm (semipreparative). 5. Solvent A. 20 mA4 LiC104 + 20 mM NaOAc m H20.CH3CN (9.1) (pH 6 5 with dilute AcOH) 6 Solvent B* 600 mA4LiC104 + 20 mMNaOAc m H20.CH3CN (9.1) (pH 6.5 with dilute AcOH)
3. Methods 3.1. Oligoribonucleotide Synthesis Ribozymes can be synthesized on a 1 pm01 scale column (trityl-off) using the 1 pm01 RNA cycle (15) (see Note 1). RNA phosphoramtdttes are diluted
Synthesis, Analysis, and Purification
53
with dry acetomtrile to a concentration of 0.1 M. These phosphoramidlte solutions should be used within 3 d of dilution (see Note 2) 3.7.7. Synthesis of Chimeric and Phosphorothioate Oligoribonucleotides If the RNA phosphoramldites are attached at bottle positions l-4, and DNA phosphoramldltes (Applied Blosystems) at bottle positions 5-8 (on an ABI model 392/4 with 8 bottle positions), mixed DNA/RNA ohgonucleotldes may be synthesized (25). 2’-O-alkyl RNA/RNA oligonucleotides can also be synthesized slmllarly by attaching the RNA phosphoramidites to bottle positions 14 and 2’-0alkyl RNA phosphoramidltes (Glen Research) to bottle positions 5-8. Phosphorothioate oligoribonucleotides can be synthesized by replacing the oxidizing reagent (iodine/water/pyridine) with the sulfurizing reagent tetraethylthluramdisulfide/acetonitrile (TETD) (Applied Biosystems) (16). 3.2. Cleavage, Deprotection, and Desalting (Postsynthesis) To cleave the oligorlbonucleotlde from the support and to deprotect the baseprotecting groups, a 3:l mixture of 30% aqueous ammomum hydroxide and ethanol is employed. The cleavage can be performed either on or off the mstrument. Protocols for the 2’-hydroxyl deprotection with either TBAF or Et,N(HF), and subsequent desalting then follow. 3.2.1. Cleavage on the Synthesizer 1. Use the End RNA procedure, which is mcluded m the permanently encoded cycle files on the instrument (392/4). 2. On completion of the end procedure, remove and cap the collection vial, and then heat for 4 h at 55T for complete removal of the base-protectmg groups (see Note 3).
3.2.2. Cleavage off the Synthesizer This may be implemented through the double-syringe method (Z 7). 1. After completion of the synthesis, dry the synthesis column with a flush of argon. 2 Load a fresh syringe (with luer tip) with a 2 mL solution of 3:l concentrated ammoma:ethanol. 3. Mount another empty syringe, with plunger fully inserted, mto one end of the synthesis column Mount the ammoma:ethanol-loaded syringe into the other end of the column. 4. Holding a syringe m each hand, gently pass the reagent through the column to the
empty syringe, and return severaltimes. 5 Let stand for 2-3 h at ambient temperature.
54
Vinayak
6 Withdraw the ammonia:ethanol solution mto one syringe, and inject the solution into a screw-cap vial 7. Heat at 5S’C for 4 h for complete removal of the base-protecting groups.
3.2.3. 2’- Hydroxyl Deprotection (Desiiylation) with TBAF 1 Measure the OD of the crude oligorlbonucleotlde (see Note 4) 2. Dry the ammoma:ethanol solution contammg the crude ohgorlbonucleotlde (trltyl off) after heating it for 4-5 h at 55°C (see Note 5). 3 Add a 1 Msolution of TBAF in THF. Use 15 pL/optlcal dens@ unit (ODU) (40 ccg) of the crude ohgorlbonucleotlde (see Note 6) 4. Vortex thoroughly, and stir the solution with a magnetic stir bar at amblent temperature for 2430 h. 5. Quench the reaction with an equal volume of sterile deionized water
3.2.4. Desalting with G-25 Sephadex@ (Size-Exclusion Chromatography) When Using TBAF Desalting procedures remove morgamc salts, traces of organic compounds, low-mol-wt impurities, and short failure sequences. 1. Concentratethe quenchedsolution(Sectton3.2.3,step5) to approximatelyone-half its original volume usmg a vacuum centrifuge (see Note 7). 2 Swell the G-25 Sephadex in sterile deionized water for 4-5 h. Load a Blo-Rad Econo-column (0 7 x 20 cm, Blo-Rad P/N 737-72 1) with this slurry A maximum of 100 ODU of crude RNA can be loaded on this column. 3 Allow the slurry to flow through the column until the Sephadex has settled (up to 16cm). 4. Carefully load the RNA sample in a mmimum amount of sterile deionized water, After the sample has descended to the Sephadex@ level, carefully add additional deionized water to the top of the column (about 10 mL) Collect 1 mL fractions in sterile tubes once the sample has been loaded 5. Collect 10 x 1 mL fractions. The RNA product elutes m tubes 2-5. 6 Assay each fraction on a UV spectrometer at 260 nm to determine which tubes contam the RNA ohgonucleotlde 7 Pool the fractions containing RNA, and evaporate to dryness 8. Dissolve the dried RNA m water. It 1snow ready for analysis
3.2.5. Desilylation with Et,N(HF), at Ambient Temperatures (see Note 8) 1 Add a neat solution of Et3N(HF)3 (10 pL/ODU) to the crude ohgoribonucleotlde (see Note 9) obtained from step 2 of Section 3 2 3 2 Vortex thoroughly and stir the solution with a magnetic stir bar at ambient temperature for 24-30 h. 3 Quench the reaction with sterile deionized water (2 pL/ODU).
Synthesis, Analysis, and Purification
55
3.2.6. Desilylation with Et,N(HF), at Elevated Temperatures 1 Add 9 pL/ODU of Et,N(HF), followed by 3 pL/ODU of DMF to the crude RNA obtamed from step 2 of Section 3 2 5 2. Vortex thoroughly, and heat to 55°C for 1 h (see Note 10) 3 Cool the solution and quench the reaction with sterile deionized water (2 &/ODU)
3.2.7. Desalting and Precipitation When Using Et3N(HF)3 1 To the solution obtained from step 3 of Section 3 2 5 and of 3 2.6., add I-butanol (100 pL/ODU), mix, and chill the solution at -20°C or lower for about 45 mm (or m dry ice/ acetone for 20 min) 2 Centrifuge the tube at >3OOOg for 5 min, and decant the butanol to collect the precipitated RNA (see Note 11). 3. Dtssolve the precipitated RNA in water. It 1snow ready for analysis.
3.3. Analysis and Purification The fully desalted and deprotected ohgortbonucleotide (tntyl-off) analyzed and purified HPLC (IS).
either by reverse phase HPLC
can be
or by anion-exchange
3.3.1. RP-HPLC Cartridge: Gradient
220 x 4 6 mm (RI’-300, C-8) Time. mm 0 24 34 Mobile phase. 0.1 M trtethylammomum acetate (TEAA) acetonitrile Flow rate. 1.O mL/mm RP-HPLC
purification
1s generally
limited
% Acetomtrile 0 20 40
to ollgorlbonucleottdes
>20
bases, provided they give sharp peaks and good resolution. This cartridge is suitable for analysis of about 0.3-1.0 ODU of crude oligonucleotide. It may also be used for purifications up to 15 ODU, with some loss of resolution. A larger column (250 x 7 mm, Applied Biosystems P/N 0712-0034) gives better separation with greater loading. Retention times for trityl-off oligoribonucleotides are sequence- and lengthdependent. Generally, ohgonucieotides between 10 and 20 nucleotides elute between 15 and 25 min. Ribozymes with 30 or more bases, or those that form stable secondary structures, may give broad peaks by RP-HPLC analysis, because the mobile phase (TEAAlwaterlacetonitrile) is not denaturing. Anionexchange HPLC may be the preferred method for analysis and purification for such oltgorlbonucleotldes.
Vinayak
56 3.3.2. An/on-Exchange
HPLC
Cartridge, Gradtent.
Nucleopac PA- 100 anion-exchange column Ttme. mm %B 0 0 30 50 Mobile phase. Solvent A: 20 mkf L&10, f 20 mMNaOAc in H20: CHsCN (9 1) Solvent B: 600 mM LiClO, + 20 rr& NaOAc m H20* CHsCN (9.1) (see Note 11) Flow rate* 1 0 mL/mm Temperature* 50-70°C The analytical cartridge is suitable for loading about 5 ODU of crude oligonbonucleotide. The semipreparatlve column may also be used for purtficatron of up to 50 ODU, with some loss of resolutron. An even larger column 1s available for purrfying up to 200 ODU of the ollgoribonucleotide. Oligoribonucleotrdes that form stable secondary structures or hairpins will deviate from their size-dependent elutlon pattern and may elute as broad peaks (see Note 13). Oltgoribonucleotldes purified by anion-exchange HPLC must subsequently be desalted by either size-exclusion chromatography (Section 3.2.4 ) or by precipitation of RNA by the addition of propanol as follows. 1 Collect the product peak in a sterile tube (when using anion-exchange HPLC gradient) 2 Add 3-4 vol of I-propanol Mix thoroughly, and keep the tube at -20°C for 4-6 h 3 Centrifuge at >5OOOg for approximately 10 mm. 4 Decant the propanol, wash the pellet with 1-propanol, and dry 5. Minute amounts of salts remammg may be further desalted by size-excluston chromatography as described m Section 3.2 4 (see Note 14)
4. Notes 1. For nbozymes longer than 40 bases, the tradmonal activator tetrazole should be replaced with a 0.75 A4 solutron of 5-ethylthro-lH-tetrazole m acetomtrrle as an activator This activator provides a higher couplmg efficiency (12) 2. Exposing the reagents or soluttons to moisture will result m degradation of the phosphoramldites, significantly affecting synthesis performance In addition, care must be exercised at every step to ensure good quahty of the final product. It 1s essential to use fresh reagents, anhydrous acetonitrile, gloves, and sterile, RNasefree materials for high-quality synthettc RNA. 3. This process also removes the 2-cyanoethyl (phosphate protecting) group For rlbozymes longer than 40 bases, a 5-6 h deprotection time is required The concentration of ammonia 1scritical. Use fresh, concentrated ammonium hydroxide that has been opened less than 1 mo. Use of anhydrous ammonia m ethanol for
Synthesis, Analysis, and Punficatlon
4
5
10
11. 12.
13 14
57
base deprotectlon is reported. However, the volatile nature of this reagent precludes its use on an automated instrument (28) The expected yield of a 20-mer after cleavage from the support is 80-100 ODU (1 ODU 1s that amount of material that gives an absorbance of 1 0 when dlssolved m 1 mL of water m a cuvet with a path length of 1 0 cm at 260 nm). The 2’-O-silyl ohgoribonucleotides thus obtained are relatively stable compounds They are resistant to ribonucleases and may be stored for extended times as a dry pellet or m cold, aqueous, neutral solutions, preferably sterile deionized water. Use a fresh solution of TBAF ~6 mo old, preferably stored under argon at room temperature (I 9). Degradation of the oligoribonucleotides can occur if the solution IS concentrated to more than one-half. Desllylatlon with this reagent can be effected either at room temperature or at 55°C Effective use of this reagent 1sboth length- and sequence-dependent In addition, care must be taken during workup owing to limited solubility of the products (20) and during desllylatlon of chlmerlc DNA-RNA ohgonucleotldes The acidic nature of this reagent may cause some depurination of deoxyadenosme residues. Heating for more than 1 h causes degradation and loss of yield (21). This method 1s applicable to ohgorlbonucleotides in general, with the exception of certain homopolymers (e.g , poly A and poly C) or long stretches of homopolymers m a heterogenous sequence. Attempts to precipitate RNA with 1-butanol from a TBAF solution have not been successful. Since the gradient system employs LlC104 m the mobile phases, the RNA obtained 1sm hthium salt form. For some experiments, the hthmm salt form of RNA may not be preferred, and postpurification cation exchange will be necessary A column oven (e g , Hitachi CTO-6A) may be necessary to analyze and purify rlbozymes that deviate from the size-dependent predictable pattern. Purified RNA can be stored as a dry pellet or m an aqueous solution, e.g , sterile water, at -20°C or lower up to 2 mo.
References 1 Gait, M. J , Pritchard, C., and Slim, G (1991) Oligonbonucleotlde synthesis, m Ollgonucleotldes and Analogues, A Practxal Approach (Eckstem, F , ed.), IRL, Oxford, pp. 25-48. 2. Damha, M. J. and Ogllvle, K. K. (1993) Ohgonbonucleotlde synthesis, in Methods m Molecular Biology, vol. 20, Protocols for Ollgonucleotldes and Analogs (Agrawal, S., ed.), Humana Press, Totowa, NJ, pp. 81-114. 3 Vinayak, R (1995) Ohgoribonucleotldes: Theory and synthesis, in Molecular Bzology* Current Innovatzons and Future Trends, part 1, (Griffin, A M. and Griffin, H G , eds ), Horizon Scientific, Wymondham, UK, pp. 107-126. 4. Milligan, J. F , Groebe, D R , Wltherell, G W , and Uhlenbeck, 0. C (1987) Oligoribonucleotlde synthesis usmg T7 RNA polymerase and synthetic DNA templates Nucleic Acids Res. 15, 8783-8798
58
Vinayak
5 Wyatt, J R., Chastam, M , and Pughsi, J. D. (1991) Synthesis and purification of large amounts of RNA oligonucleottdes. BzoTechnzques 11,7&I-769 6. Beckett, D. and Uhlenbeck, 0. C (1984) Enzymatic synthesis of oligoribonucleotides, m Oligonucleotide Syntheszs,A Practzcal Approach (Gait, M. J , ed.), IRL, Oxford, pp. 185-197 7 Heidenreich, O., Pieken, W., and Eckstem, F. (1993) Chemically modified RNA approaches and applications. FASEB J 7,90-96 8. Goodchild, J (1992) Enhancement of ribozyme catalytic activity by a contiguous oltgodeoxynucleotide (facilitator) and by 2’-0-methylation. Nucleic Aczds Res 20,4607-46 12 9. Sproat, B. S. (1993) Synthesis of 2’-0-Alkylohgoribonucleotides, m Methods zn Molecular Bzology, vol. 20, Protocols for Olzgonucleotzdes and Analogs (Agrawal, S., ed.), Humana Press, Totowa, NJ, pp 115-141 10. Chownra, B. M. and Burke, J. M (1992) Extensive phosphorothioate substttution ytelds highly active nuclease-resistant hairpin nbozymes. Nuclezc Acids Res. 20,2835-2840 11. Grasby, J A , Mersmann, K., Smgh, M., and Gait, M. J (1995) Purme functional groups m essential residues of the hairpin nbozyme required for catalytic cleavage of RNA. Bzochemzstzy 34,4068-4076 12. Sproat, B., Colonna, F , Mullah, B., Tsou, D., Andrus, A , Hampel, A , and Vmayak, R. (1995) An efficient method for the analysis and purification of ohgoribonucleotides. Nucleoszdes & Nucleotzdes 14,255-273. 13 Wmcott, F., DiRenzo, A., Shaffer, C., Tracz, D , Grtmm, S., Workman, C , Sweedler, D , Gonzalez, C , Scarmge, S., and Usman, N (1995) Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nuclezc Aczds Res. 23,2677-2684. 14 Tsou, D., Hampel, A., Andrus, A , and Vmayak, R (1995) Large scale synthesis of ohgoribonucleotides on HLP support. Nucleoszdes & Nucleotzdes 14, 148 1-1492 15 Applied Biosystems User Bulletm (1995) RNA Synthesis: Improved 1 pm01 RNA synthesis, analysis and purification, vol. 91 16. Vu, H and Hwchbem, B. (1991) Internucleottde phosphite sulfurizatton with tetraethylthiuram disulfide. Phosphorothioate oligonucleotide synthesis via phosphoramidtte chemistry. Tetrahedron Lett 32,3005-3008 17 Applied Biosystems Model 3921394 User’s Manual, Appendix VI 18 Scarmge, S. A., Francklyn, C., and Usman, N. (1990) Chemical synthesis of biologically active ohgoribonucleotides using P-cyanoethyl protected ribonucleoside phosphoramidites. Nuclezc Aczds Res. 18, 5433-544 1. 19. Hogrefe, R. I., McCaffrey, A. P., Borozdma, L. U , McCampbell, E. S., and Vaghefi, M M. (1993) Effect of excess water on the desilylation of ohgoribonucleottdes using tetrabutylammonmm fluoride Nuclezc AczdsRes. 21,4739-4741 20. Murray, J. B., Collier, A. K., and Arnold, J. R. P. (1994) A general purification procedure for chemically synthesized oligonbonucleotides. Anal. Bzochem. 218, 177-184 2 1. Vinayak, R , Andrus, A., and Hampel, A. (1995) Rapid desilylation of oligoribonucleotides at elevated temperatures. Cleavage activity m ribozyme-substrate assays. Bzomedzcal Peptzdes, Protezns and Nuclezc Aczds 1,227-230.
A Practical Method for the Production of RNA and Ribozymes Francine E. Wincott and Nassim Usman 1. Introduction As a result of both the therapeutrc (I) and structural (2) Interest in RNA, there has been an increased demand for larger amounts of oligoribonucleotides. Although great progress has been made in improving the methods for DNA synthesis, such that productron of large amounts has become commonplace, simrlar quantities of RNA are still difficult to obtam. RNA and DNA are generally synthesized and purrfied using the same methodologies. However, the one feature that embodies the difference between the two types of nucleic acrds, the 2’-hydroxyl moiety found m RNA, renders oligoribonucleotrde synthesisand purification more challenging. The typical protecting group used, t-butyldrmethylsrlyl, IS quite bulky and therefore hinders coupling. Additionally, an extra deprotection step, traditronally utilizing tetrabutyl ammomum fluoride (TBAF), is required to remove this group Finally, smce existing RNA synthesisprotocols did not allow for the production of larger (>0.5 mg) amounts, accompanymg purificatron techniques have not been developed. We have found that some rmprovements can be made during the synthesis of oligoribonucleotrdes (3), particularly with regard to RNA phosphoramidite coupling times. However, the biggest impact is achieved with improved deprotection protocols. New reagents for deprotection of both the exocychc amine and 2’-0-TBDMS hydroxyl-protecting groups can increase both the yield and recovery of the synthetic RNA. 7.1. Synthesis As m DNA synthesis, tetrazole is the activator of choice for RNA synthesis (4,5). A 0.5 A4 solution of tetrazole reacts with the RNA phosphoramrdite, and From
Methods m Molecu/ar Edlted by P C Turner
Biology, Vol 74 Rbozyme Protocols Humana Press Inc , Totowa, NJ
59
60
Wincott and Usman
the resulting activated speciesthen couples with the polymer-bound 5’-hydroxyl group for 10 mm (5). Although many attempts have been made to optimize this process by varying concentration or coupling times, improvements were not observed. However, with the advent of substttuted tetrazoles (6,7), enhancement of the couphng step could be effected. In particular, 5-ethylthto- lH-tetrazole (S-ethyl tetrazole) has been found to be a more effective activator owing to its higher solubihty properties and greater acidity (7). This reagent can be used at half the concentration (0.25 vs 0.5 M> of tetrazole and with half the coupling time, wtth no resultmg detrimental effect on full-length product yield (3). 7.2. Base Deprofecfion Judtclous choice of protecting groups on the exocyclic amines of the bases is critical to a successful synthesis. They must be stable to the synthetic cycle and, concurrently, readily cleaved at the end of the synthesis. We and others (8-11), have found that the phenoxyacetyl-type protecting groups on guanosine and adenosine and acetyl-protecting groups on cytidine meet these requirements. Typically, these acyl groups require incubation in 3:l NH,OH:EtOH for 4 h at 65°C to achieve complete removal. This is a marked reduction from the standard protecting groups, benzoyl for adenosme, isobutyryl or benzoyl for cytidme, and isobutyryl for guanosme, which using the same reagent require an mcubation time of 16-20 h at 65°C to effect complete removal. We have developed conditions that further accelerate the deprotection of oligoribonucleotides (3). A 1: 1 mixture of NH40H and methylamme (AMA) was reported to deprotect oligodeoxyribonucleotides fully at 65°C m 10 mm, if acetyl is used as the protecting group for cytidine. We have found that methylamme alone can be used to realize full base deprotection of oligoribonucleotides under the same conditions. Neither premature removal of the silyl-protecting groups, a concern when NH,OH:EtOH (3: 1) is utilized for base deprotection, nor base modification (12) is observed with AMA mcubation. 7.3.2’-O-My/ Deprofecfion Removal of the 2’-O-alkylsilyl-protecting group has traditionally been a “necessary evil.” Although the standard reagent, 1.OMTBAF, works quite well, it is a time-consuming process, requiring 8-24 h (4,5). Additionally, salts that must be removed prior to purtfication are produced. Alternative reagents have been explored. Neat triethylamine trihydrofluoride (TEA, 3HF) has been used to desilylate oligoribonucleotides (8,23) with limited success. We found that an anhydrous reagent of TEA, 3HF in N-methyl-pyrrohdinone (NMP) wrth TEA at 65°C for 0.5-l .5 h gives equivalent or better results than TBAF (3). In addition, the resulting oligomer can be isolated by anion exchange desalting or by direct precipitation from the deprotection mixture using 3 A4
61
Production of RNA and Ribozymes mAU , 50 -
Areas
40 -
1: 690.147 2:664.666 3:214.943
% 43.66 42.26 13.67
30 -
20 10 -
0
1 0
5
10
15
20
min
Fig. 1. Chromatogramof crude nbozyme 1, analyzedon a Hewlett Packard 1090 HPLC with a DronexNucleoPac@PA- 100column at 50°C using NaClO, buffers Area 2 representsthe full-length 37-mer Rz 1= ucu ccaucu GAu Gag geegaaagg ccG aaA auc ecu T Lower case= 2’-O-Me, T = 3’-3’ thymidine. sodium acetate (NaOAc) and butanol (see Section 3.3.). More recently, there have been reports of the utihty of a similar reagent where NMP IS replaced with dtmethylformamide (DMF) (14). 1.4. Analysis
Anion-exchange HPLC is the best method for accurately assessing the percentage of full-length oligomer present m a fully deprotected, crude sample. In conjunction with spectrophotometric quantitation, an accurate measurement of the amount of product can be calculated. We have found that a Dionex NucleoPac@PA-l 00 column, 4 x 250 mm, at 5O”C, used with NaC104 buffers, gives optimal resolution (3). Figure 1 shows a typical chromatogram of a 2.5~umol scale synthesis of a 37-mer, ribozyme 1, synthesized and deprotected according to the methods described herein. Spectrophotometric analysis indicated a crude yield of 422 AU. Integration by area provides a value of 42% (177 AU) for the full-length product. 1.5. Purification Prior to analysts of the oltgomer, the crude RNA is typically isolated by precipitation or anion-exchange cartridge desalting. Once the amount of full-
62
Wincott and Usman
length product has been determined, the material must be purified. Reversedphase chromatography, a useful method for the purification of short ollgomers (cl 0 bases) (15-I 7), 1s not viable for longer oligonucleotldes. Amon exchange chromatography has also been reported for the purification of shorter ohgomers (18,19) or as a preliminary purification step (20). We have found that a single anion-exchange purification of long (>30-mer), tntyl-off ohgonbonucleotldes provides material m good yield of high purity (3).
1.6. Summary The methods presented in this chapter provide an efficient protocol for the production of routine scale ohgorlbonucleotldes. Both synthesis and deprotectlon times have been reduced through the development of better reagents. These Improvements appreciably reduce the time requn-ed for the production of long ohgoribonucleotldes. Finally, the use of anion-exchange chromatography has refined the analysts and purlficatlon processes. Both the yield and quality of the final product have been enhanced by the mcorporation of these protocols
2. Materials The procedures described below were developed for the ABI 394 DNA/RNA synthesizer, although they can be modified to utilize any standard synthesizer.
2.1. Synthesis Reagents and Materials 1 Empty OPC columns for 2 5-pm01 scale syntheses (ABI [Foster City, CA]) 2. Ammomethyl polystyrene (ABI or Pharmacla [Milwaukee, WI) derlvltized using standard methods (21). 3 RNA phosphoramldites 5’-0-DMT-N6-(phenoxyacetyl)-2’-O-TBDMS-adenosme-3’-O-(P-cyanoethyl-N,N-dnsopropylamino) phosphoramldlte, Y-O-DMT~-(lsopropylphenoxyacetyl)-2’-O-TBDMS-guanos~ne-3’-O-(P-cyanoethyl-N,Ndnsopropyl-ammo) phosphoramldlte, S-0-DMT-N“-(acetyl)-2’-0-TBDMS-cytldine-3’-0-(P-cyanoethyl-N,N-dusopropylammo) phosphoramldite, 5’-O-DMT-2’0-TBDMS-undine-3’-0-(P-cyanoethyl-N, N-dlisopropylamino) phosphoramldlte (Pharmacla) See Fig 2 4 2’-O-methyl phosphoramidltes 5’-0-DMT-i@(t-butyl or phenoxyacetyl)-2’-Omethyl-adenosine-3’-O-(~-cyanoethyl-N,N-di~sopropylam~no) phosphoramidlte, 5’-0-DMT-fl-(t-butyl or isopropylphenoxyacetyl)-2’-O-methyl-guanoslne-3’-0(P-cyanoethyl-N,N-dilsopropylammo) phosphoramldite, 5’-O-DMT-N4-(acetyl)2’-O-methyl-cyt~d~ne-3’-O-(~-cyanoethyl-N,N-dnsopropylam~no) phosphorarmdlte, 5’-O-DMT-2’-O-methyl-ur~dine-3’-O-(~-cyanoethyl-N,N-dnsopropylam~no) phosphoramldite, (PerSeptlve Blosearch [Framingham, MA] or Pharmacla) See Fig. 2. 5. All phosphoramtdites are diluted on the synthesizer, usmg automated protocols (see Note 1) 6 Ancillary reagents: 2% TCA in methylene chloride (ABI), 16% N-methyl lmldazole m tetrahydrafuran (THF) (ABI); 10% acetic anhydnde, 10% 2,6-lutldme m THF
63
Production of RNA and Rlbozymes
DMTO
DMTO
y
OR
y
lPr2N / pyocE
OR
IPr2N / p‘OCE
Cytidine
Adenosine R = TBDMS, R, = H R = Me, RI = H or t-butyl
R = TBDMS R=Me
DMTO
DMTO
0
OR
?
OR
IPr2N ‘p‘OCE
Uridine
Guanosine R = TBDMS. RI = Isopropyl R = Me, RI = rsopropyl or t-butyl
R = TBDMS R=Me
Fig. 2. RNA and 2’-O-Me phosphoramidites
(ABI); 16 9 mM I,, 49 nnV pyridme, 9% water in THF (Perseptive); B & J Synthesis Grade acetonitrrle, s-ethyl tetrazole solution (0 25 M in acetonitrtle) was made up from the solid obtained from American International Chemical, Inc , Natwk, MA
2.2. Base Deprotection 1. 40% Methylamme 2. Mill1 Q water 3 EtOH/MeCN/H,O.
in water (Aldrich [Milwaukee, WI]). 3/1/l (v/v/v)
2.3. PI-O-Silyl Deprotection 1. Anhydrous TEA/HF* prepare this solution just prior to use by combining 1.5 mL N-methylpyrrohdmone, 750 pL TEA, and 1.0 mL TEA, 3HF, in this order (all reagents purchased from Aldrich). 2. Qiagen (Chatsworth, CA) desalt: Qragen column, 50 mM TEAB, 2 M TEAB. 3. Prectpttatton from destlylation. 3 M NaOAc, 1-butanol, 70% EtOH.
Wincott and Usman
64 Table 1 2.5 pmol Synthesis
Cycle
Reagent Phosphoramidites S-Ethyl tetrazole Acetic anhydride N-Methyl imidazole TCA Iodme Acetonitrile
Equtvalents
Amount
Wait time
6.5 23 8 100 186 83 2 80 NA
163 /AL 238 pL 233 /AL 233 /.IL 1.73 mL 118mL 667mL
512 5 mm 512.5 mm 5s 5s 21 s 45 s NA
2.4. Analysis 1. Analytical anion-exchange HPLC analysts. Hewlett Packard 1090 HPLC 2. Dionex (Sunnyvale, CA) NucleoPac PA-100 column, 4 x 250 mm, at 50°C Flow rate: 1.5 mL/mm 3 Buffer A* 20 mMNaC104. 4 Buffer B: 300 nn14NaC104 (Fluka [Ronkonkoma, NY]). 5 The gradient should be* Time, min
%B
0.00 5.00 20.00 21 00 23 00 24.00
0.0 38.0 73.0 100.0 1000 0.0
2.5. Purification 1. 2 3. 4. 5. 6
Milli Q water Pharmacia Mono Q@16/l 0 mm or Dtonex NucleoPac PA- 100 22 x 250 mm column Buffer A 10 mA4 NaCIO,. Buffer B. 300 mMNaC104 SepPak cartridge (C,,) (Milhpore, Bedford, MA) CHsCN. CH3CN/MeOH/H20. l/l/l (v/v/v) usmg Mill1 Q water
3. Methods 3.1. Synthesis of RNA and Ribozymes 1 Carry out small-scale syntheses on a 394 (ABI) synthesizer usmg a modified 2.5 pm01 scale protocol with a 5 min couplmg step for 2’-0-TBDMS-protected nucleottdes and 2.5 mm couplmg step for 2’-0-methylated nucleotides (see Note 2). Table 1 outlines the amounts, and the contact times, of the reagents used m
Production of RNA and Ribozymes
65
the syntheses cycle to allow the cycle to be adapted to other instruments A 6 5-fold excess (163 pL of 0.1 M = 16.3 pool) of phosphoramrdrte and a 24-fold excess of S-ethyl tetrazole (238 pL of 0 25 M = 59 5 pool) relative to polymerbound 5’-hydroxyl were used m each coupling cycle. Average couplmg yields on the 394, determmed by colorrmetric quantrtation of the trrtyl fractions, were 97 5-99%. 2 When the ollgonucleotrde 1s synthesized and automatrcally detritylated, remove the column and dry rt with a stream of argon gas
3.2. RNA and Ribozyme Deprotecfion of Exocyclic Amino-Protecfing Groups Using Methylamine 1 Transfer the dried support from the synthesis column to a 4 mL glass screwtop vral (Wheaton). 2. Add 1 mL of methylamme, screw cap on tightly and place m a heat block at 65’C for 10 mm (see Note 3) 3 Remove the vial from the heating block, place m another block at room temperature and put m a -20°C freezer until cooled 4 Decant the solutron mto a 15 mL centrifuge tube. Add 1 mL of EtOH/MeCN/H,O 3/1/l, vortex well, and allow the support to settle Decant, wash, and add to deprotectron solution 5. Repeat the washing two more times 6 Dry the combined supernatants m a Speed-Vat
3.3. RNA and Ribozyme Deprotection of P’-O-Silyl Groups Using Anhydrous
TEA/HF
1. Resuspend the base deprotected oligorrbonucleotrde in 250 & of anhydrous TEA, 3HF/NMP solutron, m a 15 mL centrtfuge tube (see Note 4) 2 Place the tube m a heatmg block at 65°C for 1 5 h 3. After heating, either precipitate drrectly from the desilylation reaction (steps 4-6 below) or quench with 9 mL of 50 mM TEAB prtor to amon exchange desalting (steps 7 and 8 below and see Note 5) 4 For preciprtation, add 25 & of 3 MNaOAc, followed by 1 mL of n-butanol to the destlylatton reactron. 5 Cool the mtxture to -70°C for 1 h, and then centrifuge at 4”C, 10,OOOgfor 30 mm. 6 Decant the supernatant, wash the pellet with 70% EtOH, and then dry it. 7. For amon-exchange desalting of the deprotected ohgomer, load the quenched reaction m TEAB onto a Qragen 500@’ anion-exchange cartridge that had been prewashed with 10 mL of 50 mM TEAB 8 Wash the loaded cartridge with 10 mL of 50 mMTEAB , and elute the RNA with 10 mL of 2 M TEAB Then dry to a white powder (5) in a vacuum centrifuge.
3.4. RNA and Ribozyme Analysis and Purification 1 Dissolve the crude material m 5 mL of RNase-freewater. 2. Inlect the sample onto either.
Wincott and Usman
66
3.
4. 5. 6 7.
a. Pharmacta Mono Q 16110 mm; or b. Dtonex NucleoPac PA- 100 22 x 250 mm column wtth 100% buffer A (10 mA4 NaCIO,). Elute the RNA using a gradient from. a 180-210 mM NaClO, at a rate of 8 mL/min for a Pharmacta Mono Q amonexchange column. b 100-l 50 mA4NaC10, at a rate of 15 mL/mm for a Dionex NucleoPac amonexchange column Analyze fractions by HPLC, and pool those containing full length product (280% by peak area) for desaltmg. Apply the pooled fractions to a C,, SepPak cartridge that had been prewashed successively with CH,CN (10 mL), CH.$N/MeOH/H,O:l/l/l (10 mL), and RNase-free H,O (20 mL). Following sample apphcatton, wash the cartridge with RNase free H,O (10 mL) to remove the salt. Elute the product from the column wtth CHsCN/MeOH/H,O.l/l/l (10 mL) and dry.
4. Notes 1. Critical to the successful production of RNA is the use ofproper handling techniques. No adventitious water must be allowed to come m contact with the oligomer durmg synthesis Therefore, all reagents and bottles must be kept dry and under argon. 2 In Table 1, watt time does not include contact ttme during delivery. Where two couplmg times are indicated, the first refers to RNA couplmg and the second to 2’-O-methyl couplmg. 3 During base deprotection, the cap on the Wheaton vial must be tightly sealed to avoid loss of contents. 4 When preparing the TEA, 3HF/NMP destlylatton solution, the components must be combined in the order specified. In addition, if the reagent IS not used nnmedtately after preparation, store tt m a warm (5565°C) heating block, capped The reagent will form an intractable gel if allowed to stand at room temperature. 5 Once the ohgomer 1sfully deprotected, special precautions must be taken to avoid degradation by nucleases. Gloves should be worn at all times and Mtlli Q water should be used.
References 1. Cech, T. (1992) Rrbozyme engineering Curr Opwon Struct Blol 2, 605-609. 2. Usman, N. and Cedergren, R. J. (1992) Explottmg the chemical synthesis of RNA Trends Blochem SCI 17,334-339
3. Wincott, F., DiRenzo, A , Shaffer, C., Grimm, S , Tracz, D., Workman, C , Sweedler, D., Gonzalez, C., Scarmge, S., and Usman, N (1995) Synthesis, deprotectton, analysis and purtficatron of RNA and ribozymes. Nucleic Acids Res 23,2677-2684. 4. Usman, N., Ogilvie, K. K., Jtang, M -Y , and Cedergren, R J. (1987) Automated
chemical synthesis of long oligoribonucleotides
using 2’-O-silyl-rtbonucleoside-
Production of RNA and Rbozymes
5
6.
7.
8.
9.
10.
11
12 13
14
15.
16
17.
67
3’-O-phosphoramrdites on a controlled-pore glass support: synthesis of a 43-nucleonde sequence srmrlar to the 3’-half molecule of an Escherichla toll formylmethtonine tRNA J. Am Chem Sot 109,7845-7854. Scaringe, S A , Francklyn, C , and Usman, N. (1990) Chemical synthesis of btologrcally actrve ohgorrbonucleottdes using j3-cyanoethyl protected rrbonucleosrde phosphoramrdites Nuclezc Acids Res 18, 5433-534 1. Andrus, A., Beaucage, S., Ohms, J , and Wert, K. (1986) A servesof 5’-substttuted tetrazoles for phosphoramrdrte activation during oligonucleotrde synthesis American Chemical Society Meeting, New York, April 1986, Organic Divisron, Abstract 333. Sproat, B , Colonna, F , Mullah, B , TSOU, D., Andrus, A., Hampel, A , and Vmayak, R (1995) An efficient method for the rsolatron and purification of ohgorrbonucleotrdes. Nucleoszdes & Nucleoades l&255-273 Gasparutto, D , Livache, T , Bazin, H., Duplaa, A.-M., Guy, A., Khorlm, A , Molko, D., Roget, A , and Teoule, R. (1992) Chemical synthesis of a biologtcally actrve natural tRNA with its minor bases Nuclezc Aczds Res. 20, 5 159-5 166. Wu, T., Ogtlvie, K. K , and Pon, R. T. (1988) N-Phenoxyacetylated guanosme and adenosme phosphoramidrtes in the solid phase syntheses of olrgoribonucleotides. synthesis of a ribozyme sequence Tetrahedron Lett 34,4249-4252. Chatx, C., Duplaa, A. M., Molko, D., and Teoule, R. (1989) Solid phase synthesis of the 5’-half of the mrttator t-RNA from B sub&s. Nuclezc Acids Res. 17, 7381-7393. Smha, N. D , Davis, P , Usman, N., Perez, J., Hodge, R., Kremsky, J., and Casale, R. (1993) Labtle exocychc amme protection of nucleosrdes in DNA, RNA and oligonucleotide analog synthesis facilitating N-deacylatron, mmimrzmg depurination and chain degradation. Bzochzmze 75, 13-23. Reddy, M. P , Hanna, N. B., and Farooqur, F (1994) Fast cleavage and deprotection of oligonucleotrdes Tetrahedron Lett 55,43 1143 14. Westman, E and Stromberg, R (1994) Removal of t-butyldrmethylsrlyl protection m RNA synthesis Trrethylamine trihydrofluorrde (TEA, 3HF) 1sa more reliable alternative to tetrabutylammonium fluoride (TBAF) Nuclezc Aczds Res 22, 2430-243 1 Vinayak, R , Andrus, A , and Hampel, A. (1995) Rapid desrlylatton of ohgoribonucleotrdes at elevated temperatures: cleavage activtty in ribozyme-substrate assays. Blomedxal Peptides, Proteins and Nucleic Acids 1,227-230 Odat, 0 , Hiroaki, H., Sakata, T , Tanaka, T., and Uesugr, S (1990) The role of a conserved guanosme residue m the hammerhead-type RNA enzyme FEBS Lett 267, 150-152. Korzumr, M and Ohtsuka, E (1991) Effects of phosphorothioate and 2-amino groups m hammerhead rrbozymes on cleavage rates and Mg2+ binding. Biochemzstry 30,5145-5150. Usman, N., Egli, M , and Rich, A (1992) Large scale chemtcal syntheses, purtfication and crystallization of RNA-DNA chimeras. Nuclezc Acids Res 20, 6695-6699
68
Wincott
and Usman
18. Slim, G. and Gait, M. J. (1991) Configurationally defined phosphorothioate-containmg oligortbonucleotides m the study of the mechamsm of cleavage of hammerhead ribozymes Nuclezc Aczds Res 19, 1183-l 188 19. Hall, K. B. and McLaughlin, L. W (1992) Properties of pseudouridme Nl ammo protons located m the major groove of an A-form RNA duplex Nuclezc Aads Res 20, 1883-1889. 20. Fu, D.-J and McLaughlm, L W (1992) Importance of specttk adenosme N7mtrogens for efficient cleavage by a hammerhead ribozyme A model for magnesium bmdmg Blochemzstry 31, 10,941-10,949. 2 1, Pon, R T., Usman, N , and Ogtlvie, K K. (1988) Derwmzation of controlled pore glass beads for sohd phase ohgonucleotide synthesis BzoTechnzques 6,768-775
Preparation of Templates for Production of Ribozymes and Substrates Rajesh K. Gaur and Guido Krupp 1. Introduction Transcrrptron by DNA dependentbacteriophage RNA polymeraseshas become a very powerful technique m molecular biology. Smgle-stranded RNAs generated by m vttro transcriptton can be used as substratesin a variety of experiments ranging from sphcmg and translation to structural studies.This chapter describesmethods for the preparation of templates suitable for in vitro transcriptton. The methods described m the followmg protocols are based primarily on the use of bacteriophage T7 RNA polymerase as the transcribing enzyme (I). For other phage polymerases, their cognate promoter sequence must be used, and optimal results may require minor changes in the transcription conditions. Three different template types can be used for in vitro transcription: plasmtds, polymerase chain reaction (PCR) products, and synthetic DNA templates. Each template has distinct advantages, depending on the investigator’s requirements. Long RNAs can be prepared as “run-off’ transcripts from linearized plasmtds. PCR-generated DNA templates provide a fast approach with certain hmitattons (see Section 3.2.). Synthetic DNA templates can provide a convenient alternative to the more costly and cumbersome chemical synthesis of short RNAs. As described here and in Chapters 10 and 12, in vitro transcription can provide the flexibility needed to produce a variety of RNAs, including znsitu 5’-terminal or internal labeled RNAs and transcripts with defined 5’-terminal sequences.Partial and quantitatively controlled modified transcripts can also be produced. 2. Materials Multicopy plasmid vector, restrrctron enzymes, T4 DNA ligase, competent E’scherichia co& cells (JM 109), IPTG, X-Gal, RNasm, T7 RNA polymerase, From
Methods Edited
by
m Molecular P C Turner
Ecology, Vcl 74 Rbozyme Humana
69
Press
Inc , Totowa,
Pfotocc/s NJ
70
Gaur and Krupp
dithiothreitol (DTT), and RNase-free RQl DNase were obtained from Promega (Madison, WI); calf intestinal alkaline phosphatase, 10X dephosphorylation buffer, and Tuq DNA polymerase were obtained from Boehringer (Mannheim, Germany); NTPs, dNTPs, and NP-40 were procured from Pharmacia Biotech (Uppsala, Sweden), and Sigma (St. LOUIS,MO), respectively. The alkaline lysis method (2,.3)or any commercially available kit can be used for plasmid isolation. For electroporation, we prefer the BRL (Gaithersburg, MD) cell-porator. PCR amplifications require a DNA Thermal Cycler (e.g., Perkm Elmer, Norwalk, CT). Ohgonucleotides can be obtained from commercial sources or synthesized m-house if a DNA synthesizer is available (e.g., Applied Biosystem’s model ABI 39 1, Foster City, CA) 1 RNA elution buffer 0 5 MTris-HCl, pH 7 0, 0 1% (w/v) SDS, 0 1 mMEDTA, 1 mMMgC12. 2 10X Transcriptton buffer: 400 mM Tris-HCl, pH 8 0, 200 mA4 MgCl,, 20 mM
spermidine. 3 10X PCRamphfication buffer: 500 mMKCI, 100 mMTrrs-HCl, pH 8.3,15 mMMgClz 4 5X Ligation buffer: 100 mM Trts-HCl, pH 7.4, 25 r&4 MgCl,, 5 mM DTT, 2 5 mM ATP, 250 ug/mL BSA 5. TE 10 mM Tris-HCI, pH 8 0, 1 mM EDTA 6. DEPC-treated water (see Note 1) 7 Restriction enzyme buffers (see Note 2) 8. IOX Dephosphorylation buffer: 500 mA4Tris-HCl, pH 8 5, 1 mA4EDTA. 9. Phenol/CHCls* phenol:CHCI,:isoamyl alcohol in the ratio 50 49.1 with 0.1% 8-hydroxyquinoline 10 CHC13/isoamyl alcohol. CHCls*isoamyl alcohol in the ratio of 24 1 11. Polyacrylamide gel loading buffer 8 Murea, 0.03% tracking dyes (bromophenol blue and xylene cyanol). 12. Luna-Bertani (LB) medium. 10 g Bacto-tryptone, 5 g Bacto-yeast extract, 5 g NaCl in 1 L water, adjusted to pH 7.5 with NaOH, and autoclaved
3. Methods 3.7. Preparation of Plasmid DNA Template Single-stranded RNAs encoded by virtually any cloned DNA molecule under the control of a T7 or SP6 promoter can be obtained by m vitro transcription (4,5). The DNA sequenceof interest is cloned downstream of the T7 or SP6 promoter into the multiple clonmg site of a multicopy plasmid (Fig. I), and the recombinant plasmid is linearized with a suitable restrtction enzyme to allow “run-off’ transcription. Restriction enzymes that generate blunt or S-overhangs should be selected for lmeartzing plasmtd DNA, since endonucleasesthat generate 3’-protrudmg ends (for example KpnI or &I) may result in the addition of extraneous sequences (6). We recommend
phenol/chloroform
extraction followed by ethanol
precipitation of the restricted DNA template prior to the transcription reaction.
71
Templates for Ribozymes and Substrates
Lmearm enzyme
wth restnctlon T?
SP6 I
,
I
Fig. I. Structure of pRG recombmant plasmtd for m vttro transcriptton reacttons. The gene of interest 1s cloned mto the multiple cloning site of the vector. Arrows indicate the dtrectton and start points of T7 and SP6 RNA polymerase-dependent transcription The j3-lactamase gene, which confers ampicillin resistance, is denoted as Amp’ The multiple cloning site within the LacZ gene allows blue/white screening for recombmants. The linearized DNA thus serves as a template for runoff transcription by either T7 or SP6 RNA polymerases
RNA transcripts from cloned DNA templates will generally include several 5’- and 3’-nucleotrdes from the multiple clonmg site of the vector. It is posstble, however, to obtain RNA transcripts with correct 5’- and/or 3’-ends by placing the sequence of interest in the plasmid in such a way that transcription begins within the desired region (7).
3.1.7. Cloning of DNA for In Vitro Transcription Digest the DNA fragment and the tion enzymes to generate compatible for recombinants, the DNA insert and different restriction enzymes to allow
plasmid vector with appropriate restricends for cloning. To simplify screening vector should each be digested with two directional clonmg.
1. Set up restnctton digests in mlcrotirge tubes in a total volume of 50 pL. by adding. 10.0 pL (5-10 pg) Plasmtd vector or DNA fragment 2.5 $ (10 U/pL) Restrictton enzyme 1OX Restriction enzyme buffer 5.0 pL Water (to 50 pL) 325 pL 2 Incubate the reaction mixture for l-2 h at the temperature appropriate for the restriction enzyme
Gaur and Krupp
72
3 For the lmeanzed vector only, to prevent self-ligation, add the following components directly to the above reaction mixture: 1OX Dephosphorylatlon buffer 10 ClL 1 U/l 00 pmol for S-protruding ends Alkaline phosphatase and 1 U/2 pmol for recessed ends 100 pL Water to final volume 4 Incubate for 60 mm at 37’C, followed by 30 mm at 55°C 5. Terminate the reactlon with 4 pL of 250 mM EDTA. 6 Extract the reaction mixture with 1 vol of phenol/chloroform. 7 Mlcrofuge the reaction for 2 mm to separate the phases and transfer the top layer to a new tube 8. Extract once with chloroform/lsoamyl alcohol (24-l) 9. Precipitate by adding 2 5 vol of 100% ethanol. 10 Collect the DNA by centrifugation at >lO,OOOg for 10 mm, wash the pellet with 70% ethanol, dry, and dissolve in TE at about 50-100 ng/pL.
3.1.2. Ligation of Plasmid Vector and DNA We recommend 1:2 and 1:5 molar ratio of vector to insert and a control without insert for the ligation reaction. 1 Set up the followmg 10 pL reactlon: 1 p.L (50-100 ng) Linearized vector DNA insert 2N5X Ligation buffer 2cLL Water 4& T4 DNA ligase (1 U/c(.L) 1 pL 2. Incubate for 5 h at 16°C 3. Add 1 & ofE colz tRNA (100 ng/pL), 2.5 pL of 2 MNaCI, 36.5 pL of water, and 150 pL of ethanol. 4 Mix and Incubate for 15 mm at -70°C 5 Collect the DNA pellet by centnfugatlon at >lO,OOOg for 10 mm, and wash the pellet with 70% ethanol 6. Dissolve the dried DNA pellet m 5 pL of water
3.7.3. Transformation
and Plasmid Isolation
Many protocols are available for bacterial transformation (8,9). We use the electroporatlon technique developed by Dower et al. (IO), since it gives higher transformation efficiency than the method employing calcium chloride-treated cells (II). Electroporation should be done as follows. 1 Thaw 25 pL of competent cells (JM 109 strain, Promega, Madison, WI). 2 Add 1 pL of the ligation reaction (Section 3 1.2 ), and subject the mixture to electroporation according to the instructions provided by the manufacturer (BRL, Galthersburg, MD)
Templates for Ribozymes and Substrates
73
3 Mix the cells with 1 mL of LB m a sterile tube 4. Incubate at 37°C for 30 mm 5 Plate 50-100 pL of the cells on an LB plate contammg 50 pg/mL amplclllm, 0.5 mM IPTG, and 40 pg/mL X-Gal Incubate at 37°C for 12-16 h 6 Select the recombinant colonies that are white. 7. Grow a single colony in 1 5 mL of LB medium containing 50 pg/mL ampicillin. 8. Isolate the plasmid DNA using an alkaline lysls method (2,3) Usually, 10-12 pg of DNA can be obtamed startmg with 1.5 mL of culture (see Note 3) 9 Verify the presence of the desired insert by restriction digestion of the plasmld followed by analysis of the reaction products by agarose gel electrophoresls
3.1.4. Linearization of Plasmid DNA 1 Digest 10-20 pg of the recombinant plasmid with the appropriate restriction enzyme that cleaves at the 3’ end of the desired sequence (see Notes 4 and 5) 2 Extract the reactlon mixture twice with 1 vol ofphenol/chloroform and once with chloroform/isoamyl alcohol. 3 Add 0.1 vol of 3 M sodium acetate (pH 5 2) and 2 5 vol of cold ethanol. 4. Chill for 5 mm on dry ice, and then mlcrofuge for 10 mm at 4°C. 5 Wash the pellet with 70% ethanol, dry, and dissolve the dried pellet m TE to a final concentration of 1-2 pg/*.
3.2. PCR for Custom Made DNA Template PCR has become a powerful tool for producmg template DNA suitable for m vitro transcription (12-14). PCR-based template preparation obviates the requirement of lengthy clonmg steps and allows the mtroductton of mutations technique
using altered PCR primers. The most important advantage of this 1s that RNA transcripts with defined ends can be obtained from
virtually any part of a specific gene. Moreover, by selecting the proper PCR primers, restriction sites for clonmg can be created m the DNA template (see Note 6). The strategy for constructmg a DNA template usmg PCR is shown m Fig. 2. The 5’-upstream forward primer (see Note 7) consists of T7 RNA polymerase promoter sequence followed by 15-20 nucleotides of the sequence from the desired region. By mtroducmg changes m the nucleotide sequence (no changes should be made m the promoter region) of the forward primer, it IS possible to generate specific mutations at the 5’-end of the template. The reverse primer consists of about 20 nucleotides and can be used to create mutations at the 3’-end of the template. Owing to the absenceofproofreadmg activity, Taq DNA polymerase can introduce mutations during the PCR amplificatron. Thus, for very long RNAs where base substitution cannot be tolerated, DNA polymerase with a lower mutation frequency, such as Pfu (Stratagene, La Jolla, CA), may be employed (15).
Gaur and Krupp
74
Target S----3’-----
DNA
AATACACGGAnrrCG---------TTATGTGCCTTAAGC ----------
3’
3’ -
AAAGGTCACCCCTAGG-----3 Tl-fCCAGTGGGGATCC -----5 TTTCCAGTGGGGATCC5’
I
PCR amphflcation buffer, dNfPs and Taq polymense
5’ TAATACGACTCACTATAG AATACACGGAAl-KG 3’AlTATGCTGAGTGATATCTTATGTGCCTTAAGC
- -- - - - - -- ----------
AAAGGTCACCCCTAGG lTKCAGTGGGGATCC5
3’
PCR template
Fig. 2. Construction of PCR-synthesized DNA template. The DNA sequence to be transcribed IS contained m a circular plasmid. Two synthetic oligonucleotide primers (forward and reverse) are designed such that each contains 15-20 nucleotides of template sequence. The forward pnmer contains a bacteriophage T7 RNA polymerase promoter sequence (bold letters), and the reverse primer represents the antisense strand of the template. In the first cycle, the bacteriophage T7 promoter sequence will not anneal to the template After 25-30 cycles, the target DNA is amplified as a linear DNA with a T7 promoter upstream of the sequence of interest
3.2. I. Protocol for PCR Amplification 1 For a 100~pL PCR reaction, rmx the followmg components in the order given below 1OX PCR buffer 10 FLL Forward primer 10 pL (100 pmol) Reverse primer 10 i.tL (100 pmol) 1OX dNTPs (2 rnM each) 10 dWater 57 GIL 1% NP-40 loa DNA template 1.0 pL (IO-20 ng1l.L) 1.0 pL (5 II/&) Tag polymerase 2. To prevent evaporation, put a layer of mineral oil (SO-100 pL) on top of the reaction mixture 3 The reaction should be cycled as follows: 25 cycles consisting of 94°C for 1 mm (denaturmg step), annealing temperature depending on the template and primer length (see Note 8), followed by 72’C for 1 mm (the extension step optimum for template of 1 kb). 4. Carefully remove the mineral oil and extract the reaction mixture twice with phenol/chloroform, once with chloroform, and followed by ethanol precipitatton
75
Templates for Ribozymes and Substrates Top rtrsnd containing pmmoter region -17 5’ TAATACGACTC*cr*T~~
Bottom strand and template
3’
containing sequence
promoter
3’AiTATGCTGAGTGATAkCGTACAGTAGCCG (I) 65’C (II) Cool
for 3 mm/denaturatlon at room temperature/
-17 TAATACGACTCACTAd 3’AllATGCTGAGTGATATCCCGTACAGTAGCCG
5’
step annealing
step
5
Incubate at 37’C wth transcnptlon buffer, NTPs and T7 RNA poiymerase 5’
pppGGGCAUGUCAUCGGC
3’
RNA
Fig. 3. A synthetic DNA template The T7 promoter and template sequence are shown +1 mdrcates the transcription mrtiatlon site. Only the promoter regton need be double-stranded
5 Collect DNA by centrtfugatton at 4°C 6 Dry and dissolve the DNA pellet m 10-20 pL of TE buffer (to avoid denaturanon, do not dissolve m water)
We recommend a trial transcription to check the quality of the PCR-amplrtied DNA template. If the expected product does not appear as a major band, it may be necessary to purify the template DNA by nondenaturmg polyacrylamrde or agarose gel electrophoresrs. 3.3. Synthetic DNA Oligos as Templates A very useful method for making small RNAs of defined length and sequence was developed by Mrlhgan et al. (26,I7) usmg synthetic DNA templates and T7 RNA polymerase (Fig 3). Here the template DNA consists of two synthetrc oligos base paired only m the promoter region (-17 to +l). Thrs method offers a number of advantages: 1 The trme- and labor-consuming steps of clonmg are not required 2. The unwanted S- and 3’-sequences from the vector DNAs of the cloned template are ehminated 3 Unltke plasmtd DNA templates, the nucleotide cornpositron of the 5’ and 3’end of the RNA can be specifically chosen. 4 Synthesis of both strands of the template DNA 1s not necessary, since only the promoter region (-17 to -1) of the template must be double-stranded.
76
Gaur and Krupp
Thus, the noncodmg universal top strand, being identical for each template, can be synthesized on a large scale. 3.4. Selection of DNA Template for Transcription Since a full description of the standard protocol for transcription, RNA isolation, and purification is given in Chapter 10 (Section 3.1.), we complete this chapter with a discussion of the effect of template type on the yield and efficiency of transcription. In our experience, the efficiency and overall yield of transcripts from plasmid DNA templates are better than that from PCR-amplified or synthetic DNA templates. Furthermore, double-stranded DNA templates (plasmids or PCR products) usually give higher yields than the synthetic DNA templates containing only a short 18-bp double-stranded region. Similar observations have been made by others, using T7 or SP6transcrtption system(18,19 and see Note 9). Since the molar massof a PCR or synthetic DNA template is much less than a plasmid template, a lesser mass of these templates should m theory be sufficient to obtain yields similar to plasmid templates. However, we have observed that a significantly larger amount of short templates is required to obtain best results. For example, m a 50-pL transcription, contammg a 150-200 nucleotide-long template, 5-10 pmol of template are required for optimum yield. In our experience, the yield of the transcription varies for different templates. We recommend a trial transcription to optimize the conditions for a particular template type. For transcripts produced from synthetic or PCR templates, we recommend that the transcription be followed by a DNase treatment step prior to purlfication of the RNA from a polyacrylamide denaturing gel (see Note 10). The first six 5’-terminal nucleotides of the template play a crucial role in determmmg the overall yield and efficiency of the transcription (26,17). Thus, the first encoded nucleotide in any RNA transcript should be a guanosine. However, a number of moditicattons can be introduced mto the 5’ half of the RNA transcript using initiator ohgos m the transcrtption reaction (20-23). For a detailed study based on the use of initiator oligos in transcription reactions,see Pitulle et al. (24). 4. Notes 1. Treat deionizedwater with 0 1%dlethyl pyrocarbonatefor 12-14 h at 37°C followed by autoclavmg for 30 mm. 2. Virtually all companiesprovide individual buffers or buffer setsfor then enzymes as 10X stocksolutions. 3. In general, most small-scale mmiprep plasmid isolation protocols include an RNaseA treatmentstepto digestbacterial RNA. Before using the plasmid DNA template for transcription, we strongly recommend protemase K treatment (5-100 &mL, at 37°C for 1 h) followed by phenol/chloroform extraction.
Templates for Ribozymes and Substrates
77
4 Complete digestion of plasmld DNA with restriction enzyme is very Important Trace amounts of supercoiled plasmld DNA will allow production of long transcripts, thus reducing the yield of the desired RNA. 5. Protruding 3’-terrmm generated by certain restrictlon enzymes can be converted to blunt ends by the Klenow fragment of E colz DNA polymerase I (25). 6 PCR-amplified DNA can be cloned directly (26) mto commercially avallable cloning vectors, such as pNoTA/T7 (5 prime + 3 prime, Boulder, CO). 7 Incomplete deprotectlon of oligonucleotldes used as PCR primers or for preparing synthetic DNA template can result in abortive products 8. As a rough estimation, the annealing temperature is calculated based on total number of pyrimidine and purme bases m a primer. A temperature of 2 and 4°C IS assigned to each pyrimidme and purme nucleotlde, respectively, and the values summed. For example, if a 20-mer primer contains an equal number of purmes and pyrimidmes, then the annealing temperature should be kept between 55 and 60°C. 9 It is possible to obtain fully double-stranded DNA templates from synthetic templates usmg a DNA polymerase (Klenow, T4 or Taq) to extend the shorter, annealed ohgonucleotide 10. When using PCR or synthetic DNA template, a DNase treatment step should be Included after the transcription, since the size of the transcript is only 17 nucleotldes shorter than the template.
Acknowledgments We are thankful to L W. McLaughlm for comments, and Nyaya Kelkar and Scott Walker for crltical reading of the manuscript. References 1 Chamberlin, M. and Ryan, T (1982) Bacteriophage DNA-dependent RNA polymerases, in The Enzymes, vol 15 (Bayer, P. D. ed.), Academic, New York, pp. 87-108. 2. Bnnboim, H. C. and Doly, J. (1979) A rapid alkaline extraction procedure for screening plasmid DNA. Nucleic Aczds Res. 7, 15 13-1523. 3. Ish-Horowitz, D. and Burke, J F (1981) Rapid and efficient cosmid cloning. Nucleic Acids Res. 9,2989-2998 4. McAllister, W. T. and Morris, C. (198 1) Utilization of bacteriophage T7 late promoters m recombinant plasmlds during mfectlon J. Mol. Biol 153, 527-544 5 Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zmn, K., and Green, M. R. (1984) Efficient in vztro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. NuclelcAclds Res 12,7035-7056 6. Schenborn, E. T. and Mierendorf, R C. (1985) A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure. Nuclezc Acids Res. 13,6223-6236. 7. Sampson, J. R. and Uhlenbeck, 0. C. (1988) Biochemical and physlcal characterizatron of an unmodified yeastphenylalanme transfer RNA transcribed zn vzzro Proc Nat1 Acad Scr USA 85, 1033-1037.
Gaur and Krupp
78
8. Alexander, D. C. (1987) An efficient vector-primer cDNA cloning system. Methods Enzymol
154,4 l-64.
9. Sambrook, J , Fritsch, E. F , and Mamatis, T (1989) Molecular Clonzng--A Laboratory Manual Cold Sprmg Harbor Laboratory Press, Cold Spring Harbor, NY 10 Dower, W J , Miller, J F., and Ragsdale, C. W. (1988) High efficiency transfonnanon of E. coli by high voltage electroporation Nuclezc Acids Res 16,6 127-6 145 11 Mandel, M and Higa, A. (1970) Calcmm-dependent bacteriophage DNA mfectton. J Mol Blol. 53, 159-162 12. Mullis, K B. and Faloona, F. (1987) Specific synthesis of DNA zn vttro via a polymerase-catalyzed chain reaction. Methods Enzymol 155,335-350 13 Stoflet, E S , Koeberl, D D., Sarkar, G., and Sommer, S S (1988) Genomic amplificatron with transcript sequencing Sczence 239,49 l-494. 14. Krupp, G., Kahle, D., Vogt, T., and Char, S. (1991) Sequence changes m both flanking sequences of a pre-tRNA influence the cleavage specificity of RNase P J Mol Blol. 217,637-648.
15. Lundberg, K. S , Shoemaker, D. D , Adams, M W. W , Short, J M , Sorge, J A , and Mathur, E J (1991) High-fidelity amphfication using a thermostable DNA polymerase isolated from Pyrococcus furzosus. Gene 108, 16. 16 Mulligan, J. F., Groebe, D R , Witherell, G W , and Uhlenbeck, 0. C (1987) Ohgoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nuclerc Aczds Res. 15,8783-8798 17. Mulligan, J. F and Uhlenbeck, 0 C (1989) Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol 180,5 l-62 18. Frugier, M., Florentz, C., Hossemi, M., Lehn, J -M , and Giege, R. (1994) Synthetic polyammes stimulate m vitro transcription by T7 RNA polymerase Nuclezc Acids Res. 22,2784-2790.
19 Stump, W. T. and Hall, K. B. (1993) SP6 RNA polymerase efficiently synthesize RNA from short double-stranded DNA templates. Nucbc AczdsRes.21,5480-5484 20 Harris, M E. and Pace, N. R. (1995) Identification of phosphates involved m catalysis by the ribozyme RNase P RNA. RNA 1,210-218. 2 1 Gaur, R K. and Krupp, G. (1993) Modification interference approach to detect nbose moieties rmportant for the optimal activity of a nbozyme Nuchc AczdsRes.21,2 l-26 22. Gaur, R. K. and Krupp, G. (1993) Enzymatic RNA synthesis with deoxynucleoside-5’-0-(l-throtriphosphates). FEBS Lett. 315, 56-60. 23. Conrad, F , Hanne, A., Gaur, R. K., and Krupp, G (1995) Enzymatic synthesis of 2’-modified nucleic acids: identification of important phosphate and ribose moieties in RNase P substrate Nuclerc Aczds Res. 23, 1845-l 853 24 Pitulle, C , Kleineidam, R G., Sproat, B , and Krupp, G (1992) Initiator ohgonucleotides for the combination of chemical and enzymatic RNA synthesis.Gene112,101-105 25 Telford, J L., Kressmann, A., Koski, R. A., Grosschedl, R , Muller, F., Clarkson, S. G., and Birnstiel, M L. (1979) Delimitation of a promoter for RNA polymerase III by means of a functional test Proc Nat1 Acad Scr USA 76,2590-2594 26 Holton, T A. and Graham, M. W (1991) A simple and efficient method for direct clomng of PCR products using ddT-tailed vectors Nucleic Acids Res. 19, 1156
Enzymatic Synthesis and Characterization of Unmodified Ribozymes and Substrates Guido Krupp 1. Introduction This chapter provides the basic procedures for RNA handling, transcription reactions, and transcript punfkation (1,2). For further analysis, the RNAs can be end-labeled. Simple procedures generate a sequence ladder to confirm colineartty of template and transcript (3,4). This is not a “mere luxury,” since examples with significant template slippage have been reported (5). If a small labeled cleavage product 1s produced, also the exact cleavage sites can be determined (6).
2. Materials 2.1. RNA Synthesis and Purification
of Transcripts
1. Template DNA (see Chapter 9) 2 NTP solutions: convenient ready-made 100 mM soluttons are available (Amersham, Pharmacta, and so forth). 3 100 mM Drthrothreitol (DTT) Prepare with sterile water; do not autoclave; store frozen 4. 10X Transcriptton buffer 400 mJ4 Trts-HCl, pH 8 0, 200 mA4 MgCl,, 20 mM spermrdine 5. Optional: RNase inhibitor, RNasm from human placenta (Boehrmger, Promega, and so forth). RNasm can be useful as a safeguard against RNase contammatton, but careful preparation of soluttons avoids the necessity. 6 50% (w/v) Polyethylene glycol (PEG) (M, 6000). Can be autoclaved; store at 4OC 7 0 1% Trrton X-100. Prepare with sterile water, and store at 4°C 8 [cx-~~P]-NTP. convenient, dye-stained, stabilized solutions are available that can be stored at 4°C (Amersham, NEN-DuPont, Hartmann-Analytic, and so forth). Note: High specific actrvtty [~c-~~P]-NTP is not essential, since an activity of 50 Cr/mmol or greater is sufficient (see Note 1). From
Methods m Molecular Edlted by P C Turner
Biology, Vol 74 Rbozyme Protocols Humana Press Inc , Totowa, NJ
79
80 9 T7 RNA polymerase or other phage RNA polymerases (AGS, Boehringer, NE-Btolabs, Pharmacta, and so forth). 10 4 M Ammonium acetate, 20 mM EDTA. Adjust to pH 7 0 and autoclave 11 Ice-cold ethanol (stored at -20°C for rapid coohng) 12 Polyacrylamide gel loading solution: 8 A4 urea, 0 03% tracking dyes (xylene cyanol/bromophenol blue). Prepare with stertle water, and store frozen Small working aliquots can be stored at room temperature 13 Permanent markers for autoradiography. fix tmy pieces of phosphorescent tape (local hardware store) on transparent Scotch tape, and enclose between two layers of Scotch tape. Alternative: use tmy pieces of filter paper, soaked with 14Cmk (mix a radtoactive sample with ink). About 50 pCt/pL are suitable for short exposure times (2-60 min), and 1 pCi/pL for longer exposures 14 Polyacrylamide gel elution buffer O.SMTris-HCl, 0 1 mMEDTA, 1 mMMgCl,, adJust to pH 7 0, autoclave, and then add 0.1% SDS. 15. 3 A4 Sodium acetate, pH 5 0 (autoclave). 16. Optional (see Note 2): high-efficiency transcriptton kit, like AmpliScrtbe (Epicentre), RiboMAX (Promega), and so on 17 Sterile water: dtethylpyrocarbonate (DEPC)-treated water (see Note 3)
2. I. 1. Special Transcription Protocols for Subsequent [5’-32P]-Labeling or for 5’-Modified RNAs (Section 3.1.3.) 1. 2 3 4.
Guanosme, nucleoside (Sigma, Dmucleotide ApG, unmodified Cap analogs m7G(5’)ppp(5’)G Longer, modified, btotmylated, have to be custom-synthesized
2.2. End-Labeling
Boehrmger, and so forth). (Sigma, USB) (Pharmacta) or fluorescent-labeled nutiator oligonucleotides or made m-house (7)
of RNA
1 5 pg/pL Glycogen, molecular-btology-grade 2 4 M Ammonium acetate, pH 7.0 3 Ice-cold ethanol.
(Boehrmger)
2.2.1. 5’-Labeling Additional
matertals
for 5’-labeling:
1. 1 M Trts-HCl, pH 8.0 2 0 2 A4 MgCl,, 32 mM spernudme. 3 [Y-~~P]-ATP with h’ig h specific activity, at least 3000 Ct/mmol (Amersham, ICN, NEN-DuPont, Hartmann-Analytic, and so forth). 4. T4 polynucleotide kinase (PNK) (NE-Btolabs, Boehnnger, Pharmacta, and so forth)
2.2.2. 3’-Labeling with T4 RNA Ligase 1. Deiomzed dimethylsulfoxide (DMSO): In a microfuge tube, mtx about 1 mL of DMSO with about 100 pL of mixed-bed ton-exchange resin, like Amberlite MB-l (Serva) or AG 501-X8 (D) (Bto-Rad). Store wtth the resm at room temperature
Unmodified Ribozymes and Substrates
81
2 Denaturatlon mix: 20 pL,of deiomzedDMSO, 10 pL of 60 mM HEPES-KOH,
pH 8.3 3 RNA ligation buffer 120 mA4HEPES-KOH, pH 8 3,25% delomzed DMSO, 10 & DTT, 30 mMMgCl,, 30 pg/mL RNase-free BSA or autoclaved gelatine. 4 150 @4ATP 5. [5’-32P]-pCp with high specific activity, at least 3000 Wmmol (Amersham, ICN, NEN-DuPont, Hartmann-Analytic, and so forth) 6 T4 RNA ligase (NE-Blolabs, and so forth)
2.2.3. 3’4abeling
with Yeast PO/Y(A) Polymerase (PAP)
I 5X PAP reaction buffer 100 WTns-HCI, pH 7.0,250 mMIW3.5 mMMnCl*, 1 WEDTA, 0 5 mg/mL RNase-free BSA (or autoclaved gelatme), 50% glycerol. 2. “Cordycepm-5’-triphosphate,” [a-32P]-3’-dATP at 5000 Wmmol (NEN-DuPont). 3 Yeast PAP (Amersham, USB).
2.3. Generation and Analysis of Sequence Ladders 1. Carrier RNA, e.g., tRNA from yeast(Boehringer). 2. Tl buffer. 8 A4 urea, 1 mM Na,EDTA, 20 mM sodium citrate, pH 3 5, 0 03% tracking dyes (store frozen). 3 RNase Tl (Boehrmger, Pharmacla, and so forth) 4 Alkali mix. 20 pL. of 9 Murea, 7 5 mL of 200 miVNaOH, 1 5 pL of water and 1 pL of 1% tracking dyes
3. Methods For synthesizmg and handling of RNAs, all equipment items (like plpet tips, microfuge tubes, glassware) and, where appropriate, solutions should be autoclaved. Plasticware can subsequently be dried m an oven (at SO’C). For glassware, baking at 120°C can replace autoclaving. For solutions that cannot be autoclaved (nucleoslde tnphosphates, DTT, spermidme, and so on), the solids are weighed out in sterile containers and dissolved in sterile water or buffer and/or filter-stenlized. Teflon-coated magnetic stir bars can be decontaminated by soaking overnight in a solution of about 20% (w/v) KOH m 50% ethanol and rinsing with sterile water. Glass plates for polyacrylamlde gels can be cleaned with ethanol, but no further precautions are required to remove nucleases. 3.1. Synthesis and Purification of Transcripts The same protocols can be used for the three different template types (plasmlds, double-stranded PCR products, partially double-stranded ollgonucleotldes) described in Chapter 9. It is only important to control the molar amounts. For example, 1 pmol corresponds to 2 B of a 3000 bp transcription plasmid, or to 40 ng of a 60 bp oligonucleotide template.
82
KruPP
For the synthesis of standard transcripts, use sections 3.1.1. or 3.1.2. If subsequent 5’4abelmg is Intended, use the modification m Section 3.1.3. 3.1.1. Standard Protocol for Preparative RNA Synthesis (High Molar Amounts with Low Specific Radioactivity) If very high amounts of RNA are needed, specialized condltlons may be superior (see Note 2). For a 100~p.L transcription reaction, combme the following soluttons m a sterile microfuge tube (see Note 4): a 1 pmol of template (for higher RNA yields, a moderate increase to about 10 pmol is suggested). b. 10 pL of 100 mMDTT. c 10 p.L of NTP mix (containing 20 & of each NTP). d Sterile water (calculate the required amount and add before the 10X transcription buffer; otherwise the DNA may precipitate wtth spermidine) (see Notes 3 and 4) e. 10 pL of 10X transcription buffer f. Optional: 50 U of RNasm g 16 pL of 50% PEG h 10 p.L of 0 1% Triton X-100 1. l-5 pCi of [u-32P]-NTP (this is a negligible molar amount, and the specific activtty is unimportant) (see Note 5). J 200 U of phage RNA polymerase (T7, SP6, and so forth, according to your template). Incubate for 1 h at 37’C (may be increased up to 5 h) Stop (see Note 6) by ethanol precipitation from high salt, which removes most of the unincorporated label. Add 100 pL of 4 M ammonium acetate, 20 mA4 EDTA, and 500 pL of ice-cold ethanol. MIX thoroughly and chill on dry ice for 15 mm (or at -70°C for 30 mm or -20°C overnight), microfuge for 15 mm, and remove the supernatant. Dry the pellet m a vacuum centrifuge, and dissolve m 10-20 pL of polyacrylamide gel loading solution Boil for 2 min in a water bath (avoid vigorous bubbling, smnnermg is sufficient) and spin down brtefly Load onto a standard denaturmg polyacrylamide sequencing gel (thickness up to 0 5 mm). Use 20% gels for transcripts up to about 50 nt, 8% for up to 400 nt, and 4% for larger RNAs (see Note 7) To ensure alignment of film and gel for autoradiography, apply permanent radioactive or phosphorescent markers, and expose for 0 5-16 h as necessary. Localize the desired transcript, excise the correspondmg gel piece with a sterile scalpel, and transfer it to a microfuge tube For RNA elution, add 200 pL of polyacrylamide gel elution buffer Agitate vigorously overnight at room temperature Mtcrofuge for a few seconds, remove the solution mto a fresh tube, rinse the gel piece with 100 pL of fresh elution buffer and combme.
Unmod/fied Ribozymes and Substrates
83
10. Precipitate by adding 20 pL of 3 A4 sodium acetate, pH 5.0, and 750 pL of ethanol, and chill as m step 3 above (see Note 8). 11. Microfuge for 15 mm, and remove the supernatant. 12. The yields of 32P-labeled transcripts can be determined by measurmg the Cerenkov radiation The RNA is dtssolved m a standard volume of water (e g , 100 pL,), and it is used directly m a scinttllation counter. No scmtillatton cocktail IS required. The counting efficiency is about 50%. This means l,OOO,OOOcpm are equivalent to 1 @I. Reasonable yields are between 10-100 pmol RNA/pm01 template DNA (see Note 9)
3.1.2. Standard Profoco/ for Synthesis of RNA with High Specific Radioactivity Follow all procedures in Section 3.1.1.) but make the following changes: 1. Replace the standard NTP mrx by NTP labelmg mrx (contaimng 10 mh4 ATP, CTP, GTP, and only 0.2 mM UTP) (see Note 1). 2. Use a high amount of [w~~P]-UTP, e.g., 10-100 uCi. 3 The expected exposure times for autoradiography vary between 1 and 30 mm.
3.1.3. Special Transcription Protocols for Subsequent [5’-32P]-Labeling or for 5’-Modified RNAs For 5’-labelmg, T4 polynucleotide kmase is used to transfer the terminal phosphate group from [Y-~*P]-ATP to a free 5’-hydroxyl of the RNA. Conventional transcripts carry a 5’-triphosphate. In principle, it can be removed by phosphatase
treatment.
However,
for a more convement
procedure with high
labeling efficiencies, RNA IS synthesized directly with a free 5’-hydroxyl group. This can be achieved m two ways. As described in Section 3.1.3.1,) an excess of free guanosine nucleoside is included m the transcription reaction, and it can (partially) replace the 5’-termmal, initiating GTP (8). An alternative with improved efficiency is outlined m Section 3.1.3 -2. In this case, an extra 5’-terminal nucleoside will be added. Here, an Initiator dmucleotide (e.g., ApG) is used, which will quantitatively replace the initiating GTP (7). As outlined in Sections 3.1.3.3. and 3.1.3.4., the same strategy can be used to obtain 5’-capped RNAs (9), to add a longer 5’-terminal sequence, and to introduce site-specific, 5’-proximal nucleotide modifications or nonradioactive labels, like biotin or fluorescein (7). Follow all procedures in Section 3,l. 1.) but make the followmg changes: 3.1.3.1.
TRANSCRIPTS WITH A FREE 5’-HYDROXYL GROUP
A ratio of 1O:l for guanosine:GTP is required. Replace the standard NTP mix to obtain 100 uM GTP (final concentration), and include 1 mM guanosme (final concentration) (Section 3.1.1.) step 1c).
84
K~UPP
The lowered GTP concentration will reduce the total transcript yield, but higher concentrations of the moderately soluble nucleoside guanosme are impracttcable. The yteld of labeled product (cpm per transcription reaction) is comparable to the two-step procedure with phosphatase treatment. 3.1.3.2.
TRANSCRIPTS WITH A FREE 5’-HYDROXYL GROUP AND AN EXTRA ADENOSINE
Include the dmucleotide ApG at an amount equimolar with GTP (Section 3.1.1.) step lc). No other changes are necessary. 3 1.3.3. ADDITION OF A ~-CAP STRUCTURE
Similar to the use of guanosme, an excessof 5: 1 for cap:GTP is suggested. Reduce the GTP to 100 pJ4 GTP, and mclude 500 pM cap dinucleotide (Section 3.1.1., step lc). 3.1.3 4 5’-EXTENDED OR 5’-MODIFIED RNAs
1 The phagepolymeraseshave ahigh preferenceto initiatewith guanosine.It is almost
impossibleto obtain adifferent 5’4ermmal nucleotide;only adenosineISaccepted, but a high excess of ATP over GTP was required to obtam uniform S-ends (I) 2 The addttton of mtttator ohgonucleotides (like ApG) gives more flexibihty Also longer oligonucleotides can be used (up to hexamers have been analyzed), only the 3’-terminal G must be maintained to replace the uuttating GTP. In addition, modtfications can be introduced, like 2’-deoxy-, 2’-O-methyl-, btotmylated, and more recently, fluorescent-labeled nucleotides. For more details, please consult ref 7 (see also Chapter 12).
3.2. End-Labeling 3.2.1. 5’-Labeling
of RNA (See Note 10)
A transcript with a free 5’-hydroxyl group should be used (see Section 3.1.3.). About 105-lo6 cpm can be expected from I pmol RNA. 1 Use about 1 pmol of transcript (with 5’-hydroxyl), add 1 pL of 1 MTns-HCl, pH 8 0, and water to obtain 8 pL
2. Heat-denatureby boiling for 2 mm, and chill on ice. Sptn down briefly. 3. Add 1 pL of 0.2 M MgC&, 32 mM spermrdme, 1 pL of 100 n&Y DTT, 3 pL (10-50 pCi) of [y-32P]-ATP (use htgh spectfic activity, at least 3000 Wmmol), and 1 pL of T4 polynucleottde kinase (10 U). 4. Incubate for 30 min at 37°C. 5 Terrnmate by ethanol precipttation from htgh salt by addmg 1 pL of (5 pg/pL) glycogen (as carrier), 14 pL of 4 A4 ammonmm acetate, pH 7 0, and 70 pL of ethanol. 6. Mix thoroughly, and chill on dry ice for 15 min (or at -70°C for 30 mm or -20°C overnight) 7 Micromge for 15 min, and remove the supernatant.
Unmodified Ribozymes and Substrates
85
8. Proceed wrth gel purlficatton as described m Sectron 3 1.1 starting at step 4. 9 The expected exposure times for autoradtography should be 1 to 20 min
3.2.2. 3’-Labeling with T4 RNA Ligase This method gives good labeling efficiencies with short RNAs, although 3’-terminal urrdines should be avoided. The alternative procedure with poly(A) polymerase should be considered especially for long RNAs (Section 3.2.3.). 1 Take 1 & (about 1 pmol) of transcript in water, and mix with 1 pL of denaturation mix. 2. Heat-denature by borlmg for 2 mm, chill on me, and then spin briefly 3. Add 2 pL of RNA ligation buffer, I pL of 150 @4 ATP, 1 $ (10-20 @I) of [5’-32P]-pCp (at least 3000 Wmmol), and 1 uL of T4 RNA hgase (10 U) Then incubate overnight at 8-14°C 4. Terminate by ethanol precipitation from high salt by adding 1 pL of (5 pg/pL) glycogen (as carrier), 10 pL of 4 A4 ammonmm acetate, pH 7.0, 3 N of water, and 50 mL of ethanol 5 Proceed as described m Sectron 3.2 1,, starting at step 6.
3.2.3. 3’-Labeling with Yeast PAP This IS the method of choice for 3’-labeling of long RNAs (IO). 1. Take 6 pL (about 1 pmol) of transcript m water, heat-denature by botlmg for 2 mm, chill on me, and spm brtefly. 2. Add 2 & of 5X PAP reaction buffer, 1 uL (10 ~CI) of [a-32P]-3’-dATP, “cordycepm-5’-trtphosphate” (5000 Cmnmol), 1 pL poly(A) polymerase (500 U), and incubate for 20 mm at 30°C. 3 Terminate by ethanol preciprtatron from hrgh salt as in Section 3.2 2. startmg at step 4
3.3. Generation
and Analysis of Sequence Ladders
For the characterization of transcripts and analysts of ribozyme reacttons, m general it IS sufficient to combme one base-specific sequence ladder with a random sequence ladder. For more complete RNA sequence analysts, consult other manuals (3,4) With the indicated amounts of radroactivrty, only an overnight exposure (at -7OOC) is required for autoradiography, if an mtensrfymg screen is used. 3.3.1. Guanosine-Specific
RNA Cleavage with RNase TI
Since the required amounts of enzyme vary it is best to perform a small dilution series. 1 Prepare26 pJLof end-labeledRNA (at least60,000 cpm) contanting26 pg carrier RNA (do not substitute, smce this 1srequired as an RNase substrate)
86
KruPP
2. Dispense 5 pL ahquots m fresh mrcrofuge tubes, and dry down all five samples. 3 Add 4 Ccs,of Tl buffer to each of four of the five samples No enzyme is added to one of these, which becomes the undigested control sample The fifth sample is used for alkali cleavage (see Section 3 2 2.) 4 Premcubate the four tubes for 5 mm at 50°C 5 To the first tube, add 1 $ of RNase Tl (about 3 U of Boehrmger enzyme), mix, and withdraw 1 pL 6 To the second tube, add 1 pL from the first tube, mix, and withdraw 1 4. 7 To the third tube, add 1 pL from the second tube 8. Incubate the four samples for 15 mm at 50°C 9 Stop the reaction by freezing on dry ice. Keep for gel analysis (see Section 3 3 3 )
3.3.2. Random RNA Cleavage with Alkali 1, To the dry RNA sample (Section 3 3.1 , step 2), add 4 pL of alkali mix 2 Heat for 2 mm at 80°C 3 Stop by freezmg on dry ice Keep for gel analysis (see Section 3 3.3 )
3.3.3 Sequenang
Gels and Analysis
Spm all frozen samples from Sections 3 3.1. and 3 3 2 briefly, and load on a standard sequencing gel. 2 Electrophorese and autoradiograph A sample result is shown in Fig 1. The following observations are evident a In the random sequence ladder with alkali, the band mtensmes are very even and decrease regularly from bottom to top. Cleavage occurred m efficient denaturing condmons b. The distances between mdividual bands m the sequence ladder vary There is a large gap before a G, which is smaller for A and U, and even smaller for C This can help to discover differences between the predicted template and the observed transcript sequence c. Although all expected guanosme bands are present m the RNase Tl sequence ladder, the band mtensmes vary greatly This is usually observed m enzymatic digests because of mefficient denaturation in the cleavage reaction d The RNA fragments analyzed m the sequence ladders carry a 3’-terminal phosphate If the ribozyme cleavage products ternnnate with a 3’-hydroxyl (like with RNase P RNA), they mtgrate more slowly m the gel and are shifted approximately one nucleotide position upward Frequently, they migrate somewhat “out of frame” (6)
4. Notes 1 The more expensive [a- 32P]-UTP with high specific activtty is not required However, consider the following The final concentration of UTP should be about 20 I.&!, equivalent to a total amount of 2 nmol in a 100~pL reaction If you use [~x-~~P]-UTP with high specific radioactivity (e.g., 3000 C~/mmol), 100 ~CI are equtvalent to 0 033 nmol (essentially negligible). With low specific activity
Unmodified Ribozymes and Substrates -Ti
87
OH-
G C
Fig. 1. Example of sequence ladders. The first lane (-) is the undigested control, lane TI is the guanosine sequence ladder, and lane OH- is the random sequence ladder. The predicted sequence is indicated at the left margin. (50 Ci/mmol), 100 pCi are equivalent to 2 nmol. This is the total amount required. Accordingly, UTP has to be omitted completely in the NTP labeling mix to obtain maximal labeling efficiency. 2. In general, a final concentration of l-2 mMNTPs is used. Considering the excess of 20 mMMgC1, (recommended to be at least 4 aabove the total NTP concentration), higher concentrations can be used and may result in improved transcript yields, but no general predictions are possible, and optimized conditions have to be worked out for the specific template used. Similarly, excellent yields can be obtained with some templates and a commercially available high yield transcription kit, like AmpliScribe (Epicentre), RiboMAX (Promega), and so forth.
88
KNAPP
3 Always use DEPC-treated water for steps involving 4 5 6
7
8 9.
10.
synthesis, storage, or handling of RNA. To avoid spermldme preclpltatlon of the DNA, transcrlptlon reactions should always be assembled at room temperature. For the synthesis of internally labeled transcripts, any [a-32P]-NTP can be used, since equlmolar concentrations of all four NTPs are used. Some protocols recommend a DNase treatment to digest the DNA template, followed by phenol extraction to remove the polymerase This is not required If the transcripts are precipitated m the presence of EDTA (to mmimlze loss of Mg-RNA precipitate) and gel-purified. Bromophenol blue comlgrates with RNAs of about 7,20, and 75 nt on 20, 8, and 4% polyacrylamlde gels, respectively. Xylene cyan01 comigrates with 27, 70, and 200 nt long RNAs Five micrograms of glycogen can be added as carrier. Glycogen is free of proteins and nucleic acids and does not interfere with any nucleic acid activity. If poor transcript yields are obtained, compare with a reference template (supplied with the enzyme by some commercial suppliers) to confirm that all transcription components are working. The following points may be helpful. a. Poor yield or high amounts of short products (especially if a smear occurs) are observed with your own and with the control template. Possible nuclease contarmnation-replace aII solutions Consider adding RNase inhibitor, If not yet present b. Degradation problem occurs only wtth your template. Phenol extract it repeatedly, ethanol-preclpltate, and wash wrth 70% ethanol. c Poor yield with your template. Maybe your template DNA IS denatured. Avoid dissolving your template in water. Always use TE (20 mM Tns-HCl, pH 8 0, 1 mM EDTA). Short templates can be renatured by heating m TE and slow coolmg. If a large plasmid fragment 1sused, prepare a fresh restriction digest. d If your template is a partially single-stranded synthetic DNA, and only the 18-mer promoter section is double-stranded, which is the most economic type for short RNAs, occasionally, this results m poor transcript yields (1 I) This can be overcome by the use of a special polyamme (IZ). A simple alternative is the elongation of the 18-mer promoter by a few (about five) cycles of PCR to obtain completely double-stranded template DNA (see Chapter 9). e Note that the quality of enzyme batches can vary Do not hesitate to complam to your supplier. f If the desired template contains a number of Us m a row, then increasing the UTP concentration (twofold) may boost transcript yield. g For short templates, increased incubation time, T7 polymerase, or template concentration may improve yields. h For long templates, mcluding morgamc pyrophosphatase (0.25 U/&) may increase transcription yield. If you observe mefficlent labeling, compare with labeling of a reference RNA Consider nuclease contamination m solutions (replace them) or m your RNA sample (phenol-extract and preclpltate).
Unmodified Ribozymes and Substrates
89
References 1 Krupp, G (1988) RNA synthesis strategies for the use of bacteriophage RNA polymerases. Gene 72,75-89 2 Mulligan, J F. and Uhlenbeck, 0. C (1989) Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 180, 5 1-62 3 Stahl, D A., Krupp, G., and Stackebrandt, E (1989) RNA sequencing m Nuclezc Acid Sequencmg A Practical Approach (Howe, C J. and Ward, E S., eds ), IRL, Oxford, pp 137-183. 4 Krupp, G (1991) Direct sequence analysis of small RNAs, m Nuclezc Aced Techniques in Bacterral Systematrcs (Stackebrandt, E and Goodfellow, M., eds ), Wiley, New York, pp. 95-114 5 Reyes, V. M. and Abelson, J (1988) Substrate recognmon and splice site determmatton m yeast tRNA sphcmg CelE 55,7 19-730 6 Krupp, G., Kahle, D , Vogt, T , and Char, S. (1991) Sequence changes m both flankmg sequences of a pre-tRNA Influence the cleavage spectficity of RNase P J A401 Blol 217, 637-648. 7 Pitulle, C., Kleineidam R G , Sproat, B., and Krupp, G. (1992) Initiator ohgonucleotides for the combmation of chemical and enzymatic RNA synthesis Gene 112,101-105
8 Harris, M. E and Pace, N. R. (1995) Identification of phosphates involved m catalysts by the ribozyme RNase P RNA RNA 1,2 10-2 18. 9 Konarska, M. M., Padgett, R A., and Sharp, P. A. (1984) Recognition of cap structure in splicing zn vitro of mRNA precursors. Cell 38, 73 l-736 IO. Lmgner, J and Keller, W (1993) 3’-End labelmg of RNA with recombinant yeast poly(A) polymerase Nucleic Acids Res 21,2917-2920 11 Frugier, M., Florentz, C , Hossemt, M W , Lehn, J -M , and Giege, R (1994) Synthetic polyammes stimulate zn vztro transcription by T7 RNA polymerase Nucleic Acids Res 22,2784--2790
T7 Transcript Length Determination Using Enzymatic RNA Sequencing Andrew Siwkowski 1. Introduction The T7 transcription method from single-stranded templates with a doublestranded promoter is a common method of preparing RNA for in vitro rrbozyme studies (I). Although the identification of full-sized rlbozyme transcripts IS fairly straightforward after gel separation, the same cannot be said for the shorter substrate transcription products. Substrate gel separation always results in a heterogeneous population of RNA bands that differ in length. Previous research has shown that the shorter than full-size RNAs are the products of aborted transcription that share Identical S-sequences. The RNAs that are one nucleotrde larger than full srze are owing to the propensity of T7 RNA polymerase for adding a single uncoded nucleotrde to the full-size product (1). RNAs that are significantly larger than the coded transcript can also be produced by T7 RNA polymerase via RNA-directed RNA polymerization (2). This phenomenon 1sbelieved to occur when the initial transcription product can be used as either an mtermolecular or intramolecular RNA primer that is subsequently extended by T7 RNA polymerase. To determine which band on the substrate gel contains the complete sequence coded for by the DNA template, enzymatic RNA sequencing IS used (3,4). This method takes advantage of the cleavage specificity of a variety of RNases that are incubated with the substrate RNA m separate reactions. The reactrons are then run out on a denaturing PAGE gel, and the resulting band patterns are compared with a hydrolysis ladder produced from the same RNA. The resulting mformatton provides a maJorrty of the specific nucleotide sequence of the substrate RNA digested, but more rmporFrom
Methods m Molecular Edlted by P C Turner
Btology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
97
92
Siwkowski
tantly provides enough Information when compared to the hydrolysis ladder to obtain the size, m nucleotldes, of the RNA digested. Once the size of one band is determined, the sizes of the remainder of the shorter transcripts can be deduced. Using this method, positive ldentlficatlon of the band of Interest IS possible This procedure is broken down into four main subsections: transcriptlon using T7 RNA polymerase, 5’-dephosphorylatlon of transcripts, 5’-end-labeling of transcripts, and enzymatic dlgestlon of RNA. 2. Materials
2.1. Transcription Required
materials
Using T7 RNA Polymerase are given m Chapter 23, Sectton 2.1
2.2. 5’-Dephosphorylation
of Transcripts
1 0 4 w m vitro transcribed RNA (3 a) 2. Sterile HZ0 3 10X TA buffer 330 mMTns-acetate, pH 7.8,660 mMpotassmm acetate, 100 mA4 magnesium acetate, 5 mM dithlothreltol (DTT) 4. 50 mA4CaC1, 5. HK Phosphatase (1 U/K), Eplcentre Technologies, Madison, WI 6. A 30°C water bath. 7. A 65°C water bath
2.3.5’-End-Labeling 1. 2 3 4. 5. 6. 7. 8. 9 10 11. 12. 13 14. 15 16. 17.
of Transcripts
Dephosphorylated RNA (from Section 3 2.) 1 WATP. 10 mM Spermidme. 10X Kinase buffer. 700 mM Tris-HCl, pH 7.6, 100 mM MgC12, 50 mM DTT r3’P ATP (10 @I/$, 4500 Cl/mmol) Sterile H20 T4 Polynucleotlde kmase (PNK) (10 U/&), Promega, Madison, WI. A 37°C water bath 3 M Sodium acetate, pH 5.2. 100% Ethanol. Glycogen (20 pg/pL), Boehrmger-Mannhelm, Germany. 98% Formamide dye consisting of 10 mA4NazEDTA and 1 mg/mL each of xylene cyan01 and bromophenol blue dyes. A -80°C freezer A 15% PAGE, 7 A4 urea gel A sterile scalpel for excising the RNA from the gel RNA extraction buffer: 0 5 Mammomum acetate, 2 mMNa,EDTA, and 0.5% SDS. A sterile mlcrocentrlfuge tube pestle for grmdmg the excised gel slice
93
T7 Transcript Length Determination 2.4. Enzymatic Digestion
of RNA
1. End-labeled RNA (from Section 3.3 ). 2 Carrter tRNA (1 75 pg/pL). 3 Sterile Hz0 4 RNases at 1 l-J/$,* RNase Tl; RNase U2, RNase Phy M; RNase B cereus 5 RNase buffer compositions: T 1, U2 buffer: 33 mA4 sodium citrate, pH 3 5,9 4 Murea, 1.5 WEDTA, and 0.04% xylene cyan01 Phy M buffer 33 mA4 sodium citrate, pH 5.0,9.4 Murea, 1 5 WEDTA, and 0 04% xylene cyan01 B cereus buffer 60 rmI4 sodium citrate, pH 5.0, 2 7 rmI4 EDTA Hydrolysis buffer 50 mM sodrum phosphate, pH 12 0 Load buffer: 9.8 A4 urea, 1.5 mM EDTA, and 0.05% xylene cyanol. 6 A 50°C water bath 7 A 15% PAGE, 7 M urea gel. All RNases are available from PharmaciaBlotech, Piscataway,NJ All RNase buffers are available from USB, Cleveland, OH (USB product number 76000)
3. Methods 3.1. Transcription Using T7 RNA Polymerase This procedure IS described in detail in Chapter 23 and ~111therefore not be addressed here. However, one issue that deserves reiteratron IS the specrfic activity of the transcription product. The basis for the followmg procedures for RNA sequencing rely on the ability to end-label the RNA to a significantly higher level than is represented by the tntemal
labeling,
whrch occurs during
transcriptton. If the radroacttvity owing to mternal labeling is not significantly less than that resultmg from end-labeling, no useful mformation will be obtamed. The followmg procedures solve thus problem by utilrzmg a small amount of Internally labeled RNA (1.2 pmol) and end-labeling It to a much hrgher specrfic activrty. When used m conjunction with the transcription procedure outlined in Chapter 23, the procedures outlined here will yield endlabeled RNA with a specific activity two to three orders of magnitude higher than the specific activity resulting from internal labeling as a result of transcription This increase IS sufficient to prevent 3’ RNase digestron fragments from appearing on the sequencing gel that is crucial to the success of the procedure. 3.2. 5’-Dephosphorylafion
of Transcripts
To 5’-end-label the RNA, the transcript must first be dephosphorylated. The use of HK phosphatase allows one to bypass the usual requirement of phenol extraction to remove the phosphatase prior to end-labeling. This
94
Siwkowski
enzyme IS efficiently inactivated when incubated at 65°C for 15 mm. This mactlvatlon IS imperative for the subsequent end-labeling to be successful. 1 Assemble the followmg 30 l.tL reactton mrx m a mtcrofuge tube 04p&‘RNA* 3lJL H,O. 20 ClL 1OX TA buffer 3c1L 50 mA4 CaCI,: 3ccL HK Phosphatase (1 U/pL) 1 pL 2. Incubate at 30°C for 1 h. 3 Heat-inactivate the phosphatase at 6S’C for 15 mm
3.3. S-End-Labeling
of Transcripts
1 Add the following to the 30 pL of dephosphorylated RNA from Section 3 2 * 1 cuz/rATP 3c1L 10 @4 sperrmdme 5 pL 10X Kmase buffer 5 pL y32P ATP (10 uCi/pL) 3 pL H20 34 T4PNK(lOU/pL) 1 pL 2 Incubate at 37°C for 1 h 3 Add 5 pL of 3 M sodium acetate, pH 5 2, 150 mL of 100% ethanol, and 1 pL of glycogen (20 pg/uL). 4 Freeze to precipitate at -80°C for 20 min. 5 Microfuge at 14,000g for 20 mm at 4°C and discard the supernatant 6 Dry the pellet under a vacuum 7. Resuspend the pellet m 10 pL of H20 and 10 pL of 98% formamtde dye 8 Heat the sample at 95°C for 2 mm, and snap-cool it on me 9. Load the sample on a 15% PAGE, 7 Murea gel (see Note 1) 10. Visualize the end-labeled RNA usmg autoradiography. 11 Excise the full-stze end-labeled RNA 12 Extract the RNA from the gel as described in Chapter 23, Section 3 1. 13 Resuspend the end-labeled, gel-purified RNA m 10 pL of H20. It IS now ready for use m the RNase digestron reactions
3.4. Enzymatic Digestion of RNA The followmg procedure was derived from a protocol that accompanied the “USB RNA Sequencing Kit-Nuclease Method” (see Note 2). The followmg protocol has been used successfully to enzymatrcally sequence RNA. 1 Make an RNA mtx by adding 6 1.18of carrier tRNA and sterile H20 (to 21 @, total) to the end-labeled RNA from Sectton 3 3. 2. Add 3 ILL of RNA mix to each of the followmg 6 reactions:
T7 Transcript Length Determnat~on Reaction Tl u2 Pby M B cereus
RNase, 1 U/& 1 pLRNaseT1 1 pL RNase U2 1 IL RNase Phy M 1 & RNase B cereus
OHControl 3. 4. 5 6
95 Buffer 7 pL Tl, U2 buffer 7 pL Tl, U2 buffer 7 pL Phy M buffer 2 pI., B cereus buffer 3 I,L hydrolyses buffer 6 pL load buffer
Incubate at 50°C for 60 min Add 6 pL of load buffer to the B cereus and OH-tubes Run on a 40 cm long 15% PAGE, 7 M urea gel. Terminate the gel run when the xylene cyan01 has run l/3 of the way down the gel
3.5. Transcription and Sequencing Results and Interpretation Figure 1 shows the typical results from transcription and sequencing of a ZO-nt RNA. The template and expected full-srze RNA product are as follows: SGCGACUGUGUCCUGAAGAAA -+I STAATACGACTCACTATAGCG 3’ 3’ATTATGCTGAGTGATATCGCTGACACAGGACTTCTTT
3’
RNA product (20-mer) partial duplex template
5’
The template consists of partial duplex DNA containing the double-stranded RNA polymerase promoter region. The transcription start site is indicated (+l). Shown above the template is the anticipated full-size transcript coded for by the template. The first step is to decide which transcription product band isolated from the transcription gel will be sequenced. Based on the fact that the 22 nt DNA marker migrates as an RNA approx 19 nt m length and that the expected full-size transcription product is a 20-mer, band A from the transcrip-
tion gel is a likely candidate for the full-size transcript. Further, the appearance of a prominent band 1 nt larger than band A would correspond to the product of T7 RNA polymerase adding a single uncoded nucleotide to the transcript. For these two reasons, band A was suspected of being the full-size transcript and was sequenced. The occurrence of bands in each of the reaction lanes from the sequencing gel corresponds to the digestion of the end-labeled RNA by each separate RNase. Although each digestron ~111result m two fragments, only those containing the end-labeled S-end of the full-size RNA will appear on the autoradtogram. The sequence of the RNA can then be obtained by observing the band patterns in each reactron lane (seeNote 3). The occurrence of bands corresponds to nucleotide identity m the followmg manner: Tl = G, U2 = A, Phy M = A or U, and B. cereus =C or U (3,4). The sequence can thus be read 5’ to 3’, bottom
Siwko wski
96
T7 Transcription
RNA Sequencing
3’ end ? A A G A A G U C C U G U G
U C A 5’ end
Fig. 1. Transcription and sequencing gels. The autoradiogram on the left is from a 15% PAGE, 7 Murea gel showing the T7 transcription products using the previously depicted template. The lettered products were excised, and the RNA extracted. A portion of the RNA isolated from band A was enzymatically sequenced. The autoradiogram on the right is from a 15% PAGE, 7 Murea gel on which the sequencing reactions were run.
to top, and the bands in the hydrolysis ladder can be associated with specific 3’-base identities. Once the sequence is determined, one can merely count the number of bands apparent in the hydrolysis ladder, starting from a band positively associated with the known sequence coded for by the template and ending with the undigested RNA band, to determine the 3’-end of the sequenced RNA (see Note 4). Based on the invariability of the T7 transcription start site, the 5’ end is already known. With these two pieces of information, the size of the transcript can be determined (see Note 5).
T7 Transcript Length Determination 4. Notes 1 It is important to gel Isolate the end-labeled product to ensure that only the fullstze transcript is used m the RNase digestions. If partial degradation of the RNA has occurred during RNA extraction, dephosphorylatton, or end-labeling, and the end-labeled products are not gel-purified, spurious bands may appear on the sequencing gel autoradiogram, which will render the RNase digestion results unusable. 2. Although the kit 1s no longer avatlable (USB Product No. 76000), the protocol can be obtained through USB technical assistance It contains mformation about how to “fine tune” the procedure for a specific apphcatron 3. The sequencing gel m Fig 1 only shows 17 of the 20 bases from the transcript. The sequence of the three bases at the S-end of the transcript are not shown These digest products ran off the gel durmg the course of electrophorests. Although no sequence mformation was obtained from them, it did not hinder the identification of transcrrpt length determmatron. 4. Some bands that occur m the hydrolysis ladder do not correspond to any observed m the reaction lane. Thts has been attributed to the variable fate of the 2’,3’-cyclic phosphate on the end-labeled fragment produced from hydrolysis This phenomenon is most evident toward the bottom of the gel, which corresponds to the smaller RNA digestion products, but is less obvious wtth the larger fragments 5. The specific base identity of the 3’-terminal nucleottde cannot be determined with this method, and 1stherefore represented on the sequencing gel by V’ Since its presence is represented by the undigested RNA band on the sequencing gel, it can still be accounted for m determmmg the length of the transcript sequenced
Acknowledgments The author would lrke to thank United States Biochemrcal Corporation assistance during the preparation of this manuscript, and Arnold Hampel support of the work contained herein (supported by NIH grant A129870).
for for
References 1 Milhgan, J. F., Groebe, D R , Wttherell, G. W., and Uhlenbeck, 0. C. (1987) Ohgoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Aczds Res 15, 8783-8798. 2. Cazenave, C. and Uhlenbeck, 0. C. (1994) RNA template-directed RNA synthesis by T7 RNA polymerase. Proc Natl. Acad. Sci USA 91,6972-6976 3 Doms-Keller, H (1980) Phy M: an RNase activity specific for U and A residues useful m RNA sequence analysis. Nucleic Acids Res 8,3 133-3 142 4 Donis-Keller, H., Maxam, A. M., and Gilbert, W. (1977) Mapping adenmes, guanmes, and pyrimtdmes in RNA Nucleic Acids Res 4,2527-2538
12 Chemical and Enzymatic Approaches to Construct Modified RNAs Rajesh K. Gaur and Guido Krupp 1. Introduction Synthesis of modified nucleottdes and then incorporatton mto an RNA chain have facilitated our understanding of the functron and mode of actron of spec~fic nucleotrdes within the rrbonuclem acid. Recent developments m the chemical and enzymatic synthesis of RNAs (I-3) have allowed the introductron of single-atom substttutrons at specific positions m an ohgortbonucleotrde. For example, mtroductron of deoxyrtbose moieties in an RNA or the replacement of natural nucleotrde by a base not normally found in nucleic acids ISnow possible (4,5). There are three major targets for modrfication of RNA: the exocyclic base, the sugar, and the mternucleotrde phosphodiester lmkage. In thus chapter, our focus wrll be mainly on the construction of modified RNAs using a combination of chemical and enzymatic techniques. 2. Materials m7G(5’)ppp(5’)G, NTPaS nucleotides and NTPs (0.1 M solutions) can be obtained from Pharmacra. DTT, RNasin, T7 RNA polymerase, and T4 polynucleotide kinase can be obtained from Promega (Madrson, WI). The sources of polyethylene glycol (PEG) 6000-8000 and T4 DNA hgase are Sigma and US Biochemical, respectively. The other reagents and buffers required are: 1. 10X Transcrlptlon buffer 400 n&I Tns-HCl, pH 8.0, 200 mA4 MgCl,, 20 mA4 spermidme. 2. 10X Kmase buffer 500 mM Tris-HCl, pH 8.0, 100 mA4 MgCl,, 100 m&I DTT 3. 10X RNA ligation buffer 500 r&I Tns-HCl, pH 7 5, 10 mA4 MgCl*, 10 mM ATP, 500 pg/mL BSA From
Methods m Molecular Edlted by P C Turner
Bfology, Vol 74 Flrbozyme Protocols Humana Press Inc , Totowa, NJ
99
700
Gaur and Krupp
4. Polyacrylamtde gel loadmg buffer: 8 Murea, 0.03% tracking dyes (bromophenol blue and xylene cyanol) 5. 10X Modtfied transcription buffer (MTB): 400 mA4 Tris-HCl, pH 8 0, 20 mJ14 spermidme. 6. 25 mMMnC1, 7 25 mA4 MnCl,, 25 mM MgCl,. 8. 50% PEG 9 0 1% Triton X-100 10 3 A4 Sodium acetate, pH 5.2. 11 Glycogen (5 pg/pL) as carrier. 12. 100% ethanol 13 PhenolKHCl,: phenol:CHC13 isoamyl alcohol m the ratio 50*49:1 with 0 1% 8-hydroxyqumolme. 14 CHCl,/isoamyl alcohol. 24.1 CHC@oamyl alcohol 15. Sterile water
3. Methods 3.1. 5’-Terminal Modified RNA 3 1.1. Introduction of Cap Analog RNA transcribed by RNA polymerase II (~0111) contains a unique Y-terminus, known as the S-cap. This cap consists of a guanosine residue methylated at the N-7 position and linked to the first encoded nucleotide via a triphosphate linkage (6). In addrtton to havmg an important role in RNA metabolism (7-g), this cap structure protects the RNA against 5’-exoribonucleases (I &Z2). Furthermore, for efficient splicing of eukaryotic pre-mRNA substrates, the presence of a S-cap structure has been shown to be important (13). Therefore, for in vitro RNA processing, it IS desirable to transcribe pre-mRNA containmg the 5’-cap structure. Depending on the requirement, high- or low-specific activity RNA can be transcribed using the followmg protocol (see Note 1 and cf Chapter 10 for a standard transcription protocol). 1. For a 50 pL transcription reaction, mix the following components: 1OX Transcription buffer 504 Water 11.5 llL 10 mM m7G (5’)ppp(5’) G 10.0 pL Mixture of NTPs: A and C at 4 mM, U and G at 1 mM 5.0 pL 0 1 MDTT SONRNasm (20 U/uL) 0.5 /.lL [a-32P]UTP (10 @I/&) 10.0 l.lL DNA template (l-2 pg/pL; l-2 pmol) 104 T7 RNA polymerase (20 U/pL) 2.0 /AL 2 Incubate for 2-3 h at 37°C.
Chemical and Enzymatic Approaches
101
3 Add 0.1 vol of 3 M sodmm acetate, pH 5.2, 1 pL of glycogen (5 pgI$) as carrier, and 1.50 pL of cold ethanol, vortex, and freeze in dry me for 5 min (see Note 2) 4. Mtcrofuge for 10 mm at top speed, drscard the supernatant, and wash the RNA pellet wtth 70% ethanol 5. Dtssolve the dry pellet m gel loading buffer (15 a), boil for 2 mm, spin down brtefly, and purrfy the RNA usmg polyacrylamtde gel electrophorests (dependmg on the srze of the RNA, the acrylamtde should be between 4 and 20%).
3. I .2. 5’- Modfica tion Using lnitia tor Oligos Modified nucleotides can be used as mitiators to prime m vitro RNA transcription by adjusting the ratro of GTP to the initiator ohgonucleotide (14,25) RNA transcripts specifically initiated with guanosine, guanosine 5’-monophosphate (GMP), guanosme S-0-( 1-thiomonophosphate) (GMPaS), ApG, AmpG, ApGm, pApGm, biotin-ApG, fluorescem-ApG, and so forth, can be prepared using approprrately modrfied nucleotide(s) (see Note 3) m the transcription reactron (1617). These S-modified RNAs can be used for the preparation of nonradioactive probes useful in sequence analysis by enzymatic or chemical methods (16). Moreover, the free 5’-hydroxyl group of the RNA obtained by nntratmg the transcription reaction with dinucleotrdes, such as ApG, or CpG, allows single-step end-labeling (18) with [Y-~~P]ATP and polynucleotrde kmase. Furthermore, RNA mmated by GMPaS can be derrvattzed with photochemrcal probes specrfic for sulfhydryl groups, such as p-azrdophenacyl bromide (19). 3.2. RNA with Partial or 100% Phosphorothioate Modification Oligoribonucleotides containing phosphorothroate lmkage (20,21) can be synthesized by either chemical or enzymatic means. However, both chemical and enzymatic syntheses of RNA phosphorothioates have some hmrtatrons; for example: l
l
l
Chemical synthesis of RNA is limited to relatively short lengths, whereas enzymatic RNA synthesis does not have such a limitation (see also Section 3.5.2.)
Unlike enzymaticRNA syntheses, site-specrficmcorporationof thephosphorothioate bond IS possible chemically. WhereasenzymatrcRNA synthesisgeneratesa pure isomer(only the Sr,drastereoisomer of NTPclS nucleotides is a substrate for T7 or SP6 RNA polymerase [20,22]), chemical syntheses generates a mixture of S, and R, isomers.
High-performance liquid chromatography (HPLC), in some cases, can be used for the separation of Sp and R, isomers (23). Using the followmg transcription protocol, RNA wtth partial or completely modified phosphodrester linkage can be prepared:
Gaur and Krupp
102 1. Set up a 50 pL transcription reaction as follows. 10X Transcription buffer 5OcLL 30 5 pL Water OlMDTT 50& 10 mMNTPaS (see a-d, below) 25NDNA template (l-2 p&L; l-2 pmol) 1.0 /.lL T7 RNA polymerase (20 U/pL) 5.0 pL [cz-~~P]UTP (vanable) lo& 2 Proceed as m Section 3 1.1 , step 2 Components
of the above transcrtption
reaction can be changed as required
For example: a. By combining CTP, GTP, UTP, and ATPaS, phosphodiester lmakges 5’ to the adenosine can be changed to phosphorothioates b By adjusting the ratio of one of the NTPs with the correspondmg NTPaS, the level of moditicatton of the phosphodrester linkage can be controlled; the mcorporation efficrenctes of NTP and NTPaS are essentially ldenttcal (22). c By prlmmg the transcription reaction with 5’-GMPaS (19) and using only unmodified NTPs, a phosphorothtoate group can specifically be placed at the 5’-termmus of the RNA d. RNA phosphorothroates useful in the modification interference assays (15,24) can be prepared by using a mixture of 1 part of the desired NTPclS and Xparts of the same unmodified NTP (where X is the number of that nucleottde per RNA [2.5]). For example, if a pre-tRNA contains 20 adenosme residues, then a mixture of 5% ATPaS and 95% of ATP generally gives the optimal modtticanon level (see also Chapter 13) For a complete analysis, four separate transcription reactions should be assembled, each with one NTPclS
3.3. Modification Chemical
of 2’-Hydroxl
synthesis of 2’-modified
Groups in RNA RNA phosphoramidrtes
(26 and references
therein) and nucleosrde trrphosphates (27,28) has widened the scope for the mtroduction of such nucleotides mto RNA. Modified nucleotides, such as 2’-fluoro-, 2’-amino-, 2’-O-methyl-, 2’-0-allyl-, or 2’-deoxy-, have been successfully mtroduced into the RNA chain using chemical, enzymatic, or combmed approaches. Using chemical synthesis,tt is possible to introduce 2’-modifications at specrfic posrtions, yet only short RNAs can be synthestzed.Furthermore, 2’-modificatron in combination with the low level of phosphorothroate linkage desirable for modrfication interference study is not possible by chemical synthesis(see Sections3.2. and 3.4.). Here we describe our recently developed protocol for the introduction
of
2’-deoxy- or 2’0methyl-nucleotrdes m RNA using T7 RNA polymerase.
3.3.1. RNA Transcripts Containing 100% of P’-Deoxynucleotide Using the protocol given below, the complete replacement of one NTP by the correspondmg dNTP IS possible. Except for dTTP, multiple mcorporation
Chemical and Enzymatic Approaches
703
of other dNTPs should be avotded within the first 10-12 nucleotrdes of the transcript. Multiple insertion of dNTPs at subsequent sites does not sigmficantly affect the efficiency of the transcription reaction. Even combinations of two dNTPs at a time are possible, although this would result m drastically reduced transcrrptlon yields of around 15% of standard reactions (29). 1 For the 100% replacementof ATP by dATP, set up the following 100 pL transcription reaction* 10X MTB 10.0 pL Water 36.0 pL 0.1 MDTT 10.0 pL 20 mA4 NTPs minus ATP 5.0 jJ.L 20 mA4 dATP 5.0 /AL 50% PEG 16.0 pL 0.1% Trtton X- 100 lo& DNA template (l-2 ccg/uL; l-2 pmol) 1.0 pL 25 mM MnCl* (see Note 4) 10.0 p.L [cL-~~P]UTP (variable) lo& T7 RNA polymerase (20 U/pL) 5.0 /AL. 2 Incubate for 3-4 h at 37°C. 3 Terminate the reaction, and isolate and purify the RNA as described m the Section 3.1 .l , starting at step 3. For partial substitution of NTPs by dNTPs or by dNTPaS nucleotides, see Sectton 3 4. and Table 1.
3.3.2. RNA Transcripts with 2’-0 -Methylnucleo tides Total or partial replacement of NTP by 2’-O-methyl NTP is not possible using the standard transcriptron protocol. However, a modified protocol (see Section 3.3.1.) and a combmation of 1% NTP and 99% of the corresponding 2’-0-methyl-NTP, full-length transcripts can be obtained. A moderate mod& cation level of 1560% can be obtained with this protocol (291, The overall yield of the RNA transcript is low and varies from 3-l 3% of the standard transcription reaction (which uses unmodified NTPs). For lower levels of modrficatron or to use 2’-0-methyl-NTPaS nucleotldes m the modrfication interference analysis, see Section 3.4. and Table 1. 3.4. Partially 2’-Modified Transcripts for Modification Interference Analysis In modrfkation interference analysis (1.5,24,29), a specific cleavage reaction is used to detect the modified nucleotides. However, a simple and direct approach is not available for the detection of 2’-modrfied ribose moietres. Thts problem was partially ctrcumvented by combmmg 2’-modificatrons with iodine-cleavable phosphorothioate linkages as described in Chapter 13 (25,30).
104 Table 1 Quantitative of Modified
Gaur and Krupp Data for Incorporation Nucleotides in Transcript9
Modified NTP, %
Modified nucleottde, %
dCTP (90) dCTP (90)* dTTP (90) dCTPaS (90) dCTPaS (90)* dTTPcLS (90) dGTPclS (90)
15 36* 27 7 13* 9 7 6 27 58*
dATPaS (90)
2’-O-Methyl-CTP (99) 2’-O-Methyl-CTP (99)* 2’-O-Methyl-CTPaS (99) 2’-O-Methyl-CTPaS (99)* 2’-O-Methyl-CTPaS (99)
10
34* 17
Discrimmator
Requrred NTP,b %
DN/h’(rnod)
73 46* 55 86 75* 82 86 88 93 79* 98 91* 96
51 16* 24 120 60* 91 120 141
268 72* 890 192* 480
OThesedata are obtamed for tRNAPhe transcripts (29) usmg T7 RNA polymerase The transcrtptlon reactions are performed as described m Section 3 3 1 MnCl, (2 5 mM) 1s used m all transcriptions, except that m some cases, a mixture of 2.5 n&I MnCI, and 2.5 n&I MgCl, gives improved results (indicated by an asterisk) The percentage of modified NTP IS 90% for dNTPs and 99% for 2’-O-methyl-NTPs (mdlcated m parentheses) The resulting percentage of mcorporated modified nucleotldes IS indicated and used to calculate the dlscnmmation factor D,, (modj, bin the last column, the required percentage of modified NTP IS given to obtam 5% of modified nucleotide incorporated m the transcript
Ideally, RNA transcripts should contain only one modified nucleottde per molecule. If both normal and modified nucleotides are mcorporated with equal efficiency, then 1 part modified nucleotide and X parts (where X is the number of that nucleotrde per RNA [25]), unmodified nucleotide should be present in the transcription reaction. However, 2’-modified NTPaS nucleottdes are much poorer substrates for T7 RNA polymerase, and therefore the ratio of modified to unmodified nucleotide should be adjusted using the discrimmation factors (DNmmod)provided m Table 1 (29) and the formula: [NTP,,d For example,
(%)MTP
if a pre-tRNA
(Oh)] = DNmmod X [Nmod (%)/ N (%)] contams
20 adenosmes,
(1) and 5% modified
adenosine in the tRNA transcript gives the desired level of modification, then the dATPccS to ATP ratio using the following formula is: [dATPaS (%)/ATP (%)] = 141 x (5/95)
(2)
[dATPaS (%)/ATP (%)] = 7.4
(3)
Chemical and Enzymatic Approaches
105
This means the ratlo of dATPaS IS 7.4 parts in 8.4 parts. Accordmgly, the NTP mix should contam 88% dATPclS and 12% ATP. For a complete analysis, four separate transcription reactions should be performed, each with one modified NTPaS at a time. 3.5. Site-Specific
Modification
of RNAs
Three different approaches can be used for site-specific modlficatlon of RNA. 1 Short RNAs can be synthesized chemically using the proper modified phosphoramldite building blocks. 2 5’-Proximal modifications in long RNA transcripts can be introduced with imtlator oligos (Sectlon 3.1 2.). 3. The greatest flexibility IS possible by ligating chemically synthesized, modified RNAs to either unmodified or modified RNAs (Section 3 5.2 )
3 5.1. Site-Specific Introduction of Phosphorothioate Standard RNA synthesis on an Applied Biosystems
Linkage in RNA
or other DNA/RNA
syn-
thesizer can be used to introduce phosphorothioate lmkages in an RNA oligomer (see Chapters 7 and 8). To generate phosphorothioate linkages, the oxldatlon step during the normal synthesis cycle is replaced by a sulfurization step, using a standard reagent (31,321 or elemental sulfur (see ref. 33; Note 5). The remaining steps are identical to the normal RNA synthesis cycle. After deprotection and isolation, RNA isomers (Sp and I$) may be separated by HPLC (23). 3.5.2. Site-Specific Modifica tron by RNA Ligation The ability of T4 DNA ligase to join two pieces of RNA hybridized to a complementary oligodeoxynucleotide has proven to be a very versatile approach for constructing RNAs modified at specific posltlons (34-36). This semlsynthetlc approach can ultimately be used for site-specific mcorporatlon of a single-atom substitution within even a large RNA (3 7,38). A schematic representation of the method is shown in Fig. 1. One or both RNA molecules may contam specific modifications, introduced by chemical or enzymatic methods (see Note 6). The example detailed in Fig. 1 IS a modlfled nucleotide introduced next to the ligation junction. The 5’-RNA is unmodified, whereas the 3’-RNA molecule is primed with an initiator dinucleottde, 4-thioUpG (modified nucleotides, such as dApG, AmpG, and so on, can also be used). Alternatively, 5’-phosphorylated dinucleotide may be used directly in the transcription reaction, thus improving incorporation efficiency (16) and slmphfying the subsequent workup steps.
Gaur and Krupp
106 3'-RNA
tkIlf
8GcuGucccuuwuuLniuuu 1
GcmwpP-ATP T4 Polynucleotide
kinose
3zPl.? GCUcuCCcuuUUUu~ S.-RN4
Hcllf
~A~GAUGUCAUACIJUAOH
Oligodeoxynucleotlde
splint
1
-A
32 PUS ccuciucccuuuuuu I IIIIIIIIIIIIII CGACACGCAMAM
1
ATP T4 DNA ligase
Ligated
RNA
Fig. 1. Constructton of a site-spectfic modified pre-mRNA substrate 32P-Labeled 4-thtoundme containing pre-mRNA substrate 1sgenerated, for example, from the adenovu-us major late transcript (40). Exons are represented as boxes. The 3’-RNA molecule 1s transcrtbed usmg 4-thtoUpG as mtttator dinucleottde, whereas S-RNA molecule 1s prtmed with m7G (5’)ppp(5’)G Both RNAs are gel-purtfied followed by phosphorylatron of 3’-RNA molecule with [Y-~~P]ATP. The two RNAs are then annealed to the sphnt ohgodeoxynucleottde, and addmon of ATP and T4 DNA hgase yields the ligated RNA
Purify both RNAs by denaturing polyacrylamlde gel electrophoresls and determine the amount of RNA by Cerenkov counting or by UV absorbance (39). If not already phosphorylated, the 3’-RNA molecule 1s phosphorylated with Y-~~P-ATPor unlabeled ATP. 3 5.2.1
5'-PHOSPHORYLATIONOF
3’-RNA
MOLECULE
1 Set up the following 10 pL kmase reactton. RNA (50-100 pmol) 1OX Kmase buffer 1 mA4ATP ([Y-~*P]ATP may be included) T4 polynucleottde kinase (10 U/pL)
7.0 /.lL
1OcLL 1.0 pL lo@-
Chemical and Enzymattc Approaches
107
2 Incubate for 30 min at 37°C. 3 Add 90 pL of water, and extract with 100 pL of phenol/chloroform followed by 100 pL of chloroform 4. Add 10 $ of 3 M sodium acetate (pH 5.2), 300 pL of absolute ethanol, and freeze in dry ice for 5 mm (see Note 2) 5 MicrofQe for 10 mm at top speed, discard the supematant, and wash the pellet with 70% ethanol. 6 Dissolve the dry RNA pellet in water to make a stock solution of 5-10 pmol/pL 3.5 2.2. LIGATION OF 5’- AND 3’-RNA
MOLECULES
1 MIX the following components to hgate the two RNA molecules. 1OX Ligation buffer 5OccL 5’-RNA molecule (50 pmol) 501.1L 3’-RNA molecule (50 pmol) 50$ Splint ohgodeoxynucleotide (100 pmol) (see Note 7) 5 0 pL 2 Heat the reaction mixture to 65°C for 5 mm, and cool slowly to anneal the complementary ohgodeoxynucleotide splint to the two RNAs (see Note 8) 3 After annealing, the reaction volume IS made up to 50 pL by addmg 1 0 pL of 1 M DTT, 2.0 pL of 50% PEG, 1.0 pL of RNasm (20 U/pL), 21 & of sterile water, and 5 0 pL of DNA hgase (10 U/a) 4. Incubate for 3-4 h at 30°C 5 Add 50 6 of water, and extract the reaction mixture with 1 vol of phenol/chloroform followed by extractlon with chloroform. 6 Precipitate the RNA with absolute ethanol, and purify the ligated product by denaturing polyacrylamlde gel electrophoresls. Determine the amount of the ligated RNA by Cerenkov counting. It 1s now ready for use m various apphcations such as those m Chapter 13 4. Notes 1 For preparation of low-specific-activity RNA, the amount of [a-32P]UTP can be reduced to 0.5 &I The amount of NTPs can be scaled up as required 2 Ammomum acetate can also be used for RNA precipitation However, It should be avoided prior to a ligation or kinase step, since these enzymes are Inhibited by ammonium ions. 3. Many dinucleotldes are available from Sigma or USB (Abbrevlatlons used: Am, 2’-0-methyladenosme, dA, 2’-deoxyadenosine; Gm, 2’-0-methylguanosme). Alternatively, modified nucleotldes, such as AmpG or ApGm, can be synthesized using commercially available normal and 2’-O-methyl RNA phosphoramldites (Glen Research). For preparation of biotin-ApG and GMPaS, see refs (16) and (19), respectively. 5’-Allphatlc amino group containing dmucleotides, such as 5’-ammoApG, are very useful in the preparation of blotin and fluorescein-derivatlzed RNAs. Such dinucleotldes can be prepared on an automatic DNA/RNA synthesizer following the standard protocol (see Chapters 7 and 8), except that after the assembly of dmucleotlde (for example, ApG),
108
4 5 6 7 8.
Gaur and Krupp ammo-modifier phosphoramidite (N-MMT-Cn-AmmoModifier, Clontech) is coupled to the 5’-OH group of adenosme. After deprotection, the modified dmucleottde is purified by HPLC and then mcorporated as an mltiator ohgo m a transcription reaction. The primary ammo group at the 5’-terminus of the RNA can then be dertvatized wtth amino-specttic probes Alternatively, dmucleotides derivatized with ammo-specific probes can be used directly in a transcription reaction For modified CTP, use a mixture of 2.5 mA4MnC12 and 2 5 mM MgCl, Sulfurization wtth elemental sulfur should be performed manually, since elemental sulfur may precipitate and clog the delivery tube RNAs containing modified nucleotides, such as nebularme and isoguanosme, at the ligation Junction can be ligated to other RNAs The splint ohgonucleottde should span at least 12-l 5 nucleotides on etther side of the hgatton Junctton. The annealing temperature for hgatton of RNAs shorter than 30 nt should be kept at 16°C
Acknowledgments We are thankful to L. W. McLaughlin for comments, and Nyaya Kelkar and Scott Walker for crltlcal reading of the manuscript. References 1 Heidenreich, O., Pieken, W., and Eckstein, F (1993) Chemically modified RNA approaches and applications. FASEB J. 7,90-96 2. Beaucage, S. L. and Iyer, R. P. (1993) The synthesis of specific rtbonucleotides and unrelated phosphorylated biomolecules by the phosphoramidite method Tetrahedron 49, lo,44 l-l 0,488. 3 Usman, N and Cedergren, R (1992) Explomng the chemical synthesis of RNA TIBS 17,334-339
4 Fu, D -J., RaJur, S. B , and McLaughlin, L W. (1993) Importance of specific guanosme fl-mtrogens and purme ammo groups for efficient cleavage by a hammerhead rtbozyme Bzochemlstry 32, 10,629-l 0,637. 5. Fu, D.-J. and McLaughlin, L. W. (1992) Importance of specific adenosme N7-mtrogens for effictent cleavage by a hammerhead ribozyme A model for magnesmm bmdmg. Bzochemzstry 31, lo,94 l-l 0,949 6 Shatkin, A. J (1976) Capping of eukaryotrc mRNAs. Cell 9,645-653. 7. Hamm, J. and MattaJ, I. W (1990) Monomethylated cap structures facilitate RNA export from the nucleus. Cell 63, 109-l 18. 8. Fihpowicz, W. (1978) Functions of the 5’-termmal m7G cap m eukaryottc mRNA FEBS Lett 96, l-l 1. 9. Shatkin, A. J. (1985) mRNA cap bindmg proteins: Essential factors for mttiatmg translation. Cell 40,223-224. 10. Furuichi, Y., LaFiandra, A., and Shatkm, A. J. (1977) 5’-Termmal structure and mRNA stability. Nature 266,235-239
Chemical
and Enzymatic
Approaches
109
11 Shlmotohno, K , Kodama, Y., Hashlmoto, J , and Miura, K I. (1977) Importance of 5’-terminal blockmg structure to stabilize mRNA m eukaryotlc protein syntheSIS Proc Nat1 Acad Scl USA 74,2734-2738. 12. Murthy, G K., Park, P., and Manley, J. L. (1991) A nuclear mlcrococcal-sensltlve, ATP-dependent exoribonuclease degrades uncapped but not capped RNA substrates Nucleic Acids Res 19,2685-2692. 13. Konarska, M. M., Padgett, R. A., and Sharp, P. A. (1984) Recognition of cap structure m sphcmg in wtro of mRNA precursors. Cell 38,73 l-736 14 Krupp, G., Kahle, D., Vogt, T., and Char, S. (1991) Sequence changes in both flanking sequences of a pre-tRNA influence the cleavage speclficlty of RNase P J. Mel Bzol 217,637-648 15 Gaur, R K and Krupp, G (1993) Modlficatlon interference approach to detect ribose moleties important for the optimal activity of a nbozyme. Nucleic Aczds Res 21,2 l-26 I6 Pitulle, C , Klemeidam, R. G , Sproat, B. S., and Krupp, G. (1992) Initiator ohgonucleotides for the combmation of chermcal and enzymatic RNA synthesis. Gene 112,lO l-105 17. Harris, M E. and Pace, N R. (1995) Identification of phosphates mvolved m catalysis by the rlbozyme RNase P RNA RNA 1,2 10-2 18 18. Stahl, D. A , Krupp, G , and Stackebrandt, E. (1989) RNA sequencing, m Nuclezc Acid Sequencing. A Practxal Approach (Howe, C. J and Ward, E S , eds ), IRL, Oxford, pp 137-183 19. Burgm, A B. and Pace, N. R. (1990) Mapping the active site of rlbonuclease P RNA using a substrate containing a photoaffmity agent EMBO J 9,4 11 l-4 118 20 Eckstem, F (1985) Nucleoside phosphorothloates. Ann Rev Blochem 54,367-402 21 Eckstein, F and Glsh, G (1989) Phosphorothloates in molecular biology. TIBS 14,97-100
22 Griffiths, A D., Potter, B V L., and Eperon, I. C (1987) Stereospecificlty of nucleases towards phosphorothloate-substituted RNA* stereochemistry of transcription by T7 RNA polymerase Nucleic Acids Res 15,4145-4 162 23 Shm, G and Gait, M. J. (1991) Configuratronally defined phosphorothloate-containmg ohgoribonucelotldes m the study of the mechanism of cleavage of hammerhead nbozymes. Nucleic Acrds Res. 19, 1183-l 188 24. Conway, L and Wlckens, M (1987) Analysis of mRNA 3’-end formation by modification interference the only modlficatlons which prevent processmg he m AAUAAA and the poly (A) site EMBO J 6,4177-4184. 25 Ruffner, D E and Uhlenbeck, 0. C. (1990) Thlophosphate interference expenments locate phosphates Important for the hammerhead RNA self-cleavage reaction Nucleic Acids Res 18,6025--6029. 26 Pieken, W. A, Olsen, D B , Benseler, F , Am-up, H., and Eckstem, F. (1991) Kmetlc characterization of nbonuclease-resistant 2’-modified hammerhead rlbozymes Sczence 253,3 14-3 17 27 Aurup, H., Williams, D. M , and Eckstem, F (1992) 2’-Fluoro- and 2’-ammo-2’deoxynucleoslde 5’-tnphosphates as substrates for T7 RNA polymerase. Bzochemzstry 31,9636-9641.
110
Gaur and Krupp
28. Gaur, R. K., Sproat, B. S., and Krupp, G. (1992) Novel solid phase synthesis of 2’-0-methylnbonucleoside 5’-trrphosphates and their a-thro analogues Tetrahedron Lett 33,3301-3304. 29 Conrad, F., Hanne, A., Gaur, R. K., and Krupp, G. (1995) Enzymatic synthesis of 2’-modified nucleic acids: tdentificatton of important phosphate and rtbose moteties m RNase P substrate Nucleic Acids Res 23, 1845-1853. 30 Gaur, R. K. and Krupp, G. (1993) Enzymatic RNA synthesis with deoxynucleostde S-O-(l-thtotrtphosphates) FEBS Lett 315, 56-60 3 1. Iyer, R P., Phillips, L. R , Egan, W., Regan, J B., and Beaucage, S. L (1990) The automated synthesis of sulfur-contammg ohgodeoxyribonucleottdes usmg 3H- 1,2-benzodithtol-3-one 1,l -dioxide as a sulfur-transfer reagent. J Org. Chem 55,46934699 32 Morvan, F., Rayner, B., and Imbach, J. L. (1990) Modified ohgonucleotrdes IV solid phase synthesis and prehmmary evaluation of phosphorothioate RNA as potential antisense agents. Tetrahedron Lett 31, 7 149-7 152. 33 Ott, J and Eckstein, F. (1987) Protection of olrgonucleotide primers against degradation by DNA polymerase I. Blochemutry 26,8237-824 1. 34 Moore, M J. and Sharp, P. A (1992) Site-specific modt’iication of pre-mRNA The 2’-hydroxyl groups at the splice sites. Scrence 256,992-997 35 Moore, M J. and Sharp, P. A (1993) Evidence for two active sites m the sphceosome provided by stereochemistry of pre-mRNA sphcmg. Nature 365, 364-368 36 Tuschl, T , Ng, M M P., Pteken, W., Benseler, F , and Eckstem, F (1993) Importance of exocychc base functional groups of central core guanosmes for hammerhead rtbozyme activity Bzochemistry 32, 11658-l 1668 37 Wyatt, J R , Sontheimer, E J . and Stenz, J. A (1992) Site-specific cross-lmkmg of mammalian U5 snRNP to the 5’ splice site before the first step of pre-mRNA spbcmg. Genes & Dev 6,2542-2553. 38. Gaur, R. K , Valcarcel, J., and Green M. R. (1995) Sequential recognition of the pre-mRNA branch point by U2AF65 and a novel sphceosome-associated 28-kDa protein. RNA 1,407-4 17. 39 Fedor, M J and Uhlenbeck, 0 C. (1990) Substrate sequence effects on “hammerhead” RNA catalytic efficiency Proc Nat1 Acad Scl USA 87, 1668-1672 40 Ztllmann, M., Zapp, M L., and Berget, S M. (1988) Gel electrophorettc tsolatton of splicing complexes containing Ul small nuclear rtbonucleoprotein parttcles Mel Cell B1o1 8, 814-821.
13 Applications
of Modified Transcripts
Rajesh K. Gaur, Frank Conrad, and Guido Krupp 1. Introduction This chapter provides protocols for two different methods that requtre modified transcripts, modification interference and phosphorothioate footprmting. Modification interference is used to identify positions (in substrate or ribozyme RNAs) where moditied nucleotides interfere with ribozyme activity (l-4), Smce all noninterfermg sites can be identified, it is safe to modify these sites without dramatic loss of activity. Thus, these results can be used for the rational design and synthesis of active, highly modified RNAs. In special cases,the enzymatic synthesis of highly modified ribozymes is possible. For example, in the synthesis of hammerhead ribozymes, CTP, GTP, and UTP can be substituted by the correspondmg NTPclS (2). Furthermore, it should be possible to replace UTP by dTTPaS, since deoxyrtbose is acceptable at all uridme positions (5). The recently developed phosphorothioate footprinting procedure is an ideal method to analyze RNA:RNA interactions. As usual, cleavage patterns are compared for free RNA and RNA bound m a complex. Unlike other footprinting methods, here only the chosen RNA type, substrate, or ribozyme carries a welldefined phosphorothioate modification and is thus sensitive to the mild iodine cleavage reaction (6). No undesired modifications occur that completely disrupt Watson.Crick base pairing, like m’A and m3C m footprintmg with chemically modified bases (7). Although not discussedin this chapter, modified transcriptsthat include fluorescent precursors have useful applications. After microinjection of internally fluorescent-labeled transcripts,intracellular distribution can be followed (8) Similarly, the formation of intracellular hybrids between comjected sense and antisense oligonucleotides has been analyzed by applying fluorescence resonance energy transfer (FRET) (9). It should be noted here that the localization of cellular RNAs From
Methods in Molecular Edlted by P C Turner
b?ology, Vol 74 Rbozyme Protocols Humana Press Inc , Totowa, NJ
111
Gaur, Conrad, and Krupp
112
can be conveniently monitored by znsztu hybrldlzatlon with fluorescent-labeled DNA ohgonucleotides, using confocal laser scannmg microscopy (IO). Recently, the site-specifically introduced combmatron of fluorescein and rhodamine dyes in hammerhead and substrate ollgoribonucleotldes has made it possible to use FRET to study rlbozyme kinetics (see Chapter 26). 2. Materials 2.7. Modification interference 2. I. 7. Modification Interference by Chemical Base Modifications of Unmodified Transcripts Pleasenote that all modification reagents are hazardous and potent mutagens All reactions have to be done tn a fume hood. Advlce for the proper discarding
of waste is included in Notes l-3 1 2 3. 4 5. 6.
7
8
9 10.
0 2-l .O x IO6 cpm of end-labeled substrate or nbozyme RNA (Chapter 10) Reaction buffer for your ribozyme and target system. Carrier DNA. e.g., plasmld DNA (avold the use of carrier RNA) 50 r&4 Sodium acetate, pH 4.0 (NaAc) Prepare dlmethyl sulfate (DMS), NaBH,, and diethylpyrocarbonate immediately before use (see Note 1) 2 MNH,OH, pH 10.0, for U-modification Dissolve hydroxylamine hydrochloride m concentrated ammonia (half of the calculated volume to obtain a 2 A4 solution). Add more ammonia until pH 10.0 is reached (control by dispensing drops on pH indicator strips), and add water to the final calculated volume Store frozen at -2O“C (see Note 2) 2 MNH,OH, pH 5.5, for C-modification. Dissolve hydroxylamine hydrochloride m water (half of the calculated volume to obtain a 2 M solution). Adjust to pH 5.5 with diethylamine (indicator strips), and add water to the final calculated volume. Store frozen at -20°C Do not substitute dlethylamme with a different base (see Note 2). 1 MAmIme, pH 4.5. Mix aniline (use a fresh, at most slightly yellowish solution) with water, and adjust to pH 4.5 with acetic acid (mdlcator strips). The mltlally turbid solution will clarify on acldificatlon. Add water to the final calculated volume If a precipitate forms, remove by centrifugation. Store m the dark (wrapped m aluminum foil), frozen at -20°C (see Note 3). “Ice-cold” ethanol for rapid coolmg (stored at -20°C) Polyacrylamlde gel loadmg solution: 8 M urea, 0 03% tracking dyes.
27.2. Modifica t/on Interference by Enzymatic Synthesis of Partially Phosphorothioate-Modified
RNAs
1. 0.2-l .O x IO6 cpm of end-labeled substrate or rlbozyme RNA as partially modlfied transcript (Chapter 12). Note. For each of the four bases, separate RNA synthesis and labeling are required. 2. Reaction buffer for your ribozyme system.
Modified Transcripts 3 4 5 6. 7
113
10 mM HEPES-KOH, pH 7.2. 30 mM I, m ethanol (always prepare a fresh solution of the solid iodine). EtOH-salt-mixture 10 pL of 3 M sodmm acetate, pH 5.0, and 300 pL of ethanol “Ice-cold” 70% ethanol for rapid cooling (stored at -2OT). Polyacrylamide gel loading solutton 8 M urea, 0.03% tracking dyes.
2.2. Phosphorothioate-Footprinting 1, About 50,000-l 00,000 cpm of end-labeled substrate or rtbozyme RNA as partially phosphorothioate-modified transcript (Chapter 12) Note For each of the four bases, separate RNA synthesis and labeling are required 2 Reaction buffer for your rtbozyme system. 3 Prepare fresh solutions of solid iodine m ethanol. 5 mM I,, 10 n&T I,, and 30 mM I2 m ethanol. 4 EtOH-salt mixture. 10 l.tL of 3 Msodmm acetate, pH 5.0, and 300 pL of ethanol 5 “Ice-cold” 70% ethanol for rapid cooling (stored at -2OT). 6 Polyacrylamide gel loading solution 8 Murea, 0.03% tracking dyes.
3. Methods 3.7. Modification interference Partially modified, end-labeled RNAs are used (see Fig. 1) Essentially, each RNA molecule carries only a single modification, and all possible sues are represented For example, a pre-tRNA (with 20 adenosines) is modified m the transcrtption reaction by replacing unmodified ATP with a mixture of 5% ATPoS and 95% ATP After performmg the reaction of interest (e.g., processing by RNase P), unreacted substrate and reaction products are separated by gel electrophoresis. In general, several enzyme:substrate ratios are compared. As a control sample, untreated RNA is also subjected to gel electrophoresis and reisolated to avoid possible artifacts of these treatments. Subsequently, the isolated RNAs are subjected to a cleavage reaction, followed by gel electrophoresis. The obtained cleavage patterns represent the relative amounts of modified nucleotides m the three RNA types. The initial distribution is seen in the control sample. In the unreacted substrate,modified nucleotrdes are detected at positions where they interfere with the analyzed reaction. In contrast, these positions are underrepresented in the reaction products. For these studies, a comparison of the different patterns by densitometer tracing IS often useful. For modtfication interference analysis, the followmg requirements must be met. It must be possible to separate and isolate substrate and reaction products, and to detect the presence of a modification by a specific cleavage reaction. Useful modifications are chemically modified bases, detected by amlme cleavage (I), and phosphorothtoates, cleaved by iodine treatment (2-4). Protocols for both approaches are provided. This includes also our recent extension to modified (2’-deoxy-, 2’-methoxy-) nbose moieties (3,4).
114
Gaur, Conrad, and Krupp Transcription
of partially modified RNA-substrate
-c Gel purification + Endlabeling of the RNA-substrate + Gel purification c Substrate Cleavage Reaction I "One
rl
Molar ratios: FWsubstrate(a) 2
~G~l’ele~t~o~~
Isolation of unreactive substrate 4
t
5
3
i 150 ,-)
Isolation of product 4
4
Fig. 1. Schematic procedure for modification interference analysis Here an example with phosphorothioate modified substrate RNA and iodine cleavage is shown. The end-labeled, partially modified RNA is subjected to the cleavage reaction, and the products are analyzed by gel electrophoresis Subsequently, unreactive substrate and cleaved product are isolated from the gel, separately for each reaction. Finally, the modified nucleotides are detected by iodme cleavage (+ lanes for samples l-5), checked for unspecific background cleavage (- lanes for samples l-5), and compared with a sequence ladder obtained by alkali treatment (lanes OH) ca)Acontrol reaction without ribozyme (lane 1) and reactions with different ribozyme/ substrate ratios (lanes 2-5) are compared. (‘)Interference at this site is overcome by high ribozyme excess. This means that the correspondmg band occurs m the product obtained with high amounts of ribozyme (samples 2). (*)Interference at this site IS not overcome by high ribozyme excess. The corresponding band m the product is absent (samples 5) or weak (samples 2). c3)In the ribozyme reaction, a fragment with this interfering site is cleaved off Interference is obvious by stronger bands m substrate samples 2 and 3.
Mod/fled Transcripts
115
3.1.1. Modification Interference by Chemical Base Modifications of Unmodified Transcripts A generally useful, streamlmed protocol for chemical RNA sequencing 1s provided that avoids the use of hazardous, anhydrous hydrazine (I, II). Endlabeled, umnodtfied transcripts (or otherwrse isolated RNAs) are used, and modified bases are mtroduced. These partially modified RNAs are subjected to the reaction of interest (e.g., target cleavage by ribozyme) and finally analyzed after cleavage by aniline treatment. It is prudent to carry out chemical RNA sequencing first without modtfication Interference to check that all solutions are working and to familiarrze oneself with the protocol. To do this, carry out steps l-3 below (see Notes 4 and 5), omit steps 4 and 5 and contmue from step 6. 1 Chemical base modifications. Mix about 0 2-l .O x lo6 cpm of end-labeled RNA with 80 pg of carrier DNA (carrier RNA should be avoided, since it could copurify with the labeled RNA). 2. Distrtbute to four mtcromge tubes, labeled A, G, U, and C 3 Dry down m a vacuum centrifuge and follow the procedures in Table 1 The partially modttied RNAs created by the operations m Table 1 can be used directly as substrates in the reactton of interest before carrying out the amlme cleavage step 4 Perform your reactton (e g., ribozyme cleavage) as usual. A mimmum of 10,000 cpmsample should be used. Leave an untreated control sample and use several enzyme substrate ratios (expected product formation should range between 20 and 80%) 5 Reisolate (see Note 6) the control RNA, unreactive substrate, and reaction products by gel electrophoresis (see Chapter 10, Section 3.1 1 ) 6 Amlme cleavage: Dtssolve each RNA pellet m 50 pL of 1 A4 aniline, pH 4 5 7 Incubate for 20 min at 60°C 8 Stop the reaction by ethanol precipttatton. Add 150 pL of NaAc, pH 4 0, and 650 pL of ethanol. 9 Mix and centrifuge immediately for 15 min in a microfuge. 10 Remove the supernatants by pipeting, wash the pellets with 800 pL of ethanol, and centrifuge agam for 15 mm 11 Remove the supernatants, dry the pellets, and dissolve each m 5 pL of polyacrylamide gel loading solution If convement, the samples can be stored frozen 12 Denature by boiling for 2 mm, chill on ice, centrifuge briefly, apply onto a sequencing gel, electrophorese, and autoradiograph.
3.1.2. Modification Interference by Enzymatic Synthesis of Part/ally Phosphorothioate-Modified RNAs Phosphorothioates have attracted much attention, both as nuclease-resistant nucleottde modrficattons and as tools In the analysis of reaction mechantsms.
Table 1 Reaction
Conditions
for Chemical
RNA Sequencing= Specificity
ReactIons
v s
Gb
A, G
U
C
Modification
10 pL 0.3% DMS m NaAc
150 & NaAc 1 pL diethylpyrocarbonate
10 pL 2M NH20H (PH 10)
10 /.L 2M NH20H @H55)
Incubation
40 sl9O”C
10 min/90”C
40 s/9O”C
7 min/90”C
STOP and 150 pL NaAc EtOH preclpltatlon
400 pL EtOH 650 pL EtOH
150 pL NaAc
150 pL NaAc 550 & EtOH
550 clr, EtOH
Second EtOH precipitation
-
150 & NaAc 450 & EtOH
150 & NaAc 450 & EtOH
150 pL NaAc 450 & EtOH
EtOH wash
800 j.L EtOH
800 j.L EtOH
800 pL EtOH
800 $ EtOH
“Add the specified modtficatton solutton(s) to the dry RNA, and incubate as indicated Vary the reactton times tf too mild or too strong cleavages are observed The reactions are termmated by mtxmg with NaAc and ethanol No freezmg step 1s required Centrifuge for 1.5 mm m a mtcrofuge Discard the supematant, and contmue with steps as described If desired, the modified RNAs can be stored at -20°C m 800 pL of ethanol at the final wash step Before further use, the washed RNA pellet 1s dried m a vacuum centrifuge Tar the G-speck modtticatton, an addmonal reduction step IS recommended Dissolve the dry RNA m 10 pL of 0 SMNaBH, (m H,O), and incubate for 10 mm on me Stop the reaction by ethanol prectpttatton (add 150 pL of NaAc, 650 pL of ethanol), centrifuge for 15 mm, wash the pellet wtth 800 pL of ethanol, centrifuge again, and dry the pellet For modtficatton interference, proceed from Section 3 1 1 , step 4 If only chemical sequencing IS intended, proceed from Sectton 3 1 1 , step 6
Modified Transcripts
117
Fully modified ribozymes or substrate RNAs are inactive. Therefore, interfering sites must be known where these modifications have to be avoided. Apart from the tedious chemical synthesis and analysis of all possible variants, modification interference is the method of choice. Until recently, only phosphorothioates could be analyzed by using the specific iodine cleavage reaction (2). This was not possible with the very interesting 2’-deoxy- and 2’-O-methylribose modifications, because they could not be detected by a cleavage reaction. This limitation has been overcome by linking the modification with the cleavable phosphorothioate. This was achieved by enzymatic RNA synthesis with 2’-deoxy-ATPaS and 2’-deoxy-TTPaS (3). More recently, we developed (4) modified transcription reaction conditions, to make available the full range of all eight 2’-deoxy- and 2’-methoxy-NTPaS (see Chapter 12). For the interpretation of the data obtained, it must be kept in mind that a few sites where 2’-modifications interfere can remain unnoticed. It is not possible to recognize interfering ribose modifications at those sites where phosphorothioates alone interfere. However, the complete set of all noninterfering sites is recognized. 1. Prepareabout 50,00~500,000 cpm of end-labeled,partially modified RNA This
2. 3. 4. 5. 6. 7 8 9 10
RNA is obtained by enzymatic synthesis, and the modification level should result m about one modified nucleotide position per RNA molecule (see discrimmation factor m Table 1 of Chapter 12 and Notes 7 and 8) Perform steps 4 and 5 in Section 3 1 1. Iodine cleavage: Dissolve the pellets m 10 pL of 10 mMHEPES-KOH, pH 7 2 Denature by heating for 2 mm at 70°C. Chill on ice and centrifuge briefly. Add 1 pL of 30 rnM I2 in ethanol (freshly prepared). Leave for 1 min at room temperature. Stop the reaction by ethanol precipitation. Add 30 pL of an EtOH-salt mixture, freeze on dry ice, and then centrifuge for 15 mm Remove the supernatants by pipetmg, wash the pellets with 800 & of 70% aqueous ethanol, freeze on dry ice, and centrifuge again for 15 min. Remove supernatants, dry the pellets, and dissolve m 5 pL of polyacrylamide gel loading solution. If desired, store frozen Do not heat the sample, centrifuge briefly, apply onto a sequencing gel, electrophorese, and autoradiograph See Fig 1 legend for points regarding interpretation (2-4).
3.2. Phosphorofhioate Footprinting This method was developed initially to analyze the interaction of tRNAs with their cognate synthetases (6). Several advantages m the analysis of RNA recognition are evident: Only the modified RNA can be cleaved, unlike the mdiscrimmate action of nucleases or EDTA-mediated cleavage; only the desired modifications ity of Watson:Crick
are introduced with very moderate effects on the stabilbase pans, in contrast to chemical base modtticatrons,
118
Gaur, Conrad, and Krupp
which can disrupt base pairing (7); strict control of the modrfkation level avoids secondary cleavages; rt provides high resolutron up to the level of mdivrdual phosphodiester sites; and last, but not least, the versatrle iodine cleavage reaction can be used m any desired concentration of monovalent and dtvalent ions, and thus can be performed m rlbozyme reaction buffer. 1 Prepare about 60,000 cpm of end-labeled, partially phosphorothloate-modified RNA Thus RNA is obtained by enzymatic synthesis (see Chapter 12), and the modlficatron level should result m about one modified nucleottde positton per RNA molecule (see Notes 7 and 8) 2 Distribute six altquots of the RNA (each about 10,000 cpm) m microfuge tubes, labeled -0 5, -1, -3, and +0 5, +l, +3, and dry m a vacuum centrifuge. 3 Dissolve each sample in 10 pL of reactton buffer for your rlbozyme system The three “-” tubes are left wrthout the reaction partner (rrbozyme or substrate RNA), which is addedto the three “+” tubes (seeNote 9) 4 Iodine cleavage using three different rodme concentrations. Add 1 pL of 5 WI2 m ethanol to the tubes labeled “0.5.” Add 1 pL of 10 mM I2 to the tubes labeled “1,” and add 1 pL of 30 mA4I2 to the tubes labeled “3” 5. Ensure that each tube is left for exactly 1 min at room temperature 6 Stop the reactions by ethanol precipitation and continue exactly as m Section 3. I .2., step 7 (seeNotes 10 and 11).
4. Notes 1. Thesecompoundshydrolyze slowly m water Leftover material can be discarded in a beaker with a large excessof water (but keep one separatebeaker for each compound!) Keep covered m the fume hood, and after a few days, the solutions are harmless 2 Leftover materral can be discarded in a beaker with a large excessof 3 A4FeC13 3 Leftover material can be discardedm a beaker with a large excessof water 4 In addition to the base-specificcleavage reactions, a random sequenceladder is useful It can be obtained by alkali cleavage of the unmodified RNAs (seeChapter 10, Section 3.3.2 ) 5. In chemical RNA sequencing, if you observe high background of nonspecific cleavage products, increasethe reaction times in the modification steps A higher extent of specific cleavage can eliminate nonspectfic fragments 6 Modified RNAs are more sensitive to improper buffer conditions, and nonspecific fragmentatton can occur m the gel elution buffer The gel elution buffer should be carefully adjustedto pH 7 0 (final pH of the mixture’) About 20 pg of carrrer RNA should be added to the mitral 200 $ elutron. Ethanol precipitate as usual, and dry the pellet. Phosphorothroate-modifiedRNAs are also sensitive. If possible, include 10 pg of carrter RNA/sample, e g , durmg gel elution after the modification interference reaction or prior to ethanol precipitation after the iodine cleavage reactions 7 For each of the four bases,a separateRNA synthesis and analysis are required.
Modified Transcripts
119
8. In addttion to the base-specific cleavage reacttons, a random sequence ladder is useful It can be obtained by alkali cleavage of the unmodified RNAs (see Chapter 10, Section 3.3 2.) Also phosphorothioate-modified RNA can be used for alkali cleavage 9 It should be checked (for example, with gel-shift assays) that under the chosen conditions, a high percentage of the partially modified RNA is bound m the enzyme*substrate complex. 10 Significant effects occur consistently at all iodine concentrations 11 In general, the effects m phosphorothioate footprint analysts are rather weak Therefore, it 1s essential to use densitometer scanning of X-ray films (or a phosphortmager) for the comparison of cleavage patterns (6) The goal of this analysis is to obtain a detailed picture of the sites where the conformation of the phosphodtester backbone is changed on complex formation This can result in weaker cleavage or protection, usually interpreted to indicate direct bmdmg sites. If stronger cleavage is observed after complex formation, this is regarded as an (indirect?) effect of conformational changes. An alternative approach 1s bmdmg interference. Here, the positrons are identified where the mtroductton of phosphorothioates interferes with complex formation owing to lost magnesmmbmdmg sites These magnesium sites can be involved directly in complex formation, or they are more distant from the mteractmg sections and cause indirect conformational changes For more details, consult ref. 12
References 1. Kahle, D , Wehmeyer, U., and Krupp, G. (1990) Substrate recognition by RNase P and by the catalytic Ml RNA. identificatton of possible contact points m pretRNAs EMBO J 9, 1929-1937 2 Ruffner, D. E and Uhlenbeck, 0. C (1990) Thiophosphate interference experiments locate phosphates important for the hammerhead RNA self-cleavage reaction Nucleic Acids Res 18, 60254029 3 Gaur, R K and Krupp, G (1993) Modification interference approach to detect ribose moieties important for the optimal activity of a ribozyme Nuclezc Aczds Res 21,2 l-26 4 Conrad, F , Hanne, A , Gaur, R K., and Krupp, G. (1995) Enzymatic synthesis of 2’-modified nucleic acids identification of important phosphate and ribose moieties m RNase P substrates Nuclezc Aczds Res 23, 1845-l 853 5. Perreault, J -P , Wu, T., Cousmeau, B., Ogilvte, K. K., and Cedergren, R (1990) Mixed deoxyribo- and riboohgonucleottdes with catalytic activity Nature 344, 565-567
6. Rudmger, J., Puglist, J D , Putz, J., Schatz, D., Eckstein, F., Florentz, C , and Giege, R. (1992) Determinant nucleottdes of yeast tRNAASp interact directly with aspartyl-tRNA synthetase Proc. Nat1 Acad Scz USA 89,5882-5886 7 Ehresmann, C., Baudm, F , Mougel, M , Romby, P , Ebel, J -P , and Ehresmann, B (1987) Probing the structure of RNAs m solutton Nuclezc Aczds Res 15, 9109-9128.
120
Gaur, Conrad, and Krupp
8. Jacobson, M. R., Cao, L G., Wang, Y -L., and Pedersen, T (1994) The RNA subunit of rtbonuclease P rapidly locahzes in the nucleolus after mtcromJectton mto the nucleus of hvmg cells. J Cell Blochem ltIC(Suppl.), 115 9 Sixou, S , Szoka, Jr F C , Green, G A, Giustt, B , Zon, G., and Chin, D J ( 1994) Intracellular ohgonucleottde hybridtzation detected by fluorescence resonance energy transfer (FRET). Nucleic Acids Res 22, 662-668 10. Harders, J , Lukacs, N , Robert-Ntcoud, M , Jovm, T M , and Rtesner, D ( 1989) Imaging of vtroids m nuclei from tomato leaf tissue by zn sztu hybrtdizatton and confocal laser scanning microscopy EMBO J 8, 3941-3949 11 Krupp, G. (199 1) Direct sequence analysis of small RNAs, zn Nuclezc Aced Techniques In Bacterzal Systematlcs (Stackebrandt, E and Goodfellow, M., eds ), Wiley, New York, pp. 95-l 14. 12. Hardt, W.-D, Warnecke, J M , Erdmann, V A, and Hartmann, R K (1995) R,-phosphorothtoate modificattons m RNase P RNA that interfere wtth tRNA bmdmg. EMBO J. 14,2935-2944.
Cloning Strategies for Catalytic Antisense
RNAs
Martin Tabler and Mina Tsagris 1. Introduction Catalytic antisense RNAs combine two RNA-based strategies for gene suppression: the antisense approach and the rlbozyme approach. Like ordinary antisense RNA, catalytic antisense RNAs are characterized by a relatively long stretchof sequences(>30 bases)that are complementary to the target RNA. Snmlar to engineered nbozymes, they contain, however, an additional functional domain (or a multiple thereof) of a catalytic RNA. In other words, catalytic antlsense RNAs associate to their target RNA in the same manner as conventional antlsenseRNAs, and as a second element of their suppressive function, they induce chemical cleavage of the phosphodiester backbone of their target RNA by the same mechanism as nbozymes. Thus, the main distinction between catalytic an&senseRNAs and conventional nbozymes 1sthe size of the antisense regions flanking the catalytic domain, which results m a different cleavage mechanism. Conventlonal rlbozymes can act as true catalysts and are designed for a multiple reaction cycle conslstmg of three phases: 1 Association
with the target RNA
2 Cleavage of the target RNA 3. Dmoclatlon
of the cleavage products.
Having completed these three phases, the ribozyme molecule may enter a new reaction cycle. For effective turnover, assoclatlon of target RNA and dlssoclatton of product RNA must proceed under the same reaction conditions with substantial rates. Effective dissociation requires relatively short antisense sequences. This demand allows just a small window for a reasonable size of the antisense sequence. Problems arise if the target region is embedded m a stable secondary structure so that a relatively small antisense sequence cannot open such a structural element, which may result in ineffective assoclatlon rates. From
Methods Edlted
by
m Molecular P C Turner
Bology, Humana
121
Vol 74 Rlbozyme Press
Inc , Totowa,
Protocols NJ
122
Tabler and Tsagris
On the contrary, catalytic antisense RNAs are designed for opttmal assoctanon, and a longer anttsense region might be better suited to resolve such stable structural domains of the target RNA. It may find an “entry site” (“kissmg structure”) for hybridizatton, from whtch complete duplex formation proceeds. The reaction scheme of catalytic antisense RNA can be described as: (1) association with the target RNA or (2) cleavage of the target RNA. Compared with multiturnover ribozymes, the product dtssoctation step is disregarded, since the long antisense sequence most likely prevents melting of the duplex RNA. Therefore, catalytic antisense RNAs will inactivate their targets on a 1: 1molar ratio, i.e., a stoichiometric rather than a catalytic mode. However, great attention is paid to the association step, and the length of the antisense arm is chosen for fast hybrtdtzation kinetics (see Chapters 16 and 30). It has been shown that the presence of a catalytic domain m an antrsenseRNA enhancestts inhibitory effects when used to inhibit rephcation of human immunodeficiency virus type 1 (HIV-l) m hvmg cells (I). Catalyttc antisenseRNAs have so far beenbased on hammerheadribozymes and have been applied to suppressthe eye ptgmentation genein Drosophila melanogaster and the npt genein plants (2,3) The following protocol describes a cloning strategy to incorporate the catalytic domain of the hammerhead ribozyme into a cDNA via premade DNA cassettesorigmally described by Tabler and Tsagris (4) some years ago. This strategy requires that certain restriction sites overlap the consensus target sequence for hammerhead ribozymes, NUX&. These sites can be used for mampulattons and msertion of short DNA sequencesas outlined for a SaZI site m Fig. 1. As a result, DNA constructs are generated that allow the synthesis of an antisense RNA that has the catalytic domain of the hammerhead ribozyme mcorporated somewhere m the middle. Other PCR-based strategies for constructmg similar RNAs are described m the Chapter 16. 2. Materials 2.1. Selection of a Target Site 1, Computer facilities for sequenceanalysis. 2 A vector system-preferentially a plasmid vector-that allows m vttro synthesis of RNA from specific promoters by RNA polymerases derived from bactertophages, such as T3, T7, or SP6.
2.2. Preparation
of the Synthetic DNA Cassette
1, Two synthetic DNA oltgonucleotldes. 2. 1OX T4 Polynucleottde kmase (PNK) buffer: 500 mM Tris-HCl, pH 7 6, 100 rmI4 MgCl*, 50 n&I dithiothrettol, 1 mM spermrdme, 0 25 mg/mL BSA (molecular biology grade), 1 m/U ATP. 3. T4 Polynucleottde kmase (molecular biology grade).
Cloning Strategies cDNA
123 5
3’
NNNN ,,,I N’N’N’N’
GTCGAC NNNN II,,,, II,, CAGC T G N’N’N’N’
Sal I dIgesflon
3’
sense
strand
5’
antisense
strand
4
5’NNNN 001, 3’ N’N’N’N’
G d CAGCT
5’NNNN D!lIO 3’ N’N’N’N’
G 0 C
7i~IlIJIlIJflg
TCGAC ;;
NNNN ;,l;s;,;,
3’ 5’
C ;;
NNNN3’ ;,;,I;,;,
5’
4
LIga tlon
4
catalytic
antlsense
RNA
-=Gk=
transcription
Fig. 1. Strategy of constructmg catalytic anttsense RNAs by inserting synthetic DNA cassettes into cDNA The strategy exploits the fact that certain NUX& motifs (N = A, C, G or U, X = A, C, or U) overlap with restriction sites For example, the GUC motif is part of the SalI recognition sequence (G/TCGAC) The four mternal nucleotides TCGA of the WI site correspond to nucleotides 16.1, 17, 1.1, and 1 2 according to the numbermg systems for hammerhead rtbozymes (5, see also Ftg 2 of Chapter 16) These nucleotides are removed by Sal1 digestion and subsequent trimming of the protrudmg ends Then, a synthetic DNA cassette IS inserted, comprismg the catalytic domain (hatched part), and additional terminal nucleotides, which replace three of the four substrate-specific nucleotides (16.1, 1 1, and 1 2) (.5J, previously removed from the protruding SalI ends by trimmmg Depending on the orientation of insertion, an RNA can be transcribed from the recombmant DNA, which is able to cleave the target RNA This msertion strategy can be used for the restriction enzymes listed m Table 1 Depending on the protrudmg ends, the DNA cassette needs to be modtfied accordmgly (modified from ref 4, with permission). 4 A beaker of about 400 mL, filled with about 150-200 mL of botlmg water and a device to incubate a 1 5 mL microfuge tube m the boilmg water (e.g , an Eprak msert, Scotlab).
2.3. Cleaving and 7’rimming the CD/VA 1 About 5 l.tg of a recombmant plasmid DNA. 2 Restriction enzymes. 3. Nuclease Sl buffer: 225 mMNaC1, 30 &potassium acetate, pH 4 5, 200 pA4 ZnS04, and 5% (v/v) glycerol. 4. Nuclease S 1 (molecular biology grade) (Boehrmger Mannhetm). 5. Ice bath. 6 Nuclease Sl stop buffer 300 mM Tris-HCI, pH 8 0, 50 n-J4 EDTA
Tabler and Tsagris
124
7 65°C Water bath 8 Phenol and chloroform/tsoamyl alcohol 24: 1 (v/v) for DNA extraction 9. TE Buffer: 10 mMTris-HCI, pH 8 0, 1 mA4EDTA (store as a 100X stock)
2.4. Incorporation
of the DNA Cassette into cDNA
1. About 0.5 pg of a trimmed DNA prepared according Sectton 3.3. 2 T4 DNA hgase. 3 Blunt-end ligation buffer 50 mA4 Tris-HCl, pH 7 5, 10 mM MgC12, 5% (v/v) PEG 8000, 1 mM DTT, and 100 ILL! ATP (store as 5X buffer without ATP) 4. 12°C Water bath or incubator. 5. Competent Escherrchia coli cells suitable for transformation 6 Restriction enzymes S&I and/or XhoI 7. Materials for DNA sequencing
2.5. Testing the Construct
in a Ribozyme Assay
1 A 32P-labeled m vitro-synthestzed RNA transcript of the target RNA. 2. Restriction enzymes for lmearization of the DNA construct encoding the catalytic antisense RNA. 3. RNase A (DNase-free). 4. Bacteriophage-encoded RNA polymerase (SP6, T3, T7) and transcrtption buffer according the mstructions of the manufacturer 5. Rtbonucleoside-triphosphates. 6. RNasm (RNase-inhibitor). 7. DNase I (RNase-free). 8. Separate stock solutions of 1 it4 Trts-HCl, pH 8.0, 1 M MgCl,, and 250 n-uV EDTA, pH 8.0. 9. Facilities for gel electrophoresis on denaturatmg polyacrylamide gels 10. Gel dryer.
3. Methods 3.7. Selection of a Target Site Suitable for Incorporation of a Premade DNA Cassette Specific for Hammerhead Ribozymes and Subcloning of the cDNA Fragment 1 Check m the target sequence for the presence of the restriction recogmtion sites listed in Table 1. 2. Select a suitable target motif that overlaps with a restriction site For example, If the cDNA contains an &zfl site (G/TCGAC), you can utilize its GUCJ motif for ribozyme construction (see Note 1) 3 Check that the cDNA fragment contams the site m question only once (see Note 2) 4. Check that the transcription vector m which you intend to subclone your cDNA (or m which it is already mserted) does not have the restriction recogmtton sequence that you selected in step 2. If the site m question is present m the polylmker (for example, s&I), make sure that you subclone your cDNA fragment such that the restrtctton site of the polylinker is deleted.
Clonmg Strategies
125
5 Subclone your cDNA fragment mto a transcription vector(s), preferably systems usmg bactertophage-encoded promoters, such as T3, T7, or SP6 You should be able to synthesize in vitro a sense and an antisense RNA of your cDNA. Plasmids that allow transcription m either dtrection owing to the presence of two different promoters, such as the pBluescript (Stratagene, La Jolla, CA) series or related plasmids, are preferred (see Note 3). 3.2. Preparation
of the Synthetic DNA Cassefte
1. Check the sequence of the synthetic cassette according to Table 1 For example, for a SalI site the following two DNA ohgonucleottdes are requtred: 5’ TTTCGGCCTCGAGGCCTCATCAGGA 3’ 5’ TCCTGATGAGGCCTCGAGGCCGAAA 3’ (see Table 1, No 8) 2. Synthesize the two DNA oligonucleotides required for the DNA cassette 3. Dissolve the synthetrc DNA oligonucleotides at a concentration of 1 OD,,, U/n& 4. Take 2 yL of the synthettc DNA oligonucleotide (this corresponds to about 8 pmol) m a total of 20 @. of 1X T4 PNK buffer. 5. Add 5 U of T4 PNK, and incubate at 37°C for 30 mm. 6 Add another 5 U T4 PNK, and incubate for another 30 mm 7 Mix the two kinase reactions 8 Heat the mtxture to 100°C for 1 min m a beaker of water, and let it cool down slowly to room temperature over about 1 h. This will anneal the two ohgos to produce the synthetic double-stranded cassette, which may be directly used for ligation and which can be stored at -20°C.
3.3. Cleaving
and Trimming
the cDNA
1. Digest about 5 pg (at least 2 ug) of the recombmant plasmrd with the restriction enzyme selected from Table 1. 2 Check an aliquot for complete digestion on an agarose gel. 3. Dissolve 2 pg of the cleaved plasmtd m 100 pL of 1X S1 buffer, and premcubate on me for about 10 mm (see Note 4) 4 Dilute nuclease Sl m 1X Si buffer to a final concentration of 1 U/pL, and also preincubate on ice 5 Add 2 U of the nuclease S 1 to the DNA, mix quickly, but do not centrifuge down to avotd any heating of the sample (unless a centrifuge m the cold room is used). 6. Incubate for 20 mm on me 7. Add 100 pL of Sl stop buffer, incubate for 10 min at 65“C, phenol-extract the DNA, extract with chloroforrn/isoamyl alcohol, and recover by precipttation with ethanol or isopropanol. 8. Dissolve the DNA in TE buffer, and load an aliquot on an agarose gel for esttmatlon of recovered maternal.
3.4. lncorporafion
of the DNA Cassette into cDNA
I. Dissolve two aliquots of about 200 ng of trimmed plasmtd DNA m 1X blunt-end ligation buffer
Tabler and Tsagris Table 1 Summary of Different Synthetic DNA Cassettes Suitable for insertion into Restriction Sites for Generation of Ribozyme-Encoding DNAs *----------------------------------------------------------------------------+ ReStT1CtlO” Recognltlonseg 1 sequenceof ) Number b DNAcasseetea enzyTnrme,a) WlCh I I cleavable=
I I
Ill
I
5’
TTCGGCCTCGAGGCCTCATCAG
G
3’
ACCI
3’
AAGCCGGAGCTCCGGAGTAGTC
C
5’
*cc1
(2)
5'
d
Cl.31 &tax
I +-----------------.----------------------------------------------------------+
I
d
TTCGGCCTCGAGGCCTCATCAG
T
3' AAGCCGGAGCTCCGGAGTAGTC A I +-.-----------------..-------.-----------------------------------------------+
3’
ACCI
5'
ACCI
d d
e
T TTCGGCCTCGAGGCCTCATCAG A
3'
BSU36I
A AAGCCGGAGCTCCGGAGTAGTC T 3' I +_________________..____________________-------------------------.
5'
ESPI e
I
TTCGGCCTCGAGGCCTCATCAG
3'
AAGCCGGAGCTCCGGAGTAGTC
5’
f AVaII Eco01091g
1
(3)
(4)
I I
5'
5’ 3’
GT CA
Ppmur f f
K5tII
I
I
WGAC
I
GTKGAC &,L&GAT
I
?ZT.LCGM
I
-TAC
I
-TAC
I
Cm= Gsu.NAGC -----------+ GI!Z!CC
I I
RGIGKCY
I
RG/Q&XY
I I
CGIWCG
+----------------------------------------------------------------------------+ I
IS1
S’GAT 3 CTA
TTCGGCCTCGAGGCCTCATCAG AAGCCGGAGCTCCGGAGTAGTC
3’ 5’
/
(6’
CT
G/GiU.CC T/G-
AIGmT
BSCYI RIGAKY ______________________________+
I +____-____-_________----------.---------------5’ 3’
BarnHI BCll
BglIx
TTCGGCCTCGAGGCCTCATCAG
G
GA AAGCCGGAGCTCCGGAGTAGTC C
I +-----------____________------------------------------------------------------.-+ 5' GT TTCGGCCTCGAGGCCTCATCAG C 3’ CA AAGCCGGAGCTCCGGAGTAGTC G I (I)
3
AYZTI
CI’XAGG
5'
NheI SW1
G/CTi,GC AIUGT
Xbal
h
TI!XJ,GA
3'
Acc651
GIG,XC
5
Kpnr SSlWI
GUCIC CIGTACG T/GT&ZA
.e*rG*
I T A
TTCGGCCTCGAGGCCTCATCAG AAGCCGGAGCTCCGGAGTAGTC
GA
3’
AVdI
CT
5’
SalI
1
Xhol
I 19’ 5’
T
TTCGGCCTCGAGGCCTCATCAG
GG
A AAGCCGGAGCTCCGGAGTAGTC CC 3’ +------------------.-------------------------------~----------------.--..----+ TTCGGCCTCGAGGCCTCATCAG I (lo) 5'3’ +-----------.------------------------------------.-.---.-...
RAGCCGGAGCTCCGGAGTAGTC
3
I
AYaI
ATG TAC
3’ 5’
BspHI
CGG GCC
3’ 5’
BSpEI
TAG
3
ma1
k
TTCGGCCTCGAGGCCTCATCAG
I
-GRG
I
I
I
-ATGA _--_-____________+
k
-CGGA
I
-TAGA
I
AAGCCGGAGCTCCGGAGTAGTC AGC 5' +--------------------------------.-----------------------.--.----------------+ (12’
3’ 5
5 GT TTCGGCCTCGAGGCCTCATCAG I I131 3’ CA AAGCCGGAGCTCCGGAGTAGTC I +---------------------------.-------------.---------...----.-----------------+ T TTCGGCCTCGAGGCCTCATCAG I (141 5’ 3 A AAGCCGGAGCTCCGGAGTAGTC I +----.-----------------------------------------------------------------------+
AC TG
3
ssrEIIe
GIGmACC
I
ASel
AWU,ATC
I
5 3 5’
aThe synthetic DNA cassette consists of two DNA ohgonucleotldes, sequence comprises the catalytic domain* 5’ 3’
I I I
-GRG -GAC -GAG
5'
k TTCGGCCTCGAGGCCTCATCAG AAGCCGGAGCTCCGGAGTAGTC I ‘11) 5’3’ +______________.________________________----------------------------...------+
I
I
TTCGGCCTCGAGGCCTCATCAG AAGCCGGAGCTCCGGAGTAGTC
the double-stranded
3’ 5’,
plus some additional nucleotlde(s) at the S- and/or 3’-end(s), which replace nucleotldes of the restrxtlon site that ~111 be removed by trmunmg, the catalytic domam has been modified so that it contams a StuI and a XhoI site
Cloning Strategies
127
2. Make an estimate of the molar@. A plasmtd of 3000 bp will have a mol wt of about 2 x lo6 Dalton, so that 200 ng would correspond to about 0 1 pmol. 3 Set up two ligation reactlons, one with about a threefold molar excess of DNA cassette and a second one with about a lo-fold molar excess Keep the volume as small as possible (5-10 pL), and incubate at 12°C for 3-12 h with about 2 U of T4 DNA ligase. 4 Transform any suitable E colz strain 5 Screen colomes for the presence of recombinant plasmlds by digesting minipreps with S&I and/or XhoI, which ~111 be introduced by the DNA cassette 6 Confirm correct insertion of the DNA cassette by sequencing. Instead of sequencing, it 1s possible to carry out a ribozyme assay first as described m Section 3 5. However, the exact sequence of each construct should be confirmed
3.5. Testing the Construct
in a Ribozyme Assay
1 Synthesize radloactlvely labeled target RNA by m vitro transcription, and dlssolve It m 10 mM TE buffer (see Note 5) 2 Prepare DNA of the recombinant plasmlds that contam the synthetic cassette. This can be “mmlprep DNA ” 3. Linearize the DNA (about 0.5-l pg) with a restriction enzyme that cleaves downstream of the catalytic antisense RNA. Add about 10 ng of DNase-free RNase to the digestion. 4 Extract twice with phenol and preclpltate the DNA 5. Synthesize catalytic antisense RNA by m vitro transcriptlon with the appropriate RNA polymerase (SP6, T3, T7) m a reactlon volume of 20 pL (without any radlonucleotides, but in the presence of RNasm m a concentration as recommended by the supplier) using all the linear DNA as template. 6. At the end of the reaction (typically about l-2 h), add 1 U of DNase I (RNasefree) to the transcription mixture, and incubate for 5 mm at 37°C 7 Inactivate RNA polymerase and DNase I for 10 mm at 6O’C. 8. Adjust an aliquot of the radioactively labeled substrate RNA to a final concentration of 50 mA4Tris-HCl, pH 8 0, and 30 mMMgC12. Take 10 pL of this mixture, ‘The restrlctlon enzymes that can be used m combmatlon with this DNA cassette CThe recogmtlon sequence 1sgiven and the positton ofthe cleavage site IS indicated, the cleavable motif corresponds to nucleotlde 16 2, 16 1, 17 (5) according to the numbering system for hammerhead RNAs (cf Fig 1) and IS underlined dAccI 1s able to cleave four different sequences, in line with this, cassettes (1) and (2) can be used for this enzyme.
“The nucleotlde N of the recognltlon sequencecan be any nucleotlde and should not be G fw can be A or T and should be T for usmg the msertlon strategy gN should be T hXbaI contains a second motif, cf cassette No (12) ‘AvaI can be used for the insertion strategy if Y = T and the cassettes (8) or (9) are needed depending on whether R = A or R = G kThe nucleotlde preceding the actual recogmtlon sequence forms nucleotlde 16 2 of the resulting hammerhead
128
9. 10 11 12
Tabler and Tsagris add 10 pL of the transcrtptton mixture (obtained with cut DNA), and incubate for 1 h at 37’C Use another 10 pL of labeled substrate RNA as a control, and mcubate under the same conditions with 10 pL of 1X transcription buffer, without any DNA or enzymes added Add EDTA to a final concentration of 25 rnM, phenol-extract, add sodium acetate to a final concentration of 0 2 A4, and precipitate with ethanol Analyze reaction products, together with the control RNA, on a denaturatmg polyacrylamide gel. V&.talize reaction products by autoradiography Check for two defined cleavage products that are not detectable for the control reaction
4. Notes For selecting target regions for the catalytic anttsense RNA, you should consult Chapters 2 and 3 For selecting a cleavable motif from Table 1, it should be noted that different NUX& motifs (N = A, C, G, or U; X = A, C, or U) are cleaved with different efficiencies by catalytic antisense RNAs based on hammerhead ribozymes. The relative rates are also influenced by the sequence context of the NUX& motif, but as an mdication, the following order of preferred motifs may be considered. NUC& > NUA$ > NUU&, and GUX& = AUXJ = > CUXL = UUX*l (6,7). According to our experience, good cleavage results can be expected with a GUC&, AU&, or UUC& motif The insertion strategy requires that the restriction site of interest that you have selected from Table 1 is present only once. Subclonmg of a shorter fragment can overcome problems caused by the presence of several sites It has been described that catalytic antisense RNAs are characterized by long antisense arms. There IS no clear answer regarding how long the antisense flanks should be The essential factor is the association with the target RNA Rittner et al. (8) have described that the association rates are influenced by the length of the antisense RNA It is, however, not possible to predict which length of the antisense flank will result in optimal hybridization Therefore, any length ranging from 10 nucleotides to several hundred nucleotides may be chosen mitially. Subsequently, different sizes of the antisense flanks may be analyzed for their association rates The trimming of the protruding single-stranded ends generated by digestion with restriction enzymes is carried out at 0°C to prevent “mbbhng” of the nuclease mto double-stranded regions of the DNA This is a general problem, especially for DNA termmi with multiple A:T pairs. In that case, the double-stranded DNA ends “breath,” i.e , both strands open for a short period of time Low temperature mmimizes this effect, however, leaving the nuclease Sl sufficiently active for degradation of the single-stranded ends. Other enzymes that degrade smglestranded DNA, for example, mung bean nuclease, are not active at that temperature The RNA transcript used for the ribozyme assay does not necessarily need to be radioactively labeled. Other detection mechamsms, such as staining, ~111 also
Cloning Strategies
129
work. However, conventtonal detection (staining with ethidmm bromide, stlverstammg) ~111 also visuahze the ribozyme RNA.
References 1 Homann, M , Tzortzakakt, S , Rittner, K., Sczaktel, G , and Tabler, M (1993) Incorporatton of the catalytic domain of a hammerhead ribozyme mto anttsense RNA enhances its mhibrtory effect on the replication of human immunodeficrency vms type 1. Nucleic Aczds Res 21,2809-2814 2. Hemrrch, J.-C , Tabler, M., and Louis, C (1993) Attenuation of white gene expression in transgemc Drosophila melanogaster possible role of a catalytic antisense RNA. Dev Genet 14,258-265 3. Wegener, D , Steinecke, P , Herget, T., Petereit, I., Philipp, C., and Schreier, P. H (1994) Expression of a reporter gene 1sreduced by a rtbozyme m transgemc plants Mel Gen Genet 245,465-410
4 Tabler, M. and Tsagrts, M (1991) Cataiyttc anttsense RNAs produced by mcorporatmg ribozyme cassettes mto cDNA. Gene 108, 175-183 5. Hertel, K J., Pardi, A., Uhlenbeck, 0 C., Kotzumt, M., Ohtsuka, E., Uesugt, S , Cedergren, R , Eckstem, F., Gerlach, W. L., Hodgson, R., and Symons, R. H (1992) Numbering system for the hammerhead Nucleic Acids Res 20,3252 6. Shrmayama, T., Nishrkawa, S., and Taira, K. (1995) Generahty of the NUX rule: kinetic analysis of the results of systematic mutations m the trmucleotide at the cleavage site of hammerhead ribozymes. Blochemlstry 34,3649-3654. 7 Zoumadakis, M. and Tabler, M. (1995) Comparative analysis of cleavage rates after systemattc permutation of the NUXJ consensus target motif for hammerhead rtbozymes Nuclerc Acids Res. 23, 1192-l 196. 8. Rtttner, K , Burmester, C , and Sczakrel, G. (1993) In vztro selection of fast hybridizing and effective antisense RNAs directed against human unmunodefictency vu-us type 1 Nucleic Acids Res. 21, 1381-1387.
15 PCR-Based Construction of Long Hammerhead Ribozymes Martin Zillmann
and Gregory Robinson
1. Introduction With the advent of antisense technology, there has been much interest m the use of long RNAs expressed in vivo to inhibit the expression of target genes. More recently, there have been numerous reports that the mcorporation of either hairpin or hammerhead rtbozyme motifs (catalytic antisense) mto such RNAs increases their effectiveness (1-3). This section will describe a generally applicable, simple, PCR-based method to construct catalyttc antisense RNA containing the hammerhead catalytic core that will cleave the target of interest at a GUC sequence.All discussion will focus on the hammerhead motif, although, m prmciple, the haupm motif could be incorporated Instead. Starting with DNA encoding the target, two sets of primers are synthesized (Fig. 1). The primer sets encode partially overlapping half-ribozymes and primers that delmeate the borders of the final ribozyme. Two separate rounds of PCR then create the final rtbozyme, which can either be transcribed directly or cloned into a suitable vector. This synthesis scheme is summarized in Fig. 2. In most of the papers dealmg with catalytic antisense RNA, the ribozyme was constructed by cloning synthetic DNAs into pre-existing or engineered restriction sites (‘2-9). Clearly, the usefulness of this approach is limited by the availability of convenient restrtction sites in the DNA encoding the target that involve the NUX cleavage motif. Several papers describe the synthesis of long hammerhead ribozymes using PCR (20-13). PCR was used either to convert partially overlapping ribozyme coding regions into duplex for transcription or cloning or to alter From
Methods Edlted
by
In Molecular
Srology,
P C Turner
Humana
131
Vol 74 Rlbozyme Press
Inc , Totowa,
Protocols NJ
Zillmann and Robinson
132 1
ClE$ $lb v CGAGTAGTGTI’GGGTCGCGAAAGGCCTTGT
S’GAAAGCGTCTAGCCATG 3’ClTTCGCAGATCGGTAC
GCTCAlCACAACCCAckXXlTTCCGGAACA
3’
SGGCC’lTTCGCCTCATCAGGCCGTTAGGCCGAAACCCAACACTACTCG3’ -
hbozyme
GTTGGCAGAAGCTATG CAACCGTCTKGATAC
3’ 5’
BamHl Se SCAC~CATAGClTCTGCCAAC3
Psll we S’CCAQ.@Zf&GAAAGCGTCTAGCCATG3
Core-
Fig. 1. The target DNA and primers for antr-hepatms C vnus model ribozyme. The relevant target DNA sequences are shown m the top panel with the desired cleavage site indicated m larger, bold caprtal letters, and the antlctpated break point in the target RNA is indicated by an arrow.
Primer set #l, shown
m the middle
panel, ~111 be used to amplify the right-hand portion of the target, and prrmer set #2, shown in the lower panel, the left-hand portion of the target Bases m bold type encode the ribozyme core, and hollow type indicates the regron that will bmd the cleavage sate m the target RNA The other bases are target-specific and ~111 differ depending on the target chosen
flanking sequence length. The technique described in this section merges both of these techniques m a novel way, usmg recombinant PCR, a well-established technique (14-16). The ribozyme core IS introduced exactly at the chosen cleavage site with concomttant mtroductron of a phage promoter or cloning sites.
2. Materials 1. 2. 3 4.
Source of target encodmg DNA (plasmtd, phage, PCR fragment, 10 n&I solutrons of the four required primers (see Figs. 1 and 3 10 n&f mixed dNTP stock. 10X Vent polymerase buffer. 100 mMKC1, 100 mM(NH,),SO,, 1% Triton X-100, 200 nnI4 Trts-H2S04, pH 8 8. 5 Vent DNA polymerase (2000 U/mL) from New England Biolabs 6 Tuq DNA polymerase (5000 U/mL).
and so forth) and Note 1) 20 mA4MgS04, (Beverly,
MA).
133
--m-e ---
-we -se
Target PCR
Yz<=
PCR Primer Set #I hbozyme Core
I
=*
I
=w
Target
-----
Pstl site
---m-w---
BanHI Site
---
V
*=
Rlbozyme Core
Rtbozyme Core
Primer Set #2 PCR Product
Fig. 2. Synthesis of anti-hepatitis C model nbozyme using primer sets #1 and #2. In the first round of PCR, depicted graphically in both portions of the top panel, two PCR reactions are set up containing either target and primer set #l or target and primer set #2. The PCR products are then gel-purified and combmed with the outside primers of primers sets #l and #2 m the second round of PCR to give the final ribozyme-encoding cassette, as depicted m the lower panel. The primer containing the BamHI restriction enzyme in this example could have been replaced by one encoding the T7 phage RNA polymerase promoter to allow immediate expression of RNA at this point
7 Make a 10: 1 v/v mixture of Taq.Vent 8. 0.8% Agarose gel cast m 1X TAE (40 mMTris-acetate, pH 8.3, 1 mM EDTA, 20 mM acetic acid) 9. 6X DNA dye: 30% v/v glycerol, 0.05% w/v bromphenol blue and xylene cyanol, and 0 25 mg/mL ethidmm bromide
Zdlmann and Robinson
134
jTc*Tm, T
GA’
S-AGTGTTGGGT GCGAAAGGCC’ITGT-3’ -1 oooooCGAGTAGTG‘ITGGGTcGCGAAAGGCC'ITGTO11UOO oo0110 GCTCATCACAACCCAGCGCTITCCGGAACA oonpo -1, 3'-GCTCATCACAACCCA CGC'I?TCCGG-5' * CT&Y A G g*GT
A
SE *TTG Fig. 3. Detail of the rrbozyme-encoding primers of primer sets #l and #2 and their relationship to the target DNA. The canonical cleavage sate m the target DNA IS shown in large, bold capitals, and the rtbozyme-encoding region of the primers 1s shown in bold capitals One of the controls for m VIVO rrbozyme experiments 1s an inactive rrbozyme. This can be constructed by mvertmg the bases indicated m hollow letters Note that the terminal C base of the GTC (GUC m the RNA) cleavage site remains unpaired. The bases not shown m bold letters will depend on the target chosen and will be different from those shown here for the hepatttrs C model rtbozyme primers.
10 Redtstrlled phenol/chloroform (1 1 v/v) equilibrated with an equal volume of 100 rnM Trts-HCl, 300 mM NaCl, 1 mM EDTA, 0 1% P-mercaptoethanol, 0.1% 8-hydroxyqumoline The pH of the aqueous phase IS adjusted to 7.4 with HCl Phenol stabilized m this way with anttoxtdants and radical quenchers has a very long shelf life (years at 4’C and months on the bench top) and 1s well worth the trouble to make 11 ChIoroform*isoamyl alcohol (24 1 v/v) 12 Appropriate restrrctton enzymes and recommended buffers 13. Absolute ethanol. 14 TE buffer: 10 mA4 Tns-HCl, pH 8 0,l mM EDTA 15. Drstrlled water. 16 Glass wool or aquarium filter media 17 T4 DNA ligase (400 U/pL) from New England Brolabs or the equrvalent and the manufacturer’s buffer 18. Approprrate cloning vector for the nbozyme encodmg insert (see text for drscusston). 19. Formamide loading dye. 90% (v/v) formamide, 10 mM EDTA, and 0.025% xylene cyan01 and phenol red
Long Hammerhead
Ribozymes
135
3. Methods 3.1. Preparation of 5’ and 3’ Half-Ribozyme Coding Regions by the First Round of PCR Although in theory, the final nbozyme-containing insert could be generated in one round of PCR using all four primers and target, in practice, it would be difficult to arrive at the optimal concentration of each DNA. For instance, the nbozyme-encoding primers may compete with each other for the binding of target (Figs 1 and 2). Therefore, the synthesis of the final insert is achieved in two steps, and the proper course of events is verified at each step. An important control for showing ribozyme rather than antisense activity is either to use just the complementary strand of the target RNA or a mutant, inactive ribozyme (see Fig. 3). The latter requires mutant ribozyme-encoding primers in addition to the wild-type nbozyme-encoding primers, but all steps m the construction of the mutant nbozyme-encoding cassetteare identical to those used to construct the active ribozyme cassette, and both can be done simultaneously. A simple sense/antlsenseencodmg cassettecan be constructed by one round of PCR using the target and outside primers from primer sets #l and #2 only, starting with Section 3.3. and usmg a bidirectional transcription vector. The sense RNA transcribed from this construct can be used either in VIVOas a control for non-specific effects or in vitro as a substrate. Antisense RNA produced form this construct can be used m vivo as a control to show that a ribozyme effect is/is not present. 1 Setup a PCR reaction in a 500 & mlcrofuge tube containing 10pL of 10X Vent buffer, 10 pL, of each primer m primer set #l, 1 pL of 10 mM dNTP stock, and 68 & of distilled water. Add 1 pL of target (10 fmol = lo* copies or about 10 ng of plasmld). Always add the target last to avoid possible contammatlon of other stocks used in the reaction 2 Set up another identical PCR reaction, except containing 10 pL of each primer in primer set #2 3 Heat both PCR reactions to 95”C, and add 0.5 pL. of Taq.Vent (10.1). MIX and overlay with mineral 011 Run 20 cycles of 95°C for 5 s, 55°C for 30 s, and 75°C for 30 s followed by 1 mm at 75’C These somewhat generic PCR conditions work well for the hepatltls C nbozyme, but the annealing temperature and extension lengths may need to be modified for other primer/target combmations (see Note 2). The annealing temperature predicted by the G + C rule (Tm [“Cl = 2 x [number As and Ts] + 4 x [number of Gs and Cs]) is often very close to optimal. The extension time should be roughly 1 mm for each kb of sequence to be amphfied. 4 At the end of the PCRcycle, the reactionsare drawn out from under the mineral oil, placed into separate tubes, and extracted with equilibrated phenoLchloroform 5. Centrifuge for 5 min in a mlcrofuge, andplace the aqueous(upper) phase into a fresh tube.
Zillmann and Robmson
136
6. Add 200 pL of ethanol to each reaction, mix, and leave on me for 30 mm to precipitate the DNA 7. Centrrfuge for 15 mm m a mtcrofuge to pellet the DNA, remove the supernatant, and dry the pellet under vacuum
3.2. Gel Puriflcafion of the 5’ and 3’ Half-Ribozyme Coding Regions The PCR products from the first round of PCR still contam large amounts of untncorporated prrmer as well as target DNA that must be removed prior to the second round of PCR. Many methods, including differential precipitation and filtratron, wtll accompltsh this aim, but gel purification has the added benefit that the product may be visualized and compared wrth molecular size markers to determme if the reaction was specific and produced a fragment of the expected size. Redissolve the DNA pellets from Section 3 1.) step 7 in 20 pL of TE buffer, and add 4 pL of 6X DNA dye. Also prepare a tube of marker DNA m a 20 & volume, and add 4 & of 6X DNA dye. Load the samples and DNA size markers onto a 0.8% agarose, TAE gel in 1X TAE buffer, and electrophorese unttl well separated. Electrophoresrs can be momtored usmg a handheld shortwave UV light. Prepare a spin extraction unit by piercing the bottom and cap of a 500 & mrcrocentrrfuge tube wtth a 22-gage needle Place a small amount of either glass wool or aquarium filter medmm mto the tube, stuffing tt into the bottom to cover the hole. Place the unit into a labeled (primer set #l and #2) 1 5 pL microcentrrfuge tube wrth the cap removed When electrophorests is finished, place the gel on a transdlummator, and carefully excise the destred bands, removing as much of the gel outside of the band as possible. Place the agarose blocks into the spin extraction unit, close the lid of the 500 pL microcentrifuge tube, and centrifuge for 5 mm m a mrcrofuge Approximately 50 pL of fluid that should fluoresce intensely will have collected m the 1.5 mL microcentrrfuge tube. The 500 pL microcentrifuge tube IS discarded
3.3. Preparation of the Ribozyme Coding Region by the Second Round of PCR The second round of PCR creates the final insert by taking advantage of the central overlap between the PCR products made in round one. On denaturanon, a small portion of molecules will anneal in a staggered fashion leaving long S-overhangs that may be filled m by polymerase. This populatton will carry both of the outside primer binding sites and will amplify rapidly usmg
these primers to give the desired product (see Fig. 2). 1. Set up a 100 p.L PCR reactron contaming 10 & of 10X Vent buffer, 10 + of each of the outside primers in primer sets #1 and #2,1 pL of 10 mMdNTPs, 68 pL
Long Hammerhead
Ribozymes
137
of distilled water, and 0.5 pL (about l/lOOth of the sample) of each gel purtfied product from round 1 of PCR Heat the PCR reaction to 95°C add 0.5 pL of Tuq:Vent (lO*l), mrx, and overlay with mmeral 011. Carry out the amplification as m Section 3.1, step 3. On completton of the PCR, the reaction is removed from under the oil, extracted sequenttally wtth an equal volume of buffered phenol/chloroform, an equal volume of chloroform/tsoamyl alcohol, and precipitated with 2 vol of ethanol. After 30 min on ice, recover the product by centrifugation m a microfuge for 15 mm. Resuspend in 10 pL of TE buffer Analyze 1 pL of the PCR product on a 0 8% agarose TAE gel by electrophoresis next to appropnate DNA standards as in Section 3.2., step 2. If the desired product is the pnmary product,proceeddirectlyto Section3 4. Otherwise,gelpurificatronasm Section 3 2. should be performed The desired DNA can be conveniently recovered from the agaroseblock using GeneClean (Bio 101, Vista, CA) or a vanety of alternate approaches If the PCR reaction is optimrzed properly, this step should not be necessary.
3.4. Cloning of the Ribozyme Coding Region Many vectors are available that produce large amounts of transcript either in vivo (1,3,17) or in vitro (Bluescript series [Stratagene,La Jolla, CA], pGem series [Promega, Madison, WI], pcDNA series [Invrtrogen, SanDiego, CA]). It has been documented that flanking sequencescan adversely affect nbozyme act&y (Z&19) making it prudent to check that the ribozyme is active in vrtro (see Note 3) before embarking on more difficult in vivo experiments. Hence, cloning mto both types of vectors should be performed srmultaneously. Cloning vectors are prepared by double digestion of 1 l.tgof DNA with the same restriction enzymesused to cleave the PCR product (I.e., the sites present m the primers) and subjected without further purification to agarose gel purificatron as outlined m Section 3.2. 1. Double-digest 5 pL of the product from Section 3 3 m a 20 pL reaction with 20 U each of the desired restrictton enzymes overnight at the required temperature using the manufacturer’s most suitable buffer. Most manufacturers supply tables of the activity of each enzyme m the various buffers supplied by them. 2. Clean up the restriction digestion by adding 30 pL of TE buffer and extracting sequentially with 50 pL of buffered phenol/chloroform and then 50 pL of chloroform/isoamyl alcohol. 3 Precipitate the Insert DNA with 100 pL of ethanol 4 Leave on ice for 30 min, and collect the DNA by centrifugation m a microfuge for 15 mm. 5. Resuspend the pellet in 16 pL of distlled water. Add 2 pL of 1OX T4 DNA hgase buffer, 1 pL of gel-purified, double-digested vector, and 0.1 pL of 400 U/pL T4 DNA hgase 6 Incubate overnight at 16°C and then use 5 pL of ligation mix to transform competent Eschemhla COIL 7 Screen recombmants by blue/white selectton, m-gel lyns, or slmllar techmque
Zillmann and Robinson 4. Notes 1 One of the ribozyme-encodmg primers (see Fig. 3) may migrate anomalously, often as two bands when analyzed by denaturmg gel electrophorests Thts behavior is owing to the unusually high T,,, of the haupm m the catalytic core of the primer complementary to the rtbozyme and its resistance to denaturatton 2 Because of tts resistance to denaturatton, the hammerhead catalytic core is extremely difficult to replicate In practical terms, this means that the polymerase will spend more time trying to read through this region, and fewer polymerase molecules will extend to the other primer site resulting m less product during the second round of PCR, as compared to either mutant rlbozyme or antisense alone Worse yet, shorter PCR products can arise when the active catalytic core is bemg replicated. On transcription, shorter, macttve RNA is produced from these products The appearance of these PCR products can be mnumtzed by. a Choosing primers with high Tm values b. Keeping the annealing temperature as high as possible and the annealing ttme as short as possible. c Keeping the outside primers as far away from the intended cleavage site as possible A very systematic study of the effect of flank length on acttvtty determined that flanking sequences longer than about 30 bases on each side of the ribozyme core are necessary for full in vivo activity (10). 3. Analysis of in vitro cleavage reactions with flanking regions greater than about 25 bases can become difficult due to incomplete denaturation of the ribozymel substrate or ribozyme/product complex during electrophorests. If material migratmg larger than substrate alone is observed, the followmg procedure will usually correct the problem. Dilute the sample (~20 pL) with urea buffer (175 mM NaCl, 5 mMEDTA, 0.5% [w/v] SDS, 7 Murea, and 5 mMTris-HCl, pH 7.4) up to 100 pL Add 10 pg of RNase free glycogen or tRNA as carrier, and precipitate with 2-3 vol of ethanol, depending on the length of the RNAs being precipitated (3 vol for molecules under 100 bases and 2 for larger RNAs). After 30 mm on ice, the RNA is collected by centrifugation for 15 mm m a microfuge The ethanol IS decanted, and the pellet resuspended m formamide loadmg dye. Aggregation and incomplete denaturatton are also mmlmized by using as little Mg2+ as possible m in vitro cleavage reactions.
References 1 De Young, M. B , Kmcade-Denker, J., Boehm, C A., Riek, R. P , Mamone, J. A , McSwtggen, J. A., and Graham, R. M. (1994) Functional characterization of ribozymes expressed using Ul and T7 vectors for the intracellular cleavage of ANF mRNA Bzochemzstry 33,12,127-12,138 2. Homann, M., Tabler, M., Tzortzakaki, S., and Sczaktel. G. (1994) Extension of helix II of an HIV-l-directed hammerhead ribozyme with long antisense flanks does not alter kmettc parameters m vrtro but causes loss of the mhibitory potential m hvmg cells. Nuclerc Acids Res. 22,3951-3957
Long Hammerhead
Ribozymes
139
3 Lteber, A. and Strauss, M. (1995) Selection of efficrent cleavage sites in target RNAs by usmg a ribozyme expression library. A4oZ Cell BzoE. 15,540-55 1 4 Cantor, G. H., McElwam, T F , Btrkebak, T. A., and Palmer, G H. (1993) Rtbozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression Proc NatZ Acad. Sci USA 90, 10,932--10,936. 5 Deshler, J 0 , Li, H., Rossi, J. J , and Castanotto, D. (1995) Ribozymes expressed within the loop of a natural anttsense RNA form functional transcription termmators Gene 155,35-43 6. Ellis, J and Rogers, J. (1993) Design and spectfictty of hammerhead rtbozymes against calretmm mRNA. NucZezcAczds Res 21, 5 17 l-5 178. 7. Ferbeyre, G , Bratty, J., Chen, H , and Cedergren, R. (1995) A hammerhead rtbozyme inhibits ADE 1 gene expression in yeast. Gene 155,45-50. 8 Gast, F -U., Amtri, K M A, and Hagerman, P. J. (1994) Interhelix geometry of stems I and II of a self-cleaving hammerhead RNA. Biochemistry 35, 1788-l 796 9 Mazzolmi, L., Axelos, M , Lescure, N , and Yot, P (1992) Assaying synthetic ribozymes m plants. hrgh-level expresston of a functional hammerhead structure fails to mhibtt target gene activity in transiently transformed protoplasts. PZant MoZ Biol 20,715-731 10 Crisell, P., Thompson, S , and James, W (1993) Inhibrtron of HIV-l replication by rtbozymes that show poor activity rn vitro. Nucleic Acids Res. 21,5251-5255. 11 Kobayasht, H , Dorai, T., Holland, J. F., and Ohnuma, T. (1994) Reversal of drug sensitivity m multidrug-resistant tumor cells by MDRl (PGY 1) rtbozyme Cancer Res 54, 1271-1275 12 Sane, D C. and Chema, D J (1995) PCR-based production of a ribozyme to plasmmogen activator mhibnor I. Bzotechmques 18,208-210 13 Tablet-, M , Homann, M , Tzortzakaki, S., and Sczakiel, G (1994) A three-nucleotide helix I is sufficient for full activity of a hammerhead rtbozyme advantages of an asymmetric design Nuclezc Acids Res. 22, 3958-3965 14. Htguchi, R., Krummel, B , and Saikt, R. K (1988) A general method of in vitro preparatron and specific mutagenesis of DNA fragments* study of protein and DNA interacttons. Nuclezc Aczds Res 16, 735 l-7367 15 Mullis, K , Faloona, F , Scharf, S , Saiki, R., Horn, G., and Ehrhch, H. (1986) Specific enzymatic amphficatron of DNA tn vztro the polymerase chain reactron Cold Sprmg Harbor Sym. 51,263-273 16 Vallette, F., Mege, E , Reiss, A., and Adesmk, M. (1989) Construction of mutant and chtmeric genes using the polymerase cham reaction. NucZelc AczdsRes 17,723-733 17. Noonberg, S. B., Scott, G K , Garovoy, M. R., Benz, C. C , and Hunt, C. A. (1994) In vrvo generation of highly abundant sequence-specific oligonucleottdes for antisense and triplex gene regulation. Nuclezc Aczds Res 22, 2830-2836 18. Fedor, M. and Uhlenbeck, 0. (1990) Substrate sequence effects of “hammerhead” RNA catalytic efficrency Proc NatZ Acad Sci USA 87,1668-1672 19. Woodson, S. and Cech, T (199 1) Alternative secondary structures m the 5’ exon affects both forward and reverse self-sphcmg of the Tetrahymena mtervenmg sequence RNA Blochemlstry 30,2042-2050
Design and Production of Asymmetric Hammerhead
Ribozymes
Martin Tabler and Georg Sczakiel 1. Introduction Asymmetric hammerhead rtbozymes represent a variation of catalytic antisense RNAs that have been introduced m this book as a specialized form of rtbozymes m Chapter 14. Catalyttc antisense RNAs are characterized by a relatively long antisense sequence (>30 bases) that allow efficient association with the target RNA. Owing to their long antisense flanks, multiple turnover cleavage of several target RNA molecules cannot be anticipated, but instead, one molecule of catalytic anttsense RNA is expected to inactivate one target RNA molecule. In those catalytic antisense RNAs described in Chapter 14, the catalytic domain of the hammerhead ribozymes was flanked by two relatively long antisense regions. By contrast, asymmetric hammerhead ribozymes contain only one long antisense flank-the one that forms helix III in the hammerhead complex-whereas the other flank that forms helix I is truncated to as little as three nucleotides (1). This “destgn” (see Fig. 1) has the advantage that the catalytic antisense RNA is physically dissected into its two functional domains, which control (1) association with the target RNA and (2) cleavage of the target RNA. Such an asymmetrtc hammerhead ribozyme resembles an anttsense RNA with an additional cleavage domain (“bombshell”) at the 5’-terminus. The association of the asymmetric hammerhead ribozyme with its target RNA is entirely controlled by the antisense domain downstream of the catalytic domain. This allows straightforward optimization of the length of helix III for efficient association with the target RNA, a method that is outlined m Chapter 30 The general strategy for applying asymmetric hammerhead ribozymes is to create first a construct with a hehx III-forming region of about 200 nt or more. From
Methods III Molecular Edlted by P C Turner
B/o/ogy, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
141
142
Tabler and Sczakiel asymmetrlc
hammerhead Helix
rlbozyme
III
Helix
I
3’
Truncation of
helix
SelectIon fast
3’F
III
head
3’7
for
rlbozymes
5’ 3’-
hybrldiztng
asymmetrlc
!j’
hammer-
5’ 3’7
5’ 3’-E
*’
Fig. 1. The general “design” of an asymmetrrc hammerhead nbozyme is given (top) The actual catalytic domain is flanked by a short helix I, which can be as little as three nucleotides, and a long helix III, consisting of up to 200 nt or more The helix III domain is responsible for association with the target RNA. By truncation of helix III, a fast-hybridizing catalytic RNA can be selected (bottom).
For further improvement, this antisense domam is truncated, and the resultmg catalytic RNAs are experimentally tested for fast hybridization with their target. This will select catalytic RNA with “optimized” bindmg kmetics. Two ways will be considered to generate an asymmetric hammerhead ribozyme. The first approach uses amphfication by the polymerase chain reaction (PCR) to introduce the entire catalytic domain as well as the (short) helix I region via a synthetic DNA ohgonucleotide (see Fig. 2A) This ohgonucleotide should also contam a restriction recogmtion sequence suitable for clonmg mto a transcription vector. Although this approach IS feasible, it does require the synthesis of a DNA ohgonucleotide of 50 nt or more. Owing to the self-complementarity required for the helix II region wlthm the catalytic domam, it is unavoidable that the required DNA ohgonucleotide primer will base pair both within itself and with a second primer molecule. This may cause artifacts durmg PCR amphfication. The second approach makes use of premade DNA vectors that contam the catalytic domain of hammerhead ribozymes with a restriction site engineered mto it. The DNA fragment amphfied by PCR gets inserted mto this restriction site (see Fig. 2B). The complementmg part of the catalytic domain and the helix I region will be provided by the premade plasmid. We have currently about 16 vectors available that can be received on request. If these vectors are used, the oligonucleotide required for PCR amphfication can be much smaller
Asymmetric Hammerhead sense ’
L
Ribozymes
143
primer Helix
III “oa”~ge
Helix
I
Fig. 2. Prtmers required for construction of asymmetric hammerhead nbozymes by PCR amplification (A) Outlines the strategy of Method 1. An asymmetric hammerhead rlbozyme 1sgiven, and the nucleottdes are numbered according to the conventtonal system (2) The “sense primer” 1s of the same polarity as the target RNA and contams typically 12-18 matching nucleotides at its 3’-end (not detailed). This sequence would correspond to nucleottdes (16.n - 16 [n- 111) or 16 n-16 [n- 171) according to the numbermg system (2). At the S-end, the sense primer carries a restrlctton recognition sequence (not detailed) The “antisense primer” contains the four sequences (a), (b), (c), and (d), which are indicated in part A (see Section 3.1.3.). Part (a) contains 10-15 nucleotides matchmg the anttsense sequence of the target RNA close to the selected cleavable NUXJ motif (nucleottdes [ 15.1- 15 lo] or [ 15.1 - 15.151). The anttsense prtmer also comprises the entire catalytic domain (b), which m part A is taken from the satellite of the tobacco rmg spot virus (3), plus the nucleottdes 2.3 -2.1, which represent a short hehx I-formmg region (c). Like the sense primer, also the antisense primer will contain a restriction recognition sequence at its 5’-end (d) (B) Outlines the strategy of Method 2 Here, the catalytic domain is modified It contams a XhoI recogmtron sequence CYTCGAG between nucleotrdes 10.4 and 11.4. The anttsense prtmer contains lust part (b’) of the catalytic domain with the XhoI site plus two additional nucleotrdes at its 5’-end The resultmg amplified DNA fragment, whtch becomes amplified by PCR, 1sinserted into a plasmid vector that delivers the “mtssmg” sequence between nucleottdes 2.3 and 10 3
144
Tabler and Sczakiel
2. Materials 1 Computer facilities for sequence analysis 2 Computer program to select ohgonucleottdes for PCR amphflcation, for example, the program “OLIGO” (distributed by National Biosciences 725 Tower Drive Hamel, MN 55340) 3. Synthetic DNA oligonucleotides, spectfically destgned for the sequence of the target RNA 4. TE buffer: 10 mM Tris-HCl, pH 8.0, 1 m/t4 EDTA (stored as a 100X stock) 5 PCR machme and reactton tubes 6. 5X PCR buffer 100 mA4KC1, 200 mMTrts-HCl, pH 8 8, 100 mA4 (NH&S04, 20 n-J4 MgS04, 1.O % Tnton X-100 7 Bovine serum albumm (molecular-biology grade) at 1 mg/mL 8. Deoxynucleoside trtphosphates (dNTPs): a solution contaimng each dNTP at 10 mM. 9 cDNA of target RNA 10 Tuq polymerase (or equivalent enzyme). 11 Equipment for agarose or polyacrylamtde gel electrophoresis. 12 Phenol and chloroformtsoamyl alcohol 24.1 (v/v) for DNA extraction 13 Restriction enzymes and manufacturer’s buffers. 14 Vector system suitable for m vitro synthesis of RNA 15 T4 DNA hgase and manufacturer’s buffer 16. Competent Escherzchza colz cells suitable for transformatton 17. Matertals for DNA sequencing. 18 A 32P-labeled m vitro-synthesized RNA transcrtpt of the target RNA. 19. RNase A (DNase-free). 20 Bacteriophage-encoded RNA polymerase (SP6, T3, T7) and transcription buffer according the mstructions of the manufacturer 2 1 Rtbonucleoside triphosphates (NTPs) a solution contammg each NTP at 20 mM 22. RNasin (RNase mhibttor). 23 DNase I (RNase-free). 24 Separate stock soluttons of 1 MTns-HCl, pH 8.0,l MMgC12, 250 mA4EDTA, pH 8 0
3. Methods 3.7. Generation of Asymmetric Hammerhead Ribozymes by Direct PCR Amplification 1 Select an NUXJ cleavable motif within your target sequence (see Note 1) This IS the three-nucleottde motif that you would like to cleave by an asymmetric hammerhead ribozyme The two DNA ohgonucleotides required for PCR amphfication must be designed according to the sequence context of the NUX& motif The primer close to the cleavable motif 1s the “antisense primer” and the backprimer that will determme the 3’-end of the asymmetric hammerhead rtbozyme is the “sense prtmer” (Fig. 2A) 2. Design the sense prtmer (see Note 2) to contain about 12-18 nucleotides matching the target RNA. At its 5’-end, it should contain a newly introduced restrtc-
Asymmetric Hammerhead
3.
4
5
6.
Ribozymes
145
tion sate suitable for clonmg the amplified DNA In addition to the terminal restriction site, there should be at least two further nucleotides (preferentially C and G) preceding the recognition sequence. For example, the S-terminal part of the sense primer could be 5’ GGG/AATTC . . , wherein “GG” precedes the EcoRI site G/AATTC, which is itself followed by the stretch of target-specific sequences Design the antisense primer (see Notes 2 and 3), and pay attention to the four sequence elements (a-d) shown m Fig 2, which will be listed from 3’ to 5’ a The sequence (a) represents the target-specific region. It is of antisense polarity with respect to the target RNA It should consist of about l&l5 nucleottdes This implies that the 3’-end of sequence (a) should be located between nucleotides 15.15 and 15.10, respectively, according to the nomenclature for hammerhead ribozymes (2) (see Fig. 2A). The target-specific region should include nucleotide 15 1, which is usually the A residue opposite to the U of the NUX& cleavage motif b The sequence (b) represents the actual catalytic domam, which is attached 5’ to sequence (a). Sequence (b) is usually composed of 22 bases between nucleotrdes 3 and 14 accordmg to the numbering system This could be, for example, the sequence 5’-CsTGATGAGTCCGTGAGGACGAA,,-3’, which is the naturally occurrmg sequence found in the positive strand of the satelhte of tobacco rmgspot vnus (sTobRV) (3) If the presence of restrictton sites within the catalytic domain IS desired, the followmg sequence can be used instead 5’-C3TGATGAGGCCTCGAGGCCGAAi4-3’ This sequence has been successfully tested (4,5). It contains a site for-01 (CTCGAG) and StuI (AGGKCT). c Preceding the catalytic domam, the oligonucleotide needs to have at least the three nucleotides that will form helix I within the hammerhead These are nucleotides 2 3-2 1 according to the numbermg system for hammerheads (2), which are complementary to nucleottdes 1 l-l 3 of the target RNA, that represent the nucleotides downstream of the NUXJ target motif. d Sequence (d) IS located at the 5’-terminus of the antisense primer It should introduce a restriction site for cloning mto a transcription vector. In addition to the recognition site for a restriction endonuclease, it must contain at least two extra nucleotides as outlined in step 2. It IS recommended to check the selected DNA ohgonucleottdes for their potential to form either intramolecular structures (self-complementarity) or drmers by computer programs that are available Both these structures should be munmized or avoided by varying the length of target-specific sequences within the two primers Calculate the proper melting temperatures using an appropriate computer programme (for example, “OLIGO”). Take only those parts of the primer sequences in account that anneal to the cDNA of the target RNA-disregard the newly introduced sequences Synthesize the required DNA oligonucleotides for PCR amplification, and dissolve them in TE buffer at a concentration of 1 pmol/pL (=l pM)
146
Tabler and Sczakiel
7. Dilute the recombmant vector contammg the cDNA template of the target sequence to about 10 pg/pL in TE buffer. 8. Set up the followmg 50 pL PCR reaction (see Notes 4 and 5). Pipet into small reaction tubes (keep to the order given to mmimize possible contammation) Water 5NBSA ( 1 mg/mL) 10 NdNTPs 10 mM 5cLL 5X PCR buffer 10 ClL Sense primer (5 pmol) 5c1L Anttsense primer (5 pmol) 5ccL DNA template ( 10 pg/pL) (see Note 6) 10 pL 9 Add 2 U of Tag polymerase, and depending on the type of PCR machine, you should cover the mixture with a layer of paraffin 011. 10 Carry out the PCR reactton using the following parameters* 7 mm at 94’C, followed by 30 cycles consistmg of: 30 s at 94°C; 30 s at the annealmg temperature, which should be 0-5°C below the melting temperature calculated, and 2 mm at 72°C. A final elongation step at 72’C for 5 mm is carried out, and the reaction mixture cooled to 4°C 11 Check about 10% of the PCR reaction mixture on an appropriate gel system (polyacrylamtde or agarose) for the presence of the expected DNA fragment 12. Extract the reactton mixture with phenol, followed by extraction with chloroform/tsoamyl alcohol (24: l), and collect the DNA by ethanol precipitation and centrifugation. 13. Digest about 0.5 pg ofthe amphfied DNA wrth the two restrtctron enzymes whose recogmtton sequences were engineered mto the sense and antisense primers (see Note 7). 14 Cut an appropriate vector that allows in vitro transcrtption by bactertophagedenved RNA polymerases, such as SP6, T3, or T7 RNA polymerase with the same two restrictton endonucleases, and ligate the DNA fragment into tt Transform competent cells and plate out. 15. Check the resultmg recombinant plasmtds for the presence for the PCR fragment. This is particularly simple if the catalytic domain was designed to contain an addtttonal restriction sate, for example, SluI. 16. Synthesize an asymmetrtc hammerhead ribozyme by m vitro transcrtption (see Chapter 10) and analyze for ribozyme acttvtty as outhned in Chapter 14 17 Confirm correct construction by sequencing
3.2. Generation of Asymmetric Hammerhead Ribozymes by PCR Amplification Using Premade Plasmid Vectors 1 Select an NUX$ cleavable motif within your target sequence as described in Section 3 1 , step 1. Check whether the three following nucleottdes (nucleotides 1 1, 1 2, 1.3, according to the numbermg system of hammerhead ribozymes) match with one of the plasmids listed m Table 1, and ask for the plasmtd from the first author 2 Design the sense primer as described in Section 3.1 , step 2.
Asymmetric Hammerhead Table 1 Summary
Rlbozymes
of Available
147
Three-Nucleotide Hehx I box=
Plasmld pFORTH-AAA pFORTH-AAC pFORTH-ACC pFORTH-ACT PBS-UCU pJH-CAC pFORTH-CCC PBS-Rz 12/3 PBS-Rz12/2 PBS-GCT/AGC pFORTH-GGC PBS-RzlUl pFORTH-TAG pFORTH-TCC PBS-TTA/TAA PBS-Rzl2/0
5’N UX
Helix I Box Vectors Ref.
NNN
Target RNA mot@
AAA AAC ACC ACT AGA CAC ccc GAC GAT GCT GGC GTT TAG TCC TTA TTT
Unpubhshed Unpublished Unpublished Unpublished
1 Unpublished Unpublished
1 1 Unpublished 1 Unpublished Unpublished Unpublished Unpublished I
“The three-nucleotlde helix I box corresponds to the sequence that follows downstream of the NUX& consensus sequencefor hammerheadRNAs For example, plasmld PBS-Rz12/3 can be used for construchon of asymmetric hammerhead rlbozymes for any NTXGAC sequence found in the cDNA of the target RNA. bThe target sequence 1sgwen In its general form as RNA The sequence NNN that follows the NUX& motif represents nucleotldes 1 1, 1 2, and 1 3, according to the numbering system for hammerhead RNAs (2) 3 Design the antisense primer, and pay attention to four sequence elements (a) and (b’) wherein (a) is the same as in Section 3.1 , step 3 Sequence (b’) will be attached 5’ to sequence (a), and it will consist of the sequence 5’-GCCTCGAGGCCGAA14-3’ for plasmids of the PBS series, which contain a XhoI site (CYTCGAG) For other plasmlds listed m Table 1, sequence (b’) slightly differs, and you would be informed of the modifications on receipt of the corresponding plasmld 4 Follow the residual steps of Section 3.1. as described from step 4 onward, except that you should use XhoI m combination with the restriction site engmeered mto the sense primer for digestion of the amplified PCR product It IS also necessary to use the plasmid vector of Table 1 in step 13.
4. Notes 1 For selecting target regions for the planned asymmetric hammerhead rlbozymes and for the mltlal size of hehx III, consult Chapter 2. For the selection of a spe-
Tabler and Sczakiel
2. 3
4
5. 6.
7
ctfic cleavable NUX& motif (N = A, C, G, or U, X = A, C, or U), take mto account that different mottfs are cleaved with varying eftictenctes by hammerhead ribozymes The relative rates are also influenced by the sequence context of the NUX$ motif, but as an mdication, the following order of preferred motifs may be considered: NUC& > NUA& > NUU& and GUX& = AUXL > CUX& = UUX& (6,7), According to our experience, good cleavage results can be expected with a GUC$, AU& or UUC& motif. Please note that the “sense primer” used m PCR amplification is of the same polarity as the target RNA, and the “anttsense primer” has the opposite polartty In addition to the actual asymmetric hammerhead ribozyme, generating a control construct that is mutated m the catalytic domain is recommended, so that it is catalytically inactive When tested in living cells, such a construct can serve as an “anttsense control.” In prmciple, each of the conserved nucleotides can be changed or deleted m order to generate catalytically mcompetent RNA Deletion of G,,, for example, ~111 completely destroy cleavage activity The constructton of asymmetric hammerhead rtbozymes is based on PCR. The actual ampllficatton protocol described has worked well m our hands However, it may well be that other reaction condtttons for PCR may work equally well or better Performmg a control PCR without DNA template added 1srecommended The total amount of DNA template used for PCR ampltficatton is about 100 pg For a typical plasmid with a mol wt of about 2 x lo6 Dalton, this corresponds to about 1@I8 mole or about 600,000 molecules. Digesting the PCR fragments with the two restriction endonucleases that cleave wtthm the sequences of the sense and anttsense primer wtll require a high concentration of enzyme, since it IS a relatively small DNA fragment One mtcrogram of this DNA will therefore have many more sites to be cleaved than 1 pg of plasmtd with a smgle site, let alone 1 pg of h DNA, for which the units of restrtcnon enzymes are usually defined If it 1snot possible to use a high concentratton of the restrtction enzymes, try reducmg the amount of the PCR fragment to achieve complete digestton.
References 1. Tabler, M , Homann, M., Tzortzakakt, S., and Sczaktel, G (1994) A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme advantages of an asymmetrtc design Nucleic Aczds Res 22, 3958-3965 2 Hertel, K. J , Pardi, A., Uhlenbeck, 0. C., Koizumt, M , Ohtsuka, E , Uesugt, S , Cedergren, R , Eckstem, F , Gerlach, W L , Hodgson, R , and Symons, R H (1992) Numbering system for the hammerhead Nuclezc Aczds Res 20, 3252 3. Buzayan, J. M , Gerlach, W L , and Bruemng, G (1986) Satellite of tobacco rmgspot vnus RNA a subset of the RNA sequence is suffctent for autolyttc processing. Proc Nat1 Acad Scz USA 83,8859-62 4 Homann, M , Tzortzakaki, S., Rittner, K., Sczaktel, G., and Tabler, M (1993) Incorporatton of the catalytic domain of a hammerhead rtbozyme into antisense
Asymmetric Hammerhead
Ribozymes
149
RNA enhances its mhtbttory effect on the replication of human mnnunodeficlency VKUS type 1. Nuclezc Acids Res 21,280%28 14 5 Heinrich, J.-C., Tabler, M , and Louts, C (1993) Attenuation of whzte gene expression m transgemc Drosophzla melanogaster. posstble role of a catalytic antisense RNA Dev Genetzcs 14,258-265. 6 Shtmayama, T., Ntshtkawa, S , and Taira, K. (1995) Generality of the NUX rule kinetic analysis of the results of systematic mutations in the trmucleotrde at the cleavage site of hammerhead rtbozymes Bzochemzstry 34,3649-3654. 7 Zoumadakts, M and Tabler, M. (1995) Comparatrve analysrs of cleavage rates after systematic permutation of the NUX& consensus target motrf for hammerhead ribozymes. Nuclezc Aczds Res 23, 1192-l 196
17 Minimized
Hammerhead
Ribozymes
Maxine J. McCall, Philip Hendry, and Trevor
J. Lockett
1. Introduction The hammerhead ribozyme as engineered by Haseloff and Gerlach (I) consists of the conserved nucleotides C3-A9 and Gi2-Cr5 2 connected by nucleotides that form stem-loop II, and nucleotrdes at the 5’- and 3’-ends, which form helix I and hehx III, respectively, in complex with the substrate. Such a ribozyme is shown m Fig. 1. Most hammerhead ribozymes of this type are constructed with 12 nucleotrdes in stem-loop II, with four nucleotides in the loop and eight nucleotides forming a 4 bp double helix. Smaller, active rrbozymes can be made by eliminating helix II or truncating its standard 4 bp form (4-s). We define a minizyme (minimized rtbozyme) as a hammerhead ribozyme in which helix II has been replaced by a short lmker containmg no Watson-Crick base pairs, and a mimrrbozyme as one that has a helix II ofjust one basepair. Such ribozymes are chemically synthesized more cheaply and in greater yields than the standard-sized ribozymes, by virtue of the fewer nucleotides they contain. Further reductions in costs and increases in yields may be obtamed when many of the ribonucleotides are replaced by deoxyribonucleotides. Therefore, these minimized rtbozymes are likely to be the economically preferred form of ribozyme developed for use as exogenously supplied pharmaceuticals. The design of DNA-containing mmizymes and miniribozymes is described in this chapter. The design rules are not only applicable to mmlmized ribozymes for commercial use, but also to rrbozymes synthesized on smaller scales for research purposes when costs are an issue. In addition to their economic advantages, minimized ribozymes may be superior to full-sized ribozymes in their function, if helix II in the larger ribozyme interacts detrimentally with parts of the folded mRNA target or other molecules. The possibility of steric interference by helix II is supported by the From
Methods m Molecular Edlteci by P C Turner
Bology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
151
McCall, Hendry, and Lockett
152 H&x
Hehx I
1J.I
5' -------NNNNNNNNG,JJ,6,C,7 3’
NNNNNNNNC,,
&, 44
4
NNNNNN---------NNNNNN 5’
Substrate hbozyme
C,U,Gs A6
43 (42
3’
&,%U,
C-G A.U G-C G-C A G GU
Heltx II Loop II
Fig. 1. An RNA substrate and hammerhead ribozyme m the form described by Haseloff and Gerlach (2). The substrate 1sdrawn containing the triplet GUC, whrch IS the triplet usually chosen for cleavage Cleavage occurs on the 3’-side of C, 7 as shown by the arrow. The remauung sequence of the substrate determines the identities of each N in the ribozyme. The conserved nucleotides C3-A, and G,,-A,, ,(C,, 2) are in the ribozyme. On bmdmg to the substrate, nucleotides m the S- and 3’-arms of the ribozyme form helix I and helix III, respectively. The nucleotrdes joining A, and G,, form helix II and loop II; the sequence of stem-loop II shown here occurs naturally in the satellite RNA (+) strand of tobacco rmgspot virus (2) Generally, most synthetic ribozymes are constructed with 4 bp in helix II and 4 nucleotides m loop II. The nucleotrdes are numbered accordmg to the scheme of Hertel et al. (3)
observation that a mimzyme, in which stem-loop II was replaced by 4 nucleotides, cleaved a 428-nucleotrde RNA transcript m vitro at a faster rate than did a ribozyme with a standard-sized stem-loop II, even though the mmrzyme was slower than the larger ribozyme at cleaving a short 13-mer substrate (8). Therefore, all-RNA miniribozymes, which in general would not be chemically synthesized, but rather formed by transcription from a DNA plasmid in vrtro or m cells, should be considered along with full-sized rrbozymes as potential tools for gene therapy. Guidelines for designing all-RNA minimized rrbozymes are also included here The mnnzymes and mmirrbozymes described here may cleave short substrates with rate constants smaller than those measured for analogous ribozymes. For example, all-RNA miniribozymes have been reported to cleave short substrates with approx 10% the rates observed for full-sized, all-RNA ribozymes (67). DNA-containing miniribozymes cleave short substrates (of approx 13 nucleotides) at better than 20% the rates observed by analogous DNA-containing ribozymes, with the differences between the cleavage rates lessening as the lengths of hehces I and III increase (unpublished data). How-
Minimized Hammerhead 3’nnnnnCA
Rlbozymes A G” t t
153
nnnnnnn 5’ CUG A AGU g t Linker
Mmizyme
Fig. 2. DNA-contammg mnnzyme wrth d(GTTTT) lmker The lurker and the S- and 3’-arms that hybridize to the substrate are composed of deoxyrtbonucleotides (except for A,, 1 and Cl5 *) and conserved nucleottdes are rtbonucleottdes. Upper-case letters represent RNA and lower-case letters DNA. Thts mimzyme 1s designed to bmd to a 1S-nucleottde substrate contammg the sequence GUX and to cleave on the 3’-side of X
ever, since cleavage is probably not the rate-limiting step m the mteraction of rtbozymes with long RNA substrates in vrtro or in cells (8-10), the slower cleavage rates of mmimtzed rtbozymes against short substrates should not be of concern, provided the rate of cleavage is above a threshold (and, of course, that the target site in the cell is accessible to the ribozyme).
At present, we do
not have a reliable value for this threshold cleavage rate. As a guide, a DNAcontaining mmizyme with a lmker of sequence S’dGTTTT, which cleaved a 15-mer substrate m vitro with a rate constant of 0.27 mix’ at 37°C pH 8.2, m 10 rnA4 MgCl,, was effective m inhibiting the production of interleukin-2 m human peripheral blood mononuclear cells (unpubluhed data); a mmtzyme of this type is shown in Fig. 2. A full-sized
DNA-armed rrbozyme cleaved the same short substrate m vitro with a rate constant five times faster than the
mmizyme, but was no more effective than the mmizyme in inhibiting interleukm-2 levels m the peripheral blood cells. 2. Guidelines for Designing Minimized Ribozymes 2.1. The DNA-Containing Minimized Ribozyme DNA-containing minimized ribozymes may be synthesized chemically, as described m Chapters 7 and 8 (see Note 1). In considering the several aspects of designing a minimized ribozyme, the nucleotides of a ribozyme may be classed conveniently mto three separate groups: these are: 1. The conserved nucleottdes. 2 The nucleotides replacing stem-loop II 3 The nucleotides n-rthe 5’- and 3’-hybridizing
arms.
Figures 2 and 3 (A) show two sequencesthat may be used for a DNA-containing minimized ribozyme
McCall, Hendry, and Lockett
154
A
nnnnnnn
3’ nnnnnCA A A G
5’
CUG AGUA
DNA-contammg
mmlnbozyme
c-g t
t t t
B
3’NNNNNCA A A G
NNNNNNN CUG A AGU
5’ All-RNA
mmulbozyme
CG u
u uu
Fig. 3. (A) DNA-containing minmbozyme with d(GTTTTC) lmker and (B) all-RNA mnnribozyme with r(GUUUUC) linker. Upper-case letters represent RNA and lowercase letters DNA These mmmbozymes are designed to bind to 15 nucleottdes of RNA contammg the sequence GUX, and to cleave on the 3’-side of X
2.1.1. The Conserved Nucleotides The identities of the conserved nucleotides are C3-U4-GS-A6-N,-Gs-A9 and Gt2-At3-At4-At5 t-Nt5 2 (11-13). All of these nucleotides should be ribonucleotides for optimum acttvtty. N, may be U or C (see Note 2) N,, 2 must form a Watson-Crick base pair with the nucleotide at position 16.2 in the substrate, so its identity is determined by the sequence of the target RNA (see Note 3).
2.1.2. The Nucleotides Replacing Stem-Loop II The best sequence for nucleotides loming the conserved A9 and Gt2 is d(GTTTTC) as shown in Fig. 3(A). These nucleotides preferentially are deoxyribonucleotides, m order to minimize costs and increase yields. If it 1sessential to keep the number of nucleotides to a mmimum, this sequence may be d(GTTTC), which contams one less deoxyribothymtdme (see Note 4). If nonspecific effects are observed, and it is suspected that these are owing to the miniribozyme binding and cleaving at another site or other sites of sequence stmilar, but not identical to the desired target, then the effects may be reduced by slowing down the cleavage rates by using the sequence d(GTTTT) m place of stem-loop II (see Note 5).
2. I .3. Nucleotides in the 5’- and 3’-Hybridizing Arms The sequence of these nucleotides get RNA. The number of nucleotides
IS determined by the sequence of the tar1s optimally seven or eight in the 5’-arm,
Mmimrzed Hammerhead
155
Rlbozymes
and five or SIX (excluding At5 , and N,, *) m the 3’-arm, so that when bound to the substrate, the mimribozyme forms a helix I and a helix III each of 7-8 bp (see Note 6). Except for A,5 r and Nt5 *, these nucleottdes preferentially are deoxyrtbonucleottdes (see Note 7). 2.7.4. Summary for DNA-Containing
Miniribozymes
A typical sequence for a DNA-contammg minnibozyme will be: 5’-nnnnnnnCUGAUGAgttttcGAAANnnnnn-3’
where upper-case letters represent ribonucleotides, lower-case letters deoxyrrbonucleotides, and the n (and N) are such that the mmiribozyme will form Watson-Crick base pairs when bound to the target RNA. This molecule contains 30 nucleotides ofwhich 12 (40%) are ribonucleotides (seeNote 8). A mmiribozyme of this type 1sdepicted m Fig. 3 (A), where N 1sC. In complex wtth its substrate, the miniribozyme of Fig. 3 will span I5 nucleottdes of the target RNA. 2.2. The A/I-R/VA Minimized Ribozyme All-RNA minimized ribozymes, hke full-sized ribozymes, may be synthesized chemically or transcribed from DNA plasmtds m vitro or m cells, as described in Chapters 7, 8, and 10, respectively. In general, the guidelines for designing all-RNA mmimrzed ribozymes are analogous to those for the DNAcontaining versions, so the above section also should be read. 2.2.1. The Conserved Nucleotides The identitres of the conserved nucleotrdes m all-RNA mimribozymes are the same as for DNA-contaming mimribozymes, and that for Nt5 2 1s determined by the sequence of the target RNA. The best nucleotrde to use for N, 1s U (see Note 9). 2.2.2. The Nucleotides Replacing Stem-Loop II The best sequence for nucleotides Joming the conserved Ag and Glz is r(GUUUUC), or r(GUUUGC) (see Note 10). 2.2.3. Nucleotides in the 5’- and 3’-Hybridizing Arms The sequenceof nbonucleotides in the hybridizing arms must be complementary to the sequence of the target RNA. Since most all-RNA mimribozymes are likely to be made by transcrtption, the number of nucleotrdes m the 5- and 3’-arms 1snot greatly limited by costsof synthesis,and so may be varied. If the concentration of ribozyme is high relative to the substrate, and each mimribozyme is required to cleave only one substratemolecule, then the hybrtdrzing arms of the mininbozyme may contam as many nucleotrdes as the full-length RNA being tar-
McCall, Hendry, and Lockett
156
geted (seeNote 11). If turnover ISrequired, the number of nucleotldes 1s optimally five to etght in the 5’-arm, and three to SIX (excludmg Al 5 1 and N , 5 *) m the 3’-arm, similar to the case for DNA-armed mmlribozyrnes (see Note 12).
2.2.4. Summary for All-RNA Miniribozymes A typical sequence for an all-RNA
mimrlbozyme
5’-(N)$UGAUGAGUUUUCGAAANo,
will be. -3’
where the N nucleotldes are such that the mmlrrbozyme will form WatsonCrick base pairs when bound to the substrate. The values of x and y are typically 7-8 and 5-6, respectively, but may be larger. A mmlrrbozyme of this type is shown in Fig. 3 (B).
3. Notes 1. At present, chlmenc minizymes, mmmbozymes, and nbozymes, which contain nbonucleotides and deoxynbonucleotides, may be made on automated synthesizers by sequentially coupling activated and protected nucleotide monomers to produce a protected nucleotlde chain. During the synthesis, the coupling times for addmg RNA monomers are longer than when adding DNA monomers. The chlmenc oligomer should be treated as If it is 100% RNA when removing the protecting groups and when punfymg the full-length product from the shorter contaminants Compared with then all-RNA counterparts, chimenc oligomers electrophorese a httle more rapidly through polyacrylamlde gels, with mob&y mcreasmg with greater DNA content 2 A DNA-contammg minizyme, in which stem-loop II was replaced by d(TTTT), showed equal cleavage activity against a short RNA substrate when N, was U or C, but a fourfold reduction m cleavage rate when N, was A or G (8) However, a DNAcontaining minmbozyme may requtre N, to be A or G if it is to be exposed to serum, since a DNA-contammg, full-sized nbozyme was degraded m serum by pynmldmespecific endoribonucleases, and U, was a particularly sensitive site (14); alternatively, for protection against these nucleases, N, may be a modified undme (see Note 8) 3 The sequences of RNA molecules targeted by ribozymes and minimized rlbozymes usually contain GUC (G,, *LJlh ,C17, see Fig. 1) where cleavage occurs on the 3’- side of C,,, and hence N,, 2 m the minmbozyme IS usually C. However, rules for choosmg the RNA target sequence appear to be similar for nbozymes and mmimlzed ribozymes, so the target sequence m general may contain NUH, where H 1s not G (13,15-18). 4 We have found that cleavage rate constants for DNA-containmg mmlnbozymes, with d(GTTTTC) or d(GTTTC) linkers, are at least 20% of those for analogous full-sized nbozymes with DNA in stem-loop II and m the hybridizing arms. Actual values for the rate constants vary with the sequence of the target RNA, and with the number of nucleotldes of target RNA bound, with the mmiribozyme sometimes having better activity than the analogous DNA-containing full-sized rtbozyme when the mmlnbozyme bmds to 15 or more nucleotldes of the target
Minimized Hammerhead
5.
6
7
8.
Ribozymes
157
RNA The cleavage rate constant for a mmlribozyme contaming the lmker d(GTTTC) 1sabout 70% that of a mmtribozyme containing the linker d(GTTTTC). Greater discrimmatton between the correct target and one of similar sequence can be achieved by a rtbozyme, either by slowing the rate of chemrstry, or by increasmg the rate of dissoctation of the substrate from the rtbozyme (I 9) The cleavage rate constant for a DNA-containing minizyme with linker d(GTTTT) is about 5- to 1O-fold less than for a mmirtbozyme with d(GTTTC) or d(GTTTTC) linker Unlike full-sized ribozymes, mimribozymes are not advantaged m their cleavage activtttes by having a short S-arm (see Chapter 27) Rather, a similar, small number of nucleotides in each hybridizing arm will assist turnover and reduce the likelihood of dissociation of one of the products being rate determining Seven to eight nucleotides m each hybrrdlzmg arm provide a good balance between fast cleavage (favored m a mimribozyme by more base pairs m helix I and helix III) and turnover (favored by fewer base pairs). In the special case where the target RNA contains a run of G or C residues (but not alternating G-C), so that a run of four or more rG.dC or rC dG basepatrs is formed in the mmirtbozyme-substrate complex, the number of nucleotldes in the correspondmg hybrrdizing arm(s) should be reduced to assist product dtssoctation. Although a small number of nucleotides m the hybridizmg arms assist turnover of the mmutbozyme m vitro, it is not known if the same effect will be observed in vtvo A mtxture of nbonucleottdes and deoxyribonucleotides m the 5’- and 3’-arms may be beneficial m some cases For example, a DNA-contaming mimzyme, with deoxynbonucleottdes at the 5’- and 3’-termmt and nbonucleotides m the hybndizmg arms closer to the cleavage site, cleaved a short target, and a 428-nucleotide RNA transcript containing the sequence of the short target, faster than did a mmtzyme with all-DNA hybridizmg arms or an all-RNA mimzyme (8) Also, melting temperatures of hehces I and III may be manipulated by adjustmg the RNAiDNA composmon of the 5’- and 3’-hybridizing arms. In the extreme case of a target sequence that is pyrtmidme-rich, so that helix I and/or helix III m the ribozymesubstrate complex have a predommantly RNA pyrimrdme strand and a predominantly DNA purine strand, the melting temperatures of those helices will be abnormally low relative to mixed sequence RNA-DNA hybrids; m this case, to ensure bmding at 37’C, it may be wise to include some RNA m the 5’- and 3’-arms of the mmuibozyme. It is likely that some of the nucleotides in a DNA-contammg mmnibozyme will have to be modified (either at the base, the sugar, or the phosphate group) to protect the molecule against nucleases when used in vivo. The nucleotides to be modified and the types of modification most probably can be adapted from those found to be suttable for a Ml-sized, DNA-containing nbozyme (14) or an all-RNA nbozyme (20,21). In general, these studies have shown that almost all ribonucleotides in a hammerhead nbozyme may be modified, with the following important exceptions. Ribonucleondes modified at the 2’-positton of the sugar group cannot be placed at posmons Gs, At5 t, and, to a lesser extent, Gs without loss of cleavage activity, and Gt2 1ssensitive to the type of modification (reviewed m 19). Phosphorothioate linkages in place of the normal phosphodiester bonds 5’ to Ag, A,,, and At4 result m loss of activity (22,23)
158
McCall, Hendry, and Lockett
9 There has been no systematic study on the optimum nucleotlde to use for N, in an all-RNA mmmbozyme In a full-sized all-RNA nbozyme, cleavage rates were found to decrease with varying N, m the order U > G > A > C (13) This contrasts with results obtained for a DNA-contammg mmlzyme as described m Note 2 above 10 We have found that an all-RNA miniribozyme with stem-loop II replaced by r[GUUUUC] (analogous to the best sequence d(GTTTTC) found for DNA-contaming mmmbozymes) cleaves a short synthetic substrate at 20% the rate observed for the analogous, full-sized, all-RNA nbozyme (unpublished data) In another system, when stem-loop II is replaced by r(GUUUGC), cleavage actlvlty 1s10% that of the analogous full-sized nbozyme (7}, this mmmbozyme with r(GUUUGC) lmker was representative of the group of fast-cleaving molecules selected for cleavage activity m vitro from a library of hammerhead nbozymes containing six randomized nucleotldes m place of stem-loop II (7) A third mmmbozyme, with r(GCUUGC) lmker m place of stem-loop II, had a turnover rate constant k,,, at 10% that of the comparable full-sized nbozyme, with a fourfold increase m K, (6) Although the m vitro cleavage of short substrates by all these mmmbozymes 1sslower than by the analogous full-sized nbozymes, the absolute values of then cleavage rate constants are sufficiently fast that they are unlikely to be rate-determmmg m vlvo 11. A long mminbozyme may fold to form a stable mtramolecular structure that 1s incapable of bmdmg to its substrate If this occurs, the number of nucleotldes m the hybrldlzmg arms must be reduced 12 The comments for DNA-containing mmmbozymes m Note 6 also apply to allRNA mmmbozymes If turnover 1snot fast enough, the number of nucleotldes m the hybrldlzmg arms may be reduced, but probably not below 5 m the 5’-arm and 4 (excluding A,, , and C,5 2) in the 3’ arm.
References 1 Haseloff, J and Gerlach, W L. (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities Nature 334, 585-591 2 Buzayan, J M., Gerlach, W. L., Bruemng, G , Keese, P., and Gould, A R. (1986) Nucleotlde sequence of satellite tobacco rmgspot virus RNA and its relationship to multimeric forms Vzrology 151, 186199 3. Hertel, K J., Pardi, A , Uhlenbeck, 0. C., Kolzuml, M , Ohtsuka, E , Uesugl, S , Cedergren, R., Eckstem, F , Gerlach, W. L., Hodgson, R., and Symons, R H (1992) Numbering system for the hammerhead. Nucleic Acrds Res 20,3252 4 Goodchild, J and Kohh, V. (199 1) Rlbozymes that cleave an RNA sequence from human lmmunodeficlency virus the effect of flanking sequence on rate Arch Blochem Blophys
284,386-391
5. McCall, M. J., Hendry, P., and Jennings, P. A. (1992) Mmimal sequence reqmrements for ribozyme activity. Proc Nat1 Acad Scl USA 89, 571&5714 6 Tuschl, T and Eckstem, F. (1993) Hammerhead nbozymes: importance of stemloop II for activity Proc Nat1 Acad Scl USA 90,6991-6994 7 Long, D. M and Uhlenbeck, 0 C (1994) Kinetic characterlsatlon of mtramolecular and intermolecular hammerhead RNAs with stem II deletions. Proc Nat1 Acad Scz USA 91,6977-6981
Minlmued Hammerhead
Ribozymes
159
8 Hendry, P , McCall, M J , Santiago, F S., and Jennmgs, P A (1995) In vitro activity of mmtmised hammerhead ribozymes. Nucleic Acids Res 23,3922-3927 9 Heidenreich, 0 and Eckstem, F (1992) Hammerhead rrbozyme-mediated cleavage of the long termmal repeat RNA of human immunodeficiency virus type 1 .J Blol Chem 267, 1904-1909 10 Ellis, J. and Rogers, J. (1993) Design and spectficrty of hammerhead rtbozymes against calretmin mRNA. Nuclezc Acids Res 21, 5171-5178. 11. Forster, A C and Symons, R. H (1987) Self-cleavage of vrrusord RNA IS performed by the proposed 55-nucleottde active site. Cell 50,9-16. 12 Sheldon, C. C. and Symons, R H (1989) Mutagenesis analysts of a self-cleaving RNA. Nuclezc Acids Res 17, 5679-5685. 13 Ruffner, D E , Stormo, G D , and Uhlenbeck, 0 C (1990) Sequence requirements of the hammerhead RNA self-cleavage reaction. Biochemistry 29, 10,695-l 0,702. 14 Shimayama, T , Nishtkawa, F , Nishikawa, S., and Tan-a, K. (1993) Nuclease-resistant chrmertc ribozymes contammg deoxynbonucleotrdes and phosphorothtoate linkages Nucleic Aczds Res 21,2605-2611 15. Kotzumr, M., Iwat, S., and Ohtsuka, E. (1988) Constructton of a series of several self-cleavmg RNA duplexes usmg synthetic 21-mers FEBS Lett 228,228-230 16 Penman, R , Delves, A , and Gerlach, W. L. (1992) Extended target-site specifictty for a hammerhead rrbozyme. Gene 113, 157-l 63 17. Shtmayama, T., Nishtkawa, S , and Taira, K. (1995) Generality of the NUX rule kinetic analysis of the results of systematic mutations m the trmucleotide at the cleavage site of hammerhead ribozymes Bzochemzstry 34,3649-3654 18. Zoumadakis, M. and Tabler, M (1995) Comparative analysts of cleavage rates after systematic permutation of the NUX consensus target motif for hammerhead ribozymes Nucleic Acids Res 23, 1192-l 196 19 Herschlag, D. (1991) Implmations of rrbozyme kinetics for targeting the cleavage of specific RNA molecules zn vzvo: more isn’t always better. Proc Nat1 Acad Scl USA 88,692 l-6925 20 Bratty, J , Chartrand, P , Ferbeyre, G , and Cedergren, R. (1993) The hammerhead RNA domam, a model ribozyme. Bzochzm Bzophys Acta 1216,345-359 21. Beigelman, L., McSwiggen, J. A , Draper, K G , Gonzalez, C , Jensen, K , Karpelsky, A M., Moolak, A S., Matuhcademic, J., Drrenzo, A B , Haeberlr, P., Sweedler, D , Tracz, D., Grmrm, S., Wmcott, F: E , Thackray, V G , and Usman, N (1995) Chemical modificatton of hammerhead nbozymes-Catalytic activity and nuclease resistance. J B~ol Chem 270,25,702-25,708. 22 Buzayan, J M., van Tol, H., Feldstem, P A., and Bruening, G. (1990) Identification of a non-junction phosphodrester that influences an autolytrc processing reactton of RNA. Nuclezc Acids Res l&4447-445 1 23 Ruffner, D. E. and Uhlenbeck, 0. C. (1990) Thiophosphate interference experrments locate phosphates important for the hammerhead RNA self-cleavage reaction. Nuclezc Acids Res 18,6025-6029
18 Design of Hairpin Ribozymes for In Vitro and Cellular Applications Qiao Yu and John M. Burke 1. Introduction 1.7. Ribozyme Targeting Following the discovery of catalytic RNA (I), a number of different rrbozymes have been found Most rrbozymes carry out site-specific cleavage of the RNA phosphodtester backbone, although important exceptions may be emerging (2,3). The catalytic center and reaction site of several naturally occurring self-cleaving molecules have been dissected, and used to develop rrbozymes that cleave external substrates (4). Because RNA structure IS responsible for both catalytic activity and substrate recognitron, rrbozymes may be engineered to direct the inactrvatron of targeted cellular and viral RNAs through a catalytic cleavage mechamsm (5). 1.2. Hairpin Ribozyme The hanpm nbozyme was originally found m the minus strand of Tobacco Rmgspot Virus Satellite ([-]TRSV) RNA, endowing this RNA with the ability to self-cleave durmg the rephcation cycle without the assistanceof proteins in vitro (6,7). Deletton studies showed the mmimum sequence requirement for the cleavage reaction: a 50-nucleotrde catalytic RNA sequence and a 14-nucleotrde substrate sequence (8) The secondary structure of the complex between the hairpin rrbozyme and its substrate consists of two short mtermolecular hehces (termed Hl and H2) and two mtramolecular hehces (H3 and H4), separated by two internal loops (A and B) (Fig. 1). The rrbozyme catalyzes a reversible, site-specific cleavage reaction to the 5’-side of guanosine within loop A (9). Cleavage yields two products: the 3’-product contains a S-hydroxyl From
Methods Edited
by
in Molecular P C Turner
Biology, Humana
161
Vol 74 Rbozyme Press
Inc , Totowa,
Protocols NJ
162
Yu and Burke HELIX
I
111111
HELIX2
J2/1
A
3’
vi?‘:
51AAACAGA
GUCAA-UA .
GAAe J7/2
;I: A-U
lo
J3/4
C
A
20.
A
G
B
“”
A
J4/3
A ill
A
AC
A
I
y;*
C-G
’ HELIX 4 _ -’
U
30.G
U Fig. 1. The secondary structure of the tram+acting (-)sTRSV hairpin ribozyme and its cognate substrate. Arrow indicates substrate cleavage site, and dashes indicate Watson-Crick base pairs. Ribozyme nucleotides are numbered from l-50. Substrate nucleotides are numbered consecutively from the cleavage site; those to the S-side of the cleavage site have negative numbers, whereas those to the 3’-side have positive numbers. HI-H4 indicate secondary structure elements (helices l-4). A and B indicate nonhelical segments connecting helices (loop A-B).
terminus, and the S-product contains a 2’, 3’-cyclic phosphate terminus. The cleavage reaction has a K, of 30-50 nA4 and kcatof about 2-3 min-’ at 37°C in a buffer containing 12 nG14MgC12, 2 mA4 spermidine, and 40 mA4 Tris-HCl, pH 7.5 (8,ZO). The hairpin ribozyme binds its substrate by WatsonCrick base pairs forming helix 1 and helix 2 (Fig. 1). The substrate specificity of the hairpin ribozyme can, therefore, be altered by changing the ribozyme sequence in helix 1 and helix 2 (II). Selection and mutation assays have shown that most bases within loops A and B are essential for catalytic activity (12,13).
Ribozyme Design
163
2. Materials 2.7. Databases and Software for Accessing and Searching Sequences Public access to genetic sequences 1s available from numerous databases GenBank and other databases can be accessedwith World Wide Web browsing software (e.g., Netscape or Mosaic) through the US National Center for Brotechnology Informatron (NCBI) at http://www.ncbi.nlm.nih.gov/. A relatively comprehensive list of molecular biology databases and software can be found at http://www.public.iastate.edu/-pedro/research-tools.html. Sequences can be searched for potential haupm ribozyme target sites using virtually any sequence analysis software package. We use DNA Strider or MacVector. 2.2. RNA Folding Software Software for predicting RNA secondary structure is publicly available for several types of computer systems.An overview and accessto the software are available at http://hornet.mmg.uci.edu/-hjm/projects/biocomp/ma.folding.html. We use Mulfold (14) for Macintosh. This is available at ftp.bio.indiana.edu/OO/ IUBio-Software%2bData/molbio/mac/mulfold.readme. 3. Methods 3.7. Choosing a Target Site It is not yet possible to predict which of the many potential hairpin ribozyme target sites within a long RNA molecule will be optimal for cleavage m vitro or m vivo. Therefore, it is desirable to choose a number of different potential targets (e.g., 3-6), and design a ribozyme for each potential target for synthesis and evaluation. In attemptmg to target ribozymes against a virus or an mRNA, one should search for potential target sites that are conserved among different isolates, and where possible, among other viruses or mRNAs in the same family (see Chapter 4). It is anticipated that targeting ribozymes to essential sequenceswill decreasethe frequency of viruses or mRNAs that escapethrough cleavage site mutation, and that these rtbozymes may have therapeutic value against several members of the same family in potential chmcal applications and animal studies. The sequence requirement of the substrate for the rtbozyme can be all perfect matches with the optimal hairpin ribozyme substrate sequence from-3 to +4 (RCN/GUCB, B: C,G or U; N: any base; R: G or A); (1I,Z5-18) or suboptimal sequences (NYN/GUCN; Fig. 2). The optimal and suboptimal sites need to be ranked according to sequence conservation. This can be done by searching the sequence data set with the entire sequence capable of being strongly recognized by the rtbozyme (5 nt upstream of the target site through 8 nt downstream of target sequence, with an N at position -1, since it 1s not
164
Yu and Burke
3’-NNNNNN” IIIIII
5’-NNNNNN
A
I
G
A UA
Fig. 2. How to design a hairpin ribozyme. The structural framework of the optimized trans-acting hairpin ribozyme and its substrate. Arrow indicates substrate cleavage site, and dashes indicate Watson-Crick base pairs. N: any base; R: G or A; Y: C or U.
recognized). The extent of site conservation can be quantitated by computer identification, alignment, and analysis using standard search algorithms (e.g., FASTA)
and the GenBank
database.
3.2. Design of a Trans-Acting Hairpin Ribozyme The structural framework of the engineered hairpin ribozymes is outlined in Fig. 2. Base substitutions within the substrate binding domain (helix 1 and helix 2) are necessary for changes in target sites. In contrast, sequences in loop A and loop B are essential for high levels of catalytic activity and so should not be changed. The sole exception is that the U& substitution increases ribozyme activity (16) (Fig. 2). The sequenceof helix 3 is not critically important as long as base pairing is maintained. However, we routinely use the wild-type sequence(Fig. 2). The stability of helix 4 is increased by extension from 3-6 bp and by capping with a stabilizing GUAA tetraloop (Fig. 2). This modification leads to an increase in the catalytic efficiency of the ribozyme (19). We suggest using the same ribozyme
structural framework
as in Fig. 2.
Ribozyme Design
165
3.3. Factors That Can Enhance or Diminish Ribozyme Activity In Vitro Some modifications, such as U39C substltutlon and extension of helix 4, increase the rlbozyme activity significantly, whereas dimerlzatlon or misfoldmg of rlbozyme or substrate may decrease the catalytic activity (20). The dlmerlzation of the hairpin rlbozyme IS inherent, because the bases in both helix 3 and helix 4 are self-complementary, but it can be avoided by using rlbozyme concentrations ~0.5 @4 or by renaturing the ribozyme at 37OC for 10 mm instead of heating up to 90°C and renaturing. The potential misfoldings of both ribozyme and substrate can, to some extent, be predicted and mmlmlzed through the use of RNA folding programs. 3.4. Factors That Can Enhance or Diminish Ribozyme Activity In Vivo The potential factors that may affect rlbozyme activity for m vivo work are. The extensive secondary structure of the target RNA may affect the accesslblhty of the rlbozyme to its substrate. The RNA folding program may be able to predict some of it Proteins or cellular RNAs that can bmd to the target RNA or the rlbozyme may increase or decrease the rlbozyme activity The low Mg2+ concentration m cells IS likely to decrease the rlbozyme activity. The ribozyme efficiency may decrease greatly if it 1snot m the same subcellular location as the target RNA Mutations m the target sequence will cause the mismatch of ribozyme with the substrate, thereby decreasing the rlbozyme efficiency. That IS why conserved sequences are used as target sites. The existence of the numerous rlbonucleases m cells may degrade the nbozyme. Two methods have been used to compensate for the ribonuclease effect m VIVO. One IS to produce large amounts of rlbozyme m the cells by lmkmg the ribozyme sequence to a strong promoter and transfecting the cells. The other method IS to modify the ribozyme chemically, so that it IS nuclease-resistant while maintaining the activity (24), and deliver them to cells by microinJectlon Preliminary results of hairpin ribozyme against HIV-I m human cells are promising despite these potential problems (21-23)
3.5. Alternative Constructs for Trans-Acting Hairpin Ribozymes Both of the alternative constructs of the trans-acting hairpin ribozymes are separated m two pieces. The bisected rlbozyme (Fig. 3B) IS constructed by replacing the three base loop GUU with three G-C base pairs. The activity of this bisected ribozyme IS nearly identical to the intact ribozyme (24). The advantage of using the bisected rlbozyme IS that each piece of RNA can be
166 .-1’ , ‘.-s
Yu and Burke +I
UG,/
‘NNNNNNC I,!,,, NNNNNNA
s,,.---., YRNN , I I I GYNNA-“A“
QAA*q,
A
:-:A-U Q-C
G
M’A
:
v-1:
c
A
A
U
,t [ P-2 A-U
C-G G A “A
/
+I UG . ’ ‘;“;‘:“I’: NNNNNA
NYRNI; I I I I GYNN GA A*,O
B
CA
A
Self-cleaving constructs
3’N
I”
S’AAAUAG~
A-VA
CuGA
GA
$yyy=’ AGCGA3’
I 2-z G-C C-G A-U
E-Z A-U Q-C
G
m*A
C A
A
A
Bisected ribozyme
3wyy:yy
A
C
U u A.40
t
:-: G*A A.” A . A”
C A
Separated domains
C
cAc-GG’ A-U C-G
21; Erg
U-A G-C A-U G A “A
Fig. 3. Alternative haqm rlbozyme constructs Arrow mdlcates substrate cleavage sites, dashes indicate Watson-Crick base pair, dashed lines indicate the covalent linker, and dots indicate noncanonical base pairs N: any base, R G or A, Y C or U (A) Selfcleaving ribozyme, the substrate IS covalently linked to the rlbozyme either at the S-end, at the 3’-end, or both (B) Bisected rlbozyme the rlbozyme 1s dissected along the axis of the helix 3, loop B, and helix 4. Helix 4 is extended by replacing the threebase loop GUU with three G-C base pairs (C) Separated domain ribozyme. the substrate binding domain of the rlbozyme 1s separated from the loop B domain at the hinge region.
synthesized directly from the RNA synthesizer (synthetic RNAs are not practlcal beyond 40 nt). The separate domam rlbozyme (Fig. 3C) is constructed by the separation of the substrate binding domain (nbozyme part of the hehx 1, loop A, and helix 2) from the loop B domain (helix 3, loop B, and helix 4) at the hinge region of the intact ribozyme. The separate domain ribozyme is 104fold less efficient than the intact rlbozyme (25), but it 1svery useful for studymg the tertiary interactions and catalytic mechanisms of the nbozyme. 3.6. Self-Cleaving
Hairpin Ribozyme Constructs In a self-cleaving ribozyme (Fig. 3A), the substrate is covalently linked to the ribozyme, which 1sthe native form of the hairpin rlbozyme and 1sessential for the rolling circle replication of TRSV satellite RNA. The linker between 5’-substrate and 3’-ribozyme must be at least 5 nt to prevent the coaxial stacking of helix 2 and helix 3 (26). The minimum lmker between 3’-ribozyme and S-substrate is usually 4 nt, but it has not been thoroughly studied yet (26,271. In addition to its natural tinctlon, the self-cleaving rlbozyme can be used for posttranscriptional processmg to give a construct with a well-defined 3’-end both m vitro and in vivo (27).
Ribozyme Design
167
3.7. Ribozyme Synthesis and Characterization Two assayscan be used to examme rlbozyme activity m vitro-analysis of catalytic efficiency using oligonucleotide substrates and examination of cleavage extent using long substrates (28) In these assays,oligoribonucleotide analogs of the viral target sequences are directly synthesized using RNA phosphoramidite chemistry on the DNA/RNA synthesizer (see Chapters 7 and 8). To generate hairpin ribozymes that are longer than 40 nt, DNA templates with duplex promoters are generated on the synthesizer and used for m vrtro transcrlptlon with T7 RNA polymerase (29) (see Chapter 10). RNA products are worked up and purified by standard methods (10) Multiple-turnover and single-turnover kinetics are carried out as described m Chapter 23 (Z0,30). 4. Note The state of the art with regard to designing hairpin rlbozymes is such that we can design with a reasonably high level of confidence a rlbozyme that will cleave an oligonucleotide target using the rules described above. Factors that will affect the rlbozyme’s activity, such as folding of the rlbozyme or target into inactive or unreactive conformations, can be dealt with to some extent using RNA folding software, but cannot be anticipated m all cases.This challenge is more daunting when It comes to cleaving long RNA molecules in vitro, and RNA cleavage in VIVO. The relationships between rlbozyme activity m cleavage of ohgonucleotides in vitro and the cleavage of long RNA molecules in vitro and rn vlvo have not been experimentally determined. Acknowledgments This work was supported by research grants AI29829 and AI30534 from the National Institutes of Health. References 1. Cech, T. R., Zaug, A. J , and Grabowski, P. J. (1981) In v&o sphcmg of rRNA precursor in Tetrahymena: involvement of a guanosmenucleotide in the exclslon of the intervening sequence.Cell 27,487-496. 2. Noller, H F , Hoffarth, V., andZlmmak, L. (1992) Unusual resistanceof peptldyl transferaseto protein extraction procedures.Sczence 256, 1416-1419 3. Plccmlli, J. A, McConnell, T S , Zaug, A. J., Noller, H. F., and Cech, T. R. (1992) Ammoacyl esteraseactivity of the Tetrahymena nbozyme. Science256, 1420-1424. 4. Long, D. M. andUhlenbeck,0. C. (1993) Self-cleaving catalyticRNA. FASEB J 7,25-30.
5. Christoffersen, R. E. and Marr, J. J (1995) J A4ed Chem. 38,2023-2037. 6. Prody,G. A., Bakos,J. T., Buzayan,J. M., Schneider,I. R.,andBruening, G (1986) Autolytlc processingof dimeric plant virus satelhteRNA. Sczence 321,1577-l 580.
168
Yu and Burke
7 Haseloff, J and Gerlach, W. L (1989) Sequences required for self-catalysed cleavage of the satellite RNA of tobacco rmgspot virus Gene 82,43-52 8. Hampel, A. and Tntz, R. (1989) RNA catalytic properties of the minimum (-)sTRSV sequence. Blochemwy 28,4929-4933. 9. Chowrtra, B. M and Burke, J M. (1991) Bmdmg and cleavage of nucleic acids by the hatrpm ribozyme Bzochemzstry 30,8518-8522 10 Buzayan, J. M , Hampel, A , and Bruenmg, G. (1986) Nucleotide sequence and newly formed phosphodiester bond of spontaneously ligated satellite tobacco rmgspot vu-us RNA. Nuclezc Acids Res 14,9729-9743 11. Joseph, S., Berzal-Herranz, A., Chowrtra, B. M , Butcher, S E , and Burke, J. M (1993) Substrate selection rules for the hairpin ribozyme determmed by zn wtro selection, mutatton, and analysis of mismatched substrates Genes Dev 7, 136138 12 Berzal-Herranz, A , Joseph, S , and Burke, J M (1992) In vztro selection of acttve hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions Genes Dev 6,129-134. 13. Berzal-Herranz, A., Joseph, S., Chowrira, B. M., Butcher, S. E , and Burke, J. M. (1993) Essential nucleotide sequences and secondary structure elements of the haupm ribozyme. EMBO J 12,2567-2574. 14 Zuker, M (1989) On finding all subopttmal foldmgs of an RNA molecule. Sczence 244,48-52 15 Hampel, A , Tritz, R , Hicks, M , and Cruz, P (1990) “Hanpm” catalytic RNA model* evidence for hehces and sequence requirement for substrate RNA NucZezc Acids Res l&299-304 16. Joseph, S. and Burke, J. M. (1993) Opttmization of an anti-HIV haupm ribozyme by m vitro selection. J BzoE Chem. 268,24,515-24,5 18 17. Anderson, P., Monforte, J., Tritz, R., Nesbitt, S , Hearst, J., and Hampel, A. (1994) Mutagenesis of the hatrpm ribozyme Nuclezc Aczds Res 22, 1096-l 100 18 Sargueil, B. S , McKenna, J , Butcher, S E., and Burke, J. M. (1996) In vztro genetic analysts Identifies noncanonical base pairs used for acttve site alignment by the hanpm rtbozyme, m preparation 19 Sargued, B , Pecchia, D. B., and Burke, J M (1995) An improved verston of the hanpm nbozyme functions as a nbonucleoprotem complex Blochemlstry 34,7739-7748 20. Butcher, S E and Burke, J. M. (1994) A photo-cross-lmkable tertiary structure motif found m functionally distmct RNA molecules is essential for catalytic function of the haupm rtbozyme Biochemistry 33,992-999 21 Ojwang, J. 0 , Hampel, A , Looney, D. J., Wong-Staal, F , and Rappaport, J (1992) Inhibition of human nnmunodefictency vu-us type 1 expresston by a hairpm rtbozyme. Proc. Natl. Acad. Set USA 89, 10,802-10,806. 22. Yu, M., OJwang, J., Yamada, 0, Hampel, A, Rapapport, J , Looney, D., and Wong-Staal, F. (1993) A harrpm rtbozyme mhtbtts expresston of dtverse strams of human mununodeficiency VKUStype 1 Proc Nat1 Acad Scz USA 90,6340-6344 23 Yamada, 0 , Yu, M., Yee, J K , Kraus, G , Looney, D , and Wong-Staal, F (1994) Intracellular nnmun~zation of human T cells with a hairpin ribozyme against human immunodefictency virus type 1 Gene Ther 1,38-45
Rlbozyme Design
169
24. Chowrtra, B. M. and Burke, J. M. (1992) Extensive phosphorothioate substttutton yields highly active and nuclease-reststant hairpin rtbozymes. Nucleic Aczds Res 20,2835-2840 25
26
27
28 29 30
Butcher, S E., Heckman, J E., and Burke, J M (1995) Reconstttutton of halt-pm rtbozyme acttvtty followmg separation of functional domains J Bzol Chem 270, 29,648-29,65 1 Feldstein, P A. and Bruening, G. (1993) Catalytically active geometry m the reversible ctrcularization of “mun-monomer” RNAs derived from the complementary strand of tobacco rmgspot virus satellite RNA. Nuclezc Aczds Res 21, 1991-1998 Chowrua, B. M , Pavco, P A , and McSwrggen, J. A. (1994) In vztro and In vzvo compartson of hammerhead, hairpin, and hepatttts Delta virus self-processing rtbozyme cassettes J Btol Chem 269,25,856--25,864 Lteber, A and Strauss, M (1995) Selectton of efficient cleavage sites in target RNAs by using a rtbozyme expresston library A401 Cell Bzol 15,540-55 1 Mtlhgan, J. F. and Uhlenbeck, 0 C. (1989) Synthesis of small RNAs using T7 RNA polymerase Methods Enzymol 180,5 l-62 Chowrira, B M , Berzal-Herranz, A , and Burke, J M (1993) Ionic requirements for RNA binding, cleavage, and ligation by the hanpm rtbozyme Bzochemzstry 32, 1088-1095.
19 Design of the Hairpin Ribozyme for Targeting Specific RNA Sequences Arnold Hampel, Mary Beth DeYoung, Scott Galasinski, and Andrew Siwkowski 1. Introduction The hairpin ribozyme has been developed and designed to target and cleave efficiently heterologous RNA sequences in a trans-reaction (J-3) Heterologous RNA cleavage has been carried out, targeting rules defined, systemsidentified, and very effective m vivo downregulation of gene expression obtamed using these design rules (4,5) This chapter describes the rules and steps necessary for designing the hanpin ribozyme to cleave specific target sequences efficiently. In the past, these rules have been used to design ribozymes that are very effective against HIV- 1 m vivo. A conventtonal hanpin rtbozyme was designed to cleave the sequence UGCCC*GUCUGUUGUGU, with cleavage at the*, m the 5’-leader of the HIV-I vn-us. When assayedm vivo m human T-cells against mfecttous HIV-l, expression of the virus was decreased by 3-4 logs m the presence of the ribozyme (5). A hairpin tetraloop ribozyme, where loop 3 of the conventional hairpin ribozyme was replaced by a GGAC(UUCG)GUCC tetraloop sequence (3), was designed, also by the rules of this chapter, to cleave a regton m the Pol gene of HIV-l. The sequence cleaved was CACCU*GUCAACAUAA. The tetraloop hairpin rtbozyme targeted to this region also reduced expression of the HIV-l virus by 3-4 logs (6). Currently, both of these ribozymes are bemg prepared for testing m human clmrcal trials as HIV-l antivtrals by Wong Staal (7). Thus, the targeting rules described herein have proven to be very effective m the design and preparation of hairpin ribozymes for the specttic downregulation of gene expression. From
Methods m Molecular Edited by P C Turner
Biology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
171
Hampel et al.
172 Site
Catalytic RNA U
Loop 4
GUAU$WAC GUG . . .
U
CAC A G Loop 3
CAAAG Helix 4
Loop 2
of
cleavage
3'
50 A U CUGG . . . . . . . . A GACC A mA
20
. . . . . . . m....m 5’basel
AGA Helix 3
Helix 2
Loop 1
Helix 1
Fig. 1. The hairpin ribozymedesignedto cleaveheterologousRNA. Two molecules, the ribozyme(catalytic RNA) and the corresponding substrateRNA, are shown. The B nucleotide is C, G, or U (not A) andthe V nucleotide is G, C, or A (not U).
The engineered conventional hairpin ribozyme (Fig. 1) is capable of being designed to cleave effectively heterologous RNA (4). Without the substrate binding region, it is a basic 36-nt domain that forms two helices (helix 3 and 4) and three internal loops (loops 2,3, and 4). The ribozyme recognizes substrate in two helical regions, helix 1 and 2 by specific base pairing. These two helices flank a 4-base sequence N*GUC (loop 5) in the substrate, and opposite this is a 4-base sequence AGAA (loop 1) in the ribozyme. The targeting rules for substrate recognition and cleavage are a BN*GUC sequence requirement in the substrate with base pairing between ribozyme and substrate in the flanking helices 1 and 2. The * is the site of cleavage. The B nucleotide is the first base of the substrate in helix 2. Helix 2 is fixed at 4 bp for optimal activity. The first basepair in this helix is B:V where B is the basein the substrateand can be G, C, or U. Replacement with an A prevents activity. The V nucleotide, which is the corresponding nucleotide in the ribozyme, does not include a U complement to the substrate A. The remaining three nucleotides in the substrateof this helix can be anything, including wobble basepairs in the first baseof the helix, as long as base pairing is maintained, Helix 1 is of variable length. The native sTRSV hairpin ribozyme sequence has a 6 bp helix 1. This can be extended or shortened with corresponding effects on k,,, and K,. That is, as the arm lengths get longer, K, tends to get smaller, but so does k,,,. The length of helix 1 for optimal catalytic efficiency is dependent on its sequence and must be optimized for each new target sequence. It typically is between 5 and 9 bp for optimal activity. Simple straightforward methods will be described for optimizing the length of this helix. The substrate loop has the sequence N*GUC, where the GUC is preferred for the sTRSV based hairpin ribozyme. The G base is absolutely required with no cleavage of substrate when it is changed. The UC bases are preferred with very low catalytic efficiency, kJK,,,, when they are changed.
Hairpin Ribozyme for Specific RNA Sequences
173
A large number of heterologous targets have been successfully cleaved using these targeting rules. The methods described allow logical development of an optimally active hairpin rrbozyme.
2. Materials Since this chapter describes the principles used to design a hairpin rrbozyme, no specrfic materials are required. The reader 1s referred to other chapters in this book at specific points for details of the appropriate protocols (Chapters 4, 11, and 23), but should also compare Chapter 18.
3. Methods 3.1. Selection
of the Target Sites
1. Using appropriate search methods, search the DNA sequence data bases to identify BN*GUC sequences m the selected RNA transcripts (see Chapter 4) The GUC is the preferred sequence with the G base absolutely required. The UC bases are preferred, since there is very low cleavage activity (k,,,/K,) when they are changed For example, changmg the C results m a 12 fold reduction in cleavage efficiency for A or G and 30-fold reduction for U m this position. The B nucleotide can be a C, G, or U, but cannot be an A. 2. If the target gene has potential heterogeneity, try to identify potential target sites that are in regions of high homology. As detailed in Chapter 4, by using sequence comparison methods, such as BLAST, these regions of homology can be identified 3 In addition to having the BN*GUC requirement and being m conserved sequence regions, the target sites should also be m regions where there is minimal interference from RNA structure or bound proteins. The methods given in Chapters 2 and 3 should help to identify such sites. These preferred regions are often near the S-cap, near the 3’-termmus, and near splice acceptor sites. Sequences near splice donor sites m general have a high degree of secondary structure and should be avoided.
3.2. The Ribozyme 1 With identification of an appropriate target sequence, a hairpin ribozyme should be designed to cleave this target sequence. The conventional hairpin ribozyme should have the features shown in Fig. 1 2 The ribozyme component of helix 2 should be designed to base pair with the four nucleotides upstream of the N*GUC sequence of the target sequence. Standard Watson-Crick base pairs should be used here, since we have not seen any advantage m using wobble base pans. 3 The ribozyme component of helix 1 should be designed to base pair with the 10 nucleotides downstream of the N*GUC sequence. Again, standard Watson-Crick base pairs should be used. We have not seen any obvious constraints in the sequence of helix 1, This is notably true m the first base pan following the *GUC. All four nucleotides work very well in this position. Note that a 10 bp helix 1 can
Hampel et al.
174
be designed, with the intention of using this ribozyme to assay a range of substrates gtvmg a range of hehx 1 lengths m order to optlmlze the length of helix 1 m the final ribozyme sequence (see Chapter 11). By making a ribozyme capable of formmg a range of lengths of hehx 1 up to 10 bp the range of helix 1 lengths can be tested with a single ribozyme 4 The ribozyme DNA template sequence should be synthesized and then transcribed (see Chapter 23) to produce the hairpin ribozyme designed to cleave the specific target sequence selected m Section 3 1 The ribozyme should have a GGG at the S-terminus to facilitate transcription T7 Promoter S'TAATACGACTCACTATAf'GGG 3'ATTATGCTGAGTGATAThCCCNNNNNNNNNNTCTTNNNNTGGTCTCTTT GTGTGCAACACCATATAATGGACCAT5' Astart of transcription (Ribozyme
DNA Template Sequence) We have tested the activity of a number of ribozymes both with and without the SGGG sequence, and found the addition of GGG to the S-terminus has no effect on activity. After transcription, the ribozyme should be isolated from a 10% polyacrylamide-8 M urea gel as described m Chapter 23
3.3. The Substrate A prmciple m designing the substrate for in vitro testing is to keep it short The use of long m vitro substrates IS not recommended, since extensive mterfermg secondary structure may occur in long RNA m the absence of cellular factors Secondary structure m the substrate introduces variables that interfere with the oblective of determmating in vitro catalytic activity For the hairpin ribozyme to be effective, the target sequence must be exposed The use of long hehx 1 lengths to compete out secondary structure IS not encouraged, because the result IS essentially an antisense effect with very low turnover rates. It ts dtfficult to predtct if a structure will be exposed m vivo or not This needs to be determmed experimentally (8) The substrate DNA template sequence should be designed to produce a full length substrate with a 10 bp helix 1 The substrate should begin with a GCG sequence to ensure high transcription levels and the presence of at least one C m the 5’ cleavage fragment This enables detection m the catalytic assay if the transcripts are labeled durmg transcription with radioactive CTP T7 Promoter 5’TAATACGACTCACTATAAGCG 3'ATTATGCTGAGTGATATK!GCNNNNNCTGNNNNNNNNNN5' Astart of transcription
(Substrate
DNA Template Sequence) Transcription should be carried out usmg a- 32P-CTP and the products separated on a 15% polyacrylamide-8 M urea gel as described m Chapter 23
Hairpin Ribozyme for Specific RNA Sequences site
Catalytic RNA G C
Loop 4
GUAUAWAC GUCCGUG . . . . . . . CAGGCAC A
U U
Helix 4
of
cleavage
i
3
U CUGG l
e*e
. .
.
.
l
AGACCAmA Loop 2
.e***.
m....m5’basel
CA24AG Loop 3
175
AGA Helix 3
Helix 2
Loop 1
Helix 1
Fig. 2. Hairpin tetraloop ribozyme. Loop 3 of the native hairpin ribozyme structure (Fig. 1) has been replaced with a GGAC(UUCG)GUCC tetraloop sequence.
5. Substrate RNA bands representing a range of helix 1 lengths can be isolated from the gel (see Chapter 11). In addition to the full-length transcript, a range of transcripts representing substrate with sequentially one less nucleotide on the 3’-terminus are obtained. These bands are owing to premature termination of transcription, which is common from the single-stranded template used here. Each sequentially smaller transcript represents one less nucleotide on the 3’-terminus (confirmed by direct RNA sequencing [see Chapter 1 l]), and thus, serially shortened helix 1 lengths are produced in the ribozyme/substrate complex, which is ultimately formed. These substrate bands can be isolated and correspond to helix 1 lengths of 5-10 bp.
3.4. Optimization
of He/ix I Length
1. Using the range of substrates generated from the substrate transcription in Section 3.3., cleavage assays should be carried out to determine which helix 1 length is optimal. The correct way to do the analysis is to determine catalytic efficiency (k,,,/K,) with multiple turnover reactions for each helix 1 length. This entails much initial effort. A quicker, but less precise method, which points the way to the optimal helix length, is to carry out the cleavage assay with multiple turnover using high substrate concentrations, i.e., higher than the initial estimate of K,. From the initial velocity of this reaction, a first-order rate constant keact is calculated. The high substrate concentration used will cause the K, + [S] term in the denominator of the Michaelis-Menten equation to approach [S] and, consequently, the velocity of the reaction will approach V,,,,,. Thus, at high substrate concentrations, the first-order rate constant, kreact,will approach k,,,. This method is satisfactory for an initial screen of helix 1 lengths. 2. The catalytic activity assays themselves are carried out as described in Chapter 23.
3.5. Tetraloop
Modification
of the Hairpin Ribozyme
1. The tetraloop addition to the hairpin ribozyme is a modification that has greatly improved catalytic efficiency for certain hairpin ribozymes. Loop 3 of the native hairpin ribozyme is replaced with the GGAC(UUCG)GUCC tetraloop sequence. The result of this modification is shown in Fig. 2.
176
Hampel et al.
2. The tetraloop forms a very stable stem loop structure (9) and, thus, likely stablhzes the ribozyme itself against thermal denaturatton Depending on the specific target sequence to be cleaved by the ribozyme, replacement of loop 3 by the tetraloop sequence either has no effect on activity, decreases activity slightly, or activity is greatly mcreased The change m the catalytic parameters of the HIV- 1 pol specific haupm ribozyme was most significant. When the tetraloop addition was made to the basic hair-pm ribozyme, the K,, decreased from 42-4.7 nM and the k,,, increased from 0 2-O 5 mm’ This gave an overall increase m catalytrc efficiency (k,,,/K,) of 15-fold when the tetraloop was added to this sequencespecific ribozyme (6). 3. The hanpm tetraloop ribozyme should be designed to cleave specific target sequences following the same targetmg rules for helix 1 and 2 as for the conventional hairpin ribozyme described above. 4. The DNA correspondmg to the tetraloop hairpm ribozyme should be designed as follows where the sequence corresponding to the tetraloop is underlined. T7 promoter. 5’TAATACGACTCACTATAAGGG 3’ATTATGCTGAGTGATAT*CCCNNNNNNNNNNTCTTNNNNTGGTCTCTTT GTGTGCCTGAAGCCAGGCACCATATAATGGACCAT5’
(Ribozyme DNA Template Sequence) 5 Synthesis of DNA, transcription, and deternunation of catalytic activity should be carried out as for the conventional hanpin ribozyme.
4. Summary The following steps should be taken when designing the hatrpin ribozyme cleave a specific target sequence.
to
1. Select a target sequence contammg BN*GUC where B is C, G, or U 2 Select the target sequence m areas least likely to have extensive interfering structure 3 Design the conventional haupm ribozyme as shown m Fig. 1, such that it can form a 4 bp helix 2 and hehx 1 lengths up to 10 bp 4 Synthesize this ribozyme from single-stranded DNA templates with a doublestranded T7 promoter 5 Prepare a series of short substrates capable of formmg a range of helix 1 lengths of 5-10 bp. 6 Identify these by direct RNA sequencmg. 7 Assay the extent of cleavage of each substrate to identify the optimal length of helix 1 8. Prepare the hairpin tetraloop ribozyme to determine if catalytic efficiency can be improved.
Acknowledgment This work is supported by NIH grant ROl AI29870
to A H.
HaIrpIn Ribozyme for Speafic RNA Sequences
177
References 1 Hampel, A and Tntz, R (1989) RNA catalytic properties of the minimum (-)sTRSV sequence. Blochemutry 28,4929--4933. 2. Hampel, A., Tritz, R., Hicks, M , and Cruz, P. (1990) Hairpin catalytic RNA model* evidence for hehces and sequence requirement for substrate RNA Nucleic Acids Res l&299-304. 3 Anderson, P., Monforte, J , Tritz, R , Nesbttt, S , Hearst, J , and Hampel, A. (1994) Mutagenesis of the hau-pm ribozyme Nuclerc Acids Res. 22, 1096-l 100 4 Ojwang, J , Hampel, A, Looney, D , Wong-Staal, F , and Rappaport, J (1992) Inhibition of human immunodefictency vtrus type-l (HIV-I) expression by a hairpm rtbozyme. Proc Nat1 Acad Scl USA 89, 10,802-10,806. 5 Yamada, 0 , Yu, M , Yee, J , Kraus, G , Looney, D , and Wong-Staal, F (1994) Intracellular tmmumzatton of human T-cells with a hairpin rtbozyme against human immunodeficiency virus type 1 Gene Ther 1,38+5 6 Yu, M , Poeschla E , Yamada, 0 , Degrandis, P , Leavitt, M , Heusch, M , Yee, J , Wong-Staal, F , and Hampel, A (1995) In vztro and zn vzvo characterization of a second functional hairpin ribozyme against HIV-l Vzrology 206,381-386 Wong-Staal, F (1994) Testing the promise of gene therapy HIV-Adv Res Ther 4, 3-8.
Zaug, A and Cech, T (1995) Analysis of the structure of Tetrahymena nuclear RNAs zn vzvo. telomerase RNA, the self-splicing rRNA mtron, and U2 snRNA RNA 1,363-374. Cheong, C , Varam, G , and Tmoco, I (1990) Solution structure of an unusually stable RNA hairpin, 5’ GGAC(UUCG)GUCC Nature 346,680-682.
Design and Preparation of Sequence-Specific RNase P Ribozymes Denis Drainas and Guido Krupp 1. Introduction The catalyttc RNA subunit of Escherichia colz RNase P (Ml RNA) is a structure-specific endonuclease that cleaves pre-tRNA substrates m trans. By combining catalytic and substrate RNAs in one RNA molecule, self-cleavmg ribozymes have been created (Z-3). These constructs were converted to sequence-specific endonucleases by deleting 5’-segments of the tethered tRNA (1) (see Fig. 1). It has also been shown that by linking a guide sequence to the 3’-end of the Ml RNA, a sequence-specific ribozyme could be designed (2) (see Fig. 2). This chapter provides protocols for the construction of sequence-specific RNase P ribozymes following published procedures. Two types of RNase P ribozymes are presented, the cn-cularly permuted E. coli RNase P RNA with an internal guide sequence, termed Endo P (I), and the E. coli RNase P RNA with a guide sequence covalently attached to the 3’-end of the RNase P RNA, termed MlGS RNA (3) (see Ftg. 2). An alternative, but untested, approach is suggested for Endo Pl .RNA (see Note 1 and Fig. 1). 2. Materials 2.1. Construction of Endo P Ribozymes 1. Plasmids:pTP292, p 153Bsttay (available on request from N R. Pace, see ref. I) 2 Primers END01 * S’-CGGAATTCTAATACGACTCACTATAGTTCAGTTGGTTAGAATGCC-3’ END02* S’-CGGAATTCTAATACGACTCACTATAGTTGGTTAGAATGCCTGCC-3’ -*
From, Methods In Molecular Edlted by P C Turner
Bology, Vo/ 74 Rfbozyme Protocols Humana Press Inc , Totowa. NJ
179
A
Endo.Pl RNA
cleavage
site lhker
Rep1 RNA 5’.GGGAGACCGGAAUUCGAGCUCGGUACCCAAAAU
r;7GCCHGGU
Iii
. II
ACGCCCGUAWGAACCCG
-3
T .-
3-AU
CI
kz-,G
Internal Guide
sequence
Rime4
PR92
reverse
Ak
U-A G-C
C-G c U
c A GUC
B EndoP2 RNA Re.PI
RNA
G-C C-G c
c A
U GUC
C EndoP3 RNA Re.Pl
RNA
5
sequence
Fig. 1. Design of sequence specific Endo.P-based RNase P ribozymes Arrows denote sites of cleavage within the exogenous substrate RNAs. The underlined sequences denote the positions of the forward and reverse primers for the PCR Endo P3 RNA 1sa theoretical approach and has not been checked expenmentally.
Sequence-Specific
RNase P Mbozymes
181
1111111
5’- IWNNNNNNNACCAC-3’ -T olil7 Primer
4 linker
* RZF
Fig. 2. Design of a sequence specific MlGS-based RNase P ribozyme The arrow denotes the site of cleavage wtthm the exogenous RNA substrate. The underlined sequences denote the sites for the forward and reverse primers for the PCR The mternal guide sequence is indicated by a series of nucleottdes (N), complementary to the cleaved target sequence (see also Note 3) Stmllar to Endo.Pl RNA, the internal guide sequence forms the 3’-half of a 7 bp acceptor stem, but in this case, no full-size tRNA structure is present (compare ref 1 with ref 2)
3 4 5.
6
7 8 9
PT292 reverse. 5’-GAAGATCTACGGGTTCAGTACGGGCCGT-3’ (see Note 2) Restrtctton enzymes EcoRI, BglII, BumHI, FokI, and manufacturer’s buffers. Reaction buffer (mmus MgClJ 16 5 mA4 PIPES, 44 mM Trts-HCI, pH 8.0, 2.5 A4 ammomum acetate, 0.1% SDS. 100 mMMgC&. Substrate RNAs: either Pre.Pl, Pre P2, or a substrate designed by the reader. These can be chemically synthesized (see Chapters 7 and 8) or transcribed m vitro (see Chapter 10). 1 mg/mL Glycogen as carrier 50 rnA4EDTA. 6% Denaturing polyacrylamtde gel
2.2. Construction
of MlGS RNA
1 Plasmid pTKl17 (available on request from S. Altman, see ref. 2). 2 Primers Forward: 5’-TAATACGACTCACTATAG-3’ Reverse 5’-GTGGTNNNN. NNTATGACCATGATTACGCC-3’ (see Note 3) 3. Transcriptton buffer 40 mMTrts-HCl, pH 7.6,24 mA4MgC12,2 mMspermtdine, 10 mM diothreitol, 0.01% (v/v) Trtton Xl00 Made as a 5X or 10X stock and stored frozen. 4. NTPs. 38 mA4ATP, 53 mA4GTP, 41 mMCTP, 25 mMUTP. 5 RNasm. 6. T7 RNA polymerase. 7. DNase, RNase-free
182
Dramas and Krupp
8. Phenol-chloroform and chloroform. 9 Sephadex G50 column. 10 End-labeled substrate RNA* either uniformly labeled with [cx-~*P] GTP or 5’-end labeled with [Y-~~P] ATP 11 Cleavage reaction buffer. 50 mMTns-HCl, pH 7 5,100 mMNH,Cl, 100 mMMgC1, 12 8MUrea 13 15 or 20% Denaturing polyacrylamide gel
3. Methods
3.1. Construction of Endo P Ribozymes The constructron of Endo P-based ribozymes (see Fig. 1) has been factlttated by the followmg three steps having been taken by workers in the field. 1 The constructton of a circularly permuted RNase P RNA (CPM 1 RNA) (4,5) 2 The construction of a pre-tRNA-RNase P RNA conjugate This tethered molecule consists of cpM1 RNA joined to Bacdlus subth pre-tRNAASP (I) 3 The modification of the tethered molecule to function as a sequence specific endoribonuclease (1).
3.1.7. Protocol for Construction of Endo P DNA Templates 1. Use PCR to construct Endo P 1 or Endo P2 templates using pTP292 and ohgonucleotides END01 or END02 as forward primers and PT292 reverse as the reverse primer (see Chapter 9 for details of the PCR reaction) TP292 was constructed by fusing the 3’-end of pre-tRNA, using a six-nucleotide lmker to the 5’-end of a circularly permuted RNase P gene that begms at position G292 END01 S-CGGAATTCTAATACGACTCACTATAGTTCAGTTGGTTAGAATGCC-3 =’ S’-CGGAATTCTAATACGACTCACTATAGTTGGTTAGAATGCCTGCC-3’ PT292 reverse.5’-GAAGATCTACGGGTTCAGTACGGGCCGT-3’ The END01 and END02 oligonucleotides contain an EcoRI site, a T7 promoter and the 3’-sequences (m bold) correspond to the 5’-proximal sequences of Endo Pl or Endo P2 RNA The PT292 reverse primer contams a BgAI site, and the underlured sequences correspond to the 3’-proximal sequences of Endo P RNA (see Fig 1) 2 The PCR products can be used directly as templates for transcrtption by T7 RNA polymerase (consult Chapter 10 for transcription details and see also Note 2) 3. Alternatively, to clone the templates prior to transcriptton, digest PCR fragments with EcoRI and BgZII according to the manufacturer’s mstructions 4. Insert the EcoRI-BgZII-digested PCR fragments mto the EcoRI and BamHI sues of plasmid p 153Bsttay (5) to create plasmids pENDO 1 and pENDO
3.1.2. Preparation of RNA Transcripts of Endo P Genes RNAs can be synthesized by transcription with T7 RNA polymerase, using the PCR-generated template or plasmtd pENDO (or pEND02), lmeartzed
Sequence-Specific
RNase P Ribozymes
183
with F&I (see Fig. 1and also Chapter 10 where it 1srecommended to use 5 mM of each NTP and 26 mA4 MgClz m the transcnptlon). 3.1.3. Cleavage Assays Cleavage reactions are assembled by mlxmg Endo.P rlbozyme and substrate RNA m reaction buffer (minus MgC&) on ice. To do this, the Endo.P transcripts from Section 3.1.2. should be dissolved m reaction buffer at a concentration of 1 mM. Substrate RNA (e.g., Pre.Pl or Pre.P2, ref. I) should be similarly prepared. 1 Set up a 45 & cleavage reactlon on ice containing 100 ti rlbozyme (e g , Endo.Pl) and 100 ti substrate RNA (1 e , Pre Pl) 2 Heat for 5 min at 65’C 3 Transfer the assay mixture to 50°C. 4. Add MgC12 to 10 mM(1.e) 5 $ of 100 mUstock) 5 Incubate for 60 mm 6 Stop the reaction by ethanol precipitation Add l-2 vol of 50 mMEDTA, 4 pg of glycogen, and 3 vol of Ice-cold ethanol 7 Collect the RNAs by microfugmg at > 10,OOOgfor 15 mm 8 Resolve the product RNAs by electrophoresis through denaturatmg 6% polyacrylamlde-7 Murea gels
3.2. Construction
of MIGS RNA
The strategy for the production of M 1GS RNA rlbozymes 1sto make a DNA template m which a guide sequence (GS) complementary to the target RNA is Joined using an 18-nucleotlde linker to the 3’-end of Ml RNA (2) (see Fig. 2). Large-scale transcrlptlon of this template generates the MlGS nbozyme. The DNA template for MlGS transcription is synthesized by PCR from the gene for M 1 RNA present in the plasmld pTKl17 (6), a derivative of pUC 19 that contains the bacteriophage T7 promoter followed by the gene for Ml RNA (7). The 5’-primer ohgonucleotlde contains the T7 promoter (OliT7), and the 3’-primer oligonucleotide contains the appropriate guide sequence. Primers. Forward (OliT7)* 5’-TAATACGACTCACTATAG-3’ Reverse: 5'-GTGGTNNNNNNNTATGACCATGATTACGCC-3'
In the reverse primer, the bold sequence of 18 nucleotldes at the 3’-end anneals to the pUCl9 sequence of pTK117, the underhned sequence corresponds to the 3’-ACCAC sequence (see Note 4), and the NNNNNNN sequence corresponds to the guide sequence that should be complementary to the chosen target (see Note 3). A large-scale transcrlptlon of the PCR template DNA with T7 RNA qolymerase 1sperformed. For additional details, see Chapter 10 (7).
184
Drainas and Krupp
1 Assemble a 200 or 500 pL transcriptron reaction contammg one-fifth volume of 5X transcription buffer, one-tenth volume of NTP solutton, RNasm (80 U/mL), T7 RNA polymerase (800 U/mL), and DNA template (PCR product) at 40 pg/mL. 2 Incubate overnight at 37’C. 3 Add RNase free DNase to 10 pg/mL, and incubate for 10 min at 37°C 4 Extract the RNAs once with 1 vol of phenol/chloroform and twice with chloroform 5 Ethanol-precipitate by adding 2 vol of cold ethanol 6 Mtcrofuge at > 10,OOOgfor 15 mm Dry the pellet, and dtssolve m sterile water 7. Separate the MlGS RNA from unincorporated nucleottdes by centrtfugation through a Sephadex G50 column (8)
3.2.1. Cleavage Assays 1 Assemble a SO@ cleavage reaction containing 20 n&f MlGS RNA and 50 mA4 labeled substrate RNA m cleavage reaction buffer 2. Incubate for 30 min at 37O or 50°C 3. Stop the reaction wtth an equal volume of 8 M urea 4 Separate the products on a 15 or 20% polyacrylamtde-8 M urea gel, and analyze by autoradiography (see Notes 5 and 6).
4. Notes 1. A possible alternative strategy with ENDO.Pl RNA could follow the concept of the MlGS rtbozyme. Concerning MlGS, the partial tRNA molecule could be replaced by the 3’-terminal half of the acceptor stem, but in contrast to MIGS, tt would be tethered to the internal nucleotide 292 of M 1 RNA. For this approach, primer END0 1 would be replaced by END030 5’-CGGAATTCTAATACGACT CACTATAGTCCGGACCGCCA(Gut linker GGATCC)-3’, in which the bold sequence contains the T7 promoter and the underlmed sequence corresponds to the internal guide sequence. The position of primer END03 is also indicated m Frg. 1. The procedures to obtam PCR-generated or cloned templates are the same as described. Thts construct provides flexibility m the design of the IGS, since tt IS located near the 5’-end and Included m the sequence of primer END03. This suggested approach has not yet been checked experimentally. 2 The PT292 reverse primer has a nme-nucleotide extension for BgflI recogmtion. If the PCR products are used directly as templates, omit these nme nucleottdes 3 The standard acceptor stem is 7 bp, but larger sequences can be used (2) 4 The presence of a 3’-terminal CCA sequence in the gutde sequence 1s important for maximum effctency of cleavage. 5. The addition of C5 protein (to 400 r&Z), in the presence of 5 rr&f MgCl*, sttmulates the cleavage by MlGS RNA by a factor of 30. 6. If longer RNAs are used as substrates, like mRNAs, the concentratton of Mg2’ can be lowered to 20 mA4.
References 1. Frank, D N , Harris, M E., and Pace, N. R. (1994) Rational design of self-cleaving pre-tRNA-ribonuclease P RNA conJugates. Bzochemwry 33, 10,80&10,808
Sequence-Specific
RNase P Ribozymes
185
2 Liu, F. and Altman, S (1995) Inhtbmon of viral gene expresston by the catalytrc RNA subunit of RNase P from Escherzchra colz Genes Dev 9,47 l-480 3 Kikuchl, Y. and Suzuki-FuJtta, K. (1995) Syntheses and self- cleavage reaction of a chrmeric molecule between RNase P-RNA and its model substrate J Bzochem 117,197-200
4 Harris, M E., Nolan, J M , Malhotra, A., Brown, J W , Harvey, S C , and Pace, N. R. (1994) Use ofphotoaffimty crosslmkmg and molecular modeling to analyze the global architecture of rrbonuclease P RNA. EMBO J 13,3953-3963 5. Nolan, J M , Burke, D H , and Pace, N. R. (1993) Circularly permuted tRNAs as spectfic photoafftmty probes of nbonuclease P RNA structure Sczence261,762-765 6. Guerrrer-Takada, C. and Altman, S (1992) Reconstrtutron of enzymatic actrvrty from fragments of M 1 RNA. Proc Nat1 Acad Scl USA 89, 12661270 7. Vtoque, A , Arnez, J , and Altman, S. (1988) Protein-RNA mteractron m the RNase P holoenzyme from Escherichza cok. J Mol Brol 202, 835-848 8. Mamatrs, T , Frttsch, E F , and Sambrook, J. (1982) Molecular Clonzng, A Laboratory Manual. Cold Sprmg Harbor Laboratory Press, Cold Spring Harbor, NY
21 Theoretical Considerations in Measuring Reaction Parameters Timothy
S. McConnell
1. Introduction In determining reaction rates, catalytic RNA molecules follow the same rules as protein enzymes. These RNA enzymes or ribozymes use similar processes to promote their function as do their protein counterparts, such as binding their substrates m order to make brmolecular reactions ummolecular, transitton state stabtlization, and ground state destabilization (1-5). Because rtbozymes also coordinate binding, conformational, and catalytic events, the interpretation of a measured reaction rate can be involved. Although this chapter cannot resolve the meaning of every reaction rate for all mechanisms available, it will dtscuss issues to consider as one proceeds to decipher how a catalyttc RNA works. Because there 1shttle difference in the basic knowledge needed to study RNA and protein enzymes, several texts on enzymology may also provide a good reference for important issues to consider (6,7). However, this chapter will focus on issues parttcularly pertinent to rtbozymes. First, one establishes conditions where one can observe a reaction occurring. In the observed rate of reactton, the disappearance of substrate should show good single-exponential behavior (23 half-lives; see Chapter 22). Then, one varies the concentratton of the important components (e.g., ribozyme, substrate, or cofactor) and observes the effect each has on the reaction. These rate effects are then described in terms of kinetic constants, such as k&Km or k,,,. Without further mechanistic analysis, these constants only describe the effect that a particular component has on the reaction observed under the conditions used; it cannot be concluded that they represent a physical event, such as chemFrom
Methods m Molecular Edited by P C Turner
Biology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa. NJ
187
188
McConnell $ (m.t.) ,’
$ (s.t.1 :
:
:
: 8’
: ‘\
single
turnover:
. ..’
: ,4 *
: : :
: 8’
:
,*-.
: : : :
: 3’
:
: :
‘\
‘.*_,’
,’ ,’
Kd
E+S
-
k, _
k E*S
-
products
k-1
multiple
turnover:
Kd kl E+S
B
E*S
-
k
E*P
e
E+P
k-1
Fig. 1.
Free energy diagramsof single- and multiple-turnover reactions
istry or binding, There IS unique value in examming the kinetics of a reaction beyond the terms “kcat)’ and “K,. ” A detailed kinetic description of a reaction can provide the informatton necessary to equate a rate constant and a physical event. Further, deciphering the energetic contribution that each component makes to the overall reaction attaches the appropriate significance to the interaction studied. Failure to make a correct assessment of the kmetic values obtained can misdirect future study. 2. Reaction Mechanisms and Free Energy Diagrams 2.1. General Considerations A mechanism contains the mmimum number of steps required to describe a reaction. The free energy diagram maps out how each step m the mechanism contributes energetically to the overall reaction (Fig. 1). The peaks of the graph represent how difficult a step m the reaction is to achieve: the higher the peak, the slower the rate. The troughs represent the stability of each ribozyme state relative to each other: the deeper the trough the more stable the ribozyme state. These free energy diagrams are constructed to examine how the assembly of elemental rate constants describes the overall reaction. In a reaction mechanism, each step is described by two elemental rate constants representing the forward and reverse occurrences of a physical event, e.g., binding or chemistry. In the mechanism shown m Fig. 1, k, is the rate
TheoretIcal Considerations
189
constant of substrate association. It describes how fast substrate binds and depends on the concentration of the component (ribozyme or substrate) that is m excess.The term k, is the rate constant of substrate dissociation. It describes how fast substrate falls off the rtbozyme, and is independent of ribozyme or substrate concentration. The equilibrium dissociation constant (or bmdmg constant) of substrate is the ratio of the rate constants of substrate dissociation and association (& = kilk,). The term k, is the rate constant for the chemical step. This concentration-independent term represents how fast cleavage occurs (see Note 1). In combination, the elemental rate constants describe the overall reaction mechanism. Each rate constant is related to free energy by the followmg equation: AG$
= -RTln(hklksT)
(1) where T is the temperature m Kelvin at which the reactions are performed, R is the gas constant (0.001987 kcal/mol * K), h is Planck’s constant (6.63 x 1&34 J * s), kn is Boltzman’s constant (1.38 x 1O-23J/K), and k is the first-order rate constant. For all second-order events (i.e., bmdmg events), an arbitrary concentration is chosen and the pseudo-first-order rate is determined (e.g , if the association rate constant of a substrate is 2 x 1O6W’s’ and 1O4 M substratewas used, then the pseudo-first-order rate is 0.02 se&; AG$ = 21.5 kcal/mol at 50°C). Usually concentrations are chosen that are relevant to the experiments being performed. It is often helpful for problem-solving purposes to complete the diagram with reasonable values that were determmed in related research. For example, the dissociation rate constant of a substrate can be determined if one has measured its bmdmg constant and one assumesthat association rate constant should be that of duplex formation. From this model, the prediction of the rate constant of substrate dissociation will allow one to design an experiment better to measure this value. From a working diagram, you can visualize the consequences of putting together your kmettc data and make predictions about experiments to test the model 2.2. Single- vs Multiple-Turnover
Reactions
“Single-turnover” or “presteady state” experiments examme a ribozyme’s ability to promote the conversion of a single substrate to products (solid curve, Fig. 1). Self-sphcmg RNAs (group I, group II, hammerhead, and so on) are evolutionarily designed to perform a single set of reactions. Single-turnover experiments are best achieved by having a concentration of ribozyme in excess (210 times) of substrate concentration. Under these conditions, each ribozyme will have a chance to react with only one substrate molecule. “Multtple-turn-
over” or “steady-state”experiments examine a rlbozyme’s ability to promote many turnovers (solid and dashed curve, Fig. 1). RNase P, as well as the ribo-
790
McConnell
some and spliceosome (see Note 2), performs multiple-turnover experiments m the cell. These expertments are called “steady-state” because the ribozyme species have reached a constant population; the rates of formation and breakdown have reached a temporary balance utihzing the substrates available. For the purpose of deciphering how a ribozyme works, the single-turnover experiment has one paramount advantage: fewer steps are involved. Consider the free energy diagram in Fig. 1. In multiple-turnover experiments, one must evaluate the importance of all steps m the reactton. In single-turnover experiments, one only has to consider the steps up to the chemical step (see Note 3). Many reaction mechanisms will contam more than three steps, and thus, performmg single-turnover experiments can reduce the number of possible ratelimitmg steps by nearly half. When trymg to determme the sigmficance of the kmettc constants measured, the task becomes much simpler wtth the smgleturnover approach. This issue of having fewer steps to consider will become apparent in the next sections. One physical difference between RNA and protems is the stable secondary structure of an RNA duplex. It ts common for an RNA substrate to make extensive interactions with its cognate ribozymes. The strong bmdmg of an RNA substrate increases the propensity for binding to be rate limiting. In the case of multiple-turnover experiments, this means that the rate of product dtssociatron is likely to be the rate-limiting step, not the chemical step. With a slow product dtssociatton, studying the binding of substrate or the chemical step by a multiple-turnover approach would be difficult. Let us examme a common situatton. One varies the concentration of a substrate m the reaction and obtains rate constants for each condition (see Note 4) When these observed rate constants are plotted as a functton of substrate concentration, they show a square-hyperbohc dependence (Fig. 2). This curve depicts the classic Michaehs-Menten kinetic behavior. Values for k&K,,,, Km, and kc,, can be obtained from thts curve. Many researchers stop wtth the basic characterization of the reaction phenomena. In many situations, this may be sufficient to continue on in other aspectsof catalytic RNA research. However, if one assumesthat K, is a bmdmg constant and k,,, is the chemical step, then one is making a serious oversight. If current or future projects require knowledge of the binding constant or the rate of the chemical step, further testing of the kmettc data is required. A more detatled description of these kinetic values is provided in the following sections. The value of kc,,/& for a substrate in a reaction is determined from the mmal slope of the Michaelis-Menten curve. It is m this concentration range of the substrate where the observed rate constant mcreases linearly. The mea-
Theoretical Conslderatlons
191
Fig. 2. A plot of the observedrate of a ribozymereaction asa function of substrate concentrationdrsplaymg Mrchaelis-Mentenbehavior
sured kcat/K,,, is a second-order rate constant having units of concentration and time (usually M-‘/min or M-‘/s). In the free energy diagram, this value represents the energetic barrier from the startmg initial state (free enzyme) to the highest peak (the rate-limitmg step m the reaction, mdicated by $ m each dragram). In Fig. 3, four free energy diagrams depict different mechanisms for a rrbozyme reaction The solid curve in each dragram represents the reaction under kJK,,, conditions. If the mechanism is a simple two-step process and chemistry is rate-limiting, then k,,,/K, is equal to the rate constant for the chemical step, kc, over the bmdmg constant of the substrate, Kd (k,,,/K, = kJKd; see Fig. 3A). Demonstration that chemistry is rate-limiting would be consistent with this model. Changes m the reactivity of substrate used (a phosphorothioate or any of a variety of modified nucleotides at the cleavage site) or the reaction condmons (pH, divalent metal, or temperature) can be utrlrzed to affect the rate of the chemical step (see Note 5). If there are more than two steps involved m the reaction, the Km term of k,,,/K, may not be equivalent to Kd (see Section 4.). If binding of the substrate is rate-hmitmg (i.e., the binding barrier is the highest), then k,,,/K, equals the rate constant for substrate association, kl (Fig. 3B). To confirm this conclusion, it is recommended to compare this value to similar values measured m model systemswhere the rate constant of assocration is shown to be diffusion-controlled or nucleation-limited. For example, detailed kinetics of the nucleation of RNA duplexes have been measured (8). To rule out a rate-limiting chemrcal step, the substrate or reaction condmons can
McConnell
e
E+S
G==
E*!j
-
E+S
E+S
_
E.S
-
E + s’ =
E*S e
E-S’ = +s
E-S’ -
E.S’*S
-
Fig. 3. Free energy diagrams of four possible reaction mechamsms
be perturbed affecting chemistry, but demonstratmg no effect on the reaction rate (Note 5). The change m the chemical step should not be too large because that may result in a change m rate-limiting step. The failure to see an effect on k,,t/& by affecting the chemical step only eliminates the chemical step from being rate-limrtmg; any other step, mcluding substrate association, could be rate limiting. If more than two steps are important, the defimtion of k&K, can become considerably more mvolved. In Fig. 3C, chemistry remains limitmg, but K, of substrate is not a simple process. It mvolves a two-step process of bmdmg and then a conformational change (E + S = E S = E S’). As drawn, K,,, would represent both binding and conformational change, and thus, k,,,/K, would also reflect both steps. Although the experimental tests for the mechamsms m Fig. 3A and B apply to this mechanism as well, dtfferenttatmg between models in Fig. 3A and C requires more careful analysis of Km. Measuring kcat/Km for a reaction described by the mechanism shown in Fig. 3D is more comphcated. As shown, the rate measured would be a third-order rate constant depending on the concentration of both substrates m the reaction. Measuring reaction rates under these conditions should be avoided. An altemative verston of this mechanism is if the first step of the reaction is not binding of another substrate, but a conformational change. If so, then the second-order l
l
TheoretIcal Considerations
193
rate constant, &/Km, will also reflect this conformational change m addition to bmdmg and chemistry. This may be avoided by finding better premcubation conditions (see Chapter 22) In multiple-turnover experiments, any number of steps could be rate-limiting. As shown in Fig. 1, k,.JK,,, represents the free energy difference between unbound ribozyme and the product dissociation step. There are several scenarios where the rate-hmitmg step for k,,,/K,,, will be neither substrate association nor the chemical step. In these cases, demonstratmg that kcat/Km is too slow to be diffusion controlled and that the chemical step is not hmtting suggests another step determines the rate of reaction. To resolve what other step (i.e., conformational changes) is rate-limiting will require alternative approaches. The value of reducing the number of steps involved by performmg smgle-turnover experiments may avotd these comphcattons. 4. K,,, The value of Km is defined as the concentration of the substrate at one-half maximal velocity. Km IS a kinetic value, not an equilibrium constant; however, sometimes it can equal the equihbrmm dissociation constant of substrate, Kd. Despite the fact that it is described only m terms of concentration (Ml), definmg Km on the free energy profile depends on the individual mechanism. In Fig 3, free energy diagrams demonstrate the differences between the meaning of K,,, m different mechanistic models. As drawn, the mechanistic scheme has rtbozyme species(E and E * S) aligned below then respective stable troughs m the free energy curve. The arrows between the solid and dashed curves indicate the effect of increasing substrate concentration. The dashed curves represent the free energy profile for the substrate (or ribozyme) concentration at Km. The followmg analysts will examme four general mechanistic possibtlities for what Km can represent. 4.1. Case 1 When a simple two-step model (bmdmg and chemistry; Fig. 3A) fits the data and the rate of substrate dissociation (k-,) is faster than that of chemistry, then Km equals Kd. At Km, free ribozyme (trough a) is at the same level as bound ribozyme (trough b), and thus, both states are equally represented. The slower rate of chemistry has allowed an equilibrium to be established between the free and bound rtbozyme states. When one can establish this model, this is an ideal case for kmetically determmmg the binding constant of a substrate. Not only does one directly determine the energetic contribution to binding, but one also has directly related this bmdmg event to catalysts by the rtbozyme. Other methods that measure bmdmg independent of rrbozyme acttvtty always have the caveat that one may observe nonproduc-
194
McConnell
tive binding (a binding event that does not lead to catalysis). The model shown m Fig. 3A cannot be estabhshed by a single experiment. Primary to estabhshmg this model is to provide evidence that the chemical step is ratelimiting. This can be estabhshed by pulse-chase experiments (see Chapter 22) or by repeating the K,,, experiment under conditions that affect the chemical step, but not binding Distinguishing whether substrate assocration or the chemical step is ratelimiting can be accomplished by performing pulse-chase experiments. By fully binding substrate with a high ribozyme concentration (the pulse), all the labeled substrate will be bound m the most stable ribozyme substrate complex. Then, the complex is challenged with excess (unlabeled) product and an essential catalytic element, such as guanosme. If the chemical step is faster than substrate dissociation (k, > ki), then the labeled substrate will react. If substrate dissociation is faster (k, c k,), labeled substrate will fall off and not react. This type of experiment provides an overview of what the reaction profile looks like* Is chemistry or bmdmg rate-limttmg? The results from these experiments could be pivotal m determmmg which mechamsm best descrtbes the reactton being studied.
4.2. Case 2 When the rate constant for the chemical step is faster than the rate constant of substrate dissociation (k, > k-i), K,,, will be greater than & Once the substrate is bound, the barrier to dtssoctate (barrier c, Fig. 3B) is much higher than the barrier (d) for chemistry. Thus, every time the substrate bmds a reaction occurs. This kmetic effect prevents an equihbrmm from establishing between the free and bound statesof the substrate and ribozyme. The reaction rate eventually saturates after the rate of association becomes faster than the rate constant for the chemical step. As shown by the dashed curve, K, occurs at a much higher concentration than Kd (compare to Fig. 3A). A pulse-chase experiment where all the substrate reacts rather than dissociates would provide evidence for this model.
4.3. Case 3 If there are any intermediates that build up subsequent to the binding of substrate, K, will be less than Kti Such intermediates (trough f) will build up when they are more stable than a simple ribozyme-substrate complex (trough e). At Km,the free ribozyme trough only rises to the more stable intermediate (trough f), indicating stronger apparent binding than initially exists between substrate and ribozyme. More stable intermediates may be owing to conformational changes that provide direct mteractions between ribozyme and substrate. Alternatively, substrate may Just be occluded from solvent. In either situation,
Theoretical Considerations
195
K,,,represents a binding constant for a two-step event. Estabhshing thts mechanism requires a comparison of ribozyme binding to that of a relevant model system, such as duplex formation. Also, biophysical approaches that show structural changes on bmdmg can provide strong evidence for this model (9, IO). Considering such a model may provide a better understanding of ribozyme function. 4.4. Case 4
If there is a change in the rate-limiting step to a step other than the binding of substrate or chemistry, K,,, will be less than Kb This other step may be the bmdmg of another substrate or cofactor, as shown in Fig. 3D, or may be a conformational change. As substrate concentration is increased, the rate-hmiting step changes from chemistry ($1) to the bmdmg of the other substrate ($2). Because of the change m the rate-hmitmg step, the rate levels off at substrate concentrations less than that required to measure Kd for S (when troughs g and h would be level). A test of this model would be to demonstrate the loss of an effect on the chemical step (such as a phosphorothioate effect) as the concentration 1sincreased from subsaturating to saturating (1 I).
5. kcat The value k,,$ is the rate of reaction at a saturating concentration of substrate (or ribozyme; Fig. 2). It represents the free energy required to reach the ratelimiting step from the state or statesof ribozyme speciespresent at the concentration used. If there is only one species of bound ribozyme and only one rate-limitmg step, k,,, will be more precisely defined. In Fig. 3A, k,,, represents rate constant for the chemical step, k,. In this case, the rate should be dependent on reaction conditions important for chemistry. Although this mechanism is the preferred case (from the standpoint of collecting data), many enzymes (and apparently ribozymes) have evolved to bmd their substrates sufficiently tightly that the rate of the reaction is diffusioncontrolled. As a result, substrate bmdmg is often rate-limitmg (particularly m multiple-turnover experiments) Perturbing reaction conditions to establish a mechanism like that shown m Fig. 3A is recommended. Determinmg conditions where K,,, = Kd and k,, = kc provides the basis for subsequently describmg the reaction under more biologically relevant conditions where these kinetic terms may be more complicated. It is also true that when saturation is reached for the reaction described by the mechanism m Fig. 3B that the chemical step will be rate-limiting. However, the amount of ribozyme will have far exceeded what is necessary to bind substrate fully. There is the possrbihty that at high concentrations, RNA aggregation and depletion of available Mg2+ will become issues. In these situations,
196
McConnell
it may be useful to prebmd substrate with ribozyme (at a lower concentration, >&) and initiate the reaction with another essential factor, such as guanosme, increased pH, or divalent metal ion. For the mechanism described m Fig. 3C, k,,, also equals kc. While K, mvolves a two-step process, considerably useful information can still be obtained from studying a reaction with this mechanism. There are likely many steps that are kinetically invisible, so establishing that binding occurs in two steps provides a more detailed description of ribozyme function. In the situation where an additional conformational step exists, a major concern is that this step 1sslow relative to the chemical step Then, the situation described for the model m Fig. 3D will apply. The value kcatwould equal the rate of the conformatlonal change. In Fig. 3D, kcat does not equal kc. In fact, this kinetic term may be fairly complicated with more than one step partially rate-hmitmg at saturating concentrations. Since at K, not even half the substrate is bound, all substrate may still not be bound at kinetically “saturating” concentrations. As drawn, kc would be predominated by association of the other substrate, S’. Remember this slow step (Indicated by $2 in Fig. 3D) does not need to be the bmdmg of another substrate and does not need to precede substrate binding. It could be a conformatronal change that precedes the chemical step. Then kc would reflect the rate constant of this conformatronal change. Establishing characteristics expected for the chemical step will be important in characterizing a reactron that fits this model. As seen m the multiple-turnover mechanism m Fig. 1, kc,, IS equal to the rate of product dissociation (8m.t.). Although this may be a useful value to obtam, it will take further experimentation to establish that kcat 1sequal to the rate of product release. Measuring multiple-turnover rate constants can still be valuable, but it IS best if these experiments complement an established single-turnover approach. In Chapter 22, a multiple-turnover experiment is described m order to measure the burst of product release after the first turnover. Such an observation establishes that a step after chemical conversion is rate-limiting. Each of the four possible mechanisms shown have provided general issues to consider in measuring kinetics of RNA catalysis. These models represent common kinetic situations. However, they do not represent all possibilities. There is also the prospect that more than one situatron wrll apply For example, the binding of RNA substrate to the Tetrahymena ribozyme is limited by the rate constant of association (like Fig. 3B), but substrate bmdmg 1salso a twostep process (like Fig. 3C) (1,22). From this analysis, a basis for deciphermg reaction kinetics is available providing the opportumty to understand catalysis by RNA further.
Theoretical Considerations
197
6. Notes 1. Like all reactions, k, IS also reversible, but usually experimental design will allow the reverse reaction to be ignored. 2 The RNA portions of the sphceosome and of the ribosome have yet to be shown to be the catalytic portion of the RNA-protein complexes However, the RNAs of these complexes are known to be directly involved in substrate recognmon 3 One exception to this is the situation where product formation is very unstable, and substrates are rapidly reformed. Then one must consider the next step beyond the chemical step 4. The term substrate will be used from here on in this chapter for simplicity. The term substrate can refer to other cofactors, such as guanosme or Mg2+ or a protem facilitator. Also, m single-turnover experiments, the ribozyme (not the substrate) concentration is varied to measure kinetic constants for substrate, if that substrate is being experimentally observed (1 e , the 32P-labeled substrate). 5 Changing the identity of substrate or changing the reaction conditions to affect the rate of chemistry may also affect binding. The effect of these changes on substrate bmdmg must be tested independently
References 1. Cech, T R , Herschlag, D , Piccnilli, J A , and Pyle, A M. (1992) RNA catalysis by a Group I ribozyme. J Bzol Chem 267, 17,479-17,482 2. Narhkar, G J., Gopalakrishnan, V., McConnell, T. S , Usman, N., and Herschlag, D. (1995) Use of bmdmg energy by an RNA enzyme for catalysis by positioning and substrate destabilization Proc Nat1 Acad. Scl USA 92, 3668-3672 3. Pan, T , Long, D M , and Uhlenbeck, 0 C (1993) Divalent metal ions m RNA folding and catalysis, m The RNA WorZd (Gestland, R. F. and Atkins, J. F., eds ), Cold Spring Harbor Laboratory Press, Plamview, NY, pp 271-302 4 Cech, T R. (1993) Structure and mechanism of the large catalytic RNAs group I and group II and nbonuclease P, m The RNA World (Gestland, R. F. and Atkins, J F , eds ), Cold Spring Harbor Laboratory Press, Plainview, NY, pp 239-269 5 Hertel, K J., Herschlag, D., and Uhlenbeck, 0 C. (1994) A kinetic and thermodynamic framework for the hammerhead rrbozyme reaction Bzochemzstry 33, 3374-3385. 6 Fersht, A (1977) Enzyme Structure and Mechanzsm, 2nd ed W H Freeman and Company, New York. 7 Jencks, W P (1969) Catalyszs zn Chemistry and Enzymology. McGraw Hill, New York. 8. Turner, D H , Sugimoto, N , and Freier, S. M (1990) Thermodynamics and kinetics of base-pairing and of DNA and RNA self-assembly and helix coil transition, m Nuclezc Aczds, Landolt-Bornstem, Springer-Verlag, Berlin, pp. 201-227 9. Bevilacqua, P. C., Kierzek, R., Johnson, K. A., and Turner D. H. (1992) Dynam-
ics of ribozyme bmdmg of substrate revealed by flourescence-detected stoppedflow methods. Science 258,1355-l 358.
198
McConnell
10 Wang, J.-F, Downs, W. D., and Cech, T R (1993) Movement of the gmde sequence during RNA catalysts by a group I ribozyme. Sczence 260,504-508. 11 Herschlag, D and Khosla, M (1994) Compartson of pH dependenctes of the Tetrahymena rtbozyme reactions with RNA 2’-substituted and phosphorothioate substrates reveals a rate-ltmtting conformattonal step Bzochemzstry 33, 5291-5297. 12 Cech, T. R., Bevtlacqua, P C., Doudna, J A, McConnell, T S , Strobel, S A , and Weinstein, L. B (1993) Mechanism and structure of a catalytic RNA molecule, m Robert A Welch Foundatzon Conferences on Chemical Research, vol 37, Welch Foundation, Houston, TX, pp 91-110
22 Experimental Approaches for Measuring Reaction Parameters Timothy
S. McConnell
1. Introduction To understand the function of a ribozyme, it is necessary to decipher the reaction the catalytic RNA promotes. As more and more RNA catalysts are discovered, then activity will be compared to gam greater understanding of how each functions. Measurement of reaction parameters provides vital mformation to quantify differences between rtbozymes (2). There is also an increased interest, both academic and mdustrral, in utihzmg reactions promoted by the catalytic RNA m VIVO.A firmer understanding of catalysis of a ribozyme in vitro will supply a stronger basis for describing how cellular factors may affect RNA catalysis m viva (2). The first objective for characterlzmg a ribozyme reaction is estabhshmg condmons where the reaction is “well behaved,” i.e., that it occurs via a single exponential decay (%Sremalnlng = e-kt, Fig. 1). Ideally under single-turnover reaction conditions, activity should be linear on a semilogarithmic plot for at least three half-lives. Conditions that result in more than 30% unreacted substrate should be avoided. In special cases,such as a phosphorothioate substrate where only one diasteriomer readily reacts, one can accurately measure the reaction rate (and the fraction unreacted) simply by taking more time-pomts. If any unreacted substrate is observed, the data should be corrected for unreacted substrate (%Scorrected = [%S, - %S,]/[ 100 - “/OS,] x 100, where %S, and %S, are the remaining substrate at any time and infinrte time, respectively). Although contemporary computer programs will allow you to fit a nonzero endpoint to the data, it requires two variables to be fit decreasing the accuracy of the rate constant measurement. If an unreacted fraction is unavoidable, a standard correction for all related data is advisable. From
Methods III Molecular Edtted by P C Turner
Bfology, Vol 74 Rlbozyme Protocols Humana Press Inc , Totowa, NJ
199
200
McConnell
1
2 Time bun)
3
Fig. 1. A semllogarlthmlc plot of the disappearanceof substrateas a function of time demonstratmga t1,2= 1 min and single-exponentialdecayof three half-lives
Finding appropriate premcubation conditions 1s of primary importance m obtaming good kmetlc behavior from a ribozyme. Because alternative secondary interactlons of RNA can be stable with slow rates of conformatlonal change, it 1s necessary to allow time for all the RNA molecules to find a stable and active structure. This often requires appropriate salt (Mg2+ and monovalent) concentrations as well as a sufficient temperature to allow the RNA molecules to search conformational possibilltles and find a stable active structure. For the Tetrahymena ribozyme, a premcubation of at least 2 mM Mg2+ and 10 mm at 50°C 1srequired in order to fold -90% of the ribozyme molecules into an active conformation (3). There exist a number of variations of preincubatlon condltlons that allow folding of RNA molecules mto an active form (4-Q. The following methods were originally designed to measure rate constants for a group I ribozyme. However, the explanations should provide information that is applicable to any nbozyme. Accurately measuring any rate constant requires some knowledge of other related rate constants m the reaction mechanism. The methods describe how each experiment 1sperformed after a basic survey of the reaction (like Fig. 1) has been done to obtain estimates for kinetic values. Estimates of related rate constants should be confirmed by experimentation m order to establish the working model. 2. Materials The materials used are common among all the methods. However, these materials will vary depending on the ribozyme. It 1simportant to have equip-
Ribozyme Kinetics
201
ment that accurately measures volumes, temperature, and time for these experiments. 1 Sterile, RNase-free (sihcomzed, optional) mtcrofuge tubes 2. P-20 and P-10 Pipetmen, at least one accurately calibrated to 0 5 pL 3 20% Polyacrylamide, 7-8 Murea gel; 1X TBE (0 1 MTrts-borate, pH 8 3, 1 mA4 EDTA). 4 Constant temperature water circulator and bath. 5 Radioanalytic scanner or densitometer. 6 L-2 1 Sea I rrbozyme, 220 luV stock, gel- and column purified (7) 7. Gel-purtfted 32P-end-labeled substrates, CCCUCUA, CCCUC(dU)A, and CCCUCUspA (where “dU” indicates a 2’-deoxyribose and “sp” mdmates a phosphorothroate). 8 Unlabeled CCCUCUA and CCCUCU, 220 pA4. 9 Guanosine (G), 24 mM stock (heat to 65°C to dissolve before use) 10 Sterile deionized water. 11 5X Stock of Mg/Mes reaction buffers: 250 mM Mes, pH 5 5 and 7.0 (at 25”(Z), 50 mM MgC12 (final concentrations of 50 mM Mes and 10 mM MgC12). 12. Stop buffer containing 80% formamide and 50 WEDTA, with 0 05% bromophenol blue, 0 05% xylene cyanol, and 2 mA4 Tris-borate, pH 8.3
3. Methods 3.1. Measuring kc&,,, for Guanosine This method is applicable for measurmg the second-order rate constant,k,,,lK,, for a substrate or cofactor that IS not the observable (or labeled) substrate m the reactton. For the following single-turnover experiments (Sections 3.1.-3.4.), the ribozyme concentratron, [El, must be much greater than (210-fold) the 32P-labeled substrate concentratton, [S] (3). 1 Choose a ribozyme concentration (200 “M) that is greater than Kd for substrate and binds sufficiently fast on initiation of the reaction such that association is not rate-limiting m the reaction. The rate constant of association multtplred by the ribozyme concentration plus the rate constant of dissoctation gives the observed rate to equilibrmm, keq = k, x [E] + k-i = lO*M-*lmin x 200 nA4+ 0.2 mu-‘, = 20 mu-r, tij2 = ln2/k,, = 2 s (see Chapter 21, Section 3.). 2. Choose guanosine concentrations for each reactron ranging from 0 to ~20% of Km (see Note 1). 3. Prepare a time-course for each reaction that includes a preincubation start time, a reaction start time, and a stop time for each time-point taken (six time-points are suggested) The time-points should be distributed such that half are m the first half-life of the reaction and half are in the second and third half-lives of the reaction (see Notes 2 and 3). 4 Prepare and number reaction and stop microfuge tubes. Aliquot 6 pL of stop buffer mto each stop tube
McConnell
202
5. To each reaction tube, add 4 IJL of 5X reaction buffer, pH 7 0, 2 pL of 2 pM ribozyme, 2 pL, of the appropriate 10X (O-50 @4) guanosine stock and 10 pL of water (see Note 4) 6. Begin time-courses by premcubatmg each mixture at 50°C as its start time occurs. After the 20 mm premcubation, reactions are initiated with 2 pL of -20,000 cpm/pL 32P-CCCUCUA, mixing rapidly usmg a Pipetman. Ahquots (1 5-2 &) are then taken out of the reaction tube, and mixed into a stop tube (step 4) at each designated time-point and placed on ice. 7 Load samples on a 20% polyacrylamide 7 M urea gel, and electrophorese long enough to separate substrate and product sufficiently 8 Analyze data with a radioanalytic scanner/densitometer quantitating the amount of substrate and product at each time-pomt. Determine the percentage of substrate remammg at each tune-pomt and plot %S remammg (%S = counts S/[counts S + counts P] X 100) as a function of time on a semiloganthmic graph (Fig 1). Determme kobsfor each reaction from the exact half-time of the reaction or an exponential tit to the data 9. Plot kobsas a function of [G]. it should be linear. Determmmg the slope of the lme that is kcat/K,,, for guanosme (see Note 5) If the plot shows curvature (a levelmg off) at higher concentrations, then lower concentrations of G should be used
3.2. Measuring
k&t,,,
for Substrate
This method 1s applicable for measurmg kca,/Kmfor the 32P-labeled substrate in the reaction. Because this reaction IS done m single-turnover ([El >> [S]), it is the ribozyme concentration that dictates the reaction rate (3). 1. Choose ribozyme concentrations (3-20 nM) for each reaction from zero to ~20% of K,,, (see Note 6). 2. Repeat steps 3 and 4 of Section 3 1. 3 To each reaction tube add 4 pL of 5X reaction buffer, pH 7 0,2.3 $ of 8.6 mA4 G (65’C) stock, 2 pL of the appropriate 10X (30-200 nM) ribozyme stock, and 9 7 pL of water. 4 Repeat steps 6-8 of Section 3.1 5. Plot kobsas a function of [El: it should be linear. Determme the slope of the lure, which is k,,dK, for substrate (see Note 7)
3.3. Measuring
K, for Guanosine
This method IS an expanded version of Sectton 3.1. The guanosme concentration ranges below and above K, and the identlty of substrate is changed m order to observe the reaction at high [G] (8,9). 1 Use a high (200 nM) rtbozyme concentration (see Section 3 1 , step 1) 2 Choose guanosine concentrations such that half are above the expected Km and half below (see Notes 2,3, and 8). A mmtmum of six concentrations are required. 3 Repeat steps 3 and 4 of Section 3 1 In addmon, label another tube for ribozyme m each reaction.
Ribozyme Kinetics
203
4 To each reaction tube, add 4 pL of 5X reactton buffer, pH 7 0,2 ).tL of -40,000 cpm 32P-CCCUC(dU)A, 2 pL of the appropriate 10X (O-50 pA4) guanosme stock and 9.6 pL of water. To the rtbozyme tube m each reaction, add 2.4 pL of 2 pA4 ribozyme and 0.6 pL of 5X reaction buffer (see Note 9). 5 Begin time-courses by preincubatmg each rrbozyme and reaction tube at 50°C as its start time occurs (see Note 10) After the 20 min premcubatron, reactions are initiated by adding 2.4 pL of rtbozyme, mixing rapidly using a Prpetman Aliquots (1 5-2 pL,> are then removed as in Section 3.1 , step 6. 6 Repeat steps 7 and 8 in Section 3.1. 7 Plot kobsas a function of [G]: the data should show a square hyperbolic curve, and not be srgmotdal (see Notes 5,9, and 11). Fit the data using a least-squares tit to the Michaelis-Menten equation. kobs = k,,,[G]I(K, + [G]) Note kcat 1salso determined for single turnover by this fit.
3.4. Measuring K,,, for Substrate For strong binding ohgonucleotides (& < 10 nM), measurmg K, may not be very useful because dissociation 1soften slower than chemistry (k, c k,; see Section 4 of Chapter 21). For weaker bmding
substrates where km, > kc, a K,,,
measurement can be valuable (Z). For trght binding substrates,one can decrease the rate of chemistry by decreasing the pH or the guanosme concentratron, or using a less reactive substrate. However, tt 1srecommended that pulse-chase be used for measurmg the binding of substrate where k-, I kc. Here 1sa method for measuring the binding of a weaker bmdmg substrate (-20 n&I) with a lower reactivity. 1. Choose rrbozyme concentrations (3-200 &I) such that half are above Km and half below (see Note 8) 2. Follow steps 2-4 of Section 3 2 , but only use the slightly weaker bmdmg (and slower reacting) substrate, CCCUC(dU)A, and use the pH 5 5 5X reaction buffer Under these conditions, the chemrstry ~111 be slower than the rate constant of substrate drssoctation (see Sectron 3., Chapter 21) 3. Plot kobs as a function of [E] the data should show a square hyperbolic curve and not be stgmotdal (see Notes 11, and 12). Fit the data using a least-squares fit to the equation kobs = ~c,,[WWm+ PI)
3.5. Measuring Bursts and Multiple-Turnover Kinetics Performing some multiple-turnover experiments can be useful in conjunctton with single-turnover experiments. Such comparrsons can distingursh between possible mechanisms. For strong bmdmg substrates, evidence of a burst suggests that a step after chemistry, a conformational change, or product release 1srate-limiting. For weak binding substrates, determining that k,,, for single- and multiple-turnover are equal provides evidence for the same step being rate-ltmrtmg under both condmons (see Section 5. of Chapter 2 1).
McConnell 1. Choose substrate concentrations that are greater than both Kd and [El. To measure the burst of a strong bindmg substrate, choose an [S] that 1s3-l 0 x [E] For weak bmding substrates, it may be necessary to have several hundred to several thousand times excess substrate to measure kcataccurately. 2. Prepare a time-course for each reaction that includes a premcubation start time, a reaction start time, and a stop time for each time-pomt taken (six time-points are suggested). The time-points should be distributed such that all are taken before 20% of the substrate is consumed. 3 Prepare and number reaction and stop microfuge tubes Aliquot 6 pL of stop buffer into each stop tube. 4 To each reaction tube, add 4 pL of 5X reaction buffer, pH 7 0, 2 pL of 1 @4 ribozyme, 2 pL of 8.6 mM guanosme stock, and 8 pL of water 5 Begin time-courses by preincubatmg each mixture at 50°C as its start time occurs After the 20 mm premcubation, reactions are mmated with 4 pL of -20,000 cprr&L 32P-CCCUCUA and five times the concentration of unlabeled CCCUCUA (determmed in step 1, 10 CIM), mixmg rapidly using a Pipetman. Time-points are taken as m Section 3.1 6. Follow steps 7 and 8 of Section 3.1.) but only plot the fraction of product formed vs time, and obtain a linear fit to the data. The slope of the lme is kobsand k,,, = k ohsx [S]/[E] When a burst exists, it should equal the ratio of enzyme to substrate m the reaction if a step after chemistry is fully rate-hmitmg.
3.6. Pulse-Chase
Dissociation
Measurements
Pulse-chase experiments are very powerful experiments providing means of measuring elemental rate constants as well as distmgutshmg between mechanistic models. A pulse-chase experiment allows a ribozyme-substrate complex to form, and then challenges it with a competitor or by dilution ($5). This challenge provides the ability to question whether the energetic barrter for bmdmg is greater than that of the chemical step. If the bound substrate goes on to react after the challenge, then the binding barrier is greater. If substrate dtssocrates and does not react, then the chemical step is slower than dissoctation (see Note 13). The first pulse-chase experiment measures the dissociation rate constant (kl). 1 Prepare a time-course for each reaction that includes a premcubation start time, a 16-mm spin time (see Note lo), a pulse start time, a chase start time (20 s later), and a stop time for each time-pomt taken @ix time-points are suggested). The timepoints should be distributed as described in Section 3.1., keeping m mind that the observed rate of reaction is equal to the sum of the rate of chemistry and dissociation 2. To each reaction tube, add 1 pL of 5X reaction buffer, pH 7 0, 1 pL of 2 I.~V ribozyme (sufficient to bind substrate fully and rapidly), and 1 pL of water. 3. Make chase solutions of 10 pL of 5X reaction buffer, pH 7 0, 5 pL of 20 l.uV CCCUCU, and no G, 5 pL of 10 @4 G, or 11.6 pL of 8.6 mM G, and water to a final volume of 50 pL (see Note 14).
Rbozyme Kmetics
205
4. Begin time-courses by premcubatmg each mixture at 50°C as its start time occurs. After the 20 mm preincubatton, reactions are initiated with 2 pL of -50,000 cpm/pL of 32P-CCCUCUA, mixmg raprdly using a Pipetman. 5. At 20 s, rapidly mix in chase solution. Aliquots (2 pL+) are then removed from the reaction tube, mixed into a stop tube at each designated time-point and placed on ice. 6. Follow steps 7 and 8 of Section 3.1 The chase with high G should show that all substrate has reacted to product, indicating that the rate constant of the chemical step is faster than that of ohgonucleotrde dissociatton For 0 and 1 pMG, the rate constant for dissociation is determined by subtractmg the rate of reaction (k[O or 1 pMG], measured in Section 3.1.) from the observed rate of the pulse-chase reactton (kobs = k, + k[O or 1 pM G]). Since some substrate will dissociate before reactmg, to measure the pulse-chase reaction rate, the data must be corrected for unreacted substrate (see Section 1.).
3.7. Pulse-Double-Chase
Dissociation
Measurements
An alternative pulse-chase experiment provides data that directly measure the dissociation rate constant (k-r) without having to correct for the rate of reaction by G. In this experiment, the chase is broken into two parts. The first sets up the competition between ribozyme-bound 32P-labeled substrate and excess unlabeled product. The second chase causes all the bound substrate to react to product. Such pulse-double-chase experiments allow you to examine a varrety of condrtions that may affect substrate binding: the first chase may have a perturbed pH, a different drvalent ion or salt, or other factor, and the second chase essentially returns the ribozyme to its highly reactive condrtions. 1. Prepare a time-course for each reaction that includes a preincubation start time, a 16 min spm time (see Note lo), a pulse start time, a chase start time (20 s later), a second chase time for each time-point taken (six time-points are suggested), and a stop time 2-3 mm later. The time-points for mixing an ahquot from the first chase into the second should be distributed over the first three half-lives of the reactton, as descrtbed m Section 3 1 2. To each reaction tube, add 1 I.~L of 5X reaction buffer, pH 7 0 and 2 pL of 1 pM rtbozyme (sufficient to bmd substrate fully). 3 For each reaction, make a chase 1 solution of 3 pL of 5X reaction buffer, 2 pL of 20 pMCCCUCU, and 10 pL of water (see Note 14). Also, make a chase 2 soiutton of 24 pL of 5X reaction buffer, pH 7 0, 12 pL of 20 pMCCCUCU (220 x [El) or 14 pL of 8.6 mM G, and water to 120 pL final volume Aliquot 20 pL of chase 2 solution mto SIX tubes, one for each time-point. 4. Begm time-courses by preincubating each mixture at 50°C as its start time occurs After the 20 mm premcubation, reactions are initiated by adding 2 pL of -50,000 cpm/pL 32P-CCCUCUA to the ribozyme tube, mixing rapidly using a Pipetman 5. At 20 s, rapidly mix m chase 1 solution. Ahquots (2 pL) are then taken out of the chase 1 reaction tube and rapidly mtxed into a chase 2 tube at each designated
206
McConnell
time-point. After 2 mm of reaction m each chase 2 tube, an ahquot (2 pL) 1s removed, added to the stop tube, and placed on ice. 6 Follow steps 7 and 8 of Section 3 1 As time contmues during the first chase, more substrate falls off and less product IS formed, since all bound substrate reacts to product m the second chase Thus, the disappearance of product is plotted on a semilogarithmtc plot as a functron of time. The observed rate 1s equal to the rate constant of substrate dissoctatton (k-i). If hydrolysis of substrate is significant durmg the 20 s bmdmg step or during the first chase, there will be a portton of product formed at infinite ttme. This can be corrected for by the same type of correctton used m single-turnover expertments (%Pcorrected = [%P, - %P,)/( 100 - %PJ x 100, where %P, and %P, are the remaining product at any time and infinite ttme, respectively)
3.8. Pulse-Chase
Association
Measurements
If condttions can be established where chemtstry is faster than substrate dtssociation, a pulse-chase experiment can be performed to measure the assoctation rate constant (k,) of strong binding substrates (see Note 15). In thts experiment, it is the pulse time that is varied and the chase time that 1s constant. 1 Prepare a time-course for each reaction that includes a premcubation start time, a pulse start time, a chase time for each time-point taken (&lx time points are suggested), and a stop time 2-3 minutes later The observed rate will be the sum of the assoctation rate (ki[E]) and the dtssoctatton rate constant (k,). Time-points should be distributed over the first three half-lives of the reactton, as described m Section 3.1 2 Prepare and number reaction, chase, and stop mtcrofuge tubes. Ahquot 9 pL of stop buffer mto each stop tube. Make chase soluttons of 24 pL of 5X reaction buffer, pH 7 0,6 pL of 20 w CCCUCU (220 x [El) or 11.6 pL of 8 6 mA4G and water to 120 pL final volume. 3. To each reaction tube, add 4 uL of 5X reaction buffer, pH 7 0,2 pL of 30-l 00 w ribozyme, and 12 pL of water 4. Begin time-courses by preincubatmg each mixture at 50°C as its start time occurs After the 20 mm premcubatton, reactions are mtttated with 2 pL of -20,000 cpm 32P-CCCUCUA (~1 nA4), mtxmg rapidly using a Ptpetman. 5. Ahquots (2 pL) are then taken out of the pulse reaction tube and raptdly mixed mto a chase tube at each designated time-point. After 2 mm of reaction m each chase tube, an ahquot (3 pL) is removed, added to the stop tube, and placed on Ice 6 Follow steps 7 and 8 of Section 3 1 Since the observed rate constant is the sum of the on and off rates (kobs= k, [E] + k,), the dtssoctatton rate constant must be measured m an independent experiment (see Secttons 3 6 and 3.7.).
4. Notes 1. Because of the fast reaction of the Tetrahymena ribozyme, 5 pA4 G 1sthe maxtmum convenient concentration under these conditions
Rlbozyme Kinetics 2 Estimating
3 4
5
6
7
8
9
10. 11
12
13
207
the rate of a reaction or its half-life (/cobs= 0 693/t,,,) is difficult without prior knowledge of the reaction rate. An mmal test is suggested with a few concentrations m the range one expects to use and with a broader range of time-points Because of a 20 mm premcubation time followed by fast time-points, it is best to stagger the start times of each reaction such that time-pomts can be conveniently taken. For best results, concentrations should be measured accurately, and ahquots made with a well-maintained Pipetman Taking ahquots for time-points may be done with a less accurate Pipetman Controls for this experiment are to vary [E] over the range of G concentrations used to show that [E] does not affect the rate Controls showing an effect on the rate by varying pH or by using substrate containing a phosphorothioate substrate provide evidence that the chemical step is rate-llmitmg (8-10). Because the rate of chemistry (k,) is faster than the rate of dissociation (k,) for CCCUCUA, K,,, (-4 CUM)is much higher than Kd (5 nM). Ribozyme concentrations above Kd are allowable m this case provided a high (21 mA4) G concentration is used (see Section 4. of Chapter 21) Vary [G] and [S] to show that these do not affect the reaction rate If changing the [S] affects the rate, mcrease the ratio of [E] to [S]. If changing the [G] affects the rate, then Increase the [G], tfposstble. An exceptron to these controls 1s If the rate of chemistry is slow compared to substrate dissociation (see Section 3 of Chapter 2 1). Ideally concentrations should go up to 10X K,,,. It is necessary that concentrations reach 4X K,,, such that sufficrent saturation is seen. Failure to observe saturation means that higher concentrations are required to determine Km. The inability to measure the rate at higher concentratrons means that K,” cannot be determmed under the conditions used. Ribozyme is incubated separately from the rest of the reactton components, so that the rrbozyme starts in the same initial state under all conditions. Whenever possible, the concentrations that need the most accurate measurements should be added to the reaction tube before premcubatron, and the essentral component whose exact concentration matters less is then added to mitiate the reaction. After 16 min, it may be necessary to mrcrofkge the ribozyme tube for 10 s to pull down evaporated water There exist several computer programs capable of least-squares fitting of data to equations This approach IS more rigorous than traditional inverse plots (I I), and avoids the error of trying to determine Km wtthout havmg reached saturation or without enough data below Km When one changes the conditions (pH, [G], temperature, substrate identity) to affect the rate of chemtstry, there IS no guarantee that this ~111 also affect the bmdmg constant